{"queries": {"437e2817-a8eb-4999-ba2d-bad745c8c41d": "How does the use of MRI in the acute phase impact the outcome and prognostic value for patients with diffuse axonal injury, as discussed in the article by Paterakis et al. (2000)?", "0a354d69-e6b2-4658-be91-252df509e03a": "Discuss the significance and potential benefits of decompressive bifrontal craniectomy in the treatment of severe refractory posttraumatic cerebral edema, as outlined in the study by Polin et al. (1997).", "ee0947a8-082f-4fb2-b4d8-8f77eef7e976": "What are the characteristic imaging findings of cerebral involvement in toxoplasmosis, and how do they differ from other cerebral infections?", "acee5ca4-ab70-4c54-b0ac-c467d105cbf8": "Describe the pathogenesis of toxoplasmosis, including how humans become infected and the progression of the disease in immunocompetent and immunocompromised individuals.", "6d6a3a1b-1fc5-4e24-a904-035336ca8f6d": "How do CT and MRI imaging techniques complement each other in the pre-placement evaluation of cochlear implants?", "25b5f145-ef43-4dc0-80f5-6a55636b7a4d": "Describe the characteristics of Incomplete Partition Type II or Mondini's malformation as seen in the CT images of temporal bones.", "cf472d58-6854-48b4-86aa-4076cd546259": "How can PET-CT be superior in identifying patients with occult metastases and unresectable tumors, and how is it useful in distinguishing malignancy from other benign processes?", "57d8b6be-6e95-462d-8287-95722fe45694": "Describe the characteristics of apical pleural caps as seen on chest radiographs, including their appearance, thickness, and prevalence in patients over the age of 45.", "3761b8b5-e256-49c7-b96b-b1a3e7854a7f": "What are the clinical implications of frontal sinus anatomy and physiology, as discussed in McLaughlin et al. (2001)?", "0263d73a-7368-4785-bc23-26e0ebd087db": "How do CT and MR findings aid in the diagnosis of fungal diseases of the paranasal sinuses, as described by Mahmud et al. (2013)?", "53b1d552-4fe9-4663-86fe-12ebfeb1babd": "What are some common intrapituitary focal abnormalities that can be identified on MRI scans of asymptomatic individuals?", "7ec446ec-3e2e-4fbb-b0a0-2e3a72f36ed8": "How is a macroadenoma of the pituitary gland defined, and what distinguishes it from other pituitary abnormalities mentioned in the text?", "df9cff71-86e0-4e43-b93b-7cb29ee2f9a3": "What imaging characteristics are typical of cartilaginous lesions, and how do they differ from vascular lesions?", "bb5e31b2-287a-4df3-b58e-92ba58275247": "Describe the three types of cysts that can arise within or in intimate association with the larynx, and explain the differences between them.", "423c6a2a-287e-4dd9-b390-a1274ff54d2f": "How are motor tasks typically designed for task-based fMRI examinations, and why are they preferred in terms of ease of performance and robust results?", "9b12663a-5202-40e1-aeea-ed9e2df2688d": "Can you provide examples of common sensorimotor tasks used in fMRI examinations, and explain how they elicit activation in specific areas of the brain related to motor function?", "1330230f-09f0-45b7-bf5e-5f51decc12fb": "In the study by Hooper et al., what was the purpose of using computed tomographic scanning in the initial staging of bronchogenic carcinoma?", "f969d48c-c9ea-4475-b441-4ac369e0b101": "According to the International Agency for Research on Cancer, what is the relationship between tobacco smoke and lung cancer as discussed in Monograph 83?", "f94747c6-d77c-4970-9d83-af0868810753": "How does proton MRS help in accurately distinguishing between brain abscesses and cystic tumors, according to the information provided?", "fb02cc36-9158-4fc5-8265-409f1cb382b1": "What specific metabolites and signals were observed in patients with neurocysticercosis, and how do these findings differ from those seen in brain neoplasms, as mentioned in the document?", "dc149985-0fa0-4427-9dec-1f0aee0561a5": "How do radicular arteriovenous fistulae differ from dural arteriovenous shunts in terms of their location within the spinal cord?", "5bb3fd0c-04e9-4a62-802d-d85ea187f4e1": "What are the typical clinical manifestations of paravertebral arteriovenous fistulae (PVAVFs) and in which demographic group are these lesions more commonly found?", "c4380032-00ef-4a5e-84a2-280b3b724d75": "How can traumatic pseudoaneurysms be visualized on imaging studies, and why might they be missed on certain modalities?", "0224721d-814f-4815-957a-4f591edd8139": "Describe the findings on the catheter cerebral angiogram that led to the diagnosis of a traumatic right anterior choroidal pseudoaneurysm in the case presented.", "d3f2f48a-4cb4-47da-956a-4ef42f8ae0ce": "What are some potential complications associated with a displaced bronchus, and how might they manifest in patients?", "10721628-a586-4796-8106-b4692b410d59": "Describe the characteristics and clinical implications of a supernumerary bronchus known as the cardiac bronchus.", "00eac5b1-80f5-4f74-8e6f-b904e504ef6b": "How do schwannomas typically appear on noncontrast CT scans and T1-weighted MRI scans, and what characteristic feature distinguishes them from paragangliomas?", "226946b5-00e8-4344-a011-2a26637b93a4": "Describe the imaging characteristics of schwannomas on dynamic scans and explain how these scans can help differentiate schwannomas from hypervascular lesions in the poststyloid compartment.", "d3cb2f5a-14bc-4a25-926b-796c41d3a370": "How can MRI be used in the evaluation of complications such as chyle leak following pneumonectomy?", "529ee77a-14e3-480b-a99e-31046371a3d4": "What are the potential complications associated with left-sided pneumonectomy, and how can they be identified and managed postoperatively?", "2ee108d4-1a1b-44b9-9b5e-3cdb232082ca": "What are the common presenting symptoms of neuroblastoma in infants, and why is cervical neuroblastoma considered rare?", "b58980a4-4b50-45f3-a3e1-60b358d294f5": "Describe the prognosis for orbital RMS compared to other types of RMS, and explain the factors contributing to the poor survival rate in RMS due to invasion of the skull base.", "308b0039-1fcb-49d9-96e1-d9105fba2b48": "Identify the major structures located within the occipital triangle and explain their significance in relation to the posterior triangle of the neck.", "32717a0c-7ebf-4b44-9d24-193690d7130e": "How does the inferior belly of the omohyoid muscle divide the posterior triangle into two unequal parts, and what structures are located within the subclavian triangle as a result?", "8d8ddd51-50fb-4dc7-aaa6-118fae891150": "What are the different types of thymic carcinomas discussed in the document, and what are their clinicopathological characteristics?", "ca415049-2bfc-46c8-82b0-7a7105db43f7": "How do different imaging modalities, such as radionuclide, computed tomographic, sonographic, and magnetic resonance imaging, contribute to the localization of parathyroid tumors according to the document?", "ad083f5e-57e6-4ae8-ac2d-64992243770a": "How do DWI alterations in sCJD relate to the severity of the clinical course, and what impact do hypointensities in the cortex and basal ganglia have on the disease progression?", "c05f8e5c-8037-4cea-919e-e7a466ca2726": "According to the UCSF MRI criteria, what are the four MRI features that can help differentiate sCJD from nonprion diagnoses, and why is DWI signal changes considered to have higher sensitivity and specificity compared to other biomarkers like CSF 14-3-3 protein?", "c528b41c-0598-4a63-a20c-f6e6345761c8": "What are some differential diagnoses for extramedullary hematopoiesis (EMH) secondary to myelofibrosis, and how do they differ in terms of imaging characteristics?", "c779ab41-5f39-48f1-baf0-c802f49ad589": "What are the treatment options for complications of EMH, particularly in cases of spinal cord compression, and how do they vary depending on the severity of the disease?", "ce2e1fbe-7847-4adf-b494-0d49625000eb": "How can MRI using chemical shift analysis and dynamic gadolinium enhancement be used to determine whether an adrenal mass is benign?", "6f65fe24-7c5d-4e79-a122-39703712d7b4": "In what scenario is FDG PET particularly advocated for distinguishing between benign and malignant adrenal masses detected on CT, and what are the implications for further evaluation and potential surgery in patients with NSCLC and an adrenal mass with increased FDG uptake?", "8f8e21ec-b895-43d1-b854-1e502158d623": "Explain the differences between treatment-related necrosis of the brain after radiation therapy and chemotherapy-induced necrosis, as discussed in the article by Kumar et al. (2000).", "641430e1-2d7a-4a83-bdc0-47833b571901": "Describe the characteristic contrast enhancement of white matter in treatment-related disseminated necrotizing leukoencephalopathy, as reported by Laxmi et al. (1996).", "ee265b35-7eea-4c5b-ac35-9699676943bd": "How does the bipolar gradient affect static tissue versus tissue with measurable velocity in the context of 2D cine-PC MRA with through-plane velocity encoding for assessment of aortic flow?", "70687531-fd2a-40dd-8bce-9db001599fad": "In the context of the data acquisition process for 2D cine-PC MRA with through-plane velocity encoding, how are instantaneous flow measurements over the cardiac cycle generated and what information do they provide about the ascending and descending aorta?", "ec853d42-3642-4da8-950e-66e6dd639522": "How can small metastases in the diplo\u00eb or dura be best detected using MRI imaging techniques?", "97b36390-811e-4771-be66-9b9fe0389adf": "Describe the differences in appearance between epidural or dural metastasis and meningioma on T2-weighted MRI images.", "8e5995ce-95b1-44e3-8ecd-51790e7a82a7": "How does compliance with AAPM Practice Guideline 1a impact CT protocol management and review in a university hospital setting, as discussed in Szczykutowicz et al's study?", "479c7680-177d-4bec-a015-68244b21d1a5": "In what ways did Udayasankar et al's study on low-dose nonenhanced head CT protocols for children with ventriculoperitoneal shunts demonstrate a balance between reducing radiation exposure and maintaining image quality?", "2d790da8-aa84-431f-a5be-00c8aba4328d": "How can volume-rendered 3D CT images be utilized in patient education and surgical planning?", "2f14a8fa-a779-443c-af88-cf6edf104ac2": "What is the significance of DCE \"perfusion\" CT in evaluating micro vascularity of tumors before and after treatment?", "57523150-3b82-432d-bda1-c8cd615e92fe": "How does HRCT compare to conventional thick-section CT and chest radiography in terms of sensitivity for detecting and characterizing interstitial lung disease (ILD)?", "31b7b901-f926-410a-8dba-ecff7138db39": "Explain the significance of lung attenuation in CT scans and how it is expressed in terms of Hounsfield units (HU).", "7a0a45bc-1068-4798-bdd5-0ef2e074ea1c": "Explain the concept of k-space in MRI and how it is related to phase-encoding gradients. Provide examples of how gradients are used to traverse through k-space.", "5aa13a81-c60d-4d1e-a220-e475310c94d2": "Describe the process of phase-encoding in MRI and how it affects the phase of spins in different locations. How are different phase-encoding lines collected using gradients with varying strengths?", "2da5e234-4537-480b-a9ed-2ab1cf4105b6": "How does functional MRI utilize cortical blood flow changes to create activation maps, and what are some of the potential artifacts that may be demonstrated in the imaging process?", "0589b771-de76-4c52-83f7-0cdf599a63eb": "Why is MRI crucial for localizing arteriovenous malformations (AVMs) in relation to eloquent cortex or deep gray matter structures, and what specific characteristics can be evaluated in adjacent brain parenchyma using MRI?", "eb2bcfda-9358-41d8-a636-3891aff11341": "What are the diagnostic findings of cylindrical bronchiectasis on thin-section CT imaging, as discussed in the document?", "01edf6d9-5605-4764-8a90-ee1abc74a42e": "Describe the role of radiation therapy and chemotherapy in the management of airway tumors other than small-cell carcinoma and non-small-cell carcinoma, as outlined in the text.", "58d54bdb-3c4a-4315-aff7-9c6508100f12": "What are the primary differential diagnoses for congenital cervical teratomas, and how can fetal MRI be helpful in distinguishing them?", "0029cb99-3173-4daa-8d05-f3098e2a3580": "Describe the imaging characteristics of cervical teratomas on CT and MRI, including their size, composition, presence of calcifications, and signal intensity on different sequences.", "a0ffe8d5-10bf-426e-bf53-b0baa21f97db": "Identify and describe the structures labeled as piriform sinus (PS) and aryepiglottic fold (*) in the axial postcontrast CT image. How do these structures relate to each other anatomically?", "b51f52ea-acf5-445c-ae29-03142e719d37": "On the axial postcontrast T1-weighted image, what structures are indicated by the white arrows and black arrows? How do these structures contribute to the delineation of the postcricoid region?", "5384ce97-9bd2-483c-9375-ac8cfddeffbb": "Describe the imaging findings in the case of a DVA associated with a neuronal migration anomaly as shown in the provided MRI images.", "e468296d-1884-42ab-9278-6d6c107ce1c3": "How can cerebral angiography be used to confirm the presence of a DVA in patients with neuronal migration anomalies, as illustrated in the case presented in the document?", "c1504d9a-6759-4a4b-8706-d76d73df1b72": "How does direct tumor invasion differ from diffuse invasion in terms of muscle bulk and signal intensity?", "cbe12245-19ec-48ae-a920-980249d8e941": "According to the American Joint Committee on Cancer Staging Manual, what are the criteria for TNM staging of nasopharyngeal carcinoma (NPC)?", "0c167741-bacc-4cce-98f8-29460a72d4dd": "What are the radiographic and CT findings in patients with mucoepidermoid carcinoma of the tracheobronchial tree, as described in the document?", "af3a5aba-0508-49d7-8076-2c8db5e9cc14": "Describe the complications associated with cystic intrathoracic derivatives of the foregut, as discussed in the document.", "9d1814fa-dee8-41ef-9dfd-490833a0862a": "What are some examples of benign lesions that can arise from the mucosa of the larynx, and why are they rarely evaluated by CT or MRI studies?", "782778d0-77cc-444c-b00e-8b2c91842538": "Describe the characteristics of verrucous carcinoma and explain why it is considered a slow-growing variant of squamous cell carcinoma.", "d11eb348-ecb4-4847-8f8d-c85dfdcc5ea1": "How does MDCT differ from single-detector-row scanners in terms of image acquisition and resolution?", "79c5c457-bfa2-490a-9e37-14e00ad381dd": "How does the use of MDCT improve diagnostic evaluation of the bronchi and vessels, as well as visualization of parenchymal processes?", "c54b2b1a-fb52-4213-9c5e-224c59c72648": "Explain the development of the branchial apparatus and its components in the face and neck region during gestation. How do the branchial arches, ectodermal clefts, and endodermally derived pharyngeal pouches contribute to the formation of facial structures?", "c6e6f9d0-9f95-4cb8-8568-59d43a3b8a41": "Discuss the formation of the cervical sinus of His and its relationship to the growth of the branchial arches. How does the disappearance of the branchial apparatus typically occur between the fourth and sixth weeks of life, and what factors contribute to this process?", "f69ad2c4-7bed-4e84-9f3e-0ddc649e1657": "What are the characteristic imaging findings of Modic Type I changes in the vertebral end plates?", "8ddcd7af-18d3-4de3-a96c-40ec31391a4f": "How do patients with Modic Type I changes differ in terms of inflammatory markers and degenerative changes compared to patients with normal end plates or Modic Type II changes?", "8913ac30-79ad-45a7-894c-66b46c346de1": "What are the potential complications associated with vein of Galen malformations, and how do they vary based on the age of the patient at presentation?", "3108575e-39ca-49c5-a1a6-2cdd880e8e6a": "Describe the imaging findings and classification of a dural arteriovenous fistula (AVF) involving the right sigmoid sinus as shown in the lateral right external carotid angiogram.", "a35d7e1b-86ee-44f6-ab92-d7a165f50d08": "Describe the histologic characteristics of squamous cell carcinoma in the context of lung cancer.", "e44a027c-8b22-4b26-bae3-3b4dc90f9ee3": "How is non-small cell lung carcinoma further subdivided based on histologic types, and what are some features of NSCLCs with neuroendocrine differentiation?", "440ec75b-1c68-4883-b469-ff2e4c44dfe3": "How does pre-existing spinal stenosis play a role in sudden quadriplegia after minor trauma, as discussed in the study by Firooznia et al. (1985)?", "3c778985-d5e0-486d-9157-07dab5a17f11": "According to the research by Flanders et al. (1999), what is the relationship between the functional abilities of patients with cervical spinal cord injury and the severity of damage revealed by MR imaging?", "c1867c38-7097-44f7-ad8b-599335dc64ee": "In the study by Zamora et al. (1989), what were the key findings regarding diffuse alveolar hemorrhage and systemic lupus erythematosus? Discuss the clinical presentation, histology, survival, and outcome mentioned in the study.", "452c109e-55c3-4a51-ab86-41eaa3107ae1": "How did Zwirewich et al. (1991) contribute to the field of radiology with their research on low-dose high-resolution CT of lung parenchyma? Discuss the significance of their findings and how it impacted the quality of imaging in thoracic radiology.", "30822c89-6591-448e-bbbe-0f5a351a3219": "In an emergency setting, what are some unique challenges that may arise when performing a CT scan on a patient who arrives unconscious and unable to move?", "307f7e6b-c32e-4ebc-8ed5-5b3ddac7a07f": "Describe a scenario where a patient may be brought directly to a CT scanner in the emergency department following a traumatic event. What areas of the body would a typical trauma CT protocol cover in this situation?", "43c85611-2175-48cd-801e-3f5404641dd2": "What are the clinical and radiologic findings associated with complete labyrinthine aplasia, as discussed in the literature review by Ozgen et al. in 2009?", "6d6e5dd5-4374-4f31-a7f8-5f0754a47bf9": "Describe the classification and findings of lesions of the petrous apex as outlined in the study by Razek and Huang in 2012.", "76ccbb28-2a6a-4a25-8da1-96bbb28f2ea1": "What are the key characteristics of intracranial aneurysms in patients with familial subarachnoid hemorrhage, as discussed in the document?", "a12fa070-9f8f-4d8e-98da-4107c1651d9b": "How do physical factors affect cerebral aneurysm pathophysiology, according to the information provided in the document?", "4a01716a-b04e-4cb6-8fb8-809ddebb0d85": "What are the key findings and recommendations outlined in the BTS guidelines for the management of pleural infection as discussed in the article by Davies et al. (2003)?", "287af466-d68c-48ff-9311-26d5e33a1897": "How does thoracoscopy talc poudrage compare to other treatment options for pleural effusions based on the 15-year experience reported by de Campos et al. (2001)?", "9c08c88e-6e20-42e1-a910-9bd91b51e15e": "What are some of the severe damages that can occur in the first and second trimester infections in the context of brain infections?", "bcbe033d-b636-4313-8335-49bd52d73418": "What are the major causes of septic emboli to the brain, and what complications can arise from infective endocarditis caused by Staphylococcus aureus?", "ce5804a8-ab46-4bca-a9ef-22eb790fe93f": "What are the different computed tomography post-processing modalities compared in the study by Mehanna et al, and how do they contribute to the assessment of various middle ear disorders?", "9dc40129-2d89-428d-b016-75c3e6f6c7f2": "In the study by Moody et al, what staging system was evaluated for squamous cell carcinoma of the external auditory canal, and what were the key findings regarding the evaluation of this system?", "e380ff90-122f-4098-ae4a-761bdafc4088": "What are the differential diagnoses for interstitial lung disease (ILD) in patients with progressive systemic sclerosis?", "0b768e43-116f-425b-b635-2fb7f7694e9c": "Describe the HRCT findings associated with interstitial fibrosis, including specific abnormalities and their distribution in the lungs.", "ca781d30-993b-4e95-b05c-0e12a4ef3922": "What are the diagnostic criteria for vascular dementia according to the report of the NINDS-AIREN International Workshop in Neurology in 1993?", "8e10d124-9bde-429a-96f8-21734593a746": "How do patterns of brain atrophy differ in frontotemporal dementia and semantic dementia, as discussed in the study by Rosen et al. in Neurology in 2002?", "fc5d1c0e-b489-4f9e-bf9e-384d9d387af4": "Identify and describe the anatomical structures visible in the images labeled D, E, G, and H. How do these structures relate to each other in the temporal bone?", "3d4fb961-8edd-40bd-8c54-f8a0887a92b4": "Explain the significance of the incudostapedial joint (I-S joint) in the auditory system. How does the location of the oval window and round window niche play a role in hearing function?", "1871aa63-93b1-4ef9-8c8e-af83a79ba91b": "How are teratomas classified and what is their biological behavior?", "adb3296b-8773-4cd3-a2b0-2d59fe16f5ea": "What are the common locations for teratomas in the head and neck region in the pediatric population?", "ebab8918-bdc6-4ce8-8166-dcb7e0d220da": "How are basal encephaloceles classified based on the point at which the skull defect and hernia emerge externally?", "3eb72860-04a6-432f-b5f9-692517650d77": "Describe the complications that can occur depending on the size of the mass in basal encephaloceles, providing examples of potential issues that may arise.", "e854b1d1-2e12-46b1-bace-2a629ff65326": "How does the tearing of cortical veins contribute to the occurrence of subdural hematomas (SDHs), and what other types of hemorrhagic lesions can result from lateral blows?", "6f8cae9d-8f22-4524-b867-ee3a48d7b6fd": "Explain the importance of understanding the anatomy of fluid spaces and the relationship of meningeal layers to the brain surface and inner table of the skull in identifying different extracranial hemorrhagic lesions.", "6aae37e3-2f3a-41d5-b319-9d9143a022eb": "How can a torn or avulsed lower epiglottis be seen, particularly with horizontal fractures, and why may this abnormality not be detectable by CT scans?", "f1a40edb-5c07-48b7-bbfe-d2a5e9d48a27": "Describe the characteristics of a cricoid fracture and how it differs from fractures of the arytenoid cartilage and cricoarytenoid joint.", "6f00dcd7-b8c5-4d47-84d1-698e554ae792": "Describe the different types of branchial cleft cysts and their locations in the head and neck area.", "653d5c88-ad20-4c56-87df-c63f92014e57": "How does a second branchial cleft cyst typically present, and what imaging modalities would be most effective in demonstrating an infected cyst with a tract?", "2bf23d96-48eb-4fe7-80e4-88e8fb2fb281": "Explain the importance of motion compensation techniques in fast imaging sequences for DCE-MRI, citing specific examples such as the golden-angle radial sequence with self-gating. How does this technique help in overcoming motion problems in imaging lung and liver lesions?", "25d7ad62-9942-4aea-b52f-93aeac0c9441": "Describe the differences between DCE-MRI and DSC-MRI in terms of perfusion quantification methods and the types of MR images acquired. Why is DSC-MRI primarily restricted to brain imaging, and what kinetic parameters can be calculated using this technique?", "bde1516f-5b0e-46b8-b06e-de838d039380": "In the study by Azad et al., what was the impact of 18F-FDG-PET on the management and prognostic stratification of newly diagnosed small cell lung cancer?", "f2191c3f-ec69-426c-b6fb-1d53bd9276d3": "According to Bailey-Wilson et al., where does a major lung cancer susceptibility locus map to on the chromosome?", "c51e07a4-f571-4f6e-ba57-818d272a1e7c": "How can imaging techniques such as CT, myelography, and MRI be used to diagnose and study sacral perineural cysts?", "515ff027-93bb-4302-9e35-7b4d08efb2f1": "What is the significance of the term \"syringomyelia\" and how was it first suggested as a name for cystic cavitations of the spinal cord?", "1e9a9184-07f4-4ea1-a3b6-a0b0c929c3d7": "How does the use of post-Gd fat-suppressed images help in distinguishing between the enhancing mass and the nonenhancing left optic nerve in the MRI study of optic glioma?", "1ad9ffcd-a210-4e7f-9422-b34783e20ed2": "In the MRI study of optic glioma in a patient with neurofibromatosis, what structures are indicated by the arrows on the axial T1-weighted image?", "733517a7-61db-42a5-84cc-dffb56946bdf": "What are the common characteristics of an osteoma in the maxillofacial region, and why is it often overlooked on imaging studies?", "a5aab921-a30a-40ed-95d8-5a576de359b6": "Describe the appearance and location of odontogenic cysts and tumors that may present as sinus masses, and differentiate between the radicular cyst, dentigerous cyst, and odontogenic keratocyst in terms of their features and locations.", "1800ca21-010e-42d0-93f2-cd97e0639260": "How does the accuracy of CT imaging compare to conventional radiography in predicting the cause of bronchiectasis, as discussed in the document?", "0202b2ab-802e-4643-994f-1e93f7859c96": "Describe the imaging findings and diagnostic accuracy of expiratory thin-section CT in early bronchiolitis obliterans following lung transplantation, as outlined in the document.", "0f30e311-1f11-45ae-bf0b-59a892964e86": "How can perfusion-weighted magnetic resonance imaging be used to differentiate between the recurrence of metastatic brain tumors and radiation necrosis after stereotactic radiosurgery?", "e6cc4d0e-d521-4c52-96fd-6969d576a9b7": "What are the clinical applications of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions?", "a101e2a6-7ba5-48c0-8c9d-df8cd57a23a8": "How can venous varix be best evaluated using CT imaging, and what are the key features that can help differentiate it from other enhancing lesions?", "594f0802-3a51-43ca-9fbf-a2b1f05460b2": "Describe the classification of hemangiomas and the age groups in which cavernous and capillary hemangiomas are commonly seen.", "ad66f3e4-fb42-429d-bf51-88327d069715": "How does double-dosing and triple-dosing of paramagnetic contrast agents impact the detection of parenchymal lesions with MRI?", "4720383a-5e6d-4bfc-b0fe-e82472fe6f37": "In the case of Pott's puffy tumor, why was MRI found to be superior to CT in detecting meningeal disease, and how did this impact the treatment approach for the patient?", "e35df689-5ff5-4b20-8e3c-a0aa269f788d": "In the field of oncology, what imaging techniques have been used for the assessment and staging of nasopharyngeal carcinoma according to the references provided?", "96a6c5ff-f2de-4115-a280-4c9a514c1471": "How have post-treatment imaging appearances in head and neck cancer patients been described in the literature, as discussed in the document?", "67359451-6dbf-49d7-ace4-a21193a30ab8": "What are the key imaging findings of granulomatosis as discussed in the article by Provenzale and Allen?", "f2799f86-a33a-4949-8cf6-5162a6c91070": "How has mortality from brain abscesses changed since the introduction of computerized tomography, according to the study by Rosenbaum et al.?", "8099b542-ad7b-4586-bf59-8ac74c0ca105": "How can tumor differentiation from muscle at the true vocal fold level be challenging, and what imaging techniques can be used to address this challenge?", "aadeb000-3e30-4a96-b06c-bd1d131b3e61": "Describe the potential implications of anterior growth from a supraglottic carcinoma into the preepiglottic space in terms of lymphatic drainage and nodal metastases.", "75820e94-a8b4-4a59-9bc4-1d26a3a2d73f": "What are the imaging characteristics of a dermoid cyst in the neck, and how do they differ from thyroglossal duct cysts?", "084adbc9-5a1e-4f44-829a-0ea6104a53be": "How can sectional imaging help differentiate between a deep neck abscess and other inflammatory masses in the neck?", "1a71b04c-2853-4e42-ad8c-e91bf2a0a240": "What are the potential sites for metastatic disease in chordomas, and what percentage of cases present with metastasis at initial presentation versus in advanced-stage chordomas?", "fdb28673-735e-49d7-8391-bb88fecde3f7": "Describe the pathophysiology of chordomas, including the origin of these tumors and the histologic variants they can present with.", "ea7268dd-843d-4131-84b5-2a0d3029d711": "How do chondrosarcomas typically present on radiographs, and what are some key imaging features that can help differentiate them from other tumors?", "6ecabd31-7db6-4431-b86b-2c7e5e338aa5": "What are the histologic subtypes of chondrosarcomas, and which subtype is most common?", "9c4f3524-e7bf-44a9-a17d-0be94378021c": "How does subsecond spiral data acquisition improve the performance of clinical applications such as CT angiography?", "5f51320e-51ec-45d2-9849-5192e41691e4": "What are the advantages of multidetector-row scanners in terms of coverage of anatomy and spatial resolution compared to early scanners with single data acquisition channels?", "1665c9fe-637d-4243-8093-25bfd352e01c": "How do malignant tumors of nerve sheath origin typically manifest on CT or MRI scans?", "5258b428-54b7-4dc1-bbe8-a72740d17fe8": "What are some findings that suggest malignancy in neurogenic tumors, according to the context information provided?", "7b2c6812-2331-4784-a4bc-897833b09c1d": "How can performing MRI after administration of paramagnetic contrast medium help prevent delays in diagnosing suspected aseptic meningitis?", "ede214e5-b2a9-44cb-8228-66af918c8684": "What imaging features are seen in patients with noninfectious granulomatous diseases like sarcoidosis and Wegener's granulomatosis, as described in the context information?", "cd6e5531-09dd-46bf-bf2f-bbffd008c150": "Describe the imaging findings of the lipoblastic meningioma on both T1-weighted and T2-weighted MRIs. How does the tumor appear in relation to the adjacent brain parenchyma on these images?", "6c540232-3258-452c-ad93-98da5720e50a": "How does the lipoblastic meningioma appear on post-contrast T1-weighted imaging following IV gadolinium administration? What specific aspect of the tumor does not enhance with gadolinium, and where is the tumor based within the brain?", "09aaf308-67e9-4c9c-b8c5-479ca5dca30c": "How can multiparametric 18F FDG PET/MRI be used to differentiate between progressive/recurrent neoplasm and radiation change in patients with glioblastoma?", "d4cae546-3d56-4388-90c0-2157bf398c5e": "Describe the imaging findings on DSC MR perfusion rCBV map and DCE T1-weighted MRI Ktrans map that are suggestive of recurrent/progressive glioblastoma in the case presented.", "8be8bbb4-0ea5-4d4a-a290-85ca4b3da3b2": "In the study by Maas et al. (2005), what was the focus of the research regarding traumatic brain injury and computed tomographic characteristics?", "dd1bb19a-6da5-4aed-b660-74aae5bd2e59": "According to the research by Marquez de la Plata et al. (2011), what were the diffusion tensor imaging biomarkers used for analyzing traumatic axonal injury, and how were they evaluated?", "01552ec6-9229-4b92-a5f7-f293832568a9": "What are the key components of the TOAST classification system for acute ischemic stroke, as outlined in the reference by Adams et al. (1993)?", "86919d91-b78c-41fb-a980-d5e6c7794559": "How does diffusion-weighted imaging compare to conventional and contrast-enhanced MR imaging in the evaluation of patients with subacute cerebral ischemia, as discussed in the reference by Augustin et al. (2000)?", "2b96398b-2033-4602-a133-fdbbb747d951": "What are the common sites of involvement for intracranial schwannomas and how do they differ in presentation?", "cf37962d-03e2-4b93-98cc-ca5fd4f1f839": "Describe the clinical presentation of vestibular schwannoma (acoustic neuroma) and discuss the age and sex predilections associated with this type of tumor.", "8cbd2180-08e5-4b03-b0fc-6f7b45763cf2": "How can dual-energy and spectral CT capabilities be utilized in medical imaging, and what are some of the potential applications for these technologies?", "4363d9cb-22cc-42a1-ab08-e714a4d336a9": "How does automated tube current modulation (ATCM) address the challenge of optimizing scanning parameters in real-time to minimize radiation exposure while maintaining diagnostic image quality?", "58ceb508-5f63-4302-b5f3-18160d2c7c73": "How does accurate delineation of target volume with MRI and PET/CT contribute to the delivery of radiation therapy and improve local control and disease-specific survival in patients with nasopharyngeal carcinoma?", "90acb76c-67aa-4dab-903e-c026206df110": "According to the NCCN guidelines, when is a baseline scan recommended for patients with T3-4 and/or N2-3 disease after completion of chemoradiation, and what further imaging is recommended based on signs/symptoms?", "97e80391-c578-408c-ac2c-7a141551b12c": "How did Stadlbauer et al. use DTI to correlate changes in FA and MD with the degree of tumor cell infiltration in glioma patients?", "c55c7d22-502e-483b-b3b0-e925b2f2d948": "What were the findings regarding the correlation between FA and MD values with percent tumor infiltration in the study by Stadlbauer et al.?", "6e3ad3bf-0d3d-4654-9335-2e4ac2437dd5": "How can contrast enhancement aid in the visualization of vascular pathology in patients with carotid cavernous fistulas?", "398a0e89-ade6-4a6e-8f9e-ab6712677558": "Why are MRI and MRA notorious for missing uncomplicated dural arteriovenous fistulas, and what imaging findings may help in their detection?", "cc0022ac-5656-4c66-9b38-86cf4810bb6b": "What are the three subtypes of Frontotemporal Lobar Degeneration (FTLD) and what percentage of cases do they represent at postmortem examination?", "bb6fc49a-47e6-4537-85ee-4d781d1016c7": "How is probable behavioral variant Frontotemporal Dementia (bvFTD) diagnosed according to the revised diagnostic criteria, and what neuroimaging findings are typically seen in patients with this diagnosis?", "abe646d7-c5bb-42c5-8cc9-b0f06692bf76": "How does PET with the radiotracer 18F-fluorodeoxyglucose complement CT and MRI in the evaluation of pleural and chest wall malignancies?", "b7c898b5-e309-4035-b55b-de256b101183": "In what ways is integrated PET-CT superior to PET and CT alone in the diagnosis and staging of thoracic malignancies, according to the provided information?", "bc4307f9-fa5f-4177-8e9b-17e237b72110": "Explain the significance of high-dose gadolinium-enhanced MRI for the diagnosis of meningeal metastasis, as discussed in the document.", "42b2bd9d-eccd-4674-a606-706df9dcace6": "Compare and contrast the imaging techniques and findings in superficial siderosis of the central nervous system and neoplastic meningitis, as described in the document.", "8780cca4-857e-4532-b7eb-7b7d901f0cfb": "How does CT imaging play a role in the diagnostic evaluation of tumors with presumed bone destruction, and what are the advantages of using CT in this scenario?", "4d32952e-a103-44c6-8f8d-b8f694803ee7": "Describe the role of ultrasound in the follow-up of nodal masses in the pediatric population, and discuss the differences in the primary imaging modality used for diagnosing and staging neck masses in developed countries.", "c131011a-832e-4bc5-a592-fc4659db6199": "How does the newer condensed classification system for arteriovenous malformations (AVMs) differ from the previous system, and what grades are combined in this new system?", "438c2a8a-df87-4826-8544-410d869ba0b8": "In imaging evaluation of cerebral AVMs, what are the key differences in findings between computed tomography (CT) and magnetic resonance imaging (MRI)?", "363e0705-e23d-4e3a-8310-7fc78593d143": "Describe the role and location of the thyroarytenoid muscle in the larynx, and explain its significance in imaging studies.", "21fbb8f0-5eb0-4410-8e46-b1ca51e24cab": "Discuss the structure and function of the cricothyroid and thyrohyoid membranes in relation to the outer limits of the larynx, highlighting any notable features mentioned in the text.", "860783b6-dc28-4a99-bbfd-3f587d56ffba": "How are larger cerebral aneurysms typically identified on imaging, and what characteristics are commonly associated with giant aneurysms?", "3a12864d-831e-4beb-ab89-de6f725763c2": "How can CT scans be utilized to identify skull base erosion caused by large or giant aneurysms, and what specific imaging features should be looked for in these cases?", "78de0b40-0932-42f6-a08a-618a72ce0082": "What are the typical characteristics of schwannomas, and how do they differ from neurofibromas in terms of degeneration and biopsy procedure?", "aea639a0-f180-4a35-991f-81dba3d5dd90": "Describe the imaging characteristics of schwannomas on CT scans, including their appearance, attenuation to muscle, and enhancement patterns.", "f2cad2e0-b847-47f2-9d2a-41b0e8f7a552": "What are the potential implications of elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients, as discussed in the document?", "331c02bc-eede-45fb-9b02-5c455094b66f": "How does the use of diffusion-weighted imaging and in vivo proton magnetic resonance spectroscopy aid in the differential diagnosis of ring-enhancing intracranial cystic mass lesions, as mentioned in the context information?", "2f2f0426-8c7e-4043-9737-b1ebead69fd2": "In the study comparing 18F-FDG and 11C-methionine PET in suspected recurrence of glioma, what were the key findings regarding sensitivity, inter-observer variability, and prognostic value?", "60f32332-50ce-4b82-94e3-edf4c6a50505": "How does proton MR spectroscopy aid in differentiating low-grade gliomas from focal cortical developmental malformations, as discussed in the document?", "33c229e4-a611-4719-8387-2908fb34761f": "What are the histologic compositions of neurofibromas and schwannomas, and how do they differ in terms of malignant degeneration?", "d0dd2efd-2725-4d8a-b63d-69072fe9af49": "Describe the imaging findings of peripheral nerve sheath tumors, including the appearance of solitary neurofibromas and schwannomas on CT imaging.", "118ee611-c005-4ebb-a79d-4837358975a8": "How does diffusion-weighted imaging improve outcome prediction in pediatric traumatic brain injury, according to Galloway et al. (2008)?", "afa017ae-8ef4-4ddd-a0df-c6c29af2dd7b": "What is the value of skull radiography, head computed tomographic scanning, and admission for observation in cases of minor head injury, as discussed by Feuerman et al. (1988)?", "57e1a5c7-15d2-4222-9309-59d38db3ea20": "Describe the imaging findings of lipomyeloschisis as shown in Figure 35-8. What structures are involved and what complications may arise from this condition?", "a00b423a-6a55-4150-acb8-5edae158e395": "Explain the characteristics of a posterior meningocele as depicted in Figure 35-9. What are the key features seen on imaging and how is this condition typically managed?", "349fc4b1-dac0-46c6-b7d4-a49a3dd507fa": "In the study by el-Khoury et al. (1995), what imaging modalities were found to be valuable in the evaluation of acute injuries of the cervical spine?", "1c1c645e-904e-43b7-b227-22a114846a32": "According to Jain (2012), what is the focus of the study on atlantoaxial dislocation in patients?", "78d2c6fc-2179-46b7-a739-571698ea3448": "What are the criteria used to categorize patients into high-risk or low-risk groups for spinal injury evaluation according to the CCR criteria?", "e3e0544f-5d21-4b9d-9a83-d7ebf19235c6": "When should three-view plain radiographs be used as an imaging option for evaluating spinal injuries, as mentioned in the context information?", "dad11013-8a41-47e1-afde-4a6ad61f0152": "How does phase-contrast (PC) MRA differ from TOF MRA in terms of background, susceptibility artifact, and stagnant blood suppression?", "1f1c419a-ac65-4d96-86bf-468859ce44a5": "What are some of the concerns and considerations regarding the use of MRI in patients with cerebral aneurysm clips, as discussed in the provided text?", "4956bd58-a31b-4a47-bcc7-4d21df41741b": "What is the difference between diaphragmatic eventration and diaphragmatic rupture in terms of their causes and presentation?", "c7a40202-9655-4b28-bb68-55dfa696bdd5": "How can pneumoperitoneum be detected on imaging studies, and why is its detection important in clinical practice?", "8f45af82-b272-4faa-ad14-e79b21b50f38": "What are the imaging features of gastric lymphoma and how do they differ from other malignant diagnoses?", "92515f1b-a7cb-4d1e-9732-75ab2985b10d": "How does posttransplant lymphoproliferative disorder (PTLD) differ from Burkitt lymphoma in terms of etiology, presentation, and response to treatment?", "f6ad0aea-4742-451d-be7e-c1f3dd909dc6": "How does nuclear scintigraphy with 99mTc hepatobiliary iminodiacetic acid (HIDA) aid in the diagnosis of acute cholecystitis, and what is the significance of a gallbladder not being observed after 4 hours of injection?", "e265e08d-aa69-43d1-b3ed-cc8008de13a2": "Describe the imaging findings on contrast-enhanced CT and HIDA scan in a patient with acute cholecystitis. How do these findings help in confirming the diagnosis, and what are the potential complications associated with acute cholecystitis?", "93f096b1-01db-4840-a497-daf1c4a3f356": "What are the major risks associated with hepatic hydatid cyst infection, and why is percutaneous aspiration not contraindicated in most cases?", "47f40dc1-bbec-4010-9627-c00cd82d4d33": "Describe the imaging findings associated with hepatic schistosomiasis, including characteristic features such as periportal edema, fibrosis, and calcifications.", "558fec0a-06ed-4be2-9dea-dfc66ce1a7cd": "How does the presence of a fecalith in the appendix contribute to the development of appendicitis, and what imaging modalities can be used to detect it?", "6dd5cd6e-6e99-47cb-86c7-f13d08ac4497": "What are the challenges in diagnosing appendicitis using ultrasound, and why is CT considered the investigation of choice in adults?", "d65db8ef-66a9-4c9b-8dbc-ab283bbf7733": "Describe the imaging findings in the 79-year-old woman with a cirrhotic liver and a segment V HCC. What features were seen on the arterial, PVP, and delayed contrast-enhanced CT scans?", "ca3ddf86-29a9-4aa4-834c-ffe84c758b76": "In the case of the 63-year-old woman with a dysplastic nodule, what imaging characteristics differentiate it from an HCC on the fat-saturated T2-weighted, fat-saturated T1-weighted, and hepatobiliary postcontrast MRI scans?", "32ff2772-22d6-4d88-a8df-a87cc86ee28b": "What are some of the causes of colonic strictures discussed in the text, and how do they differ in terms of presentation and potential complications?", "771a4980-de5b-4a22-8667-2dbd96067bdd": "Describe the pathophysiology and clinical manifestations of scleroderma as it relates to gastrointestinal involvement. How does this condition lead to atonic bowel and dilatation in affected individuals?", "10b1dbf1-57ea-4b7f-af0a-4da13bdbee8d": "What are the key clinical manifestations and characteristics of Crohn's disease, and how does it differ from other gastrointestinal conditions?", "a6500919-de02-40ab-9375-9ad42e320378": "How can Crohn's disease be diagnosed, and what role does imaging play in confirming the diagnosis?", "9c144afe-0d6c-4dc4-b807-59f8f26fe6c5": "How does vasculitis affect the small bowel, and which autoimmune diseases can cause this condition?", "571b2eb9-0c41-4e5f-b1a2-7fce5deabff8": "Describe the imaging findings associated with small bowel varices and how they differ from other causes of intramural small bowel hemorrhage.", "0e3b4c89-50f4-4bfe-9474-80ee01bd157d": "How do fat-suppression techniques enhance the evaluation of disease in anatomical locations with a large amount of normal fat on MRI scans?", "ec10065d-f376-45f4-a57c-8bad0d2dcbc1": "Explain the difference in behavior and excretion of extracellular contrast agents versus hepatobiliary contrast agents in MRI imaging of liver lesions.", "24fa1ca0-d476-4513-8ded-25dfe9c587fe": "Describe the imaging findings seen in a 51-year-old man with amebic liver abscess as shown in Figure 6-154.", "b2aef51f-5f0a-4768-92b3-854e65c64539": "What are the characteristic imaging features of hydatid disease of the liver and spleen, as demonstrated in a 7-year-old boy in Figure 6-155?", "f659d177-26ec-4c48-904d-2b328c244885": "Describe the imaging findings seen in a 73-year-old man with a large, thick-walled loculated hepatic abscess based on the axial contrast-enhanced CT scan provided in Figure 6-147.", "dd61dfae-cb8b-4938-8def-d448c08128ce": "How does the axial contrast-enhanced CT scan in Figure 6-146 help in diagnosing Bartonella infection (cat-scratch disease) of the liver and spleen in a 27-year-old patient?", "cf499f1b-fbba-4711-83f5-60e89d8e5339": "What are the common causes of gastric outlet obstruction, both benign and malignant, as discussed in the text?", "a8ccf678-39f4-451d-aa82-87121638319f": "Describe the characteristics and potential complications associated with gastric bezoars, including different types and their impact on gastric function.", "89f26272-021c-4a48-92b5-5dc9a06b8e23": "How can gastric varices be diagnosed, and what are the common causes of this condition?", "edfe6b2a-ccd2-4b3d-b404-25730996412c": "What are the risk factors associated with gastric carcinoma, and how does gastric atrophy play a role in the development of this malignancy?", "0418248f-55b2-4279-9553-7bf729d354a1": "What are the key differences between epidermolysis bullosa and tylosis in terms of their esophageal manifestations and associated risks?", "92123227-0e71-4a5f-9634-575d3a134fa9": "Describe the characteristic findings of glycogenic acanthosis and ectopic gastric mucosa in the esophagus, and discuss their clinical significance in gastrointestinal imaging.", "109cd728-473b-4eb2-970f-74f8d6aa6e62": "How can the echogenicity of a steatotic liver affect the appearance of hemangiomas on ultrasound imaging compared to normal liver parenchyma?", "955fcbb6-08c2-49c0-bf84-91c1c58ff974": "Why are sclerosing hemangiomas particularly challenging to diagnose, and what imaging features may suggest malignancy, requiring further evaluation such as percutaneous biopsy?", "af1fb6a1-d593-4149-a65a-bd553f8960b7": "How can retroperitoneal fibrosis be differentiated from diffuse retroperitoneal lymphadenopathy on FDG-PET imaging?", "16c60c73-d6b6-4240-ad75-6a2258848a2f": "What are some conditions associated with extramedullary hematopoiesis, and in what locations can hematopoiesis develop in these patients?", "1a25d666-cea1-4ed1-a163-1c995e6f4338": "In the study by Kim J H et al on MR cholangiography in symptomatic gallstones, what was the diagnostic accuracy according to clinical risk group?", "59894219-16ee-4978-becd-1066de1791b1": "In the case presented in Figure 8-81, what imaging modality was used to confirm the perihepatic and peritoneal fluid as biliary in origin in a 67-year-old patient with fever?", "c422b183-f348-4c2a-9fb8-420644438d65": "In the case of the 67-year-old woman with antral linitis plastica from gastric adenocarcinoma, describe the imaging findings seen on the UGI series, axial contrast-enhanced CT, and coronal contrast-enhanced CT.", "8154d88f-b4bc-453a-8973-c5887837f187": "Discuss the imaging findings in the 66-year-old woman with a cardial tumor extending into the lower esophagus and metastatic lymph nodes with uptake on PET. How do these findings differ from the case of the 62-year-old man with mural thickening of the gastric body due to adenocarcinoma?", "4d91f057-5745-4e60-883d-2363b599932e": "How can antispasmodics be useful in the detection of small polyps during a barium enema examination, and what techniques should be employed to increase diagnostic confidence in lesion detection?", "9d707a85-45f1-4820-9670-68b081e33cb2": "What role does computed tomography (CT) play in the evaluation of colonic diseases, and why is it important for radiologists to carefully evaluate the entire colon during CT scans performed for other indications?", "64b77dfb-5ecc-4d16-8738-f79184aed605": "Describe the imaging findings seen in the axial contrast-enhanced CT scan of the 48-year-old woman with metastatic gastric cancer. What features indicate metastasis in this case?", "c033d013-f8de-464c-9f1a-a11b277c6862": "In the axial contrast-enhanced CT scan of the 61-year-old woman with metastatic ovarian cancer, what specific characteristic is mentioned regarding the liver capsule? How does this feature help in the diagnosis of metastatic ovarian cancer?", "34634598-71ae-4492-aca5-bbb2a50b8729": "How can fecal impaction be caused, and what are some common symptoms reported by patients experiencing this condition?", "b652295d-c985-485b-b93e-0c16afab7191": "Describe the imaging findings associated with fecal impaction and stercoral ulceration, and explain how these conditions can be identified on plain radiography and CT scans.", "e7f391b7-fddd-45e7-be7a-19c1116ba271": "What are the typical characteristics of primary appendiceal Crohn disease and how is it usually diagnosed?", "aea77ff1-5585-4fbd-a621-4985fcd8c9f9": "Describe the imaging findings and potential clinical significance of an appendiceal stump identified on barium enema after appendectomy.", "6c01f86a-8a38-4194-b618-5fe3c6896dcc": "How does the context information provided impact the way in which students should approach studying for the upcoming quiz/examination?", "f93ec21c-7995-4754-9681-5d8e54171e28": "In what ways can students demonstrate their understanding of the context information in their responses to the quiz/examination questions?", "713c6776-5836-4f03-8924-c1c1d2e098ea": "What are the different types of colonic polyps mentioned in the table, and what are their respective malignant potentials and subtypes?", "5253739e-cdbc-4257-9de9-6df4aa968017": "Describe the findings in the imaging studies (DCBE and CTC) of patients with tubular adenoma and tubulovillous polyp, as shown in Figures 5-83, 5-84, and 5-86.", "d9324baf-ca2d-4650-b696-b351884e8705": "How do giant diverticula appear on plain radiography or CT scans, and what distinguishes them from simple diverticula?", "1a47839d-ad5e-43c3-8320-c72eae93552f": "Describe the process by which diverticulitis can develop in some patients with diverticular disease, including the role of stool impaction and inflammatory reactions.", "b88243be-10c8-45fe-ba31-9d55e966d973": "Explain the difference between a Billroth I and a Billroth II operation in gastric surgery, including the anatomy involved and potential complications.", "e81ef20b-e2fc-4b95-8794-7e57d39dcc7d": "How can scleroderma, chronic intestinal pseudoobstruction, and neurogenic conditions such as central or peripheral neuropathies lead to gastric atony and what are the implications for gastrointestinal imaging?", "f6ac7f06-e572-4e8d-893d-3f38786a13e7": "What are the typical measurements that indicate hypertrophic pyloric stenosis in infants, and what is the recommended treatment for this condition?", "2a746347-dff4-42c9-9cb2-431490a76b03": "How can gastric diverticula be distinguished on imaging studies such as CT and UGI series, and what are the potential complications associated with fundal diverticula versus antral diverticula?", "94b42c0f-f1ab-4cb8-96fb-092e4373982d": "Describe the imaging findings on the contrast-enhanced CT scan of the 52-year-old man with a circumferential terminal ileal mass. How can the appearance of the mass be similar to some forms of lymphoma?", "7c9701ae-663f-485b-aa89-3d9bb8346bad": "What are the key features seen on the contrast-enhanced CT scan of the 55-year-old man with a 1.8-cm terminal ileal mass due to a carcinoid tumor? Describe the mesenteric and liver metastases identified in the scan.", "a663e6ba-1cbb-4558-9c51-6b04e5118179": "What are the potential consequences of severe colonic changes, such as colonic pneumatosis, on imaging studies like CT scans? How can these changes lead to mesenteric venous gas and intrahepatic portal venous gas?", "b337f934-da40-4e45-ab3a-cd0f438186de": "Describe the characteristics and potential causes of reversible ischemic colitis, also known as jogger's or runner's colitis. How does this condition differ from other forms of colitis, and what are the proposed mechanisms of injury in otherwise healthy patients?", "12db0280-ba7d-41a5-96db-68d30c5b350c": "How does the presence of Thorotrast in the spleen lead to chronic reactive processes and ultimately fibrosis and splenic contraction?", "e09dadf2-82f1-4068-8eda-26629f6ab177": "What are the different types of benign splenic lesions mentioned in the document, and how do they differ in terms of being single or multiple?", "7688fb2f-ec3c-4adb-9661-b9ec33c93fa3": "How does the diffusion weighting in MRI imaging help differentiate between tissues with high cellularity and predominantly water-based tissues? Provide an explanation using the concept of restricted and nonrestricted diffusion.", "e601ecea-de58-4c0c-b6dc-b214f845900c": "Describe how the apparent diffusion coefficient (ADC) is used to quantify proton motion in capillaries and tissues. How does the ADC value differ between malignant lesions and benign lesions on ADC maps?", "6f27e168-e4af-4027-9ece-9305c66d1cc1": "How can hepatic radiation manifest on imaging studies, and what are the characteristic findings associated with proton beam therapy in the liver?", "037e14b0-9f5a-4fa3-92a3-5b9f1a0cde33": "What is the most common complication seen in the hepatic vein following a procedure, and how can Doppler US help evaluate the direction of blood flow in cases of obstruction or stenosis?", "46cf1b40-79f2-4c6d-acd7-fa2ac1bd2ae9": "How can portal venous gas be distinguished from intrahepatic biliary gas on imaging studies?", "0e10881d-5980-4cf5-9e06-4b291a40a77b": "What are the common causes of hepatic trauma, and how is hepatic laceration identified on CT imaging?", "0febd83d-b30b-439a-bafd-475b7ebc087f": "How can giant duodenal ulcers mimic the configuration of the bulb itself, and what features can help differentiate them from a normal bulb on imaging studies?", "26bbea49-627a-4e53-b502-91a18eb35d66": "Describe the potential complications of duodenal ulcers, focusing on perforation. How can perforation be identified on CT imaging, and what are the key findings that suggest a perforated duodenal ulcer?", "ef822bc5-2282-4b47-845d-9e68086819ae": "What are the potential clinical manifestations of ulcerative colitis outside of the colonic mucosa?", "8a8c6133-457b-4061-b0fc-05978dee3558": "Describe the imaging features that can help diagnose severe ulcerative colitis, including toxic megacolon, on plain abdominal radiography.", "9cd18c11-0b16-472a-bbdb-8277db82dcce": "How can pancreatitis be evaluated using contrast-enhanced CT imaging, and what are some key findings that may be observed in patients with pancreatitis?", "896d584f-18dc-4fd8-a436-585b87a15e20": "Describe the significance of pancreatic necrosis in acute pancreatitis, including its impact on patient prognosis and the recommended treatment approach for patients with necrotizing pancreatitis.", "fb240a9a-debc-4fff-8c2a-483a35cf3501": "How can multiplanar images help in determining the surgical resectability of a pancreatic tumor, particularly in relation to adjacent vessels?", "e2fa415c-482d-4252-9c0e-b2286d7684e4": "In what scenarios would a pancreatic tumor be deemed unresectable based on its encasement of key vascular structures such as the superior mesenteric artery, portal vein, celiac axis, and splenic vein?", "ce79ec2c-1f0e-4d92-8e96-aa26b3867d11": "What imaging modalities are commonly used to visualize hernias, and how are they best appreciated in the context of gastrointestinal imaging?", "5ef562ff-ee29-43ff-8188-eab56c170faf": "Describe the characteristics of extramural esophageal impressions and provide examples of benign causes that can lead to these impressions.", "11f09d4f-c123-4f23-806c-e8972fa7a5ef": "Describe the imaging findings of a cavernous hemangioma in a 46-year-old woman based on the sagittal US, PVP, and delayed contrast-enhanced CT images provided in the document.", "58314adf-eae4-47d3-bb45-cd93bed65e7e": "Identify and differentiate between the hypervascular lesions seen in the arterial-phase contrast-enhanced CT scans of a 33-year-old man, a 41-year-old woman, a 36-year-old woman, and a 57-year-old man, based on the specific characteristics mentioned in the document.", "445802f6-4581-46fe-8278-08c759c30058": "How do jejunal and ileal diverticula typically present in the elderly population, and what are the potential consequences of bacterial overgrowth within these diverticula?", "641ceaf1-2521-4d5c-a532-3624588fba25": "In what ways can inflammatory conditions such as Crohn disease and scleroderma lead to the formation of pseudodiverticula in the small bowel, and how do these false diverticula differ from true diverticula in imaging studies?", "e28e636e-6b04-400e-8d83-e04d5422dc9c": "What are the potential causes of drug-induced colitis, and how do they manifest in the colon?", "0c9e62f9-94a6-46bc-8612-b520447ba00b": "Describe the characteristics and affected areas of typhlitis, also known as neutropenic colitis, as mentioned in the context information.", "9866bf7f-6a67-402b-959a-7e6e33826f5b": "What are some potential causes of pneumatosis intestinalis, and how can it be identified on imaging studies such as CT scans?", "e142d164-94f0-4c74-948a-bec7935b4375": "Describe the difference between a fistula and a sinus, and explain how these abnormalities can be visualized on imaging studies like small bowel follow-through tests or CT scans.", "aa8db727-48e4-437c-ab9f-2296b651c9f7": "In the case of the 78-year-old woman involved in a motor vehicle accident, describe the findings on the noncontrast CT scan that indicate a left diaphragmatic rupture and herniation of the splenic flexure into the chest. How does this condition affect the surrounding structures, specifically the lungs?", "b333f708-e588-49da-910a-878ce545ac77": "What are some common causes of pneumoperitoneum as listed in Box 10-1? Provide examples of iatrogenic causes and perforated viscus causes. How can pneumoperitoneum be visualized on an upright plain abdominal radiograph, as seen in the case of the 51-year-old woman who recently underwent abdominal surgery?", "30fd11fd-5e67-450c-a60f-3bdc9e7b39bd": "What are the potential causes of small bowel mucosal thickening and narrowing seen in gastrointestinal imaging, and how can they be differentiated based on imaging findings?", "fc459f27-4556-4145-8bfc-122ed37d672f": "Describe the clinical presentation and imaging features of Henoch-Sch\u00f6nlein purpura, including the age group most commonly affected and the possible triggers for the disease.", "6ee0817a-fa96-4e13-bf7a-c78ffcbecb35": "How can abdominal wall hemorrhage be differentiated from other soft tissue masses on CT imaging, and what are some common causes of this condition?", "b9903a3c-a10a-4666-b43d-b1501e2d3c14": "Describe the appearance of AlloDerm spacers on CT imaging and explain their purpose in patients undergoing radiation or proton beam therapy.", "0c862d5e-adf0-45c7-8805-caf23c82f451": "What are the different layers of smooth muscle in the stomach and what is the function of each layer?", "9802eef3-2ae0-4c19-b16c-d58ea928d1f9": "Describe the recommended technique for performing a barium examination of the stomach, including patient positioning and sequence of spot radiographs.", "85af8edd-bbc7-4f2b-a37b-e612b46f8a57": "How does delayed contrast washout from a lesion help differentiate hepatocellular carcinoma (HCC) from benign lesions on imaging studies?", "e4003959-7fdd-4519-8d0b-1ab49379f54b": "Describe the imaging features of fibrolamellar hepatocellular carcinoma and explain how it differs from HCC in terms of histology, aggressiveness, and curability.", "75b14f19-dc0a-4222-87aa-926d187b83a9": "What are the common symptoms and causes of acute mesenteric ischemia, and why is it considered a surgical emergency?", "9ed7becb-b032-471f-a82c-07ba66775194": "How can gastrointestinal amyloidosis manifest in the small bowel, and what are the different types of amyloid proteins that can be deposited in the body?", "343d96a1-61f2-4dca-9b2a-8c8117d20d65": "How can deteriorating liver function post liver transplant be evaluated using imaging techniques, specifically focusing on the role of Doppler ultrasound and the criteria for normal hepatic arterial flow?", "f78c1739-d388-4c38-a907-e9760eacabf1": "What are the potential complications that can arise post liver transplant, and how can they be diagnosed using imaging modalities such as ultrasound and CT scans?", "77d1c8c6-e703-42a4-bdbe-f60c14a7141a": "What are the typical locations of IPMNs in the pancreas, and how do main duct variants differ from side branch lesions in terms of presentation and characteristics?", "3d3486a7-17ab-4a8d-95d0-8b091bf49581": "Describe the recommended follow-up and management strategies for incidentally detected IPMNs, considering factors such as patient age, lesion size, and risk of malignant degeneration.", "a17cc497-b15d-4341-8131-4558b555ed51": "What are the potential complications associated with Nissen fundoplication surgery for treating GERD?", "602c57c2-e2db-4a03-ba5a-a431f62fbeda": "Describe the differences between a Roux-en-Y bariatric operation and a sleeve gastrectomy in terms of their anatomical structures and functions.", "1f94b8c3-8488-4425-b1fa-1003c39ea445": "How can foreign bodies in the gastrointestinal tract be visualized, and what are the potential complications associated with sharp foreign bodies?", "3a5d39cb-6ec2-49e6-b95e-f080064210c5": "What are the common causes of colonic pneumatosis, and how can the diagnosis of intussusception differ between children and adults in terms of imaging modalities and treatment approaches?", "db4a7efc-254c-40ee-93fa-d1a53e18b949": "What are the characteristic features of duodenal carcinomas, and how do they typically present at imaging studies?", "5c8344de-a3e5-4a77-8793-e63838fcd04f": "How can duodenal adenomas be differentiated from other types of duodenal polyps, and what are the predisposing factors for the development of duodenal carcinomas?", "13c0fabd-2df6-426b-8d64-d113a5df17f0": "How can Crohn's disease manifest in the small bowel, as seen in the case of the 20-year-old man with a terminal ileal stricture? What imaging modalities were used to diagnose this condition?", "a9374b72-4bb1-41f5-81b5-e076cda217b1": "Describe the potential complications and diagnostic findings associated with foreign bodies in the small bowel, as discussed in the document. How can foreign bodies, such as drug-filled condoms, lead to life-threatening situations?", "0e8a00bf-fcdd-4c5e-9903-795fa84240a2": "What are the clinical findings associated with glucagonomas, and why do they often present late and large at the time of diagnosis?", "f9a6d713-7ff4-4884-9ab1-1da2991e6456": "Describe the characteristics and clinical manifestations of VIPomas, including the syndrome they produce and their likelihood of malignancy.", "455ce1c0-10c8-448b-a793-1676c861f7d2": "Describe the imaging findings in a 44-year-old woman with a pancreatic pseudocyst as shown in Figure 9-28. What imaging modalities were used and what specific features were identified in the images?", "82148810-3001-42b8-b678-3a273b4a0f2f": "In Figure 9-31, what are the key findings in the axial contrast-enhanced CT of a 42-year-old man with an acute episode of chronic pancreatitis? Describe the pancreatic changes, peripancreatic findings, and any associated complications seen in the image.", "3b362211-28c2-4018-a870-3c4015777c80": "How can gallbladder polyps be differentiated from gallstones on ultrasound imaging?", "5155ca82-e225-47cd-b84e-054b7b38d43e": "What imaging modalities can be used to identify biliary intraductal papillary mucinous neoplasm, and what are the typical findings associated with this condition?", "6ec4fae6-63eb-4be1-8269-0603fce238c3": "How can the presence of a shunt be visualized on contrast-enhanced CT or MRI, and what are the features that indicate early portal venous opacification?", "6930ae57-e9f7-4f75-b6dc-c88691c71991": "What are the potential causes of arterioportal shunting in the liver, and how can shunts in the setting of cirrhosis be differentiated from small hepatocellular carcinomas (HCCs)?", "87238bc8-b433-4620-aad0-4728f52ea792": "How can mesenteric adenitis be differentiated from mesenteric metastases from carcinoid on CT imaging?", "250e3c63-6bd6-4346-aa77-59f44334e8a1": "Describe the typical presentation and patient population most commonly affected by mesenteric fat necrosis.", "c694afe3-b8a3-4ace-b0f7-095c4a2ec5e3": "How can chronic disease present in the stomach, and what are the difficulties in distinguishing it from other causes of gastric and small bowel thickening?", "24945804-119a-42fa-83be-30318ff49a38": "Describe the typical findings associated with Crohn disease involving the stomach, and how does it differ from other conditions such as Zollinger-Ellison syndrome and lymphoma?", "d6ac6aa4-067d-483e-84b2-32c32370d818": "How do splenic hamartomas typically appear on ultrasound and CT imaging, and what makes them difficult to differentiate from hemangiomas?", "9359daf3-b3e3-4c87-90ed-af752801c727": "Describe the imaging characteristics of splenic lymphangiomas and littoral cell angiomas, including their appearance on CT and MRI, and the challenges in differentiating them from other splenic tumors.", "c470020a-5b3c-4a30-ae2e-3aff1af85dcf": "How does the Couinaud system divide the liver into segments, and why is it important to determine lesion location according to this system if surgical resection is being considered?", "42c752c8-d285-415c-a973-c72be0cd8a16": "What are the advantages and limitations of ultrasound in hepatic imaging compared to CT and MRI, and in what specific scenarios is ultrasound still considered a critical imaging modality?", "39c445a1-4e7d-4dd0-b648-c808cd65352b": "How does the frequency of adenocarcinoma in esophageal tumors vary between Western Europe/United States and worldwide, according to the information provided in the document?", "b9b1e5be-6ed0-48be-9ee5-afebf1ae614e": "Describe the typical findings at UGI examination for esophageal adenocarcinoma, including early and later presentations, as outlined in the text.", "49a47485-dda3-4c2c-8981-64904fe1c936": "What are the advantages of using nonionic water-soluble contrast medium over barium in certain esophageal examinations, and in what situations is it recommended to use nonionic contrast medium?", "2e8aea1b-55dc-4717-95bd-9c1bcb518b76": "How can contrast studies of the esophagus help in characterizing different types of lesions or abnormalities, and what are the key differences in appearance between extrinsic masses, submucosal masses, and mucosal masses on contrast studies?", "46d1f0f9-d8b8-4dfb-9f64-5a3b5e5dbbb1": "Describe the findings seen in the CT images of an 81-year-old man with a massive herniation of small and large bowel through a right inguinal hernia. What is the significance of this type of herniation?", "9a398a78-16f4-4ad4-a667-9f5894a7e7e3": "What is an Amyand hernia, as seen in the CT images of an 80-year-old woman with herniation of the appendix through a right-sided femoral hernia? Who was Claudius Amyand and why is this type of hernia named after him?", "9dc8e79b-af19-4631-bc66-e99006d13839": "How can the diagnosis of Crohn disease be confirmed, and what role does imaging play in the diagnosis process according to the provided information?", "398d7932-d1a1-47dc-8ff6-e927261815a4": "Describe at least three specific imaging findings of Crohn disease in the small bowel as outlined in Table 4-2 of the context information.", "48be3595-c033-45df-9233-8447e4406353": "How is the pancreas formed embryologically, and what are the roles of the ventral and dorsal buds in its development?", "38ef115e-086f-40f8-ae2d-f87c12df289d": "Describe the characteristics and diagnostic methods for detecting annular pancreas, including its presentation in both children and adults.", "f8ba1d49-f097-449c-bb2b-b5b07ffcd18f": "In the case of the 76-year-old man with a large pancreatic adenocarcinoma, describe the findings seen on both the axial and coronal contrast-enhanced CT images. How does the tumor impact the surrounding structures?", "9fc8598c-9462-49d0-b103-ec61ce284999": "In the case of the 53-year-old man with chronic pancreatitis and a new pancreatic head mass caused by adenocarcinoma, what imaging modalities were used to diagnose the condition? Describe the findings seen on both the axial contrast-enhanced CT and ERCP images.", "52e1b38a-e846-43b7-be2b-aa6c9f81025a": "What are the key imaging findings associated with Budd-Chiari syndrome on noncontrast CT and contrast-enhanced CT scans?", "dac82543-6c79-419a-b084-64922bbb761a": "How does venoocclusive disease differ from Budd-Chiari syndrome in terms of etiology, clinical presentation, and imaging features?", "514da75c-e728-4795-b60f-0a67796aff52": "What are some examples of primary malignancies that can lead to hypervascular hepatic metastases, as mentioned in Box 6-7 of the document?", "26c52f1e-f022-467a-be15-932183124f2e": "Why is it important to perform both arterial and portal venous phase imaging for patients with certain underlying malignancies, as discussed in the document?", "3bbf9a1d-8615-48da-b49d-169d32b2ff20": "What are the different muscle layers present in the esophagus, and how do they vary in terms of muscle type and location along the esophagus?", "cc830e1a-7abf-48e9-8250-30b0d9eaf4c2": "Describe the technique and steps involved in performing a UGI swallow examination, including the importance of patient compliance and the use of contrast agents.", "00adc2ce-1e92-41ff-a3f1-fa520813f681": "What are the primary and secondary peristaltic waves involved in normal esophageal motility, and how do they differ in their initiation and function?", "4b9578cf-f9ac-418b-92fc-a550afcd1e32": "Describe the pathophysiology and clinical presentation of achalasia, including the role of myenteric ganglia in the lower esophageal sphincter and the potential complications associated with the condition.", "32e20f2e-0fe6-43b9-b13c-d1ff3cda509b": "What are the key characteristics of serous microcystic pancreatic neoplasms, and how do they differ from other cystic neoplasms?", "70015740-0f0e-4c6b-b064-116cbafb3566": "How can simple pancreatic cysts be differentiated from more concerning cystic pancreatic neoplasms based on imaging findings and patient demographics?", "29464653-9fe1-48ac-ac95-066d562153f2": "Describe the imaging findings seen in a 48-year-old woman with a sclerosing angiomatoid nodular transformation (SANT) in the spleen as shown in Figure 7-48. What features were observed on the axial portal venous phase and delayed contrast-enhanced CT scans?", "45e0cd20-7468-4d53-9444-8b2b3abaab30": "In Figure 7-47, what were the imaging characteristics of the hypodense splenic lesions in a 66-year-old woman that were identified as littoral cell angiomas? Describe the findings seen on the axial and coronal contrast-enhanced CT scans.", "50cf92f2-2d6b-480d-a2d2-727cf9ea9b6e": "What are some potential complications associated with ectopic pancreas, and where are these ectopic pancreatic rests typically found in the body?", "9d62336b-bbf5-4958-9b08-5b0d6341b555": "How does fatty pancreatic replacement manifest in conditions such as aging, cystic fibrosis, and uneven lipomatosis, and what imaging techniques can be used to distinguish between these conditions?", "102b5269-6576-450a-b8b4-37a1138479bd": "What are the common features of small bowel involvement in Chagas disease, and how does it contribute to malabsorptive patterns in affected individuals?", "3942a1d0-875d-4ed6-b93b-ae9c0b68ffe7": "Describe the diagnostic features of Chagas disease in its acute phase, including the Roma\u00f1a sign, and explain how the disease is transmitted to humans in Central and South America.", "9c967d38-2818-437b-abbd-061cefaff947": "What are the characteristic features of inflammatory fibroid polyps on imaging, and where are they typically found in the gastrointestinal tract?", "11e8762e-b7bf-4f0a-9703-2965f4b243cb": "Describe the characteristics of gastrointestinal stromal tumors (GISTs), including their common locations, potential for malignancy, and the receptors they express.", "290f8449-622e-4632-ab8c-c6c5c3d54815": "How does diffusion-weighted imaging play a role in characterizing hemangiomas, and why may it be unhelpful in some cases?", "c8472a9f-6e1d-4e62-bf24-dccba794b6e9": "Describe the imaging characteristics of giant hemangiomas, including their enhancement patterns, presence of central scar, and T2 signal characteristics. How can these features differentiate giant hemangiomas from other liver lesions?", "a45574d6-6543-4449-b30a-c1fafcaa143f": "What are the typical imaging methods used for diagnosing primary sclerosing cholangitis, and why are they preferred for this condition?", "a9aa7383-1e13-4ab0-b2c1-a64b63b2c37c": "What are some of the associated autoimmune diseases with primary sclerosing cholangitis, and how do they contribute to the progression of the disease?", "be678993-b5cc-4e94-8519-653ca302c6e7": "How do simple hepatic cysts typically appear on contrast-enhanced CT scans, and what is their typical enhancement pattern?", "c99e0c9a-2f07-42bc-9648-413950618142": "How can simple hepatic cysts be differentiated from biliary cystadenomas and biliary hamartomas on cross-sectional imaging?", "ef0c8251-d85d-4bd5-bfe3-d9028529ba16": "In the case study of the 53-year-old man with cholangiocarcinoma, what imaging modality was used to visualize the AlloDerm spacers and how did their appearance change over time?", "c8a6e66e-0f01-4601-b4fb-bdc6f99ac7aa": "Describe the case of the 22-year-old woman with a curvilineal density in the pelvis and an associated abscess. What was the likely cause of these findings and how were they related to a previous surgical procedure?", "26871561-3ad3-4b3e-885c-26b7e8395547": "How can CT imaging be more beneficial in evaluating the presence and extent of inflammatory bowel disease compared to contrast enema?", "bf9d21e1-e036-4ee1-a3ff-fe41f54f045a": "Describe the characteristic features seen in CT imaging for chronic ulcerative colitis, including the \"lead piping\" appearance and the \"fat halo\" sign.", "441d530a-06c7-4ed1-a920-c7696d069d76": "What are some imaging features that can help differentiate solid and papillary epithelial neoplasms from other cystic pancreatic neoplasms?", "486c6e59-9d99-4efa-b706-ff3f730ea237": "Describe the presentation and imaging characteristics of cystic teratomas of the pancreas.", "0ef52deb-d0a1-4ef9-8674-941e975ac84a": "How can submucosal intramural gastric tumors, including GISTs, be differentiated from other mesenchymal tumors based on imaging findings?", "b0a30368-019c-46b4-a77d-5889b75bef13": "Describe the imaging characteristics and typical location of lipomas in the stomach, and explain how they can be diagnosed on CT scans.", "a2204903-db2c-4e22-b9a8-5ae979037f48": "How is the duodenum classified into four parts, and what are the characteristics of each part?", "9d4a4e26-6cc2-45bc-83cf-71c20ec5f348": "Describe the imaging evaluation of the duodenum, including the historical methods used and the importance of CT evaluation.", "c81685fa-eea3-486a-b89a-559f41b6a639": "What are some potential causes of splenic calcification as mentioned in the context information?", "d587cfa5-5aac-414a-813c-9bd45ce7560e": "Describe the imaging findings in the cases of splenic calcification due to sickle cell disease and systemic lupus erythematosus, as presented in the document.", "ff48e9ae-ae6a-4542-98c5-ab87dbb22db3": "What are the possible causes of duodenal hemorrhage, and how can it present on imaging studies?", "748d114d-e90f-4c90-999b-8a0c5ed251d7": "Describe the appearance of lymphoid hyperplasia in the duodenum and discuss its significance in adults versus children.", "bbaedbe6-f520-4ebc-b3c8-18d4ab7ec50c": "What are the different causes of diffuse gastric mucosal thickening, and how do they differ in terms of benign and malignant conditions?", "b59a56c8-f5d8-43ee-9657-9f969609c306": "Describe the features and locations of different types of gastritis as outlined in Table 2-2.", "91fac67b-f86e-427b-a119-4bfe6e28eca4": "What are the common imaging findings associated with volvulus of the stomach, and how can the diagnosis be confirmed using different imaging modalities?", "b33c87a0-9b02-4a52-b091-a66afdc50de0": "Describe the imaging features of gastritis, including the characteristic findings on barium UGI series and CT scans. How has the evaluation of gastritis evolved over time with the introduction of new diagnostic techniques?", "03f2e402-2baf-4535-9307-f8ad175e10ca": "How does hepatobiliary imaging help in characterizing suspected focal nodular hyperplasia (FNH) lesions, and what are the key imaging findings associated with FNH on hepatobiliary imaging?", "e2140247-36a9-4e25-8a03-80c6f8cbd3a0": "Describe the imaging characteristics of metastases on MRI, specifically focusing on T2 signal intensity, contrast enhancement patterns, and differences in enhancement between arterial and portal venous phases.", "e70e6e90-e20f-4ff4-9b18-65e428dc54de": "What are the characteristic features of nonfunctioning insulinomas and how do they differ from functioning insulinomas?", "110e556c-1359-421a-87ed-c7eb12577621": "Describe the clinical presentation and associated syndrome of VIPomas.", "0d4b47fe-cf0c-466b-83f1-b4477d3adc71": "How does an annular pancreas differ from a normal pancreas in terms of its anatomical structure and positioning in relation to the duodenum?", "7e662cdc-e100-4d5b-8f20-8aefd7982035": "Describe the embryological development of the pancreas, specifically focusing on the fusion of the ventral and dorsal buds.", "9867425e-f4ac-4ccf-9f87-670d8b877c9c": "How does secretin affect pancreatic fluid production and duct dilation, and how can this be measured in a healthy patient versus a patient with a functional obstruction?", "a321203c-3a68-4021-8fd1-d8251785cbc8": "Describe the findings seen on axial contrast-enhanced CT scans in the cases of a congenitally short pancreas with a missing tail, partial agenesis of the pancreas, and pancreas divisum.", "f7be74fc-bfd9-4fb5-892e-28be09604717": "How does superior mesenteric artery syndrome typically present in adults, and what are the key diagnostic features seen on contrast-enhanced CT imaging?", "93eb7e66-39b9-428d-85c5-62f1c8f9185e": "Describe the appearance and clinical significance of Brunner gland hyperplasia in the duodenal bulb, including how it can be visualized on UGI series.", "2c403bfb-dd4b-4d76-90f4-cdfe6aac9593": "What are the key symptoms and imaging findings associated with Salmonella typhi infection, specifically in relation to typhoid fever?", "cb35c164-649c-4bd1-8246-a90dac96d002": "How does Yersinia enterocolitica present in terms of symptoms and imaging findings, and how can it be differentiated from acute appendicitis?", "d0187b91-2894-4aac-a7d4-40e9fca137f1": "Describe the radiographic findings in a 39-year-old woman with a Bochdalek hernia as shown in the images provided. What structures are identified on the chest radiograph and contrast-enhanced CT images?", "835a0a01-fe00-4d46-a24e-96e21b0cec23": "In the case of a 77-year-old man with a Morgagni hernia, what abnormality is observed on the lateral plain radiograph of the chest and contrast-enhanced CT images? Describe the positioning of the hepatic colonic flexure and the presence of a left subphrenic collection.", "af00e010-fa7f-44bf-ad82-15ecac48681f": "What are the imaging features of amebiasis in the colon, and how can the disease progress if left untreated?", "516ef998-8dd1-4c09-ad71-2e8beab8c931": "How can colonic schistosomiasis mimic other conditions such as ulcerative colitis or adenocarcinoma, and what are some key factors that should raise suspicion for this diagnosis in patients traveling from endemic regions?", "2c896681-ed21-4a24-9e61-9dd9dcb8a80e": "What are the characteristic imaging findings of parasitic cholangitis caused by Ascaris lumbricoides, and how can the presence of the parasite be identified in the gallbladder?", "109a532d-8e85-4179-8362-20bb92b667de": "Describe the etiology, clinical presentation, and imaging findings of Asiatic or Oriental Cholangitis caused by Clonorchis sinensis, including the complications associated with this disease.", "4889dd76-1bed-4a33-a721-6bfb59679c30": "Describe the findings seen on the axial and coronal CT images of a 76-year-old man with a strangulated inguinal hernia and infarcted small bowel. What is the significance of these findings in terms of patient management and prognosis?", "667ff32e-493d-4a6d-b756-52fcd5f38227": "In the case of a 49-year-old woman with an incarcerated incisional hernia, what are the key imaging findings on the contrast-enhanced CT scan? How do these findings indicate the presence of proximal small bowel obstruction and distal small bowel wall thickening due to vascular compromise?"}, "corpus": {"b4ad2fb2-768a-41c8-aeaa-f72ac14ae318": "Neurosurgery \u200315(6):855\u2013858, \u20031984.\n107.\u2003Paterakis \u2003K,\u2003Kar antanas \u2003AH,\u2003Ko mnos \u2003A,\u2003et\u2003al:\u2003Out come \u2003of\u2003patie nts\u2003with\u2003\ndiffuse \u2003axonal \u2003injur y:\u2003The\u2003significanc e\u2003and\u2003pr ognostic \u2003val ue\u2003of\u2003MRI\u2003in\u2003\nthe\u2003acute \u2003phase. \u2003J Trauma \u200349(6):1071\u20131075, \u20032000.\n108.\u2003Peng \u2003R,\u2003Chang \u2003C,\u2003Gilmor e\u2003D,\u2003et\u2003al:\u2003Epid emiology \u2003of\u2003immediat e\u2003and\u2003\nearly \u2003trauma \u2003deaths \u2003at\u2003an\u2003urban \u2003lev el\u2003I\u2003tr auma \u2003ce nter.\u2003Am Surg \u2003\n64(10):950\u2013954, \u20031998.\n109.\u2003Polin \u2003RS,\u2003Shaffre y\u2003ME,\u2003Bo gaev\u2003CA,\u2003et\u2003al:\u2003De compressive \u2003bifr ontal \u2003\ncraniectomy \u2003in\u2003the\u2003tr eatment \u2003of\u2003sev ere\u2003re fractory \u2003postt raumatic \u2003\ncerebral \u2003edema. \u2003Neurosurgery \u200341(1):84\u201394, \u20031997.\n110.\u2003Povlishock \u2003J,\u2003Je nkins \u2003L:\u2003Ar e\u2003the\u2003pathob iological \u2003chang es\u2003ev oked \u2003by\u2003\ntraumatic \u2003brain \u2003injur y\u2003immediat e\u2003and\u2003irr eversible? \u2003Brain Pathol \u2003\n5(4):415\u2013426, \u20031995.\n111.\u2003Provenzale \u2003JM:\u2003Imag ing\u2003of\u2003tr aumatic \u2003br ain\u2003injur y:\u2003A\u2003re view\u2003of\u2003the\u2003\nrecent \u2003medical \u2003lite rature. \u2003AJR Am J Roentgenol \u2003194(1):16\u201319, \u20032010.\n112.\u2003Reichenbach \u2003J,\u2003Ve nkatesan \u2003R,\u2003Yab lonskiy \u2003D,\u2003et\u2003al:\u2003The ory\u2003and\u2003\napplication \u2003of\u2003static \u2003field\u2003inhomo geneity \u2003eff ects\u2003in\u2003gr adient-echo \u2003\nimaging. \u2003J Magn Reson Imaging \u20037(2):266\u2013279, \u20031997.", "ebfd1aee-fb85-4b39-b2ac-0ff424b56af2": "CHAPTER 10 \u2003 Cerebral \u2003Infections \u2003and\u2003Inflammation 301\nis\u2003the\u2003most \u2003commo n\u2003site\u2003of\u2003invol vement, \u2003with\u2003brain \u2003invol vement \u2003seen\u2003\nin\u20032%\u2003to\u200327%\u2003of\u2003cases. \u2003Gran ulomatous \u2003reac tion\u2003occur s\u2003in\u2003the\u2003brain \u2003in\u2003\nresponse \u2003to\u2003the\u2003organism. \u2003MRI\u2003may\u2003rev eal\u2003multiple \u2003ring\u2003enhancing, \u2003\nconglomerate \u2003lesions \u2003with\u2003surr ounding \u2003ede ma\u2003and\u2003freq uent\u2003associate d\u2003\nhemorrhage. \u2003A\u2003tunnel sign \u2003is\u2003a\u2003T1\u2003hypointense \u2003and\u2003T2\u2003hyp erintense \u2003\ncolumnar \u2003or\u2003fusifor m\u2003lesion \u2003that\u2003may\u2003be\u2003seen\u2003in\u2003some \u2003cases.1\nMost \u2003of\u2003the\u2003chro nic\u2003gran ulomas \u2003calcify. \u2003Plain \u2003films \u2003show \u2003chara cter-\nistic\u2003\u201csoap \u2003bubble\u201d \u2003intra cranial \u2003calcifications. \u2003CT\u2003scans \u2003show \u2003multiple \u2003\ndensely \u2003calcified \u2003areas \u2003with\u2003various \u2003nodular \u2003shapes \u2003around \u2003and\u2003within \u2003\nthe\u2003lateral \u2003ventricles \u2003and\u2003high\u2003ove r\u2003the\u2003cer ebral \u2003con vexities.139,141\nToxoplasmosis\nToxoplasmosis \u2003is\u2003caused \u2003by\u2003an\u2003intra cellular \u2003prot ozoan, \u2003Toxoplasma \ngondii .\u2003Humans \u2003are\u2003infec ted\u2003by\u2003ingestio n\u2003of\u2003cysts\u2003in\u2003under cooked \u2003por k\u2003\nor\u2003food\u2003contaminated \u2003with\u2003cat\u2003fec es.\u2003Initial \u2003infec tion\u2003with\u2003rapidl y\u2003\nmultiplying \u2003tach yzoites \u2003is\u2003subc linical \u2003or\u2003mildly \u2003asympt omatic \u2003in\u2003\nimmunocompetent \u2003patients. \u2003Subseq uently, \u2003latent \u2003infec tion\u2003dev elops, \u2003\nwith\u2003formation \u2003of\u2003cysts\u2003containing \u2003nonre plicating \u2003bra dyzoites \u2003in\u2003dif-\nferent \u2003tissues \u2003including \u2003the\u2003brain. \u2003Reac tivation \u2003of\u2003latent \u2003disease \u2003occur s\u2003\nin\u2003immunocompromised \u2003individ uals,\u2003which \u2003is\u2003seen\u2003most \u2003freq uently \u2003in\u2003\nAIDS. \u2003Toxoplasmosis \u2003is\u2003the\u2003most \u2003commo n\u2003opp ortunistic \u2003infec tion\u2003of\u2003\nCNS\u2003in\u2003AIDS \u2003despite \u2003rec ent\u2003dec line\u2003due\u2003to\u2003HAART.6\nToxoplasmosis \u2003usuall y\u2003prese nts\u2003as\u2003multiple \u2003parenc hymal \u2003abscesses, \u2003\ntypically \u2003seen\u2003in\u2003the\u2003basal \u2003ganglia, \u2003thalamus, \u2003and\u2003cor ticomedullary \u2003\njunction.", "36661fcf-38a9-49dc-acaf-05b98de64243": "Bef ore\u2003place ment \u2003of\u2003coc hlear \u2003\nimplants, \u2003patients \u2003are\u2003studied \u2003with\u2003CT\u2003and\u2003MRI\u2003to\u2003chara cterize \u2003the\u2003\ninner \u2003ear\u2003anomalies. \u2003CT\u2003is\u2003supe rior\u2003to\u2003study \u2003the\u2003bon y\u2003struc tures \u2003for\u2003\nsurgical \u2003planning, \u2003wher eas\u2003MRI\u2003can\u2003confir m\u2003that\u2003the\u2003space \u2003within \u2003the\u2003\nbony \u2003otic\u2003capsule \u2003is\u2003filled \u2003with\u2003fluid\u2003and\u2003allow s\u2003eval uation \u2003of\u2003the\u2003ves-\ntibulocochlear \u2003nerv e.107\nSemicircular Canal Dehiscence Syndrome.  SCC\u2003dehiscence \u2003syn-\ndrome \u2003results \u2003from \u2003absence \u2003of\u2003the\u2003osseous \u2003cov ering \u2003of\u2003an\u2003SCC, \u2003usuall y\u2003\nFIG 21-9  Incomplete partition type II or Mondini\u2019s malformation. A and B, Axial high-resolution multidetector \nCT images of temporal bones show an incomplete partition of the cochlea, with normal basal turn and cystic \napices, with 1.5 turns (black arrows). Dilatation of the vestibule (long white arrows)  and the vestibular aque -\nduct is also seen (short white arrows).  \nA B", "49c5dd72-d2a4-4570-9557-2f06c06f8c5d": "Imp ortantly, \u2003PET -CT\u2003is\u2003sup e-\nrior\u2003in\u2003identifying \u2003patie nts\u2003with\u2003oc cult\u2003metastases \u2003and\u2003unrese ctable \u2003\ntumors.45\u2003PET-CT \u2003is\u2003also\u2003ve ry\u2003useful \u2003fo r\u2003distinguishing \u2003malignancy \u2003\nfrom \u2003atelectasis, \u2003infe ction, \u2003and\u2003other \u2003be nign\u2003pr ocesses45\u2003(Fig.\u200339-6).\nPathology\nApical Pleural Cap.  Apical \u2003opacities, \u2003or\u2003apical \u2003caps, \u2003are\u2003a\u2003co mmon \u2003\nnonspecific \u2003finding \u2003that\u2003may\u2003be\u2003idiopathic \u2003or\u2003see n\u2003in\u2003var ious\u2003disease \u2003\nstates \u2003including \u2003infe ction, \u2003inflammato ry\u2003co nditions, \u2003rea ction \u2003to\u2003ra dio-\ntherapy, \u2003neoplasms \u2003suc h\u2003as\u2003Panc oast\u2003tumo r,\u2003mediast inal\u2003hemo rrhage, \u2003\nmediastinal \u2003lipo matosis, \u2003and\u2003pe ripheral \u2003upp er\u2003lob e\u2003col lapse.55\nOn\u2003chest \u2003radiographs, \u2003idiopathic \u2003asymp tomatic \u2003apical \u2003pleur al\u2003caps\u2003\nare\u2003irregular \u2003homo geneous \u2003de nsities \u2003less\u2003than\u20035\u2003mm\u2003in\u2003thickness \u2003ov er\u2003\nthe\u2003lung\u2003apex. \u2003The\u2003unde rsurface \u2003is\u2003usual ly\u2003sharpl y\u2003marginat ed.81\u2003Apical \u2003\npleural \u2003caps\u2003are\u2003as\u2003co mmonly \u2003unilate ral\u2003as\u2003bilat eral\u2003and\u2003are\u2003increas -\ningly \u2003common \u2003with\u2003aging; \u2003they\u2003are\u2003found \u2003in\u2003as\u2003many \u2003as\u200316%\u2003of\u2003patie nts\u2003\nover\u2003age\u200345.103\u2003When \u2003they\u2003are\u2003bilat eral,\u2003apical \u2003pleur al\u2003caps\u2003are\u2003usual ly\u2003\nasymmetric.103\u2003Apical \u2003opacities \u2003re lated \u2003to\u2003tub erculosis \u2003te nd\u2003to\u2003be\u2003\nthicker \u2003than\u2003idiopathic \u2003scars, \u2003measur ing\u2003up\u2003to\u20032.5\u2003cm\u2003in\u2003thickness.", "79a16327-5f36-4862-8c7b-6837c350070c": "J Comput Assist Tomogr \u2003\n30:122\u2013125, \u20032006.\n41.\u2003Madani \u2003G,\u2003Beale \u2003TJ:\u2003Sino nasal \u2003inflammato ry\u2003disease. \u2003Semin Ultrasound \nCT MR \u200330:17\u201324, \u20032009.\n42.\u2003Mafee \u2003MF:\u2003No nepithelial \u2003tumo rs\u2003of\u2003paranasal \u2003sinuses \u2003and\u2003nasal \u2003cav ity.\u2003\nRadiol Clin North Am \u200331:61-75-90, \u20031993.\n43.\u2003Mahmud \u2003MB,\u2003Ilica\u2003TA,\u2003Mal uf\u2003F,\u2003et\u2003al:\u2003The\u2003many \u2003fac es\u2003of\u2003fungal \u2003disease \u2003\nof\u2003the\u2003paranasal \u2003sinuses \u2003:\u2003CT\u2003and\u2003MR\u2003findings. \u2003Diagn Interv Radiol \u2003\n19:195\u2013200, \u20032013.\n44.\u2003McLaughlin \u2003RB,\u2003Jr,\u2003Re hl\u2003RM,\u2003Lanza \u2003DC:\u2003Clinical ly\u2003re levant \u2003fro ntal\u2003\u2003\nsinus \u2003anatomy \u2003and\u2003ph ysiology. \u2003Otolaryngol Clin North Am \u200334(1):1\u201322, \u2003\n2001.\n45.\u2003Meyer \u2003Tk,\u2003Ko cak\u2003M,\u2003Smith \u2003MM, \u2003et\u2003al:\u2003Co ronal \u2003CT\u2003analy sis\u2003of\u2003fro ntal\u2003\ncells. \u2003Am J Rhinol \u200317:163\u2013168, \u20032003.\n46.\u2003Mohammadi \u2003HA,\u2003Ha ery\u2003C:\u2003Fibr o-osseus \u2003lesions \u2003of\u2003cranio-fa cial\u2003\nbones\u2014Role \u2003of\u2003imaging .\u2003Radiol Clin North Am \u200331:121\u2013134, \u20031993.\n47.\u2003Momeni \u2003AK,\u2003Ro berts \u2003CC,\u2003Che w\u2003FS:\u2003Imag ing\u2003of\u2003chr onic\u2003and\u2003ex otic\u2003\nsinonasal \u2003disease \u2003:\u2003A\u2003re view. \u2003AJR Am J Roentgenol \u2003189:S35\u2013S45, \u20032007.\n48.\u2003Muhle \u2003C,\u2003Re inhold-Keller \u2003E,\u2003Ric hter\u2003C,\u2003et\u2003al:\u2003MRI\u2003of\u2003the\u2003nasal \u2003cav ity,\u2003the\u2003\nparanasal \u2003sinuses \u2003and\u2003or bits\u2003in\u2003We gener\u2019s \u2003gr anulomatosis. \u2003Eur Radiol \u2003\n7(4):566\u2013570, \u20031997.\n49.\u2003Mukherji \u2003SK,\u2003Figuer oa\u2003RE,\u2003Ginsbe rg\u2003LE,\u2003et\u2003al:\u2003Al lergic \u2003fungal \u2003sinusit is\u2003:\u2003\nCT\u2003findings. \u2003Radiology \u2003207:417\u2013422, \u20031998.\n50.", "3461c1b3-544d-4012-adf7-f12632c08bbb": "CHAPTER 9 \u2003 Intracranial \u2003Neoplasms 231\ncases, \u2003notably \u2003invol ving\u2003the\u2003meninges \u2003and\u2003parenc hymal \u2003struc tures \u2003at\u2003\nthe\u2003base\u2003of\u2003the\u2003brain. \u2003On\u2003imaging \u2003studies, \u2003multiple \u2003foci\u2003of\u2003ill-define d\u2003\ncontrast \u2003enhancement \u2003are\u2003seen\u2003within \u2003and\u2003env eloping \u2003the\u2003surfa ces\u2003of\u2003\nthe\u2003hypothalamus, \u2003opt ic\u2003chiasm, \u2003and\u2003pituitary \u2003stalk71\u2003(Fig.\u20039-54).\nIntrapituitary \u2003focal \u2003abnor malities \u2003are\u2003commo nly\u2003ident ified\u2003on\u2003MRI\u2003\nof\u2003asymptomatic \u2003volunt eers\u2003and\u2003as\u2003incidental \u2003findings \u2003in\u2003large \u2003auto psy\u2003\nseries. \u2003These \u2003includ e\u2003not\u2003only\u2003microa denomas \u2003but\u2003also\u2003Rathke \u2019s\u2003cleft\u2003\ncysts\u2003(see\u2003Fig.\u20039-59) \u2003(see\u2003later) \u2003and\u2003other \u2003benig n\u2003cysts\u2003of\u2003uncer tain\u2003\norigin. \u2003The\u2003incidenc e\u2003of\u2003such\u2003cysts\u2003on\u2003auto psy\u2003series \u2003varies \u2003from \u20035.8% \u2003\nto\u20038.3% \u2003of\u2003individ uals\u2003older \u2003than\u200330\u2003years. \u2003In\u2003one\u2003double-b lind\u2003series \u2003\nof\u2003asymptomatic \u2003adult \u2003volunt eers,\u2003MRI\u2003demo nstrated \u2003intrapit uitary \u2003\nfocal \u2003hypointensities \u2003on\u2003T1-weig hted\u2003imaging \u2003that\u2003wer e\u2003consist ent\u2003\nwith\u2003microadenoma \u2003or\u2003benig n\u2003pituitary \u2003cyst\u2003in\u200315%\u2003of\u2003subje cts.\u2003\nAnother \u2003possible \u2003explanatio n\u2003pro posed \u2003for\u2003these \u2003\u201cincidentalo mas\u201d \u2003is\u2003\nmagnetic \u2003susceptibility \u2003induct ion\u2003of\u2003signal \u2003distor tion\u2003in\u2003the\u2003floor \u2003of\u2003\nthe\u2003sella\u2003near\u2003the\u2003junct ion\u2003with\u2003the\u2003spheno id\u2003sinus. \u2003Most \u2003of\u2003these \u2003\nlesions, \u2003apparent \u2003or\u2003real,\u2003are\u2003ver y\u2003small \u2003(<3\u2003mm) \u2003and\u2003in\u2003the\u2003absence \u2003\nof\u2003correlating \u2003clinical \u2003sympt oms\u2003or\u2003signs \u2003can\u2003be\u2003follo wed\u2003with\u2003per iodic \u2003\nmonitoring \u2003on\u2003an\u2003annual \u2003or\u2003biannual \u2003basis.137\nMacroadenoma.  When \u2003an\u2003adenoma \u2003of\u2003the\u2003pituitary \u2003gland \u2003reac hes\u2003\nor\u2003exceeds \u200310\u2003mm\u2003in\u2003diamete r,\u2003it\u2003is\u2003designat ed\u2003by\u2003con vention \u2003a\u2003mac-\nroadenoma .", "a2026c64-37f5-4217-85d7-4ea7dac7d47d": "The\u2003cartilaginous \u2003matrix \u2003is\u2003the\u2003most \u2003chara cteristic \u2003finding \u2003at\u2003\nimaging \u2003(see\u2003Fig.\u200325-18). \u2003CT\u2003scans \u2003are\u2003bett er\u2003than\u2003MRI\u2003studies \u2003at\u2003\ndemonstrating \u2003the\u2003calcifications \u2003within \u2003the\u2003matrix \u2003of\u2003the\u2003tumor .\u2003Such \u2003\ncalcifications \u2003are\u2003extr emely \u2003rare\u2003in\u2003other \u2003lesions. \u2003Relapsing \u2003poly chon -\ndritis \u2003can\u2003give\u2003fairly \u2003exte nsive \u2003calcification \u2003but\u2003is\u2003extr emely \u2003rare\u2003and\u2003\nshould \u2003not\u2003invol ve\u2003the\u2003larynx \u2003exc lusively.\nIf\u2003the\u2003lesion \u2003does\u2003not\u2003have\u2003the\u2003imaging \u2003chara cteristics \u2003of\u2003a\u2003cartilag e\u2003\nlesion, \u2003the\u2003radiologist \u2003tries\u2003to\u2003det ermine \u2003whethe r\u2003the\u2003lesion \u2003is\u2003vascular. \u2003\nHemangiomas, \u2003venous \u2003vascular \u2003malfor mations, \u2003and\u2003paragang liomas \u2003\nenhance \u2003intensely \u2003on\u2003CT\u2003scans \u2003if\u2003a\u2003bolus \u2003or\u2003rapid \u2003drip\u2003of\u2003intra venous \u2003\ncontrast \u2003mater ial\u2003is\u2003used. \u2003Know ledge \u2003that\u2003a\u2003tumor \u2003is\u2003vascular \u2003has\u2003\nobvious \u2003implications \u2003if\u2003biopsy \u2003or\u2003resec tion\u2003is\u2003planned.\nOther \u2003than\u2003chondr osarcomas \u2003and\u2003vascular \u2003lesions, \u2003soft\u2003tissue \u2003\ntumors \u2003do\u2003not\u2003have\u2003specific \u2003ident ifying \u2003chara cteristics. \u2003They \u2003do\u2003not\u2003\nhave\u2003a\u2003cartilaginous \u2003matrix \u2003and\u2003do\u2003not\u2003enhance \u2003brig htly.\u2003The\u2003absence \u2003\nof\u2003these \u2003two\u2003imaging \u2003chara cteristics \u2003is\u2003useful \u2003infor mation \u2003in\u2003limiting \u2003\nthe\u2003diagnostic \u2003possibilit ies.\nCysts\nCysts \u2003also\u2003present \u2003as\u2003subm ucosal \u2003masses. \u2003Thre e\u2003typ es\u2003of\u2003cysts\u2003typical ly\u2003\narise\u2003within \u2003or\u2003in\u2003intimate \u2003associatio n\u2003with\u2003the\u2003larynx. \u2003The\u2003saccular \u2003\ncyst\u2003(laryngocele) \u2003and\u2003the\u2003mucosal \u2003cyst\u2003arise\u2003within \u2003the\u2003larynx. \u2003The\u2003\nthyroglossal \u2003duct\u2003cyst\u2003arises \u2003just\u2003outside \u2003the\u2003larynx \u2003in\u2003close \u2003association \u2003\nwith\u2003the\u2003strap \u2003muscles.\nThe\u2003saccular \u2003cyst\u2003(laryngo cele)\u2003rep resents \u2003a\u2003dilatation \u2003of\u2003the\u2003ven-\ntricular \u2003saccule \u2003or\u2003appe ndix\u2003(Fig.\u200325-19).", "f788758b-d8f0-4420-98c7-39454235cb1e": "PART II \u2003 CT \u2003and\u2003MR\u2003Imaging \u2003of\u2003the\u2003Whole \u2003Body 490\nFIG 16-1  Typical block design used for task-based fMRI examinations is depicted in this diagram. Equivalent-\nduration epochs of rest alternate with epochs of sustained repetitive activity (motor, language, or visual task \nperformance). The upper half of the image displays the summation of individual stimulus-related hemody -\nnamic responses as effectively sustained increase in BOLD signal during the activity blocks compared to the resting blocks. Rest Task Task TaskBOLD signal intensity\nRest Rest Activity\ndesign \u2003paradigms \u2003are\u2003gene rally\u2003used\u2003because \u2003they\u2003are\u2003gene rally\u2003easier \u2003\nto\u2003perform, \u2003are\u2003more \u2003efficient, \u2003and\u2003pro duce \u2003more \u2003statistical ly\u2003rob ust\u2003\nresults.65\nMotor Tasks.  All\u2003the\u2003motor \u2003tasks \u2003we\u2003use\u2003are\u2003designe d\u2003as\u2003a\u2003bloc k\u2003\ndesign \u2003paradigm, \u2003with\u200330\u2003seco nds\u2003of\u2003rest\u2003alter nating \u2003with\u200330\u2003seco nds\u2003\nof\u2003activity \u2003within \u2003each\u2003cycle, \u2003with\u2003the\u2003visual \u2003(or\u2003aural) \u2003instruc tions \u2003to\u2003\n\u201cstop\u201d \u2003or\u2003\u201cgo.\u201d\u2003The\u2003most \u2003commo n\u2003sensor imotor \u2003tasks \u2003includ e\u2003a\u2003foot\u2003\nmovement \u2003task\u2003(with \u2003cont inuous \u2003bilate ral\u2003gentle \u2003plantar \u2003flexion \u2003and\u2003\ndorsiflexion \u2003of\u2003the\u2003foot\u2003at\u2003the\u2003ankle \u2003at\u2003a\u2003stead y\u2003pace, \u2003or\u2003alter natively \u2003\ntoe\u2003flexion \u2003and\u2003exte nsion), \u2003a\u2003finger \u2003move ment \u2003task\u2003(which \u2003includ es\u2003\nbilateral \u2003simultaneous \u2003seque ntial\u2003finger \u2003tapping), \u2003and\u2003a\u2003ver tical\u2003tongue-\nmovement \u2003task\u2003(with \u2003cont inuous \u2003gentle \u2003up-and-dow n\u2003move ment \u2003of\u2003\nthe\u2003tongue \u2003at\u2003a\u2003stead y\u2003pace, \u2003with\u2003special \u2003care\u2003to\u2003avo id\u2003move ment \u2003of\u2003the\u2003\njaw)\u2003that\u2003elicits \u2003act ivation \u2003relat ed\u2003to\u2003the\u2003face\u2003motor \u2003area.\u2003Alte rnatively, \u2003\nlip-puckering \u2003may\u2003be\u2003used\u2003for\u2003eliciting \u2003act ivation \u2003in\u2003the\u2003lowe r\u2003face\u2003\nsensorimotor \u2003cor tex.\u2003A\u2003varie ty\u2003of\u2003other \u2003hand \u2003move ment \u2003tasks \u2003(e.g., \u2003\nhand \u2003opening/closing, \u2003squeezing) \u2003can\u2003be\u2003used\u2003to\u2003act ivate \u2003the\u2003hand \u2003\nrepresentation \u2003area\u2003of\u2003the\u2003primar y\u2003motor \u2003cor tex.", "8c8ed924-469e-4ad3-be05-79f9eb536bc7": "Clin Radiol \u200368:e21\u2013e26, \u20032013.\n133.\u2003H ooper \u2003R G,\u2003T enholder \u2003MF ,\u2003U nderwood \u2003GH,\u2003e t \u2003al:\u2003C omputed \u2003\ntomographic \u2003scanning \u2003o f\u2003the \u2003b rain \u2003in \u2003init ial \u2003stag ing \u2003o f\u2003b ronchogenic \u2003\ncarcinoma. \u2003Chest \u200385:774\u2013776, \u20031984.\n134.\u2003H ung \u2003RJ ,\u2003M cKay \u2003JD ,\u2003Gab orieau \u2003V ,\u2003e t \u2003al:\u2003A \u2003s usceptibility \u2003lo cus \u2003f or \u2003l ung \u2003\ncancer \u2003maps \u2003t o \u2003nic otinic \u2003a cetylcholine \u2003r eceptor \u2003s ubunit \u2003g enes \u2003o n \u2003\n15q25. \u2003Nature \u2003452:633\u2013637, \u20032008.\n135.\u2003I chinose \u2003Y ,\u2003F ukuyama \u2003Y ,\u2003A soh \u2003H,\u2003e t \u2003al:\u2003I nduction \u2003c hemoradiotherapy \u2003\nand\u2003s urgical \u2003r esection \u2003f or \u2003se lected \u2003stag e \u2003IIIB \u2003no n-small-cell \u2003l ung \u2003canc er.\u2003\nAnn Thorac Surg \u200376:1810\u20131814, \u2003discussio n \u20035,\u20032003.\n136.\u2003I nfante \u2003M,\u2003C avuto \u2003S,\u2003L utman \u2003FR,\u2003e t \u2003al:\u2003A \u2003r andomized \u2003st udy \u2003o f\u2003l ung \u2003\ncancer \u2003scr eening \u2003w ith \u2003spir al \u2003c omputed \u2003t omography: \u2003T hree-year \u2003r esults \u2003\nfrom \u2003the \u2003D ANTE \u2003t rial.\u2003Am J Respir Crit Care Med \u2003180:445\u2013453, \u20032009.\n137.\u2003I nternational \u2003A gency \u2003f or \u2003R esearch \u2003o n \u2003C ancer: \u2003Tobacco smoke and \ninvoluntary smoking. IARC Monograph 83 ,\u2003L yon, \u2003F rance, \u20032004, \u2003\nInternational \u2003A gency \u2003f or \u2003R esearch \u2003o n \u2003C ancer.\n138.\u2003I shida \u2003T ,\u2003T ateishi \u2003M,\u2003K aneko \u2003S,\u2003e t \u2003al:\u2003C arcinosarcoma \u2003and \u2003spind le \u2003c ell \u2003\ncarcinoma \u2003o f\u2003the \u2003l ung.\u2003C linicopathologic \u2003and \u2003imm unohistochemical \u2003\nstudies. \u2003J Thorac Cardiovasc Surg \u2003100:844\u2013852, \u20031990.\n139.\u2003J anssen \u2003JP ,\u2003M ulder \u2003JJ ,\u2003W agenaar \u2003SS,\u2003e t \u2003al:\u2003P rimary \u2003sar coma \u2003o f\u2003the \u2003l ung:\u2003\nA\u2003c linical \u2003st udy \u2003w ith \u2003lo ng-term \u2003f ollow-up. \u2003Ann Thorac Surg \u200358:1151\u2013\n1155, \u20031994.\n140.", "170d315d-8392-4243-98b0-39e690983815": "96\u2003for\u2003MRS.233\u2003Lac\u2003and\u2003amino \u2003acid\u2003signals \u2003with\u2003or\u2003without \u2003other \u2003\nmetabolites \u2003wer e\u2003obser ved\u2003in\u200325\u2003of\u200329\u2003cases \u2003of\u2003abscesses.233\u2003In\u2003three \u2003\npatients \u2003with\u2003neuro cysticercosis \u2003in\u2003their \u2003cohor t,\u2003nonspe cific\u2003amino \u2003\nacid\u2003signals \u2003(n\u2003=\u20032),\u2003Lac\u2003(n\u2003=\u20033),\u2003acetate \u2003(n\u2003=1),\u2003succinate \u2003(n\u2003=\u20033),\u2003Cho\u2003\n(n\u2003=\u20032),\u2003and\u2003alanine \u2003(n\u2003=\u20033)\u2003were\u2003seen.233\u2003Whereas \u2003diffusion \u2003restr iction \u2003\nwas\u2003suggestive \u2003of\u2003brain \u2003abscess, \u2003in\u2003the\u2003absence \u2003of\u2003diffusion \u2003restr iction, \u2003\nproton \u2003MRS \u2003was\u2003necessar y\u2003to\u2003accur ately\u2003distinguish \u2003brain \u2003abscesses \u2003\nfrom \u2003cystic \u2003tumor s.233\nVarious \u2003studies \u2003have\u2003shown \u2003resonanc es\u2003from \u2003ace tate,\u2003succinat e,\u2003and\u2003\nsome \u2003amino \u2003acids \u2003(signals \u2003not\u2003seen\u2003in\u2003brain \u2003neoplasms) \u2003in\u2003additio n\u2003to", "dd6696de-dd14-4bc0-a121-2bfec817e140": "RAVFs \u2003in\u2003the\u2003cauda \u2003equina \u2003may\u2003be\u2003difficult \u2003to\u2003dif\u00ad\nferentiate \u2003from \u2003FTAVFs,41\u2003whereas \u2003other \u2003radicular \u2003fistulae \u2003may\u2003mimic \u2003\ndural \u2003AV\u2003shunts. \u2003The\u2003major \u2003differ ence\u2003is\u2003that\u2003radicular \u2003shunts \u2003are\u2003\npresent \u2003after\u2003the\u2003arte ry\u2003has\u2003pierc ed\u2003the\u2003dura, \u2003but\u2003dural \u2003AVFs \u2003are\u2003prese nt\u2003\nat\u2003the\u2003level\u2003of\u2003the\u2003dura. \u2003Clinical \u2003manifestatio ns\u2003and\u2003treat ment \u2003are\u2003in\u2003\nkeeping \u2003with\u2003other \u2003for ms\u2003of\u2003spinal \u2003cor d\u2003vascular \u2003malfor mations; \u2003\nhowever, \u2003radicular \u2003sympt oms\u2003are\u2003ofte n\u2003the\u2003first\u2003sympt om\u2003in\u2003these \u2003\ntypes \u2003of\u2003lesions \u2003and\u2003are\u2003rare ly\u2003seen\u2003in\u2003other \u2003vascular \u2003shunts. \u2003When \u2003the\u2003\nFIG 33-6  FTAVF in a 47-year-old woman. A, On T2 a low-lying conus suggesting tethered cord is noted, as \nwell as spinal cord congestion (arrow in A). Shunt is dually fed by anterior spinal artery (arrow in B) and \nlateral sacral artery ( B), which is clearly demonstrated on contrast-enhanced MR angiogram ( C). The arrow \nin C points to the anterior spinal artery. \nA B Canterior \u2003spinal \u2003arte ry\u2003arises \u2003from \u2003the\u2003same \u2003radicular \u2003fee der\u2003that\u2003\u2003\nsupplies \u2003the\u2003AVM, \u2003microsurg ical\u2003treat ment \u2003tends \u2003to\u2003be\u2003favo red41\u2003\n(Fig.\u200333\u00ad7).\nParavertebral Arteriovenous Fistulae (PVAVFs)\nPVAVFs \u2003(epidural \u2003AVFs) \u2003are\u2003relat ively\u2003rare\u2003lesions \u2003and\u2003occur \u2003outside \u2003\nthe\u2003dura\u2003mater \u2003betw een\u2003the\u2003radicular \u2003arte ry\u2003and\u2003epidur al\u2003venous \u2003\nplexus. \u2003They \u2003typical ly\u2003prese nt\u2003with\u2003benig n\u2003clinical \u2003sympt oms\u2003such\u2003as\u2003\nradiculopathy \u2003from \u2003a\u2003comp ressive \u2003mass \u2003effe ct\u2003on\u2003nerv e\u2003roots; \u2003only\u2003ver y\u2003\nrarely \u2003does\u2003cong estive \u2003mye lopathy \u2003due\u2003to\u2003per imedullary \u2003reflux \u2003\noccur.26,42\u2003The\u2003lesions \u2003are\u2003found \u2003more \u2003ofte n\u2003in\u2003the\u2003lumbar \u2003reg ion\u2003of\u2003\nelderly \u2003men.26\u2003On\u2003T2\u2003imaging, \u2003dilated \u2003epidur al\u2003veins \u2003comp ressing \u2003the\u2003\ncord\u2003can\u2003be\u2003noted, \u2003with\u2003multiple \u2003flow\u2003voids \u2003in\u2003the\u2003parav ertebral \u2003reg ion.", "6bdc0a8b-efd5-4f11-b1f9-bdbb4b1f9fe3": "CHAPTER 12 \u2003 Cerebral \u2003Aneurysms \u2003and\u2003Cerebrovascular \u2003Malformations 353\nFIG 12-12  A, Axial T2-weighted image demonstrates a mass with peripheral hemosiderin in the right tem -\nporal lobe uncus (arrow). B, Reconstructed collapsed MRA view does not depict the abnormality in the medial \nright temporal lobe well (arrow), although the source MRA image ( C) does (arrow). D, Lateral view of the \ncatheter right carotid cerebral angiogram documents the traumatic right anterior choroidal pseudoaneurysm \n(arrow). The pseudoaneurysm was absent on previous catheter cerebral angiography. Slow flow within the pseudoaneurysm accounted for its appearance on MRA. \nA B\nC D", "9ab2c172-d4a3-4c77-9bac-494aa1dc0bb1": "Less\u2003co mmonly \u2003the\u2003ent ire\u2003rig ht\u2003\nupper \u2003lobe\u2003br onchus \u2003may\u2003be\u2003displac ed,\u2003a\u2003co nfiguration \u2003that\u2003is\u2003also\u2003\nreferred \u2003to\u2003as\u2003a\u2003\u201cpig \u201d\u2003br onchus. \u2003Althoug h\u2003usual ly\u2003an\u2003asymp tomatic \u2003\u2003\nand\u2003incidentally \u2003de tected \u2003finding, \u2003impaire d\u2003drainag e\u2003may\u2003res ult\u2003in\u2003\nrecurrent \u2003infe ctions \u2003in\u2003some \u2003cases. \u2003Addit ionally, \u2003fol lowing \u2003end otra-\ncheal \u2003intubation, \u2003ate lectasis \u2003may\u2003oc cur\u2003in\u2003the\u2003po rtion \u2003of\u2003lung\u2003sup plied \u2003\nby\u2003the\u2003aberrant \u2003br onchus, \u2003ow ing\u2003to\u2003inad vertent \u2003obst ruction \u2003by\u2003the\u2003\nballoon \u2003cuff.\nOther \u2003types \u2003of\u2003displac ed\u2003br onchi \u2003incl ude\u2003pr oximal \u2003or\u2003distal \u2003dis-\nplacement \u2003of\u2003seg mental \u2003or\u2003subse gmental \u2003br onchi \u2003in\u2003the\u2003same \u2003lob e,\u2003\nbridging \u2003bronchus \u2003(the\u2003displac ed\u2003br onchus \u2003arises \u2003fro m\u2003the\u2003left\u2003main \u2003\nbronchus \u2003and\u2003crosses \u2003the\u2003midline \u2003to\u2003sup ply\u2003the\u2003rig ht\u2003low er\u2003lob e),\u2003and\u2003\nesophageal \u2003br onchus \u2003(the\u2003displac ed\u2003br onchus \u2003arises \u2003fro m\u2003the\u2003esop ha-\ngus\u2003and\u2003is\u2003dire cted\u2003to\u2003a\u2003low er\u2003lob e).21,51,77\nSupernumerary Bronchi.  Cardiac bronchus \u2003refers \u2003to\u2003a\u2003supernumer -\nary\u2003bronchus \u2003arising \u2003fro m\u2003the\u2003medial \u2003wall\u2003of\u2003the\u2003br onchus \u2003inte rme-\ndius.21,47,51,77\u2003This\u2003may\u2003be\u2003a\u2003blind \u2003ending \u2003or\u2003may\u2003cour se\u20031\u2003to\u20035\u2003cm\u2003\ncaudad \u2003toward \u2003the\u2003heart. \u2003It\u2003may\u2003ve ntilate \u2003a\u2003hy poplastic \u2003lob ule\u2003and\u2003can\u2003\nbe\u2003associated \u2003with\u2003a\u2003discre te\u2003soft\u2003tiss ue\u2003mass \u2003due\u2003to\u2003vascular ized\u2003br on-\nchial \u2003or\u2003vestigial \u2003pare nchymal \u2003tiss ue.\u2003Althoug h\u2003usual ly\u2003asymp tomatic, \u2003\naffected \u2003patients \u2003may\u2003pr esent \u2003with\u2003infe ction \u2003or\u2003hemo ptysis. \u2003Surg ical\u2003\nexcision \u2003is\u2003recommended \u2003fo r\u2003symp tomatic \u2003patie nts.\nFIG 40-24 \u2002 Tracheal \u2002\u201cpig\u201d \u2002bronchus.", "ee1b5eef-eb9c-4e32-8c82-f65ec75cc9b2": "CHAPTER 24 \u2003 Cervical \u2003Adenopathy \u2003and\u2003Neck \u2003Masses 727\nthe\u2003carotid \u2003sheath \u2003with\u2003the\u2003sympathet ic\u2003chain \u2003and\u2003cranial \u2003nerv es\u2003IX\u2003\nthrough \u2003XII.\u2003Thus \u2003masses \u2003arising \u2003in\u2003the\u2003poststy loid\u2003compar tment \u2003\ninclude \u2003carotid \u2003arte ry\u2003lesions, \u2003paragang liomas \u2003arising \u2003from \u2003the\u2003vagus \u2003\nnerve \u2003or\u2003the\u2003carotid \u2003bod y,\u2003neuro genic \u2003tumor s\u2003invol ving\u2003cranial \u2003nerv es\u2003\nIX\u2003to\u2003XII,\u2003or\u2003sympathet ic\u2003chain \u2003neuro genic \u2003lesions. \u2003Most \u2003schwanno mas\u2003\nare\u2003fairly \u2003homog eneous \u2003soft\u2003tissue \u2003masses \u2003and\u2003appear \u2003hyp odense \u2003or\u2003\nisodense \u2003to\u2003skele tal\u2003muscle \u2003on\u2003nonco ntrast \u2003CT\u2003and\u2003tend\u2003to\u2003be\u2003hyp oin\u00ad\ntense \u2003or\u2003isointense \u2003to\u2003skele tal\u2003muscle \u2003on\u2003T1\u00adwe ighted \u2003and\u2003variab ly\u2003\nhyperintense \u2003on\u2003T2\u00adwe ighted \u2003MRI. \u2003Despite \u2003their \u2003hyp ovascularity, \u2003they\u2003\nenhance \u2003significantly \u2003on\u2003both\u2003CT\u2003and\u2003MRI\u2003and\u2003can\u2003mimic \u2003a\u2003paragan \u00ad\nglioma. \u2003Enhanceme nt\u2003of\u2003schwanno mas\u2003is\u2003seen\u2003at\u2003least\u20032\u2003minut es\u2003after\u2003\ncontrast \u2003inject ion\u2003and\u2003depic ts\u2003the\u2003equilib rium \u2003phase \u2003of\u2003the\u2003cont rast\u2003\nagent \u2003and\u2003the\u2003poo r\u2003venous \u2003drainage \u2003of\u2003the\u2003tumor .\u2003Dynamic \u2003scans \u2003can\u2003\nreveal \u2003the\u2003true\u2003nature \u2003of\u2003the\u2003lesion \u2003and\u2003differ entiate \u2003it\u2003from \u2003hyp ervas \u00ad\ncular \u2003lesions.", "9439454a-9603-42d7-898b-eb0545c640a2": "Postsurgical \u2002ev aluation.\u2002 Following \u2003surgery, \u2003ra diography \u2003is\u2003used\u2003\nroutinely; \u2003CT\u2003is\u2003used\u2003whe n\u2003co mplications \u2003are\u2003susp ected.45\nAfter \u2003pneumonectomy, \u2003the\u2003pne umonectomy \u2003spac e\u2003fills\u2003with\u2003fluid \u2003\nat\u2003a\u2003predictable \u2003rat e,\u2003with\u2003opa cification \u2003of\u2003app roximately \u2003one\u2003addi-\ntional \u2003intercostal \u2003spac e\u2003ev ery\u20037\u2003day s\u2003by\u2003chest \u2003ra diography. \u2003If\u2003the\u2003rat e\u2003\nof\u2003filling \u2003is\u2003ex cessive, \u2003hemo rrhage \u2003or\u2003ch yle\u2003leak\u2003due\u2003to\u2003damage \u2003to\u2003the\u2003\nthoracic \u2003duct\u2003should \u2003be\u2003susp ected. \u2003MRI\u2003can\u2003be\u2003used\u2003to\u2003ev aluate \u2003the\u2003\nthoracic \u2003duct\u2003pr ior\u2003to\u2003atte mpted \u2003co rrective \u2003emb olization \u2003in\u2003cases \u2003of\u2003\nchyle \u2003leak.\u2003Co ntrarily, \u2003a\u2003de crease \u2003in\u2003ac cumulated \u2003fluid \u2003sug gests \u2003de vel-\nopment \u2003of\u2003a\u2003BPF\u2003or\u2003leakage \u2003into\u2003the\u2003abdo men\u2003via\u2003a\u2003de fect\u2003in\u2003the\u2003\nreconstructed \u2003diaphr agm.45\u2003BPF\u2003tends \u2003to\u2003pr esent \u2003within \u20031\u2003we ek\u2003to\u20033\u2003\nmonths \u2003after\u2003surg ery.40\u2003Management \u2003of\u2003BPF\u2003in\u2003the\u2003co ntexts \u2003of\u2003pne u-\nmonectomy \u2003and\u2003emp yema \u2003is\u2003similar \u2003(Fig.\u200339-30).\nHerniation \u2003of\u2003the\u2003sto mach \u2003into\u2003the\u2003thor ax\u2003is\u2003a\u2003rar e\u2003co mplication \u2003of\u2003\nleft-sided \u2003pneumonectomy \u2003that\u2003may\u2003be\u2003co mplicated \u2003by\u2003str angula -\ntion.45\u2003In\u2003the\u2003rare\u2003post pneumonectomy \u2003syndro me,\u2003ext reme \u2003rotat ion\u2003for\u2003MPM \u2003and\u2003may\u2003be\u2003useful \u2003fo r\u2003guiding \u2003thor ascopic \u2003ev aluation4\u2003\n(Figs. \u200339-23 \u2003throug h\u200339-27).\nPET-CT.", "34f36acb-ce3e-4c06-b24c-e1ff19cc5c30": "This\u2003poo r\u2003surv ival\u2003\nrate\u2003is\u2003due\u2003to\u2003a\u2003tend ency\u2003for\u2003invasio n\u2003of\u2003the\u2003skull\u2003base. \u2003Orbital \u2003RMS \u2003\nhas\u2003the\u2003best\u2003pro gnosis, \u2003with\u2003an\u200380%\u2003to\u200390%\u20032\u00adyear\u2003disease \u00adfre e\u2003surv ival\u2003\nrate.72,84,115\nNeuroblastoma\nNeuroblastoma \u2003is\u2003a\u2003neural \u2003crest\u2003tumor \u2003arising \u2003from \u2003the\u2003sympathet ic\u2003\nnervous \u2003system. \u2003It\u2003is\u2003the\u2003most \u2003commo n\u2003malignant \u2003tumor \u2003in\u2003childre n\u2003\nyounger \u2003than\u2003age\u20031.\u2003The\u2003most \u2003freq uent\u2003sites\u2003are\u2003the\u2003adre nal\u2003gland \u2003and\u2003\nretroperitoneum.109\u2003Cervical \u2003neuro blastoma \u2003in\u2003infants \u2003is\u2003rare\u2003and\u2003\naccounts \u2003for\u2003less\u2003than\u20035%\u2003of\u2003all\u2003cases \u2003of\u2003neuro blastoma. \u2003Most \u2003that\u2003are\u2003\nlocated \u2003in\u2003the\u2003neck\u2003likel y\u2003rep resent \u2003metastatic \u2003disease \u2003from \u2003an\u2003abdomi \u00ad\nnal\u2003or\u2003thoracic \u2003primar y.25,188\nPresentation.  Patients \u2003often \u2003prese nt\u2003with\u2003a\u2003painless, \u2003smooth, \u2003firm\u2003\nmass \u2003and\u2003symptoms \u2003of\u2003dysp hagia, \u2003hoarse ness,\u2003strid or,\u2003and\u2003respirat ory\u2003\ndifficulty.2,25,188\u2003Neuroblastomas \u2003are\u2003dense ly\u2003cel lular\u2003tumor s\u2003comp osed\u2003FIG 26-16  Rhabdomyosarcoma. A, Axial contrast-enhanced CT image at the level of the nasal cavity dem -\nonstrates a large enhancing aggressive soft tissue mass involving the right maxillary sinus and the infratem -\nporal fossa (arrows). Axial ( B) and coronal ( C) contrast-enhanced T1-weighted MRIs demonstrate an infiltrative \nmass involving the pharyngeal mucosal space, left infratemporal masticator space, skull base, and sphenoid \nsinus (arrows). \nA B C", "0df53e12-11ee-4ac9-90f2-5d2b959ccd49": "The\u2003two\u2003sides \u2003of\u2003each\u2003poste rior\u2003triang le\u2003are\u2003the\u2003ster nocleidomastoid \u2003\nmuscle \u2003anteriorly \u2003and\u2003the\u2003trap ezius \u2003muscle \u2003poste riorly. \u2003The\u2003base\u2003of\u2003\neach\u2003triangle \u2003is\u2003for med\u2003by\u2003the\u2003clav icle.\u2003The\u2003infer ior\u2003bel ly\u2003of\u2003the\u2003omo\u00ad\nhyoid \u2003muscle \u2003crosses \u2003the\u2003infer ior\u2003aspec t\u2003of\u2003the\u2003poste rior\u2003triang le\u2003and\u2003\ndivides \u2003it\u2003into\u2003two\u2003unequal \u2003parts, \u2003the\u2003occipital \u2003triang le\u2003supe riorly \u2003and\u2003\nthe\u2003subclavian \u2003triang le\u2003infer iorly. \u2003The\u2003major \u2003struc tures \u2003locate d\u2003within \u2003\nthe\u2003occipital \u2003triang le\u2003are\u2003the\u2003spinal \u2003acc essory \u2003nerv e\u2003(cranial \u2003nerv e\u2003XI)\u2003\nand\u2003its\u2003associated \u2003chain \u2003of\u2003lymp h\u2003nodes. \u2003The\u2003major \u2003struc tures \u2003locate d\u2003\nwithin \u2003the\u2003subclavian \u2003triang le\u2003are\u2003the\u2003transv erse\u2003cer vical\u2003vessels \u2003and\u2003\ntheir \u2003associated \u2003chain \u2003of\u2003lymp h\u2003nodes.", "aa96b412-89d7-42f0-9074-1e018ad0dd2e": "Radiology \u2003212:643\u2013648, \u20031999.\n164.\u2003K irwan \u2003W O,\u2003W albaum \u2003PR,\u2003M cCormack \u2003RJ:\u2003C ystic \u2003int rathoracic \u2003\nderivatives \u2003o f\u2003the \u2003f oregut \u2003and \u2003the ir \u2003c omplications. \u2003Thorax \u200328:424\u2013428, \u2003\n1973.\n165.\u2003K lemm \u2003KM,\u2003M oran \u2003CA:\u2003P rimary \u2003ne uroendocrine \u2003car cinomas \u2003o f\u2003the \u2003\nthymus. \u2003Semin Diagn Pathol \u200316:32\u201341, \u20031999.\n166.\u2003K lemm \u2003KM,\u2003M oran \u2003CA,\u2003S uster \u2003S:\u2003Pig mented \u2003th ymic \u2003car cinoids: \u2003A \u2003\nclinicopathological \u2003and \u2003imm unohistochemical \u2003st udy \u2003o f\u2003tw o \u2003cases. \u2003Mod \nPathol \u200312:946\u2013948, \u20031999.\n167.\u2003K napp \u2003RH,\u2003H urt \u2003RD ,\u2003P ayne \u2003W S,\u2003e t \u2003al:\u2003M alignant \u2003g erm \u2003c ell \u2003t umors \u2003o f\u2003\nthe\u2003me diastinum. \u2003J Thorac Cardiovasc Surg \u200389:82\u201389, \u20031985.\n168.\u2003K oga \u2003K,\u2003M atsuno \u2003Y ,\u2003N oguchi \u2003M,\u2003e t \u2003al:\u2003A \u2003r eview \u2003o f\u200379 \u2003th ymomas: \u2003\nModification \u2003o f\u2003stag ing \u2003sy stem \u2003and \u2003r eappraisal \u2003o f\u2003c onventional \u2003di vision \u2003\ninto\u2003in vasive \u2003and \u2003no n-invasive \u2003th ymoma. \u2003Pathol Int \u200344:359\u2013367, \u20031994.\n169.\u2003K onen \u2003E,\u2003M erchant \u2003N,\u2003G utierrez \u2003C,\u2003e t \u2003al:\u2003T rue \u2003v ersus \u2003false \u2003le ft \u2003\nventricular \u2003ane urysm: \u2003D ifferentiation \u2003w ith \u2003MR \u2003imag ing\u2013Initial \u2003\nexperience. \u2003Radiology \u2003236:65\u201370, \u20032005.\n170.\u2003K rishnan \u2003J ,\u2003Dano n \u2003AD ,\u2003F rizzera \u2003G:\u2003R eactive \u2003l ymphadenopathies \u2003and \u2003\natypical \u2003l ymphoproliferative \u2003diso rders. \u2003Am J Clin Pathol \u200399:385\u2013396, \u2003\n1993.\n171.\u2003K rubsack \u2003AJ ,\u2003W ilson \u2003SD ,\u2003La wson \u2003TL,\u2003e t \u2003al:\u2003P rospective \u2003c omparison \u2003o f\u2003\nradionuclide, \u2003c omputed \u2003t omographic, \u2003so nographic, \u2003and \u2003mag netic \u2003\nresonance \u2003lo calization \u2003o f\u2003par athyroid \u2003t umors. \u2003Surgery \u2003106:639\u2013644, \u2003\ndiscussion \u2003644\u2013646, \u20031989.\n172.", "604266c1-e8b9-428e-b08c-7277946bb9ff": "A\u2003study \u2003eval uating \u2003the\u2003\nrelationship \u2003betw een\u2003DWI \u2003alter ations \u2003and\u2003the\u2003seve rity\u2003of\u2003the\u2003clinical \u2003\ncourse \u2003in\u2003sCJD \u2003sugg ested \u2003that\u2003patients \u2003showing \u2003hyp erintensities \u2003in\u2003\nboth \u2003the\u2003cortex \u2003and\u2003basal \u2003ganglia \u2003expe rience \u2003a\u2003significantly \u2003short er\u2003\ninterval \u2003from \u2003disease \u2003onset \u2003to\u2003akinetic \u2003mut ism\u2003than\u2003those \u2003with\u2003only\u2003\ncortical \u2003ribbon \u2003hyp erintensity.142\nDWI \u2003signal \u2003changes \u2003usuall y\u2003are\u2003more \u2003evid ent\u2003and\u2003earlier \u2003in\u2003the\u2003\ndisease \u2003course \u2003than\u2003T2\u2003or\u2003FLAIR \u2003hyp erintensities,132\u2003showing \u2003focal \u2003\nchanges \u2003not\u2003yet\u2003appare nt\u2003on\u2003FLAIR \u2003images \u2003in\u2003up\u2003to\u200320%\u2003of\u2003cases.132,143\u2003\nIn\u2003sCJD, \u2003DWI \u2003has\u2003appr oximate \u2003sensiti vity\u2003and\u2003specificit y\u2003great er\u2003than\u2003\n90%,132,143\u2003which \u2003are\u2003higher \u2003than\u2003those \u2003of\u2003curre nt\u2003clinicall y\u2003availab le\u2003\ncerebrospinal \u2003fluid \u2003(CSF) \u2003biomar kers\u2003such\u2003as\u200314-3-3, \u2003total\u2003tau,\u2003and\u2003\nneuron-specific \u2003enolase.30,146\u2003The\u20032009 \u2003European \u2003crite ria\u2003for\u2003pro bable \u2003\nsCJD \u2003consider \u2003increased \u2003signal \u2003intensit y\u2003on\u2003FLAIR \u2003or\u2003DWI \u2003as\u2003an\u2003equi v-\nalent \u2003diagnostic \u2003finding \u2003to\u2003either \u2003elev ated\u2003CSF\u200314-3-3 \u2003prot ein\u2003or\u2003per i-\nodic\u2003sharp \u2003and\u2003slow\u2003wave \u2003comple xes\u2003on\u2003the\u2003elec troencephalogram.146\u2003\nIn\u2003clinical \u2003practice, \u2003sCJD \u2003is\u2003freq uently \u2003misdiagnosed \u2003as\u2003other \u2003condi -\ntions. \u2003According \u2003to\u2003UCSF \u2003(Univ ersity \u2003of\u2003Califo rnia,\u2003San\u2003Francisc o)\u2003\nMRI\u2003criteria, \u2003four\u2003MRI\u2003featur es\u2003may\u2003help\u2003differ entiate \u2003sCJD \u2003from \u2003\nnonprion \u2003diagnoses132:\u2003(1)\u2003greater \u2003hyp erintensity \u2003on\u2003DWI \u2003than\u2003on\u2003\nFLAIR, \u2003(2)\u2003subc ortical \u2003GM\u2003hyp erintensities \u2003on\u2003DWI \u2003associate d\u2003with\u2003FIG 15-6  Three common variations of sporadic Creutzfeldt-Jakob disease presentation on MRI. A, Neocorti-\ncal (solid arrow), limbic (dashed arrow), and subcortical gray matter hyperintensities (dotted arrow) on DWI \nand FLAIR scans. B, Neocortical and limbic cortex involvement.", "98c76c4d-76cd-45e7-bef9-046013a8fa3f": "In\u2003cases \u2003of\u2003EMH \u2003seco ndary \u2003to\u2003mye lofibrosis \u2003\nthere \u2003will\u2003be\u2003diffuse \u2003bon y\u2003scler osis.\u2003Sulfur \u2003collo id\u2003scan\u2003can\u2003aid\u2003the\u2003\ndiagnosis, \u2003because \u2003radiot racer \u2003will\u2003be\u2003taken \u2003up\u2003throughou t\u2003affec ted\u2003\nsites.15\nDifferential \u2003diagnosis \u2003includ es\u2003lymp homa, \u2003metastatic \u2003disease, \u2003\nhematoma, \u2003nerv e\u2003sheath \u2003tumor s,\u2003and\u2003abscesses. \u2003Lymp homa \u2003usuall y\u2003\ndemonstrates \u2003intense \u2003enhance ment, \u2003in\u2003cont rast\u2003to\u2003the\u2003mild \u2003enhance -\nment \u2003noted \u2003in\u2003most \u2003cases \u2003of\u2003EMH.7\u2003Metastatic \u2003disease \u2003usuall y\u2003invol ves\u2003\nthe\u2003vertebral \u2003bodies, \u2003and\u2003in\u2003most \u2003cases \u2003there \u2003is\u2003a\u2003known \u2003primar y\u2003\nmalignancy. \u2003It\u2003is\u2003also\u2003rare\u2003to\u2003have\u2003isolated \u2003paraspinal \u2003soft\u2003tissue \u2003invol ve-\nment \u2003with\u2003sparing \u2003of\u2003the\u2003ver tebral \u2003bodies \u2003in\u2003metastatic \u2003disease. \u2003Ner ve\u2003\nsheath \u2003tumors \u2003usuall y\u2003demo nstrate \u2003some \u2003deg ree\u2003of\u2003T2\u2003hyp erintensity \u2003\nand\u2003most \u2003commonly \u2003invol ve\u2003a\u2003single \u2003leve l,\u2003with\u2003the\u2003exc eption \u2003of\u2003neu-\nrofibromatosis \u2003patients. \u2003Epidur al\u2003hemato mas\u2003most \u2003commo nly\u2003dev elop\u2003\nacutely \u2003in\u2003the\u2003setting \u2003of\u2003trauma, \u2003and\u2003signal \u2003intensit y\u2003and\u2003enhance ment \u2003\ncharacteristics \u2003vary\u2003dep ending \u2003on\u2003the\u2003stage \u2003of\u2003the\u2003bloo d\u2003pro ducts. \u2003\nParaspinal \u2003abscesses \u2003most \u2003commo nly\u2003cause \u2003destr uctive \u2003changes \u2003in\u2003\nadjacent \u2003bone \u2003and\u2003inflammator y\u2003changes \u2003in\u2003surr ounding \u2003soft\u2003tissues.\nTreatment \u2003depends \u2003on\u2003the\u2003complicat ions\u2003of\u2003the\u2003disease. \u2003In\u2003cases \u2003of\u2003\nspinal \u2003cord\u2003compression, \u2003ster oids\u2003might \u2003help\u2003red uce\u2003inflammation \u2003and\u2003\nimprove \u2003symptoms. \u2003Surgical \u2003dec ompression \u2003is\u2003need ed\u2003in\u2003refr actory \u2003\ncases. \u2003Transfusions, \u2003radiothe rapy, \u2003and\u2003hemog lobin-stimulating \u2003agents \u2003\nalso\u2003play\u2003a\u2003role.(\u201csandwich \u2003ver tebra\u201d).", "c4277636-fa10-41b7-a16d-0b6567abc9e6": "MRI\u2003using \u2003che mical \u2003shift\u2003analy sis\u2003and\u2003dynamic \u2003ga dolinium \u2003enhanc e-\nment \u2003can\u2003also\u2003be\u2003used\u2003to\u2003de termine \u2003whe ther\u2003an\u2003adr enal\u2003mass \u2003is\u2003\nbenign34,221,268\u2003(Fig.\u200337-28).\nFDG \u2003PET\u2003is\u2003useful \u2003in\u2003distinguishing \u2003be nign\u2003fro m\u2003malignant \u2003adr enal\u2003\nmasses \u2003detected \u2003on\u2003CT\u2003and\u2003is\u2003part icularly \u2003ad vocated \u2003whe n\u2003the\u2003adr enal\u2003\nmass \u2003is\u2003small. \u2003A\u2003meta-anal ysis\u2003of\u200321\u2003studies, \u20031391 \u2003lesions \u2003in\u2003whic h\u20035\u2003\nreports \u2003were\u2003spe cifically \u2003in\u2003patie nts\u2003with\u2003lung\u2003cance r,\u2003re ported \u2003a\u2003co m-\nbined \u2003sensitivity \u2003of\u200394%\u2003and\u2003spe cificity \u2003of\u200382%\u2003of\u2003FDG \u2003PET\u2003in\u2003de tect-\ning\u2003adrenal \u2003metastasis \u2003in\u2003patie nts\u2003with\u2003lung\u2003cance r.32\u2003PET\u2003has\u2003changed \u2003\nthe\u2003imaging \u2003algo rithm \u2003used\u2003to\u2003ev aluate \u2003an\u2003inde terminate \u2003adr enal\u2003mass \u2003\ndetected \u2003on\u2003CT\u2003and\u2003is\u2003now\u2003oft en\u2003used\u2003as\u2003the\u2003definit ive\u2003imaging \u2003modal -\nity\u2003rather \u2003than\u2003MRI, \u2003part icularly \u2003whe n\u2003the\u2003adr enal\u2003mass \u2003is\u2003small. \u2003In\u2003\nfact\u2003adrenal \u2003masses \u2003can\u2003be\u2003char acterized \u2003by\u2003FDG \u2003PET ,\u2003and\u2003subse quent \u2003\nimaging \u2003is\u2003usual ly\u2003unnec essary32\u2003(see\u2003Fig.\u200337-27). \u2003In\u2003this\u2003re gard, \u2003if\u2003FDG \u2003\nuptake \u2003by\u2003an\u2003adr enal\u2003mass \u2003is\u2003nor mal\u2003in\u2003a\u2003patie nt\u2003with\u2003pot entially \u2003\nresectable \u2003NSCLC, \u2003curat ive\u2003rese ction \u2003should \u2003be\u2003co nsidered \u2003withou t\u2003\nfurther \u2003evaluation. \u2003Pat ients \u2003with\u2003NSCLC \u2003and\u2003an\u2003isolate d\u2003adr enal\u2003mass \u2003\nwith\u2003increased \u2003FDG \u2003uptak e\u2003should \u2003hav e\u2003the\u2003adr enal\u2003lesion \u2003bio psied \u2003\nbefore \u2003being \u2003de nied\u2003surg ery.", "7232c25d-348e-49ef-b46d-d13afe31be4a": "J Neuropathol Exp Neurol \u2003\n65(1):1\u201311, \u20032006.\n33.\u2003Kumar \u2003AJ,\u2003Le eds\u2003NE,\u2003Ful ler\u2003GN,\u2003et\u2003al:\u2003Malig nant\u2003glio mas:\u2003MR\u2003imaging \u2003\nspectrum \u2003of\u2003ra diation \u2003ther apy-\u2003and\u2003che motherapy-induced \u2003necr osis\u2003of\u2003\nthe\u2003brain \u2003after\u2003tr eatment. \u2003Radiology \u2003217(2):377\u2013384, \u20032000.\n34.\u2003Lassmann \u2003H,\u2003Br uck\u2003W,\u2003Luc chinetti \u2003CF:\u2003The\u2003immuno pathology \u2003of\u2003\nmultiple \u2003sclerosis: \u2003An\u2003ov erview. \u2003Brain Pathol \u200317(2):210\u2013218, \u20032007.\n35.\u2003Laxmi \u2003SN,\u2003Takahashi \u2003S,\u2003Mats umoto \u2003K,\u2003et\u2003al:\u2003Tr eatment-related \u2003\ndisseminated \u2003necr otizing \u2003leuk oencephalopathy \u2003with\u2003char acteristic \u2003\ncontrast \u2003enhancement \u2003of\u2003the\u2003whit e\u2003matte r.\u2003Radiat Med \u200314(6):303\u2013307, \u2003\n1996.\n36.\u2003Lee\u2003YY,\u2003Naue rt\u2003C,\u2003Glass \u2003JP:\u2003Tr eatment-related \u2003whit e\u2003matte r\u2003chang es\u2003in\u2003\ncancer \u2003patients. \u2003Cancer \u200357(8):1473\u20131482, \u20031986.\n37.\u2003Lewis \u2003E,\u2003Le e\u2003YY:\u2003Co mputed \u2003to mography \u2003findings \u2003of\u2003sev ere\u2003miner alizing \u2003\nmicroangiopathy \u2003in\u2003the\u2003br ain.\u2003J Comput Tomogr \u200310(4):357\u2013364, \u2003\n1986.\n38.\u2003Loes\u2003DJ,\u2003Bil ler\u2003J,\u2003Yuh\u2003WT ,\u2003et\u2003al:\u2003Le ukoencephalopathy \u2003in\u2003ce rebral \u2003\namyloid \u2003angiopathy: \u2003MR\u2003imaging \u2003in\u2003four\u2003cases. \u2003AJNR Am J Neuroradiol \u2003\n11(3):485\u2013488, \u20031990.\n39.\u2003Love\u2003S:\u2003De myelinating \u2003diseases. \u2003J Clin Pathol \u200359(11):1151\u20131159, \u20032006.\n40.\u2003Lublin \u2003FD,\u2003Re ingold \u2003SC,\u2003Cohe n\u2003JA,\u2003et\u2003al:\u2003Defining \u2003the\u2003clinical \u2003cour se\u2003of\u2003\nmultiple \u2003sclerosis: \u2003The\u20032013\u2003re visions. \u2003Neurology \u200383(3):278\u2013286, \u20032014.\n41.\u2003Mahan \u2003M,\u2003Kar l\u2003M,\u2003Gor don\u2003S:\u2003Ne uroimaging \u2003of\u2003vir al\u2003infe ctions \u2003of\u2003the\u2003\ncentral \u2003nervous \u2003syst em.\u2003Handb Clin Neurol \u2003123:149\u2013173, \u20032014.\n42.\u2003Martins \u2003AN,\u2003Johnst on\u2003JS,\u2003He nry\u2003JM,\u2003et\u2003al:\u2003De layed \u2003ra diation \u2003necr osis\u2003of\u2003\nthe\u2003brain.", "e72dd72e-daf7-4f91-a7dc-b9135837747f": "The bipolar gradient is inserted along the axis of motion encoding, here shown for the \nslice-encoding direction. B, Graphical representation of the effect of the bipolar gradient in static tissue and \nthose with measurable velocity. Zero total phase is accrued in static spins, while in moving spins, the phase accrued during the bipolar gradients is proportional to their velocities in the encoded direction. \u03b1\nGreadout\nGsliceRF/Signalt\nt\nVelocity encoding / Bipolar gradientSpoilerBIPOLAR GRADIENT\nG\nt\nStatic spinsPhase Phase\u03d5 = 0\n\u03d5 ~ \u03bd Moving spins\nFIG 4-10  2D cine-PC MRA with through-plane velocity encoding for assessment of aortic flow. The data \nwere acquired with prospective ECG gating during a 30-second breath hold. Images A and B show an end-\nsystolic time frame. A, The magnitude images show details of anatomy including good vessel delinea -\ntion of the ascending aorta (AA), the descending aorta (DA), and the pulmonary artery (PA). B, Phase \nimages show voxel-by-voxel velocity maps with flows in opposing directions for the ascending (blue) and \ndescending (red) aorta. Note zero velocity in static tissues and white noise in air. C, Instantaneous flow \nmeasurements over the cardiac cycle can be generated by integrating the measured velocities over the \nsegmented vessel area. \n-150-100-50050100150cm/s\nFlow (mL/s)\nTime in RR cycle (ms)C B140\n90\n40Ascending aorta\nDescending aorta\n-10\n40210 380 550 710 8801050\nAsubcut. fat\nAA\nPA\nDA", "7fc9d652-25a3-409f-aac3-e3becd3f601b": "PART II \u2003 CT \u2003and\u2003MR\u2003Imaging \u2003of\u2003the\u2003Whole \u2003Body 242\ntypically \u2003demonstrate \u2003intense \u2003cont rast\u2003enhance ment, \u2003but\u2003rec ognition \u2003\nof\u2003the\u2003contrast-enhancing \u2003bico nvex\u2003epidur al\u2003tumor \u2003mass \u2003can\u2003be\u2003\nmasked \u2003by\u2003the\u2003adja cent\u2003bone \u2003unless \u2003relat ively\u2003wide \u2003windo w\u2003and\u2003high\u2003\ncenter \u2003settings \u2003are\u2003used.\nIn\u2003current \u2003practice, \u2003early \u2003det ection \u2003of\u2003small \u2003metastases \u2003in\u2003the\u2003diplo\u00eb \u2003\nor\u2003dura\u2003can\u2003best\u2003be\u2003acc omplished \u2003by\u2003using \u2003T1-weig hted\u2003MRI\u2003both\u2003\nbefore \u2003and\u2003after\u2003IV\u2003administr ation \u2003of\u2003gad olinium. \u2003Small \u2003foci\u2003of\u2003intra -\ndiploic \u2003metastasis \u2003appear \u2003hyp ointense \u2003on\u2003nonco ntrast \u2003T1-weig hted\u2003\nimages \u2003and\u2003differ \u2003sharply \u2003from \u2003the\u2003adja cent\u2003hyp erintense \u2003fatty\u2003marro w\u2003\nin\u2003the\u2003diploic \u2003space \u2003(Fig.\u20039-64). \u2003Postga dolinium \u2003T1-weig hted\u2003images \u2003\nobtained \u2003with\u2003fat\u2003supp ression \u2003typical ly\u2003demo nstrate \u2003intense \u2003cont rast\u2003\nenhancement \u2003of\u2003tumor \u2003in\u2003the\u2003epidur al\u2003space \u2003or\u2003dura, \u2003which \u2003appear s\u2003\nas\u2003nodular \u2003or\u2003curvilinear \u2003bandlike \u2003thicke ning\u2003(see\u2003Fig.\u20039-64); \u2003the\u2003\nunderlying \u2003cer ebral \u2003cor tex\u2003is\u2003displace d\u2003inward, \u2003and\u2003(unlike \u2003lept omen -\ningeal \u2003metastasis) \u2003the\u2003cont rast-enhancing \u2003tumor \u2003does\u2003not\u2003exte nd\u2003into\u2003\nthe\u2003cerebral \u2003sulci. \u2003The\u2003findings \u2003may\u2003simulate \u2003those \u2003of\u2003meningio ma,\u2003but\u2003\nepidural \u2003or\u2003dural \u2003metastasis \u2003typical ly\u2003appear s\u2003hyp erintense \u2003to\u2003adja cent\u2003\ncerebral \u2003cortex \u2003on\u2003T2-weig hted\u2003images, \u2003wher eas\u2003meningio ma\u2003is\u2003nearly \u2003\nisointense \u2003to\u2003cor tex\u2003on\u2003this\u2003pulsing \u2003seque nce.313\nLeptomeningeal Metastasis (Leptomeningeal Carcinomato-\nsis).", "841440cf-7f07-4d5d-8048-059c8a81249c": "AJR Am J Roentgenol \u2003194:868\u2013873, \u20032010.\n34.\u2003Supanich\u2003 MP ,\u2003Bevins\u2003 N,\u2003Myers\u2003 D:\u2003Reducing\u2003 Radiation\u2003 Dose\u2003 in\u2003\nAbdominal\u2003 CT\u2003Studies: \u2003ACR\u2003 Dose\u2003 Index\u2003 Registry\u2003 as\u2003an\u2003Impetus\u2003 for\u2003\nQuality\u2003 Improvement. \u2003In\u2003RSNA Qual. Story Boards ,\u20032013.\n35.\u2003Szczykutowicz\u2003 TP ,\u2003Bour\u2003 RK,\u2003Pozniak\u2003 M,\u2003et\u2003al,\u2003Compliance\u2003 with\u2003 AAPM\u2003\nPractice\u2003 Guideline\u2003 1.\u2003a:\u2003CT\u2003Protocol\u2003 Management\u2003 and\u2003Review\u2014from\u2003 the\u2003\nperspective\u2003 of\u2003a\u2003university\u2003 hospital, \u200316\u2003(2015)\u2003 443\u2013457.\n36.\u2003Szczykutowicz\u2003 TP ,\u2003Siegelman\u2003 J:\u2003On\u2003the\u2003same\u2003 page\u2014Physicist\u2003 and\u2003\nradiologist\u2003 perspectives\u2003 on\u2003protocol\u2003 management\u2003 and\u2003review. \u2003J Am Coll \nRadiol \u20031\u20137,\u20032015.\n37.\u2003Toth\u2003 T,\u2003Ge\u2003Z,\u2003Daly\u2003 MP:\u2003The\u2003influence\u2003 of\u2003patient\u2003 centering\u2003 on\u2003CT\u2003dose\u2003\nand\u2003image\u2003 noise. \u2003Med Phys \u200334:3093, \u20032007.\n38.\u2003Udayasankar\u2003 UK,\u2003Braithwaite\u2003 K,\u2003Arvaniti\u2003 M,\u2003et\u2003al:\u2003Low-dose\u2003\nnonenhanced\u2003 head\u2003 CT\u2003protocol\u2003 for\u2003follow-up\u2003 evaluation\u2003 of\u2003children\u2003\nwith\u2003 ventriculoperitoneal\u2003 shunt: \u2003Reduction\u2003 of\u2003radiation\u2003 and\u2003effect\u2003 on\u2003\nimage\u2003 quality. \u2003AJNR Am J Neuroradiol \u200329:802\u2013806, \u20032008.\n39.\u2003Wang\u2003 CL,\u2003Cohan\u2003 RH,\u2003Ellis\u2003 JH,\u2003et\u2003al:\u2003Frequency, \u2003management, \u2003and\u2003\noutcome\u2003 of\u2003extravasation\u2003 of\u2003nonionic\u2003 iodinated\u2003 contrast\u2003 medium\u2003 in\u2003\n69,657\u2003 intravenous\u2003 injections. \u2003Radiology \u2003243:80\u201387, \u20032007.\n40.\u2003Yuan\u2003 M-K, \u2003Tsai\u2003D-C, \u2003Chang\u2003 S-C,\u2003et\u2003al:\u2003The\u2003risk\u2003of\u2003cataract\u2003 associated\u2003\nwith\u2003 repeated\u2003 head\u2003 and\u2003neck\u2003 CT\u2003studies: \u2003A\u2003nationwide\u2003 population-based\u2003\nstudy. \u2003Am J Roentgenol \u2003201:626\u2013630, \u20032013.\n41.\u2003Zamyatin\u2003 AA,\u2003Nakanishi\u2003 S:\u2003Extension\u2003 of\u2003the\u2003reconstruction\u2003 field\u2003 of\u2003view\u2003\nand\u2003truncation\u2003 correction\u2003 using\u2003 sinogram\u2003 decomposition. \u2003Med Phys \u2003\n34:1593, \u20032007.8.\u2003Barrett\u2003 JF,\u2003Keat\u2003 N:\u2003Artifacts\u2003 in\u2003CT:\u2003Recognition\u2003 and\u2003avoidance. \u2003\nRadiographics \u200324:1679\u20131691, \u20032004.\n9.", "e831dcd5-8f43-4305-9954-25fd2b3254d9": "Volume-rendered \u20033D\u2003CT\u2003images \u2003may\u2003show \u2003the\u2003re lationship \u2003of\u2003\ntumor \u2003to\u2003critical \u2003str uctures \u2003and\u2003are\u2003oft en\u2003used\u2003fo r\u2003patie nt\u2003ed ucation \u2003\nand\u2003surgical \u2003planning. \u2003Othe r\u2003ad vanced \u2003CT\u2003te chniques \u2003are\u2003also\u2003co ming \u2003\ninto\u2003widespread \u2003use,\u2003incl uding \u2003vol umetric \u2003analy sis\u2003with\u2003ser ial\u2003seg men-\ntation \u2003and\u2003pe rfusion \u2003CT.45,100\u2003DCE \u2003\u201cperfusion\u201d \u2003CT\u2003can\u2003be\u2003used\u2003to\u2003\nmeasure \u2003blood \u2003flow\u2003dynamics \u2003and\u2003capillar y\u2003pe rmeability, \u2003ther eby\u2003\nevaluating \u2003micro vascularity \u2003of\u2003tumo rs\u2003be fore\u2003and\u2003afte r\u2003tr eatment.45\u2003CT\u2003\ndoes\u2003not\u2003assess \u2003nodal \u2003disease \u2003ac curately, \u2003be cause \u2003nodal \u2003size\u2003do es\u2003not\u2003\ncorrelate \u2003with\u2003tumo r\u2003inv olvement.5\nThe\u2003most \u2003commonly \u2003used\u2003tumo r,\u2003nod e,\u2003metastasis \u2003(TNM) \u2003staging \u2003\nsystem \u2003for\u2003CT\u2003and\u2003MRI\u2003was\u2003pr oposed \u2003by\u2003the\u2003Int ernational \u2003Mesothe -\nlioma \u2003Interest \u2003Gr oup\u2003(IMIG) \u2003in\u20031995. \u2003De termination \u2003of\u2003rese ctability \u2003\nvaries \u2003among \u2003instit utions \u2003and\u2003is\u2003oft en\u2003co nsidered \u2003on\u2003a\u2003case-by-case \u2003\nbasis.", "fcf83005-a1da-4bec-9195-0170a18603d8": "PART II \u2003 CT \u2003and\u2003MR\u2003Imaging \u2003of\u2003the\u2003Whole \u2003Body 938\ngranulomatous \u2003lung\u2003disord ers\u2003(e.g., \u2003sarco idosis), \u2003and\u2003other \u2003for ms\u2003of\u2003\nILD,\u2003including \u2003lymp hangioleiomyomatosis \u2003(LAM), \u2003Langer hans\u2003cel l\u2003\nhistiocytosis \u2003(LCH), \u2003and\u2003eosinop hilic\u2003pneumo nia.\nHRCT \u2003(1-\u2003to\u20032-mm \u2003collimat ion)\u2003is\u2003more \u2003sensiti ve\u2003than\u2003both \u2003con-\nventional \u2003thick-sec tion\u2003CT\u2003and\u2003chest \u2003radio graphy \u2003for\u2003the\u2003det ection \u2003and\u2003\ncharacterization \u2003of\u2003ILD.\u2003With \u2003the\u2003adv ent\u2003of\u2003MDCT \u2003scanners \u2003it\u2003is\u2003also\u2003\nfeasible \u2003to\u2003per form \u2003volume tric\u2003HRCT \u2003through \u2003the\u2003entir e\u2003chest; \u2003this\u2003\napproach \u2003allows \u2003assessment \u2003of\u2003the\u2003entir e\u2003lung\u2003parenc hyma \u2003and\u2003there -\nfore\u2003minimizes \u2003the\u2003risk\u2003of\u2003a\u2003false-negat ive\u2003examinatio n.\u2003In\u2003additio n,\u2003\nvolumetric \u2003HRCT \u2003allow s\u2003use\u2003of\u2003adv anced \u2003imaging \u2003tec hniques \u2003such\u2003as\u2003\nMPRs \u2003and\u2003MIPs \u2003or\u2003MiniPs. \u2003Ther e\u2003is\u2003no\u2003significant \u2003differ ence\u2003in\u2003ove rall\u2003\nimage \u2003quality \u2003betw een\u2003volume tric\u2003HRCT \u2003and\u2003standard \u2003axial\u2003HRCT \u2003\ntechniques.265,510,548\u2003Follow-up \u2003CT\u2003studies \u2003can\u2003be\u2003per formed \u2003by\u2003using \u2003\nlow-dose \u2003technique \u2003whene ver\u2003feasible.\nBasic CT Anatomy of the Lung Parenchyma\nA\u2003basic \u2003knowledge \u2003of\u2003the\u2003anatom y\u2003of\u2003the\u2003inter stitium \u2003and\u2003seco ndary \u2003\nlobule \u2003is\u2003essential \u2003for\u2003under standing \u2003pathologic \u2003alter ations \u2003in\u2003DLDs \u2003\nand\u2003their \u2003radiographic \u2003appear ances. \u2003In\u2003gene ral,\u2003DLD \u2003can\u2003be\u2003divid ed\u2003\ninto\u2003disease \u2003invol ving\u2003primar ily\u2003the\u2003airspac e,\u2003inter stitium, \u2003or\u2003small \u2003\nairways.\nLung Attenuation.  Attenuation \u2003(densit y)\u2003on\u2003a\u2003CT\u2003scan\u2003is\u2003expr essed \u2003\nin\u2003terms \u2003of\u2003Hounsfield \u2003units \u2003(HU); \u2003under \u2003normal \u2003circumstances, \u2003water \u2003\nis\u20030\u2003HU\u2003and\u2003air\u2003is\u2003\u22121000 \u2003HU.", "5059cfe3-93be-420e-90df-313ad6e4ff54": "PART I \u2003 Principles \u2003of \u2003Computed \u2003Tomography \u2003and \u2003Magnetic \u2003Resonance \u2003Imaging 50\nFIG 3-5  A, A phase-encoding gradient is applied along the y-direction, which causes spins in different loca -\ntions in the y-direction to precess with different frequencies. When the gradient is turned off, the spins have \na phase that is dependent on their position. This phase is retained when frequency encoding is applied in a direction orthogonal to the phase encoding. B, To collect different phase-encoding lines, phase-encoding \ngradients with different strengths are used. For k\ny = 0, no phase-encoding gradient is applied, and no \ny-position\u2013dependent phase is imparted. For k y = 1, a gradient is applied with a strength and duration that \nleads to one period of a sinusoid across the field of view (FOV) in the y-direction. For k y = 2, the gradient \narea is twice that for k y = 1, and the phase variation of the magnetization over the FOV covers two periods. \nGy strengthGy strength Gy strength Gy strength\nTimeTimeTimeAt end of\ngradient\nAt end of\ngradient\nAt end of\ngradientTime\nyky = 2ky = 1ky = 0\nyyy yAt end of gradient\ny A\nB\nk-Space\nk-Space \u2003is\u2003the \u2003c ommonly \u2003use d \u2003name \u2003f or \u2003the \u2003r aw \u2003data \u2003c ollected \u2003in \u2003\nMRI.48,58,75\u2003T hese \u2003data \u2003ar e \u2003a \u2003se t \u2003o f\u2003sample d \u2003p oints \u2003st ored \u2003in \u2003a \u2003mat rix \u2003o f\u2003\nnumbers, \u2003w here \u2003ea ch \u2003line \u2003o f\u2003n umbers \u2003c orresponds \u2003t o \u2003o ne \u2003v alue \u2003o f\u2003the \u2003\nphase-encoding \u2003g radient. \u2003T he \u2003units \u2003o f\u2003k-spa ce \u2003ar e \u2003t ime \u2003(s) \u2003o r \u2003in verse \u2003\nmeters \u2003(m\u22121);\u2003b oth \u2003ar e \u2003diff erent \u2003wa ys \u2003o f\u2003lo oking \u2003at \u2003the \u2003same \u2003data. \u2003T he \u2003\nk-space \u2003data \u2003ar e \u2003e ncoded \u2003as \u2003p reviously \u2003d escribed, \u2003w ith \u2003p hase \u2003and \u2003fr e-\nquency \u2003e ncoding \u2003using \u2003mag netic \u2003fie ld \u2003g radients. \u2003T he \u2003g radients \u2003c ontrol \u2003\nthe\u2003path \u2003that \u2003is \u2003t raversed \u2003thr ough \u2003k-spa ce.\u2003A n \u2003e xample \u2003o f\u2003ho w \u2003g radi-\nents\u2003ar e \u2003use d \u2003t o \u2003\u201c drive\u201d \u2003thr ough \u2003k-spa ce \u2003is \u2003sho wn \u2003in \u2003Figur e \u20033-6.\u2003T he \u2003\nphase-encoding \u2003g radient \u2003is \u2003use d \u2003t o \u2003mo ve \u2003up \u2003and \u2003d own \u2003in \u2003k-spa ce,\u2003and \u2003\nthe\u2003r eadout \u2003g radient \u2003is \u2003use d \u2003t o \u2003mo ve \u2003t o \u2003the \u2003le ft \u2003and \u2003r ight.", "a5a26d4e-bec6-4488-a119-dd5bb4a5e225": "Functional \u2003MRI\u2003uses\u2003cor tical\u2003bloo d\u2003flow\u2003changes \u2003based \u2003on\u2003deo xy-\nhemoglobin \u2003leve ls\u2003to\u2003create \u2003act ivation \u2003maps, \u2003which \u2003may\u2003be\u2003used\u2003to\u2003turbulence, \u2003dep hasing, \u2003rep hasing, \u2003slow\u2003flow, \u2003entr y\u2003slice\u2003enhance ment, \u2003\nand\u2003phase-encoding \u2003mismapping \u2003may\u2003all\u2003be\u2003demo nstrated \u2003(Figs. \u200312-48 \u2003\nand\u200312-49). \u2003Most \u2003ofte n\u2003the\u2003nidus \u2003vessels \u2003demo nstrate \u2003signal \u2003void\u2003on\u2003\nspin\u2003echo \u2003or\u2003fast/turb o-spin \u2003echo \u2003pulse \u2003seque nces\u2003and\u2003brig ht\u2003or\u2003dark\u2003\nsignal \u2003intensity \u2003on\u2003gra dient \u2003echo \u2003seque nces, \u2003dep ending \u2003on\u2003pulse \u2003\nsequence \u2003paramet ers\u2003(see\u2003Fig.\u200312-49). \u2003The\u2003appear ance\u2003of\u2003enlarge d\u2003\nfeeding \u2003arteries \u2003and\u2003draining \u2003veins \u2003is\u2003the\u2003pro duct\u2003of\u2003bloo d\u2003flow\u2003pat-\nterns \u2003and\u2003velocity \u2003chara cteristics. \u2003Adja cent\u2003brain \u2003parenc hyma \u2003can\u2003be\u2003\nwell\u2003evaluated \u2003for\u2003ede ma\u2003or\u2003reac tive\u2003astro cytosis \u2003(gliosis), \u2003which \u2003have\u2003\nbright \u2003signal \u2003intensit y\u2003on\u2003T2-weig hted\u2003spin\u2003echo \u2003or\u2003fast/turb o-spin \u2003\necho \u2003and\u2003FLAIR \u2003studies55,383\u2003(Fig.\u200312-50). \u2003MRI\u2003is\u2003crucial \u2003for\u2003localizing \u2003\nthe\u2003AVM \u2003in\u2003relat ionship \u2003to\u2003eloq uent\u2003cor tex\u2003or\u2003dee p\u2003gra y\u2003matter \u2003struc -\ntures \u2003and\u2003significant \u2003white \u2003matter \u2003fiber\u2003tra cts,\u2003as\u2003wel l\u2003as\u2003demo nstrating", "6e46995f-0e73-4fa6-a360-6941cd870e6b": "Eur Radiol \u200311:982\u2013989, \u20032001.\n30.\u2003H olbert \u2003JM,\u2003St rollo \u2003D C:\u2003I maging \u2003o f\u2003the \u2003no rmal \u2003t rachea. \u2003J Thorac \nImaging \u200310:171\u2013179, \u20031995.\n31.\u2003H ouston \u2003HE,\u2003P ayne \u2003W S,\u2003H arrison \u2003EG,\u2003Jr ,\u2003e t \u2003al:\u2003P rimary \u2003canc ers \u2003o f\u2003the \u2003\ntrachea. \u2003Arch Surg \u200399:132\u2013140, \u20031969.\n32.\u2003I keda \u2003S,\u2003H anawa \u2003T ,\u2003K onishi \u2003T ,\u2003e t \u2003al:\u2003[D iagnosis, \u2003incid ence, \u2003\nclinicopathology \u2003and \u2003s urgical \u2003t reatment \u2003o f\u2003a cquired \u2003\ntracheobronchomalacia] \u2003J apanese. \u2003Nihon Kyobu Shikkan Gakkai Zasshi \u2003\n30:1028\u20131103, \u20031992.\n33.\u2003J ohnson \u2003TH,\u2003M ikita \u2003JJ ,\u2003W ilson \u2003RJ ,\u2003e t \u2003al:\u2003A cquired \u2003t racheomalacia. \u2003\nRadiology \u2003109:576\u2013580, \u20031973.\n34.\u2003J okinen \u2003K,\u2003P alva \u2003T ,\u2003S utinen \u2003S,\u2003e t \u2003al:\u2003A cquired \u2003t racheobronchomalacia. \u2003\nAnn Clin Res \u20039:52\u201357, \u20031977.\n35.\u2003K aminski \u2003JM,\u2003Lang er \u2003CJ ,\u2003M ovsas \u2003B:\u2003T he \u2003r ole \u2003o f\u2003r adiation \u2003the rapy \u2003and \u2003\nchemotherapy \u2003in \u2003the \u2003manag ement \u2003o f\u2003air way \u2003t umors \u2003othe r \u2003than \u2003\nsmall-cell \u2003car cinoma \u2003and \u2003no n-small-cell \u2003car cinoma. \u2003Chest Surg Clin N \nAm\u200313:149\u2013167, \u20032003.\n36.\u2003K im \u2003JS,\u2003M uller \u2003NL,\u2003P ark \u2003CS,\u2003e t \u2003al:\u2003C ylindrical \u2003b ronchiectasis: \u2003D iagnostic \u2003\nfindings \u2003o n \u2003thin-se ction \u2003CT .\u2003AJR Am J Roentgenol \u2003168:751\u2013754, \u20031997.\n37.\u2003K wak \u2003SH,\u2003L ee \u2003KS,\u2003C hung \u2003MJ ,\u2003e t \u2003al:\u2003A denoid \u2003cy stic \u2003car cinoma \u2003o f\u2003the \u2003\nairways: \u2003H elical \u2003CT \u2003and \u2003hist opathologic \u2003c orrelation. \u2003AJR Am J \nRoentgenol \u2003183:277\u2013281, \u20032004.\n38.", "fa36e8f7-e0e0-4ac3-b7f3-5a37c9280da8": "CHAPTER 26 \u2003 Imaging \u2003of\u2003the\u2003Head \u2003and\u2003Neck \u2003in\u2003the\u2003Pediatric \u2003Patient 763\nDifferential \u2002diagnosis.\u2002 The\u2003primary \u2003differ ential \u2003diagnosis \u2003is\u2003lym\u00ad\nphatic \u2003malformation, \u2003which \u2003more \u2003closel y\u2003follo ws\u2003water \u2003signal \u2003on\u2003all\u2003\npulse \u2003sequences. \u2003Because \u2003cer vical\u2003ter atoma \u2003can\u2003be\u2003difficult \u2003to\u2003distin \u00ad\nguish \u2003from \u2003a\u2003lymp hatic \u2003malfor mation \u2003with\u2003pre natal \u2003ultrasound, \u2003fetal\u2003\nMRI\u2003has\u2003been \u2003found \u2003to\u2003be\u2003helpful \u2003in\u2003such\u2003cases. \u2003Other \u2003differ ential \u2003\nconsiderations \u2003includ e\u2003cer vical\u2003neuro blastoma \u2003(which \u2003can\u2003contain \u2003cal\u00ad\ncification), \u2003complicat ed\u2003TDC \u2003or\u2003branc hial\u2003cleft\u2003cyst,\u2003goit er,\u2003hemangi \u00ad\noma, \u2003and\u2003external \u2003laryngo cele.45\nTreatment.\u2002 For\u2003congenital \u2003cer vical\u2003ter atomas, \u2003surge ry\u2003is\u2003manda \u00ad\ntory\u2003and\u2003the\u2003mortalit y\u2003rate\u2003is\u200380%\u2003to\u2003100% \u2003seco ndary \u2003to\u2003airway \u2003\u2003On\u2003CT,\u2003the\u2003imaging \u2003chara cteristics \u2003will\u2003reflec t\u2003the\u2003pathologic \u2003\nmakeup \u2003of\u2003the\u2003tumor .\u2003Most \u2003cer vical\u2003ter atomas \u2003are\u2003large, \u2003measuring \u2003\nup\u2003to\u200312\u2003cm,\u2003and\u2003can\u2003appear \u2003primar ily\u2003cystic, \u2003solid, \u2003or\u2003multicy stic;\u2003\nabout \u200350%\u2003contain \u2003calcification170,221\u2003(Fig.\u200326\u00ad12).\u2003On\u2003MRI, \u2003the\u2003mass \u2003\nshows \u2003heterogeneous \u2003signal \u2003on\u2003all\u2003seque nces\u2003and\u2003contains \u2003areas \u2003of\u2003\u2003\nT1\u2003hyperintense \u2003signal \u2003in\u2003tissues \u2003containing \u2003fatty\u2003comp onents \u2003and\u2003\nhypointense \u2003or\u2003hyp erintense \u2003signal \u2003in\u2003areas \u2003of\u2003calcification.170,221\u2003Vari\u00ad\nable\u2003enhancement \u2003is\u2003seen\u2003after\u2003cont rast\u2003administr ation. \u2003Because \u2003these \u2003\ntumors \u2003are\u2003large \u2003and\u2003can\u2003lead\u2003to\u2003airway \u2003comp romise, \u2003intubatio n\u2003is\u2003\noften \u2003required.FIG 26-11  Epidermoid. A, Axial contrast-enhanced CT image demonstrates a nonenhancing midline low-\ndensity lesion (arrow) in the oral cavity, most consistent with an epidermoid. B, Sagittal T2-weighted fetal \nMRI demonstrates a T2 bright lesion (arrow) at the floor of the mouth. \nA B\nFIG 26-12  Teratoma. A, Lateral radiograph demonstrates a large soft tissue mass with calcifications (arrow).", "e8250bd3-9383-4ffd-8ffa-10526c6c529d": "A,\u2002Axial \u2002postcontrast \u2002CT\u2002image \u2002shows \u2002piriform \u2002sinus \u2002(PS)\u2002lateral \u2002to\u2002aryepi -\nglottic \u2002fold\u2002(*).\u2002B,\u2002Similar \u2002structures \u2002are\u2002seen \u2002on\u2002axial\u2002postcontrast \u2002fat-saturated \u2002T1-weighted \u2002image. \u2002C,\u2002The\u2002\npostcricoid \u2002region \u2002is\u2002delineated \u2002by\u2002arrows \u2002on\u2002this\u2002axial\u2002postcontrast \u2002CT\u2002image. \u2002D,\u2002Axial \u2002postcontrast \u2002\nT1-weighted \u2002image \u2002shows \u2002postcricoid \u2002region \u2002(white arrows) \u2002and\u2002posterior \u2002pharyngeal \u2002wall\u2002(black arrows). \u2002\nPS\nA\nC DBPS * *\n* **", "17642ab8-5b28-42ab-9318-1d302904d697": "CHAPTER 12 \u2003 Cerebral \u2003Aneurysms \u2003and\u2003Cerebrovascular \u2003Malformations 397\nFIG 12-66  DVA associated with a neuronal migration anomaly. A, T2-weighted MRI demonstrates a right \nparietal schizencephalic cleft (short arrow) containing a DVA (long arrow) and bordering cortical dysplasia \n(curved arrow). B, Coronal postcontrast T1-weighted MRI illustrating the DVA (arrow) within the schizen-\ncephaly. C, AP view of right carotid cerebral angiogram confirming the DVA (arrow). (Case courtesy David \nWatts, MD.)\nA B\nC", "9dd2a1e4-8bf1-46e0-a491-44335fd510fe": "Direct \u2003tumor \u2003invasio n\u2003increases \u2003the\u2003muscle \u2003bulk, \u2003is\u2003focal \u2003rather \u2003than\u2003\ndiffuse, \u2003and\u2003has\u2003signal \u2003intensit y\u2003similar \u2003to\u2003tumor .64\nNPC \u2003and\u2003nodal \u2003metastases \u2003are\u2003usuall y\u2003FDG \u2003avid. \u2003Curr ently \u2003\nFDG \u00adPET/CT \u2003is\u2003consid ered\u2003useful \u2003for\u2003mapping \u2003pre cise\u2003nodal \u2003burd en,\u2003\nfor\u2003evaluating \u2003distant \u2003metastases, \u2003and\u2003in\u2003the\u2003wor kup\u2003of\u2003unknown \u2003FIG 22-12 \u2002 Posttransplant \u2002lymphoproliferative \u2002disorder \u2002(PTLD) \u2002in\u2002\n9-year-old \u2002with\u2002history \u2002of\u2002a\u2002renal \u2002transplant \u2002and\u20026\u2002weeks \u2002of\u2002coughing \u2002\nand\u2002stridor. \u2002There \u2002is\u2002diffuse \u2002thickening \u2002of\u2002hypopharyngeal \u2002and\u2002subglottic \u2002\nsoft\u2002tissues \u2002on\u2002axial\u2002postcontrast \u2002CT\u2002images. \u2002Biopsy \u2002revealed \u2002PTLD. \u2002\nInvolvement \u2002of\u2002the\u2002larynx \u2002is\u2002much \u2002less\u2002common \u2002than \u2002adenotonsillar \u2002\ninvolvement. \u2002\nage\u2003being \u200350\u2003to\u200360\u2003years, \u2003with\u2003a\u2003smaller \u2003peak\u2003in\u2003late\u2003childhoo d.\u2003NPC \u2003\nfrequently \u2003presents \u2003with\u2003cer vical\u2003metastatic \u2003nodes \u2003(in\u2003>70%) \u2003despite \u2003\nearly \u2003small \u2003primar y\u2003lesions, \u2003the\u2003other \u2003sympt oms\u2003being \u2003otitis \u2003media \u2003\n(due\u2003to\u2003eustachian \u2003tube\u2003obstr uction), \u2003sore\u2003throat, \u2003epistaxis, \u2003headac he,\u2003\nand\u2003cranial \u2003nerv e\u2003neuro pathies \u2003in\u2003adv anced \u2003cases.15,23\nStaging and treatment principles.  The\u2003criteria \u2003giv en\u2003in\u2003the\u2003\nseventh \u2003edition \u2003of\u2003the\u2003Amer ican\u2003Joint \u2003Committ ee\u2003on\u2003Cance r\u2003(AJCC) \nCancer Staging Manual \u2003for\u2003tumor \u00adnod e\u00admetastasis \u2003(TNM) \u2003staging \u2003of\u2003\nNPC \u2003are\u2003provided \u2003in\u2003Box\u200322\u00ad1.\u2003Surge ry\u2003is\u2003unable \u2003to\u2003achie ve\u2003clear \u2003resec \u00ad\ntion\u2003margins, \u2003and\u2003radiothe rapy\u2003(RT) \u2003remains \u2003the\u2003mainstay \u2003of\u2003treat\u00ad\nment.", "12b69489-798f-41fd-9642-935740af5068": "Crit Rev Diagn Imaging \u200333:311\u2013367, \u2003\n1992.\n157.\u2003K awashima \u2003A,\u2003Fishman \u2003EK,\u2003K uhlman \u2003JE,\u2003e t \u2003al:\u2003CT \u2003o f\u2003p osterior \u2003\nmediastinal \u2003masses. \u2003Radiographics \u200311:1045\u20131067, \u20031991.\n158.\u2003K eller \u2003AR,\u2003C astleman \u2003B:\u2003H odgkin\u2019s \u2003disease \u2003o f\u2003the \u2003th ymus \u2003g land. \u2003Cancer \u2003\n33:1615\u20131623, \u20031974.\n159.\u2003K eller \u2003AR,\u2003H ochholzer \u2003L,\u2003C astleman \u2003B:\u2003H yaline-vascular \u2003and \u2003plasma-\ncell\u2003t ypes \u2003o f \u2003g iant \u2003l ymph \u2003no de \u2003h yperplasia \u2003o f\u2003the \u2003me diastinum \u2003and \u2003\nother \u2003lo cations. \u2003Cancer \u200329:670\u2013683, \u20031972.\n160.\u2003K elly \u2003JD ,\u2003F orster \u2003AM,\u2003H igley \u2003B ,\u2003e t \u2003al:\u2003T echnetium-99m-tetrofosmin \u2003as \u2003a \u2003\nnew\u2003r adiopharmaceutical \u2003f or \u2003m yocardial \u2003p erfusion \u2003imag ing.\u2003J Nucl Med \u2003\n34:222\u2013227, \u20031993.\n161.\u2003K iernan \u2003PD ,\u2003H ernandez \u2003A,\u2003B yrne \u2003WD ,\u2003e t \u2003al:\u2003D escending \u2003c ervical \u2003\nmediastinitis \u2003[se e \u2003c omments]. \u2003Ann Thorac Surg \u200365:1483\u20131488, \u20031998.\n162.\u2003K im \u2003TJ ,\u2003K im \u2003HY ,\u2003L ee \u2003KW ,\u2003e t \u2003al:\u2003M ultimodality \u2003assessme nt \u2003o f\u2003\nesophageal \u2003canc er:\u2003P reoperative \u2003stag ing \u2003and \u2003mo nitoring \u2003o f\u2003r esponse \u2003t o \u2003\ntherapy. \u2003Radiographics \u200329:403\u2013421, \u20032009.\n163.\u2003K im \u2003T S,\u2003L ee \u2003KS,\u2003H an \u2003J ,\u2003e t \u2003al:\u2003M ucoepidermoid \u2003car cinoma \u2003o f\u2003the \u2003\ntracheobronchial \u2003t ree:\u2003R adiographic \u2003and \u2003CT \u2003finding s \u2003in \u200312 \u2003pat ients. \u2003\nRadiology \u2003212:643\u2013648, \u20031999.\n164.\u2003K irwan \u2003W O,\u2003W albaum \u2003PR,\u2003M cCormack \u2003RJ:\u2003C ystic \u2003int rathoracic \u2003\nderivatives \u2003o f\u2003the \u2003f oregut \u2003and \u2003the ir \u2003c omplications. \u2003Thorax \u200328:424\u2013428, \u2003\n1973.\n165.\u2003K lemm \u2003KM,\u2003M oran \u2003CA:\u2003P rimary \u2003ne uroendocrine \u2003car cinomas \u2003o f\u2003the \u2003\nthymus.", "e0f41b93-29f3-4538-840f-1f1d30aca5de": "Other Mucosal Tumors.  Many \u2003benign \u2003lesions \u2003such\u2003as\u2003poly ps\u2003and\u2003\npapillomas \u2003arise\u2003from \u2003the\u2003mucosa \u2003of\u2003the\u2003larynx. \u2003These \u2003are\u2003seldo m\u2003\nevaluated \u2003by\u2003CT\u2003or\u2003MRI\u2003studies. \u2003Subm ucosal \u2003tumor s\u2003can\u2003ulcer ate\u2003\nthrough \u2003the\u2003mucosa \u2003(see\u2003\u201cSub mucosal \u2003Tumor s\u201d).\nAlthough \u2003almost \u2003all\u2003malignancies \u2003arising \u2003from \u2003the\u2003mucosa \u2003of\u2003the\u2003\nlarynx \u2003are\u2003squamous \u2003cel l\u2003carcinoma, \u2003occasio nal\u2003malignancies \u2003arise\u2003\nfrom \u2003the\u2003minor \u2003salivar y\u2003glands, \u2003with\u2003histolog ies\u2003such\u2003as\u2003ade nocarci -\nnoma, \u2003adenoid \u2003cystic \u2003carcinoma, \u2003and\u2003muco epidermoid \u2003carcinoma.\nVerrucous \u2003carcinoma \u2003is\u2003an\u2003exo phytic \u2003slow-gr owing \u2003variant \u2003of\u2003squa-\nmous \u2003cell\u2003carcinoma. \u2003Usual ly\u2003it\u2003does\u2003not\u2003metastasize \u2003but\u2003can\u2003be\u2003locall y\u2003\naggressive. \u2003Ther e\u2003are\u2003no\u2003particular \u2003imaging \u2003featur es,\u2003but\u2003the\u2003lesion \u2003has\u2003\na\u2003typical \u2003exophytic \u2003\u201cwarty\u201d \u2003appear ance\u2003at\u2003direc t\u2003inspec tion.\nSubmucosal Tumors\nLesions \u2003presenting \u2003beneath \u2003an\u2003intact \u2003mucosa \u2003usuall y\u2003arise\u2003from \u2003the\u2003\nnonepithelial \u2003eleme nts\u2003of\u2003the\u2003larynx.3,5,12,14,28\u2003Such \u2003tumors \u2003includ e\u2003\nchondroid \u2003lesions, \u2003hemangio mas,\u2003vascular \u2003malfor mations, \u2003neuro genic \u2003\ntumors, \u2003and\u2003rare\u2003lesions \u2003such\u2003as\u2003leiom yoma, \u2003rhabdo myoma, \u2003and\u2003\nlipomas. \u2003Sarcomas \u2003arising \u2003from \u2003the\u2003same \u2003various \u2003mesench ymal", "16305e23-132b-4d45-81ed-e9d0b2e9c025": "With \u2003single-d etector-row \u2003scan-\nners, \u2003routine \u2003spiral \u2003CT\u2003imaging \u2003in\u2003the\u2003thorax \u2003is\u2003per formed \u2003with\u2003pitch \u2003\nvalues \u2003between \u20031.0\u2003and\u20031.5,\u2003using \u2003collimat ion\u2003in\u2003the\u2003range \u2003of\u20038\u2003to\u2003\n10\u2003mm\u2003and\u2003table \u2003move ment \u2003spee d\u2003of\u20038\u2003to\u200315\u2003mm/sec.\nMDCT\nThe\u2003advent \u2003of\u2003MDCT \u2003rep resents \u2003an\u2003enor mous \u2003tec hnical \u2003adv ance. \u2003The\u2003\ndevelopment \u2003of\u2003MDCT \u2003allow s\u2003higher \u2003z-axis \u2003resolu tion\u2003and\u2003faster \u2003\nimage \u2003acquisition \u2003than\u2003pre viously \u2003possible, \u2003and\u2003comb ined\u2003with\u2003PACS, \u2003\ngreater \u2003diagnostic \u2003eval uation \u2003of\u2003the\u2003bro nchi\u2003and\u2003vessels \u2003and\u2003impro ved\u2003\nvisualization \u2003of\u2003parenc hymal \u2003pro cesses. \u2003It\u2003uses\u2003a\u2003multiple-r ow\u2003det ector \u2003\nwith\u2003narrow \u2003det ector \u2003collimat ion\u2003in\u2003conj unction \u2003with\u2003a\u2003relat ively\u2003rapid \u2003\ntable \u2003translation \u2003to\u2003achie ve\u2003faster \u2003scans \u2003with\u2003thinner \u2003slices \u2003than\u2003single-\ndetector \u2003CT.558\u2003MDCT \u2003results \u2003in\u2003a\u2003gapless \u2003volume tric\u2003acq uisition \u2003that\u2003\neliminates \u2003problems \u2003of\u2003slice\u2003misreg istration \u2003caused \u2003by\u2003variat ions\u2003in\u2003the\u2003\ndepth \u2003of\u2003inspiratio n.299,305,333,461,462,558,626\u2003The\u2003resulting \u2003data\u2003set\u2003is\u2003more \u2003\naccurate, \u2003more \u2003rep roducible \u2003from \u2003one\u2003study \u2003to\u2003the\u2003next, \u2003and\u2003more \u2003\nquickly \u2003acquired. \u2003The\u2003red uced \u2003scan\u2003time\u2003of\u2003MDCT \u2003red uces\u2003motion \u2003\nartifacts, \u2003particular ly\u2003in\u2003patients \u2003with\u2003under lying \u2003lung\u2003disease.522\nKnowledge \u2003of\u2003the\u2003capabilities \u2003and\u2003limitations \u2003of\u2003MDCT \u2003allow s\u2003the\u2003\nradiologist \u2003to\u2003use\u2003MDCT \u2003appr opriately \u2003and\u2003for\u2003the\u2003best\u2003possible \u2003patient \u2003\ncare.", "d81943cd-eeea-4053-bb49-2a2acec75ac4": "The\u2003anatomic \u2003struc \u00ad\ntures \u2003of\u2003the\u2003face\u2003and\u2003neck\u2003pre dominantly \u2003der ive\u2003from \u2003the\u2003branc hial\u2003\napparatus, \u2003which \u2003is\u2003a\u2003comple x\u2003struc ture\u2003der ived\u2003from \u2003neural \u2003crest\u2003cel ls\u2003\nthat\u2003develops \u2003betw een\u2003the\u2003seco nd\u2003and\u2003seve nth\u2003weeks \u2003of\u2003gestatio n.27,54\u2003\nThe\u2003branchial \u2003apparat us\u2003consists \u2003of\u2003six\u2003paired \u2003arches \u2003separat ed\u2003on\u2003their\u2003\nouter \u2003surface \u2003by\u2003five\u2003paired \u2003ect odermal \u2003clefts \u2003and\u2003on\u2003their\u2003inner \u2003surfa ce\u2003\nby\u2003five\u2003paired \u2003endo dermally \u2003der ived\u2003pharyng eal\u2003pouches.27\u2003By\u2003the\u2003end\u2003\nof\u2003the\u2003fourth \u2003week \u2003of\u2003life,\u2003four\u2003wel l\u00addefine d\u2003pairs \u2003of\u2003arches \u2003are\u2003visible \u2003\nand\u2003the\u2003fifth\u2003and\u2003sixth \u2003arches \u2003are\u2003rudimentar y.\u2003Each \u2003arch\u2003is\u2003comp osed\u2003\nof\u2003a\u2003central \u2003cor e\u2003of\u2003mesode rm\u2003and\u2003is\u2003lined \u2003exte rnally \u2003by\u2003ect oderm \u2003and\u2003\ninternally \u2003by\u2003endo derm.\nThe\u2003cervical \u2003sinus \u2003of\u2003His\u2003is\u2003for med\u2003after\u2003the\u2003branc hial\u2003arches \u2003appear \u2003\nby\u2003accelerated \u2003mesode rmal\u2003gro wth\u2003craniall y\u2003of\u2003the\u2003first\u2003arch\u2003and\u2003a\u2003\nportion \u2003of\u2003the\u2003seco nd\u2003arch, \u2003and\u2003caudally \u2003by\u2003gro wth\u2003of\u2003the\u2003epipe ricar\u00ad\ndial\u2003ridge, \u2003which \u2003dev elops \u2003from \u2003the\u2003mesode rm\u2003later al\u2003to\u2003the\u2003fifth\u00adsixth \u2003\narch. \u2003The\u2003branchial \u2003apparat us\u2003typical ly\u2003disappear s\u2003betw een\u2003the\u2003fourth \u2003\nand\u2003sixth \u2003weeks \u2003of\u2003life.27\nEtiology of Branchial Anomalies.  The\u2003etiology \u2003of\u2003branc hial\u2003anom \u00ad\nalies\u2003is\u2003controversial, \u2003and\u2003the\u2003most \u2003acc epted \u2003theor ies\u2003to\u2003explain \u2003the\u2003FIG 26-1  Thyroglossal duct cyst (TDC). A, Axial contrast-enhanced CT image at the level of the hyoid bone \ndemonstrates a large midline nonenhancing low-attenuation mass (arrows), most consistent with a TDC. \nB, Axial contrast-enhanced CT image at the level of the hyoid bone demonstrates a large midline predomi -\nnantly low-attenuation mass with some enhancing components centrally (arrows), concerning for a TDC \ncomplicated by papillary thyroid carcinoma. \nA B", "0f7ea807-b22b-4c09-a67c-22618cce2ca2": "PART II \u2003 CT \u2003and\u2003MR\u2003Imaging \u2003of\u2003the\u2003Whole \u2003Body 832\nI/II\u2003changes, \u2003sugg esting \u2003that\u2003these \u2003changes \u2003can\u2003con vert\u2003betw een\u2003typ es.87\u2003\nModic \u2003II\u2003changes \u2003are\u2003the\u2003most \u2003commo n,\u2003follo wed\u2003by\u2003typ e\u2003I\u2003and\u2003mixed \u2003\ntype\u2003I/II.51,52,113\nType \u2003I\u2003changes \u2003show \u2003subc hondral \u2003bone \u2003marro w\u2003ede ma,\u2003as\u2003demo n-\nstrated \u2003by\u2003decr eased \u2003signal \u2003intensit y\u2003on\u2003T1-weig hted\u2003images \u2003and\u2003\nincreased \u2003signal \u2003intensit y\u2003on\u2003T2-weig hted\u2003images \u2003(Fig.\u200329-5A1-A3). \u2003\nHistologically \u2003the\u2003end\u2003plates \u2003are\u2003disrupt ed\u2003and\u2003fissure d,\u2003with\u2003the\u2003sub-\nchondral \u2003marro w\u2003infiltrat ed\u2003by\u2003fibro vascular \u2003gran ulation \u2003tissue, \u2003and\u2003\nthus\u2003exhibit \u2003enhance ment \u2003on\u2003postc ontrast \u2003images. \u2003Patie nts\u2003with\u2003Modic \u2003\nI\u2003changes \u2003have\u2003bee n\u2003docume nted\u2003to\u2003have\u2003high\u2003leve ls\u2003of\u2003C-reac tive\u2003\nprotein, \u2003which \u2003may\u2003supp ort\u2003the\u2003prese nce\u2003of\u2003a\u2003local\u2003inflammator y\u2003\nresponse \u2003within \u2003the\u2003ver tebral \u2003end\u2003plate.90\u2003Furthermore, \u2003elev ated\u2003leve ls\u2003\nof\u2003immunoreactive \u2003nerv e\u2003fiber s\u2003and\u2003TNF-immuno reactive \u2003cel ls\u2003wer e\u2003\nsignificantly \u2003higher \u2003in\u2003end\u2003plates \u2003demo nstrating \u2003Modic \u2003I\u2003changes \u2003in\u2003\ncomparison \u2003with\u2003patients \u2003with\u2003normal \u2003end\u2003plates \u2003on\u2003MRI\u2003or\u2003in\u2003end\u2003\nplates \u2003exhibiting \u2003Modic \u2003typ e\u2003II\u2003changes.64,78\u2003Luoma \u2003et\u2003al.57\u2003documented \u2003\naccelerated \u2003diskov ertebral \u2003deg enerative \u2003change \u2003in\u2003patients \u2003with\u2003Modic \u2003\nI\u2003changes, \u2003which \u2003supp orts\u2003a\u2003distinct \u2003pathologic \u2003pro cess\u2003at\u2003the\u2003leve l\u2003of\u2003cystic \u2003degeneration \u2003and\u2003inter spinous \u2003bursa \u2003for mation \u2003(see\u2003Fig.\u2003\n29-6B1-B4).", "5dbbc44b-7cd7-47cf-9ac9-50fe887538ed": "PART II \u2003 CT \u2003and\u2003MR\u2003Imaging \u2003of\u2003the\u2003Whole \u2003Body 412\nspontaneous \u2003cure\u2003but\u2003also\u2003can\u2003result \u2003in\u2003acut e\u2003hydr ocephalus, \u2003intra cra-\nnial\u2003hemorrhage, \u2003or\u2003cent ral\u2003venous \u2003hyp ertension.\nThe\u2003extent \u2003of\u2003high-flow \u2003shunting \u2003and\u2003the\u2003amount \u2003of\u2003venous \u2003\noutflow \u2003restriction \u2003in\u2003a\u2003vein\u2003of\u2003Galen \u2003malfor mation \u2003is\u2003associate d\u2003with\u2003\nthe\u2003age\u2003of\u2003the\u2003patient \u2003at\u2003prese ntation. \u2003Patie nts\u2003with\u2003high-flow \u2003multiple \u2003\nfistulas \u2003and\u2003no\u2003venous \u2003outflow \u2003stenosis \u2003(usuall y\u2003typ e\u2003I)\u2003are\u2003ofte n\u2003iden-\ntified \u2003at\u2003birth \u2003with\u2003high-out put\u2003cong estive \u2003heart \u2003failure, \u2003intra cranial \u2003\nbruit, \u2003macrocephaly, \u2003and\u2003hydr ocephalus. \u2003These \u2003patients \u2003have\u2003a\u2003gra ve\u2003\nprognosis.183\u2003If\u2003the\u2003vein\u2003of\u2003Galen \u2003shunt \u2003is\u2003seve re\u2003enough, \u2003infants \u2003can\u2003including \u2003absence \u2003of\u2003hyp oplastic \u2003sigmoid \u2003sinuses \u2003and\u2003jugular \u2003veins, \u2003\u2003\nduplicated \u2003sinuses, \u2003and\u2003per sistent \u2003marginal \u2003or\u2003occipital \u2003sinuses.115\u2003\nVenous-to-arterial \u2003shunting \u2003through \u2003a\u2003patent \u2003for amen \u2003ovale \u2003or\u2003per sis-\ntent\u2003ductus \u2003arte riosus \u2003may\u2003coe xist.87,244\nThe\u2003venous \u2003drainage \u2003of\u2003the\u2003enlarge d\u2003median \u2003prose ncephalic \u2003vein\u2003\nor\u2003vein\u2003of\u2003Galen \u2003typical ly\u2003demo nstrates \u2003a\u2003dilated \u2003venous \u2003varix \u2003cont inu-\ning\u2003into\u2003an\u2003accessory \u2003or\u2003infer ior\u2003falcine \u2003sinus. \u2003If\u2003venous \u2003outflow \u2003steno -\nsis\u2003is\u2003present \u2003and\u2003seve re\u2003enough, \u2003some \u2003vein\u2003of\u2003Galen \u2003malfor mations \u2003\nhave\u2003been \u2003docume nted\u2003to\u2003pro ceed\u2003to\u2003thromb osis\u2003that\u2003may\u2003lead\u2003to\u2003Although the DWI scan ( E) demonstrates abnormal parenchymal increased signal inten -\nsity in the territory of the abnormal cortical veins (arrow), this represents venous edematous congestion and \nnot infarction because there is no corresponding decreased signal intensity in the same region on the ADC \nmap (F). The lateral right external carotid angiogram ( G) demonstrates an isolated right sigmoid sinus dural \nAVF (blue arrow) supplied by branches of the right posterior auricular, occipital, and middle meningeal arteries \n(green arrows), with cortical venous drainage (red arrows). Classified as Cognard type III, Borden type III. \nE F\nG\nFIG 12-78, cont\u2019d", "28a0c88b-9fc7-406a-912f-0c87b618a2e0": "CT scan shows multiple small bilateral pulmonary nodules (arrows). Wedge \nresection biopsy of the middle lobe revealed carcinoid tumor (5  mm) \nand multiple carcinoid tumorlets ( <5 mm). \nHistologic Classification\nLung \u2003cancer \u2003is\u2003divid ed\u2003by\u2003the\u20032004 \u2003WHO \u2003Classificatio n\u2003into\u2003two\u2003major \u2003\nhistologic \u2003categ ories: \u2003non\u2013small cell lung carcinoma \u2003(NSCLC) \u2003and\u2003small \ncell lung carcinoma \u2003(SCLC)298,299,302\u2003(see\u2003Box\u200337-1). \u2003NSCLC \u2003is\u2003further \u2003\nsubdivided \u2003into\u2003histolog ic\u2003typ es\u2003such\u2003as\u2003squamous \u2003cel l\u2003carcinoma, \u2003\nadenocarcinoma, \u2003and\u2003large \u2003cel l\u2003carcinoma \u2003acc ording \u2003to\u2003the\u2003most \u2003dif-\nferentiated \u2003por tion\u2003of\u2003the\u2003tumor .\u2003How ever,\u2003many \u2003tumor s\u2003are\u2003comp osed\u2003\nof\u2003more \u2003than\u2003one\u2003histolog ic\u2003typ e;\u2003a\u2003definiti ve\u2003diagnosis \u2003may\u2003req uire\u2003a\u2003\nresected \u2003specimen. \u2003NSCLCs \u2003are\u2003also\u2003gra ded\u2003as\u2003wel l\u2003differ entiated, \u2003\nmoderately \u2003differ entiated, \u2003or\u2003poo rly\u2003differ entiated \u2003acc ording \u2003to\u2003the\u2003\nleast\u2003differentiated \u2003featur e.298\u2003Additionally, \u2003some \u2003NSCLCs \u2003have\u2003immu -\nnohistochemical \u2003and/or \u2003ultrast ructural \u2003featur es\u2003of\u2003neuro endocrine \u2003\ndifferentiation \u2003and\u2003are\u2003colle ctively \u2003ref erred \u2003to\u2003NSCLCs with neuroen\u00ad\ndocrine differentiation.302\nNon\u2013Small Cell Lung Carcinoma\nSquamous cell carcinoma.  Squamous \u2003cell\u2003carcinomas \u2003have\u2003bee n\u2003\ndecreasing \u2003in\u2003relat ive\u2003incidenc e\u2003and\u2003now\u2003const itute\u2003appr oximately \u200330%\u2003\nof\u2003all\u2003lung\u2003cancer s8,314\u2003Histologically, \u2003squamous \u2003cel l\u2003carcinoma \u2003gro ws\u2003\nin\u2003nests \u2003within \u2003a\u2003desmoplast ic\u2003stro ma,\u2003and\u2003the\u2003tumor \u2003cel ls\u2003demo nstrate \u2003\nkeratinization, \u2003inter cellular \u2003bridg e\u2003for mation, \u2003and\u2003squamous \u2003pearls. \u2003\nThey \u2003typically \u2003occur \u2003in\u2003cent ral\u2003bro nchi\u2003and\u2003freq uently \u2003manifest \u2003as\u2003\npostobstructive \u2003pneumo nia\u2003or\u2003atele ctasis254,271\u2003(Fig.\u200337-2).", "45e0f542-6c67-4daa-a8e4-0a9916fa8f88": "Spine (Phila Pa 1976) \u2003\n35(21 \u2003Suppl):S166\u2013S173, \u20032010.\n20.\u2003Firooznia \u2003H,\u2003Ahn\u2003J,\u2003Rafii\u2003M,\u2003et\u2003al:\u2003Sudde n\u2003quadr iplegia \u2003after\u2003a\u2003minor \u2003\ntrauma. \u2003The\u2003role\u2003of\u2003pre existing \u2003spinal \u2003stenosis. \u2003Surg Neurol \u200323(2):165\u2013\n168,\u20031985.\n21.\u2003Flanders \u2003AE,\u2003Spett ell\u2003CM,\u2003Frie dman \u2003DP ,\u2003et\u2003al:\u2003The\u2003relat ionship \u2003betw een\u2003\nthe\u2003functional \u2003abilities \u2003of\u2003patients \u2003with\u2003cer vical\u2003spinal \u2003cor d\u2003injury \u2003and\u2003\nthe\u2003severity \u2003of\u2003damage \u2003rev ealed \u2003by\u2003MR\u2003imaging. \u2003Am J Neuroradiol \u2003\n20(5):926\u2013934, \u20031999.\n22.\u2003Flanders \u2003A,\u2003Spett ell\u2003C,\u2003Tartag lino\u2003L,\u2003et\u2003al:\u2003For ecasting \u2003motor \u2003rec overy \u2003\nafter\u2003cervical \u2003spinal \u2003cor d\u2003injury :\u2003Value \u2003of\u2003MR\u2003imaging. \u2003Radiology \u2003\n201(3):649\u2013655, \u20031996.", "2ca3e571-f509-44ce-89d2-6f6695d194d8": "Mayo Clin Proc \u200364(11):1373\u20131380, \u20031989.\n652.\u2003Zamora \u2003MR,\u2003War ner\u2003ML,\u2003Tud er\u2003R,\u2003et\u2003al:\u2003Diffuse \u2003alv eolar \u2003hemo rrhage \u2003\nand\u2003systemic \u2003lupus \u2003er ythematosus. \u2003Clinical \u2003pr esentation, \u2003histolo gy,\u2003\nsurvival, \u2003and\u2003out come. \u2003Medicine (Baltimore) \u200376(3):192\u2013202, \u20031997.\n653.\u2003Zeman \u2003RK,\u2003Sil verman \u2003PM,\u2003Vie co\u2003PT,\u2003et\u2003al:\u2003CT\u2003angio graphy. \u2003AJR Am J \nRoentgenol \u2003165(5):1079\u20131088, \u20031995.\n654.\u2003Zerhouni \u2003E:\u2003Co mputed \u2003to mography \u2003of\u2003the\u2003pulmonar y\u2003pare nchyma. \u2003An\u2003\noverview. \u2003Chest \u200395(4):901\u2013907, \u20031989.\n655.\u2003Zerhouni \u2003EA,\u2003Naidic h\u2003DP ,\u2003Stit ik\u2003FP ,\u2003et\u2003al:\u2003Co mputed \u2003to mography \u2003of\u2003the\u2003\npulmonary \u2003pare nchyma. \u2003Par t\u20032:\u2003Int erstitial \u2003disease. \u2003J Thorac Imaging \u2003\n1(1):54\u201364, \u20031985.\n656.\u2003Zerhouni \u2003EA,\u2003Stit ik\u2003FP ,\u2003Sie gelman \u2003SS,\u2003et\u2003al:\u2003CT\u2003of\u2003the\u2003pulmonar y\u2003\nnodule: \u2003A\u2003cooperative \u2003stud y.\u2003Radiology \u2003160(2):319\u2013327, \u20031986.\n657.\u2003Zhang \u2003M,\u2003Ko no\u2003M:\u2003Solitar y\u2003pulmonar y\u2003nod ules:\u2003Ev aluation \u2003of\u2003blo od\u2003\nflow\u2003patterns \u2003with\u2003dynamic \u2003CT.\u2003Radiology \u2003205(2):471\u2013478, \u20031997.\n658.\u2003Zwirewich \u2003CV,\u2003Ma yo\u2003JR,\u2003Mul ler\u2003NL:\u2003Lo w-dose \u2003high-r esolution \u2003CT\u2003of\u2003\nlung\u2003parenchyma. \u2003Radiology \u2003180(2):413\u2013417, \u20031991.\n659.\u2003Zwirewich \u2003CV,\u2003Te rriff\u2003B,\u2003Mul ler\u2003NL:\u2003Hig h-spatial-frequency \u2003(bo ne)\u2003\nalgorithm \u2003impr oves\u2003qualit y\u2003of\u2003standard \u2003CT\u2003of\u2003the\u2003thor ax.\u2003AJR Am J \nRoentgenol \u2003153(6):1169\u20131173, \u20031989.617.\u2003Vallyathan \u2003V,\u2003Landsitte l\u2003DP ,\u2003Pe tsonk \u2003EL,\u2003et\u2003al:\u2003The\u2003influenc e\u2003of\u2003\u2003\ndust\u2003standards \u2003on\u2003the\u2003pr evalence \u2003and\u2003sev erity\u2003of\u2003co al\u2003wo rker\u2019s \u2003\npneumoconiosis \u2003at\u2003aut opsy\u2003in\u2003the\u2003Unit ed\u2003States \u2003of\u2003Ame rica.\u2003Arch Pathol \nLab Med \u2003135(12):1550\u20131556, \u20032011.", "276eed7f-eb6c-4eec-8541-423a02c1769d": "Protocols and Scanning in an Emergency Setting.  The\u2003p reced -\ning\u2003discussio n \u2003o f\u2003the \u2003t ypical \u2003w orkflow \u2003f or \u2003a \u2003CT \u2003e xam \u2003is \u2003t ypical \u2003f or \u2003\nnon-emergency \u2003se ttings. \u2003I n \u2003an \u2003e mergency \u2003se tting, \u2003the \u2003w orkflow \u2003and \u2003\nCT\u2003scan \u2003se tup \u2003w ill \u2003b e \u2003sig nificantly \u2003diff erent. \u2003P atients \u2003ma y \u2003ar rive \u2003at \u2003the \u2003\nCT\u2003scanne r \u2003w ithout \u2003an y \u2003id entifying \u2003inf ormation \u2003o r \u2003w ithout \u2003an \u2003o rder,\u2003\nor\u2003the y \u2003ma y \u2003b e \u2003unab le \u2003t o \u2003mo ve \u2003the ir \u2003ar ms \u2003int o \u2003the \u2003r equired \u2003p osition \u2003\nfor\u2003the \u2003e xam. \u2003T his \u2003se ction \u2003discusses \u2003so me \u2003o f\u2003the \u2003uniq ue \u2003asp ects \u2003o f\u2003the \u2003\npractice \u2003o f \u2003scanning \u2003in \u2003an \u2003e mergency \u2003d epartment \u2003(ED) \u2003se tting.\nAn\u2003e xtreme \u2003e xample \u2003o f\u2003the \u2003uniq ue \u2003c hallenges \u2003o f\u2003CT \u2003scanning \u2003in \u2003an \u2003\nemergency \u2003se tting \u2003is \u2003that \u2003o f\u2003a \u2003pat ient \u2003ar riving \u2003in \u2003the \u2003ED \u2003unc onscious \u2003\nand\u2003unab le \u2003t o \u2003mo ve,\u2003w ithout \u2003an y \u2003id entification \u2003and \u2003in \u2003ne ed \u2003o f\u2003an \u2003imme -\ndiate \u2003CT \u2003scan. \u2003One \u2003s uch \u2003sit uation \u2003is \u2003a \u2003pat ient \u2003t ransported \u2003t o \u2003the \u2003hospital \u2003\nin\u2003an \u2003amb ulance \u2003f ollowing \u2003a \u2003t raumatic \u2003car \u2003cr ash.\u2003I n \u2003these \u2003cases \u2003the \u2003\npatient \u2003ma y \u2003b e \u2003b rought \u2003dir ectly \u2003t o \u2003a \u2003CT \u2003scanne r \u2003t o \u2003d etermine \u2003the \u2003e xtent \u2003\nof\u2003the \u2003inj uries. \u2003A \u2003t ypical \u2003t rauma \u2003CT \u2003p rotocol \u2003w ill \u2003c over \u2003the \u2003pat ient\u2019s \u2003\nhead, \u2003ne ck, \u2003c hest, \u2003and \u2003abd omen.", "4485b446-71e5-40c2-8221-65a9b3230bc6": "AJR Am J \nRoentgenol \u2003151:567\u2013575, \u20031988.\n75.\u2003Ozgen \u2003B,\u2003Oguz \u2003KK,\u2003Atas\u2003A,\u2003et\u2003al:\u2003Co mplete \u2003laby rinthine \u2003aplasia: \u2003\nClinical \u2003and\u2003ra diologic \u2003findings \u2003with\u2003re view\u2003of\u2003the\u2003lite rature. \u2003AJNR Am \nJ Neuroradiol \u200330:774\u2013780, \u20032009.\n76.\u2003Patmore \u2003H,\u2003Je breel \u2003A,\u2003Up pal\u2003S,\u2003et\u2003al:\u2003Skul l\u2003base\u2003infe ction \u2003pr esenting \u2003\nwith\u2003multiple \u2003low er\u2003cranial \u2003ner ve\u2003palsies. \u2003Am J Otolaryngol \u200331:376\u2013380, \u2003\n2010.\n77.\u2003Profant \u2003M,\u2003Ste no\u2003J:\u2003Pe trous \u2003ape x\u2003cholest eatoma. \u2003Acta Otolaryngol \u2003\n120:164\u2013167, \u20032000.\n78.\u2003Quaranta \u2003N,\u2003Liuzzi \u2003C,\u2003Zizzi \u2003S,\u2003et\u2003al:\u2003Surg ical\u2003tr eatment \u2003of\u2003laby rinthine \u2003\nfistula \u2003in\u2003cholesteatoma \u2003surg ery.\u2003Otolaryngol Head Neck Surg \u2003140:406\u2013\n411,\u20032009.\n79.\u2003Rafferty \u2003MA,\u2003Mc\u2003Co nn\u2003Walsh \u2003R,\u2003Walsh \u2003MA:\u2003A\u2003co mparison \u2003of\u2003te mporal \u2003\nbone \u2003fracture \u2003classificat ion\u2003syst ems.\u2003Clin Otolaryngol \u200331:287\u2013291, \u20032006.\n80.\u2003Razek \u2003AA,\u2003Huang \u2003BY:\u2003Lesio ns\u2003of\u2003the\u2003pe trous \u2003ape x:\u2003Classificat ion\u2003and\u2003\nfindings \u2003at\u2003CT\u2003and\u2003MR\u2003imaging .\u2003Radiographics \u200332:151\u2013173, \u20032012.\n81.\u2003Rodriguez \u2003K,\u2003Shah \u2003RK,\u2003Ke nna\u2003M:\u2003Ano malies \u2003of\u2003the\u2003middle \u2003and\u2003inner \u2003\near.\u2003Otolaryngol Clin North Am \u200340:81\u201396, \u20032007.\n82.\u2003Roland \u2003PS,\u2003Me yerhoff \u2003WL:\u2003Ot osclerosis. \u2003In\u2003Baile y\u2003BJ,\u2003edit or:\u2003Head and \nneck surgery\u2014Otolaryngology ,\u20032nd\u2003ed,\u2003Philad elphia, \u20031998, \u2003Lippinc ott-\nRaven \u2003Publishers, \u2003pp\u20032083\u20132096.\n83.\u2003Romo \u2003LV ,\u2003Casse lman \u2003JW,\u2003Ro bson \u2003CD:\u2003Co ngenital \u2003anomalies \u2003of\u2003the\u2003\ntemporal \u2003bone. \u2003In\u2003So m\u2003PM,\u2003Cur tin\u2003HD,\u2003edit ors:\u2003Head and neck \nimaging ,\u20035th\u2003ed,\u2003St.\u2003Louis, \u20032011, \u2003Elsev ier\u2003Mosb y,\u2003pp\u20031097\u20131165.\n84.", "c95ab101-bcd1-4281-b87d-78cee79071c0": "AJNR Am J Neuroradiol \u200311:449\u2013456, \u2003\n1990.\n345.\u2003Ruigrok \u2003YM,\u2003Rink el\u2003GJ,\u2003Alg ra\u2003A,\u2003et\u2003al:\u2003Char acteristics \u2003of\u2003intr acranial \u2003\naneurysms \u2003in\u2003patie nts\u2003with\u2003familial \u2003subar achnoid \u2003hemo rrhage. \u2003\nNeurology \u200362:891\u2013894, \u20032004.\n346.\u2003Russell \u2003DS,\u2003Rub instein \u2003LJ:\u2003Pathology of tumors of the nervous system ,\u2003\ned\u20035,\u2003Baltimore, \u20031989, \u2003Wil liams \u2003&\u2003Wilkins.347.\u2003Sadasivan \u2003C,\u2003Fior ella\u2003DJ,\u2003Wo o\u2003HH,\u2003et\u2003al:\u2003Phy sical\u2003fac tors\u2003eff ecting \u2003\ncerebral \u2003aneurysm \u2003pathop hysiology. \u2003Ann Biomed Eng \u200341:1347\u20131365, \u2003\n2013.\n348.\u2003Sadato \u2003N,\u2003Numaguc hi\u2003T,\u2003Rig amonti \u2003D,\u2003et\u2003al:\u2003Ble eding \u2003patte rns\u2003in\u2003\nruptured \u2003posterior \u2003fossa \u2003aneur ysms: \u2003A\u2003CT\u2003stud y.\u2003J Comp Assist Tomogr \u2003\n15:612\u2013617, \u20031991.\n349.\u2003Sadler \u2003LR,\u2003Tar r\u2003RW ,\u2003Jung reis\u2003CA,\u2003et\u2003al:\u2003Sin us\u2003pe ricranii: \u2003CT\u2003and\u2003MR\u2003\nfindings. \u2003J Comp Assist Tomogr \u200314:124\u2013127, \u20031990.\n350.\u2003Sahlein \u2003DH,\u2003Mo ra\u2003P ,\u2003Be cske\u2003T,\u2003et\u2003al:\u2003Feat ures\u2003pr edictive \u2003of\u2003br ain\u2003\narteriovenous \u2003malfo rmation \u2003hemo rrhage: \u2003Ext rapolation \u2003to\u2003a\u2003\nphysiologic \u2003mod el.\u2003Stroke \u200345:1964\u20131970, \u20032014.\n351.\u2003Sahs\u2003AL,\u2003Pe rret\u2003GE,\u2003Lo cksley \u2003HB,\u2003et\u2003al:\u2003Intracranial aneurysms and \nsubarachnoid hemorrhage: A cooperative study ,\u2003Philadelphia, \u20031969, \u2003JB\u2003\nLippincott.\n352.\u2003Sailer \u2003AM,\u2003Wag emans \u2003BA,\u2003Ne lemans \u2003PJ,\u2003et\u2003al:\u2003Diag nosing \u2003intr acranial \u2003\naneurysms \u2003with\u2003MR\u2003angio graphy: \u2003Sy stematic \u2003re view\u2003and\u2003meta-anal ysis.\u2003\nStroke \u200345:119\u2013126, \u20032014.\n353.\u2003Saito \u2003Y,\u2003Ko bayashi \u2003N:\u2003Ce rebral \u2003ve nous \u2003angio mas:\u2003Clinical \u2003ev aluation \u2003\nand\u2003possible \u2003et iology. \u2003Radiology \u2003139:87\u201394, \u20031981.\n354.\u2003Sakaki \u2003T,\u2003To minaga \u2003M,\u2003Mi yamoto \u2003K,\u2003et\u2003al:\u2003Clinical \u2003studies \u2003of\u2003de\u2003nov o\u2003\naneurysms.", "23050ae4-64a6-4020-8fc2-a9d1ac309db2": "Diagn Interv \nRadiol \u20032013. \u2003d oi: \u200310.5152/dir .2013.13066.\n25.\u2003Da vies \u2003CWH, \u2003Gle eson \u2003FV ,\u2003Da vies \u2003RJO ,\u2003e t \u2003al:\u2003B TS \u2003guid elines \u2003f or \u2003\u2003\nthe\u2003manag ement \u2003o f\u2003ple ural \u2003inf ection. \u2003Thorax \u200358(S uppl \u20032):ii18\u2013ii28, \u2003\n2003.\n26.\u2003Da vis \u2003SD ,\u2003H enschke \u2003CI,\u2003Y ankelevitz \u2003DF ,\u2003e t \u2003al:\u2003MR \u2003imag ing \u2003o f\u2003ple ural \u2003\neffusions. \u2003J Comput Assist Tomogr \u200314(2):192\u2013198, \u20031990.\n27.\u2003d e \u2003C ampos \u2003JR,\u2003V argas \u2003FS,\u2003d e \u2003C ampos \u2003W erebe \u2003E,\u2003e t \u2003al:\u2003T horacoscopy \u2003\ntalc\u2003p oudrage: \u2003A \u200315-y ear \u2003e xperience. \u2003Chest \u2003119(3):801\u2013806, \u20032001.\n28.\u2003D esir \u2003A,\u2003Gha ye \u2003B:\u2003CT \u2003o f\u2003b lunt \u2003diap hragmatic \u2003r upture. \u2003Radiographics \u2003\n32(2):477\u2013498, \u20032012. \u2003d oi:\u200310.1148/rg .322115082.", "b149d37d-e7e1-4a35-8541-3b36c8aed626": "Most \u2003seve re\u2003damage \u2003occur s\u2003in\u2003\nfirst\u2003and\u2003second \u2003trimest er\u2003infec tions, \u2003result ing\u2003in\u2003lissence phaly, \u2003poly-\nmicrogyria, \u2003small \u2003cer ebellum, \u2003and\u2003vent riculomegaly. \u2003Later \u2003infec tions \u2003\nresult \u2003in\u2003white \u2003matter \u2003injury ,\u2003with\u2003T2-FLAIR \u2003hyp erintensity, \u2003per iven-\ntricular \u2003calcifications, \u2003vent riculomegaly, \u2003and\u2003per iventricular \u2003cysts. \u2003Sub-\nependymal \u2003distrib ution \u2003of\u2003calcifications \u2003differ s\u2003from \u2003the\u2003rando mly\u2003\nscattered \u2003distrib ution \u2003of\u2003calcifications \u2003seen\u2003in\u2003cong enital \u2003tox oplasmo -\nsis133\u2003(Fig.\u200310-18).\nSEPTIC EMBOLUS AND MYCOTIC ANEURYSM\nInfective \u2003endocarditis \u2003is\u2003most \u2003freq uently \u2003caused \u2003by\u2003Staphylococcus \naureus, \u2003and\u2003its\u2003major \u2003complicat ion\u2003is\u2003sept ic\u2003emboli \u2003and\u2003strok e.\u2003Other \u2003\ncauses \u2003of\u2003sept ic\u2003emboli \u2003to\u2003the\u2003brain \u2003includ e\u2003pulmonary \u2003infec tion,\u2003\npulmonary \u2003arte riovenous \u2003malfor mation \u2003with\u2003sepsis, \u2003intra venous \u2003drug\u2003\nabuse, \u2003and\u2003cyanotic \u2003heart \u2003disease. \u2003The\u2003majorit y\u2003of\u2003sept ic\u2003emboli \u2003cases \u2003\nare\u2003seen\u2003in\u2003patients \u2003with\u2003a\u2003histor y\u2003of\u2003drug\u2003abuse. \u2003Intr acranial \u2003sept ic\u2003\nemboli \u2003may\u2003lead\u2003to\u2003for mation \u2003of\u2003myc otic\u2003aneury sms,\u2003abscess \u2003for ma-\ntion,\u2003or\u2003obliterative \u2003vasculitis. \u2003Myc otic\u2003aneury sms\u2003pro bably \u2003result \u2003from \u2003\ninfarction \u2003of\u2003the\u2003arte rial\u2003wall\u2003seco ndary \u2003to\u2003infec ted\u2003emboli. \u2003Myc otic\u2003\naneurysms \u2003may\u2003be\u2003solitary \u2003or\u2003multiple, \u2003and\u2003they\u2003usuall y\u2003invol ve\u2003middle \u2003\ncerebral \u2003artery \u2003branc hes.\u2003The\u2003relat ive\u2003freq uency \u2003of\u2003middle \u2003cer ebral \u2003\nartery \u2003branch \u2003invol vement \u2003is\u2003pro bably \u2003explained \u2003by\u2003the\u2003likeliho od\u2003of\u2003\nemboli \u2003being \u2003carrie d\u2003into\u2003this\u2003ter ritory.141\nRupture \u2003of\u2003a\u2003myc otic\u2003aneury sm\u2003may\u2003pro duce\u2003an\u2003intra cerebral \u2003or\u2003\nsubdural \u2003hematoma117\u2003(Fig.\u200310-19).", "979d7fc4-44de-4a31-bbbc-b57989ec56eb": "Radiographics \u20035:985\u2013993, \u20031985.\n62.\u2003Mehanna \u2003AM,\u2003Baki\u2003FA,\u2003Eid\u2003M,\u2003et\u2003al:\u2003Co mparison \u2003of\u2003diffe rent\u2003co mputed \u2003\ntomograph \u2003post-p rocessing \u2003modalit ies\u2003in\u2003assessment \u2003of\u2003var ious\u2003middle \u2003\near\u2003disorders. \u2003Eur Arch Otorhinolaryngol \u20032014. \u2003doi:\u200310.1007/\ns00405-014-2920-y.\n63.\u2003Minor \u2003LB,\u2003Solo mon\u2003D,\u2003Zinr eich\u2003JS,\u2003et\u2003al:\u2003Sound- \u2003and/or \u2003pr essure-\ninduced \u2003vertigo \u2003due\u2003to\u2003bo ne\u2003de hiscence \u2003of\u2003the\u2003sup erior \u2003semicir cular \u2003\ncanal. \u2003Arch Otolaryngol Head Neck Surg \u2003124:249\u2013258, \u20031998.\n64.\u2003Mohan \u2003S,\u2003Ho effner \u2003E,\u2003Big elow\u2003DC,\u2003et\u2003al:\u2003Ap plications \u2003of\u2003magne tic\u2003\nresonance \u2003imaging \u2003in\u2003ad ult\u2003te mporal \u2003bo ne\u2003disor ders.\u2003Magn Reson \nImaging Clin N Am \u200320:545\u2013572, \u20032012.\n65.\u2003Moody \u2003SA,\u2003Hir sch\u2003BE,\u2003My ers\u2003EN:\u2003Sq uamous \u2003ce ll\u2003carcino ma\u2003of\u2003the\u2003\nexternal \u2003audito ry\u2003canal: \u2003An\u2003ev aluation \u2003of\u2003a\u2003staging \u2003syst em.\u2003Am J Otol \u2003\n21:582\u2013588, \u20032000.\n66.\u2003Moore \u2003KR,\u2003Har nsberger \u2003HR,\u2003Shelt on\u2003C,\u2003et\u2003al:\u2003\u201cLea ve\u2003me\u2003alone \u201d\u2003lesions \u2003\nof\u2003the\u2003petrous \u2003ape x.\u2003AJNR Am J Neuroradiol \u200319:733\u2013738, \u20031998.\n67.\u2003Mukerji \u2003SS,\u2003Par mar\u2003HA,\u2003Ib rahim \u2003M,\u2003et\u2003al:\u2003Co ngenital \u2003malfo rmations \u2003of\u2003\nthe\u2003temporal \u2003bo ne.\u2003Neuroimaging Clin N Am \u200321:603\u2013619, \u20032011.", "8e4553ae-772c-47af-8ba7-65d25c675085": "The\u2003CT\u2003differ ential \u2003diagnosis \u2003includ es\u2003\nRBILD, \u2003NSIP , \u2003and\u2003acut e\u2003or\u2003subacu te\u2003HP .ILD\u2003is\u2003the\u2003most \u2003commo n\u2003complicat ion\u2003of\u2003pro gressive \u2003syste mic\u2003\nsclerosis, \u2003occurring \u2003in\u2003up\u2003to\u200375%\u2003of\u2003cases. \u2003In\u2003the\u2003majorit y\u2003of\u2003patients, \u2003\nthe\u2003interstitial \u2003lung\u2003pathology \u2003is\u2003subc linical, \u2003being \u2003comple tely\u2003asymp -\ntomatic \u2003in\u2003the\u2003early \u2003stages, \u2003as\u2003are\u2003most \u2003other \u2003ILDs.144\nThe\u2003HRCT \u2003findings \u2003of\u2003inter stitial \u2003fibrosis \u2003includ e\u2003ground-g lass\u2003\nattenuation, \u2003subple ural\u2003ret icular \u2003opacit ies,\u2003tra ction \u2003bro nchiectasis \u2003and\u2003\nbronchiolectasis, \u2003archit ectural \u2003distor tion,\u2003pleural \u2003thicke ning\u2003or\u2003effu-\nsion, \u2003and\u2003centrilobular \u2003microno dules \u2003(follicular \u2003bro nchiolitis) \u2003in\u2003a\u2003\npredominantly \u2003per ipheral \u2003and\u2003basilar \u2003distrib ution.61,498,553\u2003Progressive \u2003\nsystemic \u2003sclerosis \u2003follo ws\u2003a\u2003less\u2003aggr essive \u2003course \u2003and\u2003has\u2003a\u2003bett er\u2003\nprognosis \u2003than\u2003IPF;\u2003it\u2003is\u2003commo nly\u2003associate d\u2003with\u2003mediastinal \u2003lymp h\u2003\nnode \u2003enlargement, \u2003pulmonary \u2003vasculitis, \u2003and\u2003pulmonary \u2003hyp erten -\nsion. \u2003Esophageal \u2003dilatation \u2003is\u2003demo nstrated \u2003on\u2003CT\u2003in\u200380%\u2003of\u2003patients \u2003\nwith\u2003ILD68\u2003(Fig.\u200336-48).\nSj\u00f6gren\u2019s syndrome.", "fede83b8-22e3-4976-8001-e9d7013f068e": "Brain \u2003134:2456\u20132477, \u20032011.\n112.\u2003Relkin \u2003N,\u2003Mar marou \u2003A,\u2003Kling e\u2003P ,\u2003et\u2003al:\u2003Diag nosing \u2003idiopathic \u2003\nnormal-pressure \u2003hy drocephalus. \u2003Neurosurgery \u200357:S4\u2013S16, \u2003discussion \u2003\nii\u2013v,\u20032005.\n113.\u2003Roman \u2003GC,\u2003Tat emichi \u2003TK,\u2003Erkinj untti \u2003T,\u2003et\u2003al:\u2003Vascular \u2003de mentia: \u2003\nDiagnostic \u2003crit eria\u2003fo r\u2003resear ch\u2003studies. \u2003Re port\u2003of\u2003the\u2003NINDS-AIREN \u2003\nInternational \u2003Wo rkshop. \u2003Neurology \u200343:250\u2013260, \u20031993.\n114.\u2003Rosen \u2003HJ,\u2003Gor no-Tempini \u2003ML,\u2003Goldman \u2003WP ,\u2003et\u2003al:\u2003Patt erns\u2003of\u2003br ain\u2003\natrophy \u2003in\u2003fro ntotemporal \u2003de mentia \u2003and\u2003semant ic\u2003de mentia. \u2003Neurology \u2003\n58:198\u2013208, \u20032002.\n115.\u2003Ross\u2003CA,\u2003Ay lward \u2003EH,\u2003Wild \u2003EJ,\u2003et\u2003al:\u2003Hunt ington \u2003disease: \u2003Nat ural\u2003\nhistory, \u2003biomarkers \u2003and\u2003pr ospects \u2003fo r\u2003ther apeutics. \u2003Nat Rev Neurol \u2003\n10:204\u2013216, \u20032014.\n116.\u2003Salat \u2003DH,\u2003Buc kner\u2003RL,\u2003Sn yder\u2003AZ,\u2003et\u2003al:\u2003Thinning \u2003of\u2003the\u2003ce rebral \u2003co rtex\u2003\nin\u2003aging. \u2003Cereb Cortex \u200314:721\u2013730, \u20032004.\n117.\u2003Savva \u2003GM,\u2003Whar ton\u2003SB,\u2003Inc e\u2003PG,\u2003et\u2003al:\u2003Ag e,\u2003neur opathology, \u2003and\u2003\ndementia. \u2003N Engl J Med \u2003360:2302\u20132309, \u20032009.\n118.\u2003Scheltens \u2003P ,\u2003Bar khof\u2003F,\u2003Le ys\u2003D,\u2003et\u2003al:\u2003A\u2003semiq uantitative \u2003rat ing\u2003scale \u2003fo r\u2003\nthe\u2003assessment \u2003of\u2003signal \u2003hy perintensities \u2003on\u2003magne tic\u2003reso nance \u2003\nimaging. \u2003J Neurol Sci \u2003114:7\u201312, \u20031993.\n119.\u2003Seeley \u2003WW, \u2003Cr awford \u2003R,\u2003Rasc ovsky \u2003K,\u2003et\u2003al:\u2003Fr ontal \u2003paralimb ic\u2003netw ork\u2003\natrophy \u2003in\u2003very\u2003mild \u2003be havioral \u2003var iant\u2003fro ntotemporal \u2003de mentia. \u2003Arch \nNeurol \u200365:249\u2013255, \u20032008.\n120.\u2003Seppi \u2003K,\u2003Po ewe\u2003W:\u2003Br ain\u2003magne tic\u2003reso nance \u2003imaging \u2003te chniques \u2003in\u2003the\u2003\ndiagnosis \u2003of\u2003parkinso nian\u2003syndro mes.\u2003Neuroimaging Clin N Am \u2003\n20:29\u201355, \u20032010.\n121.", "ec18d084-7c7f-40bb-b180-c4e238e62dbc": "CHAPTER 21 \u2003 Temporal \u2003Bone 619\nThe lenticular process of the incus and head of the stapes form the incudostapedial joint \n(I-S joint) (E). The tympanic segment of the facial nerve canal (tympanic VII) is seen superolateral to the \ncochlea and cochlear promontory (black arrowheads) (D, E). F, Oval window level. The internal auditory canal \n(IAC) is visualized divided by the crista falciformis. The oval window is seen along the lateral margin of the vestibule (v), with the stapes extending toward it. The tympanic segment of the facial nerve canal (tympanic VII) is seen just below the lateral SCC. The anterior limb of the superior SCC is also seen. G, Posterior \ntympanic level. The facial nerve recess (1) is lateral to and the sinus tympani (2) medial to the pyramidal eminence. The round window niche (round w. niche) is seen along the basal turn of the cochlea. H, Jugular \nforamen level. The mastoid segment of the facial nerve canal (black arrowheads) is seen in its vertical course. \nParts of the lateral SCC and superior SCC are seen. The mastoid antrum and jugular foramen are seen. \nTympanic\nVII\nI-S\njointLateral\nSCCSuperior\nSCC\nOval\nwindowCrista\nfalciformis\nIAC\nV\nTympanic VII\nStapes\nPyramidal\neminence\n12\nRound w.\nnicheAntrumSuperior\nSCC\nLateral\nSCC\nJugular\nforamenE F\nG H\nFIG 21-2, cont\u2019d", "0af82963-1963-46e9-8a34-a70b03b91212": "PART II \u2003 CT \u2003and\u2003MR\u2003Imaging \u2003of\u2003the\u2003Whole \u2003Body 762\nThe\u2003signal \u2003chara cteristics \u2003of\u2003this\u2003lesion \u2003can\u2003be\u2003confuse d\u2003with\u2003other \u2003\ncystic \u2003lesions \u2003such\u2003as\u2003an\u2003uncomplicat ed\u2003lymp hatic \u2003malfor mation \u2003or\u2003\nranula.\nIt\u2003is\u2003important \u2003to\u2003accur ately\u2003localize \u2003the\u2003lesions \u2003when \u2003they\u2003are\u2003\nlocated \u2003in\u2003the\u2003floor \u2003of\u2003the\u2003mouth. \u2003If\u2003the\u2003lesion \u2003is\u2003locate d\u2003abov e\u2003the\u2003\nmylohyoid \u2003muscle, \u2003it\u2003lies\u2003in\u2003the\u2003sublingual \u2003space \u2003and\u2003is\u2003amenable \u2003to\u2003an\u2003\nintraoral \u2003surgical \u2003appr oach. \u2003If\u2003it\u2003lies\u2003in\u2003the\u2003submandib ular\u2003space, \u2003a\u2003\nsubmandibular \u2003appr oach \u2003would \u2003be\u2003used. \u2003The\u2003opt imal\u2003imaging \u2003plane \u2003\nfor\u2003localizing \u2003these \u2003masses \u2003into\u2003the\u2003appr opriate \u2003space \u2003would \u2003be\u2003cor onal\u2003\nCT\u2003or\u2003MRI.191\nTeratoma\nApproximately \u20039%\u2003of\u2003all\u2003pediat ric\u2003head \u2003and\u2003neck\u2003neoplasms \u2003are\u2003ter a\u00ad\ntomas, \u2003and\u2003less\u2003than\u20035%\u2003of\u2003all\u2003ter atomas \u2003occur \u2003in\u2003the\u2003head \u2003and\u2003neck.38,99\u2003\nIn\u2003the\u2003pediatric \u2003populat ion,\u2003most \u2003ter atomas \u2003are\u2003extr agonadal \u2003in\u2003loca\u00ad\ntion,\u2003with\u200382%\u2003in\u2003the\u2003sacro coccygeal \u2003area;\u2003locatio ns\u2003in\u2003the\u2003head \u2003and\u2003\nneck\u2003include \u2003neck, \u2003nasal \u2003cavit y,\u2003paranasal \u2003sinus, \u2003oral\u2003cavit y,\u2003oro phar\u00ad\nynx,\u2003nasopharynx, \u2003temp oral\u2003bone, \u2003ear,\u2003and\u2003orb it.7,112,201,202\nTeratomas \u2003are\u2003thought \u2003to\u2003arise\u2003from \u2003misplace d\u2003plurip otential \u2003pri\u00ad\nmordial \u2003germ \u2003cel ls\u2003and\u2003are\u2003classified \u2003as\u2003true\u2003neoplasms \u2003because \u2003of\u2003their\u2003\nbiological \u2003behavior \u2003with\u2003pro gressive \u2003and\u2003invasi ve\u2003gro wth\u2003patter ns.170\nCervical Teratomas.", "34ac8a24-1549-43f5-9f4a-008db5b958e4": "They \u2003are\u2003subc lassified \u2003into\u2003nasofro ntal,\u2003\nnasoethmoidal, \u2003and\u2003nasoor bital\u2003subt ypes\u2003based \u2003on\u2003the\u2003point \u2003at\u2003which \u2003\nthe\u2003skull\u2003defect \u2003and\u2003hernia \u2003emerg e\u2003exte rnally. \u2003Various \u2003complicat ions\u2003\ncan\u2003occur \u2003dep ending \u2003on\u2003the\u2003size\u2003of\u2003the\u2003mass. \u2003For\u2003example, \u2003large \u2003\nmasses \u2003stretch \u2003and\u2003thin\u2003the\u2003skin,\u2003obscure \u2003vision, \u2003bloc k\u2003the\u2003airway ,\u2003and\u2003\nmay\u2003also\u2003cause \u2003press ure\u2003def ormities \u2003of\u2003adja cent\u2003soft\u2003tissue \u2003and\u2003bone \u2003\nat\u2003the\u2003forehead, \u2003nose, \u2003and\u2003orb its,\u2003causing \u2003tele canthus \u2003or\u2003true\u2003bon y\u2003\nhypertelorism.163,172FIG 26-14  Anterior basal encephalocele. Axial T1-weighted ( A) and coronal postcontrast (B) T1-weighted \nMRIs at the anterior skull base demonstrate a nonenhancing CSF-filled structure extending through a defect \nin the dura into the posterior ethmoid air cells and sphenoid sinus from the right middle cranial fossa (arrows). \nSagittal T1-weighted ( C) and axial T2-weighted ( D) MRIs demonstrate a CSF signal lesion extending through \na defect in the dura into the posterior ethmoid and sphenoid sinuses (arrows). \nA B\nC D", "4c2453d6-1eff-455e-ac95-9a3b01c45d37": "SDHs \u2003somet imes\u2003occur \u2003as\u2003\na\u2003result \u2003of\u2003isolated \u2003impulsive \u2003for ces\u2003without \u2003impact \u2003for\u2003this\u2003reason.8,102\u2003\nTearing \u2003of\u2003cortical \u2003veins \u2003result ing\u2003in\u2003SDH \u2003ofte n\u2003occur s\u2003in\u2003the\u2003same \u2003\ndistribution \u2003as\u2003coup \u2003and\u2003cont recoup \u2003cont usions,70\u2003and\u2003like\u2003contusions, \u2003\na\u2003large \u2003proportion \u2003of\u2003SDHs, \u2003epidur al\u2003hemato mas\u2003(EDHs), \u2003and\u2003sub-\narachnoid \u2003hemor rhage \u2003(SAH) \u2003result \u2003from \u2003later al\u2003blow s.10\nKnowledge \u2003of\u2003the\u2003anatom y\u2003of\u2003fluid \u2003spaces \u2003and\u2003the\u2003relat ionship \u2003of\u2003\nthe\u2003meningeal \u2003laye rs\u2003to\u2003the\u2003brain \u2003surfa ce\u2003and\u2003inner \u2003table \u2003of\u2003the\u2003skull \u2003\nis\u2003important \u2003to\u2003under stand \u2003commo n\u2003appear ances \u2003of\u2003differ ent\u2003extr a-\naxial\u2003hemorrhagic \u2003lesions. \u2003The\u2003pia\u2003lines\u2003the\u2003cor tical\u2003gyr i\u2003as\u2003wel l\u2003as\u2003\nperforating \u2003vessels \u2003(bridg ing\u2003veins), \u2003for ming \u2003a\u2003per ivascular \u2003space \u2003\n(Virchow-Robin \u2003space)71\u2003that\u2003communicates \u2003with\u2003the\u2003subara chnoid \u2003\nspace, \u2003lying \u2003betw een\u2003the\u2003arac hnoid \u2003and\u2003pia.\u2003SAH \u2003can\u2003result", "dda92a7e-f3d2-45ff-bad9-f01d087480dc": "CHAPTER 25\u2003 Larynx 747\nrestriction. \u2003If\u2003there \u2003is\u2003any\u2003suspicion \u2003of\u2003a\u2003fragme nt\u2003pushed \u2003towar d\u2003or\u2003\ninto\u2003the\u2003airway, \u2003direc t\u2003visualizat ion\u2003via\u2003endosc opy\u2003or\u2003ope n\u2003explor ation \u2003\nis\u2003indicated \u2003to\u2003thoroug hly\u2003assess \u2003the\u2003mucosa.\nIf\u2003there \u2003is\u2003sufficient \u2003for ce\u2003to\u2003frac ture\u2003the\u2003thyr oid\u2003cartilag e,\u2003the\u2003lowe r\u2003\nepiglottis \u2003can\u2003be\u2003tor n\u2003or\u2003avulse d.\u2003This\u2003can\u2003be\u2003seen\u2003particular ly\u2003with\u2003\nhorizontal \u2003frac tures \u2003wher e\u2003the\u2003fragme nts\u2003are\u2003pushed \u2003poste riorly, \u2003creat -\ning\u2003a\u2003shearing \u2003for ce\u2003across \u2003the\u2003lowe r\u2003epiglott is.\u2003Because \u2003the\u2003epiglott is\u2003\ndoes\u2003not\u2003calcify \u2003significantly ,\u2003this\u2003abnor mality \u2003may\u2003not\u2003be\u2003det ectable \u2003\nby\u2003CT\u2003scans. \u2003The\u2003only\u2003finding \u2003may\u2003be\u2003hemato ma\u2003obscuring \u2003the\u2003fat\u2003in\u2003\nthe\u2003preepiglottic \u2003space. \u2003The\u2003curve \u2003of\u2003the\u2003epiglott is\u2003can\u2003ofte n\u2003be\u2003out-\nlined \u2003against \u2003the\u2003preepiglottic \u2003fat\u2003in\u2003the\u2003sagittal \u2003plane, \u2003so\u2003sagittal \u2003re for-\nmatted \u2003images \u2003can\u2003be\u2003helpful \u2003in\u2003eval uating \u2003trauma \u2003cases.\nThe\u2003arytenoid \u2003cartilag e\u2003is\u2003not\u2003ofte n\u2003frac tured, \u2003but\u2003the\u2003crico aryte -\nnoid\u2003joint\u2003can\u2003be\u2003dislocate d.\u2003This\u2003can\u2003occur \u2003with\u2003fairly \u2003minimal \u2003trauma \u2003\nto\u2003the\u2003lateral \u2003larynx \u2003or\u2003result \u2003from \u2003a\u2003more \u2003significant \u2003insult \u2003associate d\u2003(Fig.\u200325-24). \u2003The\u2003ver tical\u2003frac tures \u2003are\u2003easily \u2003det ected \u2003in\u2003the\u2003axial\u2003scan\u2003\nplane, \u2003but\u2003the\u2003horiz ontal \u2003frac ture\u2003may\u2003be\u2003more \u2003difficult \u2003to\u2003diagnose \u2003\nunless \u2003there \u2003is\u2003some \u2003displace ment \u2003of\u2003the\u2003frac ture\u2003fragme nts.\u2003Ref ormat -\nted\u2003images \u2003may\u2003help\u2003define \u2003horiz ontal \u2003frac tures. \u2003These \u2003frac tures \u2003are\u2003\nless\u2003common.\nThe\u2003cricoid \u2003frac ture\u2003is\u2003chara cteristically \u2003a\u2003double \u2003break \u2003(Fig.\u200325-25).", "142bd738-0418-4de7-b14b-170c1a59f546": "CHAPTER 26 \u2003 Imaging \u2003of\u2003the\u2003Head \u2003and\u2003Neck \u2003in\u2003the\u2003Pediatric \u2003Patient 757\nto\u2003the\u2003platysma \u2003muscle \u2003and\u2003anter ior\u2003to\u2003the\u2003ster nocleidomastoid \u2003(SCM) \u2003\nmuscle \u2003(Fig.\u200326\u00ad3).\u2003This\u2003typ e\u2003of\u2003cyst\u2003is\u2003felt\u2003to\u2003rep resent \u2003a\u2003remnant \u2003of\u2003\nthe\u2003tract\u2003between \u2003the\u2003sinus \u2003of\u2003His\u2003and\u2003the\u2003skin.\u2003Typ e\u2003II\u2003cyst\u2003is\u2003the\u2003most \u2003\ncommon \u2003type\u2003and\u2003is\u2003thought \u2003to\u2003be\u2003the\u2003result \u2003of\u2003the\u2003per sistence \u2003of\u2003the\u2003\nsinus \u2003of\u2003His.\u2003This\u2003cyst\u2003is\u2003locate d\u2003poste rior\u2003and\u2003later al\u2003to\u2003the\u2003subman \u00ad\ndibular \u2003gland, \u2003anter ior\u2003and\u2003medial \u2003to\u2003the\u2003SCM \u2003muscle, \u2003and\u2003anter ior\u2003\nand\u2003lateral \u2003to\u2003the\u2003carotid \u2003space \u2003(Fig.\u200326\u00ad4).\u2003Typ e\u2003III\u2003cyst/fistula \u2003is\u2003\nthought \u2003to\u2003arise\u2003from \u2003a\u2003dilated \u2003pharyng eal\u2003pouch \u2003and\u2003courses \u2003mediall y\u2003\nbetween \u2003the\u2003inter nal\u2003and\u2003exte rnal\u2003carotid \u2003arte ries;\u2003it\u2003can\u2003exte nd\u2003up\u2003to\u2003\nthe\u2003lateral \u2003wall\u2003of\u2003the\u2003pharynx \u2003or\u2003skull\u2003base\u2003(Fig.\u200326\u00ad5).\u2003Typ e\u2003IV\u2003cyst\u2003\nlies\u2003in\u2003the\u2003mucosal \u2003space \u2003of\u2003the\u2003pharynx \u2003adja cent\u2003to\u2003the\u2003pharyng eal\u2003\nwall\u2003and\u2003is\u2003thought \u2003to\u2003arise\u2003from \u2003a\u2003remnant \u2003of\u2003the\u2003pharyng eal\u2003\npouch5,54,135,147,179\u2003(Fig.\u200326\u00ad6).\nPresentation.\u2002 The\u2003most \u2003common \u2003prese ntation \u2003of\u2003a\u2003seco nd\u2003bran\u00ad\nchial\u2003cleft\u2003cyst\u2003is\u2003as\u2003a\u2003fluctuant \u2003nonte nder\u2003mass \u2003at\u2003the\u2003later al\u2003aspec t\u2003of\u2003\nthe\u2003mandibular \u2003angle.135,191,194\u2003When \u2003infected \u2003the\u2003patient \u2003will\u2003prese nt\u2003of\u2003small \u2003fluid\u00adfille d\u2003tra cts\u2003leading \u2003to\u2003the\u2003exte rnal\u2003auditor y\u2003canal.54\u2003If\u2003\nthe\u2003cyst\u2003is\u2003infec ted\u2003and\u2003has\u2003a\u2003tra ct,\u2003cor onal\u2003T2\u00adwe ighted \u2003and\u2003postc on\u00ad\ntrast\u2003T1\u00adweighted \u2003fat\u00adsup pressed \u2003MRIs \u2003would \u2003best\u2003demo nstrate \u2003the\u2003\ntract.195\nTreatment.", "eee4a4e1-e394-469c-9007-a70c5980af0a": "Although \u2003the\u2003coo peration \u2003of\u2003patients \u2003can\u2003\nmitigate \u2003motion \u2003effe cts\u2003to\u2003some \u2003exte nt,\u2003fast\u2003imaging \u2003tec hniques \u2003with\u2003\nmotion \u2003compensation \u2003are\u2003fundamental \u2003to\u2003ove rcoming \u2003the\u2003motion \u2003\nproblems. \u2003The\u2003golde n-angle \u2003radial \u2003seque nce\u2003with\u2003self-gat ing\u2003has\u2003shown \u2003\npromise \u2003for\u2003DCE-MRI \u2003in\u2003lung\u2003and\u2003live r\u2003lesions.39,71\u2003A\u2003comparison \u2003\nbetween \u2003Cartesian \u2003and\u2003self-gat ed\u2003golde n-angle \u2003radial \u2003images \u2003in\u2003free\u2003\nbreathing \u2003is\u2003shown \u2003in\u2003Figure \u20035-7.\u2003The\u2003golde n-angle \u2003radial \u2003acq uisition \u2003\nwith\u2003self-gating \u2003achie ved\u2003a\u2003much \u2003bett er\u2003image \u2003quality \u2003eve n\u2003with\u2003free\u2003\nbreathing.\nDSC-MRI\nDynamic \u2003susceptibility \u2003cont rast\u2003(DSC) \u2003MRI\u2003is\u2003a\u2003wel l-established \u2003\u2003\nperfusion \u2003quantification \u2003method \u2003in\u2003brain \u2003imaging. \u2003In\u2003DSC-MRI, \u2003T2*-\u2003\nor\u2003T2-weighted \u2003MR\u2003images \u2003are\u2003acq uired \u2003to\u2003extr act\u2003kinetic \u2003paramet ers\u2003\nin\u2003brain \u2003perfusion \u2003instead \u2003of\u2003using \u2003the\u2003T1-weig hted\u2003images \u2003used\u2003in\u2003\nDCE-MRI. \u2003DSC-MRI \u2003is\u2003primar ily\u2003restr icted \u2003to\u2003use\u2003in\u2003brain \u2003imaging \u2003\nbecause \u2003most \u2003GBCAs \u2003leak\u2003from \u2003the\u2003vasculatur e\u2003throughou t\u2003the\u2003bod y\u2003\nexcept \u2003in\u2003the\u2003brain, \u2003wher e\u2003the\u2003agents \u2003are\u2003bloc ked\u2003by\u2003the\u2003BBB. \u2003Sev eral\u2003\nuseful \u2003kinetic \u2003paramet ers\u2003can\u2003be\u2003calculated \u2003by\u2003using \u2003DSC-MRI, \u2003includ -\ning\u2003cerebral \u2003bloo d\u2003flow\u2003(CBF), \u2003cer ebral \u2003bloo d\u2003volume \u2003(CBV), \u2003mean \u2003\ntransit \u2003time\u2003(MTT), \u2003and\u2003time\u2003to\u2003maximum \u2003(Tmax).\u2003DSC-MRI \u2003paramet -\nric\u2003maps \u2003are\u2003shown \u2003in\u2003Figure \u20035-8.\u2003Although \u2003DSC-MRI \u2003acq uisition \u2003and\u2003\ndata\u2003processing \u2003invol ve\u2003many \u2003tec hnical \u2003aspec ts,\u2003we\u2003have\u2003focuse d\u2003on\u2003FIG 5-5  Comparison of results fitted by using standard approach (SA: Tofts model) and shutter speed \napproach (SSA). A and B show two different breast lesions. C and D show corresponding results of fitting. \nThe inset in D shows the arterial input function used for all analyses. (From Huang W, et  al: Discrimination \nof benign and malignant breast lesions by using shutter-speed dynamic contrast-enhanced MR imaging.", "e39368e7-0863-4c19-98a5-34c4a7fe1357": "A\u2003light\u2003microsc opic, \u2003histo chemical, \u2003and\u2003\nultrastructural \u2003stud y\u2003with\u2003a\u2003re view\u2003of\u2003the\u2003lite rature. \u2003Cancer \u200356:2657\u2013\n2663, \u20031985.\n14.\u2003Antoch \u2003G,\u2003Stattaus \u2003J,\u2003Ne mat\u2003AT ,\u2003et\u2003al:\u2003No n-small \u2003ce ll\u2003lung\u2003cance r:\u2003\nDual-modality \u2003PET/CT \u2003in\u2003pr eoperative \u2003staging .\u2003Radiology \u2003229:526\u2013533, \u2003\n2003.\n15.\u2003Attanoos \u2003RL,\u2003Ap pleton \u2003MA,\u2003Gibbs \u2003AR:\u2003Pr imary \u2003sarc omas \u2003of\u2003the\u2003lung: \u2003A\u2003\nclinicopathological \u2003and\u2003immunohist ochemical \u2003stud y\u2003of\u200314\u2003cases. \u2003\nHistopathology \u200329:29\u201336, \u20031996.\n16.\u2003Austin \u2003JH,\u2003Garg \u2003K,\u2003Ab erle\u2003D,\u2003et\u2003al:\u2003Ra diologic \u2003implicatio ns\u2003of\u2003the\u20032011 \u2003\nclassification \u2003of\u2003ad enocarcinoma \u2003of\u2003the\u2003lung .\u2003Radiology \u2003266:62\u201371, \u2003\n2013.\n17.\u2003Azad \u2003A,\u2003Chio nh\u2003F,\u2003Scott \u2003AM,\u2003et\u2003al:\u2003Hig h\u2003impac t\u2003of\u200318F-FD G-PET \u2003on\u2003\nmanagement \u2003and\u2003pr ognostic \u2003str atification \u2003of\u2003new ly\u2003diagnose d\u2003small \u2003ce ll\u2003\nlung\u2003cancer. \u2003Mol Imaging Biol \u200312:443\u2013451, \u20032010.\n18.\u2003Bagan \u2003P ,\u2003Hassan \u2003M,\u2003Le\u2003Pimpe c\u2003Bar thes\u2003F,\u2003et\u2003al:\u2003Pr ognostic \u2003fac tors\u2003and\u2003\nsurgical \u2003indicatio ns\u2003of\u2003pulmonar y\u2003epithe lioid\u2003hemang ioendothelioma: \u2003\nA\u2003review \u2003of\u2003the\u2003lite rature. \u2003Ann Thorac Surg \u200382:2010\u20132013, \u20032006.\n19.\u2003Bailey-Wilson \u2003JE,\u2003Amos \u2003CI,\u2003Pinney \u2003SM,\u2003et\u2003al:\u2003A\u2003major \u2003lung\u2003cance r\u2003\nsusceptibility \u2003locus \u2003maps \u2003to\u2003chr omosome \u20036q23-25. \u2003Am J Hum Genet \u2003\n75:460\u2013474, \u20032004.\n20.\u2003Baltar \u2003VT,\u2003Xun\u2003WW, \u2003Ch uang \u2003SC,\u2003et\u2003al:\u2003Smoking ,\u2003sec ondhand \u2003smoke, \u2003\nand\u2003cotinine \u2003lev els\u2003in\u2003a\u2003subse t\u2003of\u2003EPIC \u2003coho rt.\u2003Cancer Epidemiol \nBiomarkers Prev \u200320:869\u2013875, \u20032011.\n21.", "acbf65b2-fd77-43d0-918c-8f4479781bd4": "Radiographs \u2003are\u2003usuall y\u2003normal \u2003but\u2003may\u2003rev eal\u2003a\u2003\nwidened \u2003canal, \u2003enlarge d\u2003for amina, \u2003and\u2003bone \u2003erosio n.\nCT. CT\u2003may\u2003demonstrate \u2003cystic \u2003masses \u2003isode nse\u2003to\u2003CSF\u2003locate d\u2003at\u2003the\u2003\nforamina, \u2003which \u2003may\u2003be\u2003enlarge d,\u2003and\u2003an\u2003enlarge d\u2003sacral \u2003canal. \u2003\nMyelography \u2003showing \u2003filling \u2003of\u2003the\u2003cyst\u2003up\u2003to\u20031\u2003hour \u2003after\u2003inject ion\u2003of\u2003\ncontrast \u2003medium \u2003is\u2003sugg estive \u2003of\u2003a\u2003per ineural \u2003cyst.\nMRI.  MRI\u2003is\u2003the\u2003gold\u2003standard \u2003to\u2003det ect\u2003sacral \u2003per ineural \u2003cysts, \u2003study \u2003\ntheir \u2003relationship \u2003with\u2003surr ounding \u2003struc tures, \u2003and\u2003plan\u2003surgical \u2003or\u2003\npercutaneous \u2003treat ment. \u2003The\u2003cysts\u2003demo nstrate \u2003low\u2003signal \u2003on\u2003\nT1-weighted \u2003images \u2003and\u2003high\u2003signal \u2003on\u2003T2-weig hted\u2003images, \u2003similar \u2003\nto\u2003CSF.\u2003Scalloping \u2003of\u2003the\u2003sacral \u2003ver tebral \u2003bod y\u2003or\u2003poste rior\u2003arches, \u2003\ncaused \u2003by\u2003a\u2003slow\u2003increase \u2003in\u2003size\u2003of\u2003the\u2003cysts, \u2003can\u2003be\u2003seen\u2003on\u2003both\u2003MRI\u2003\nand\u2003CT.\u2003A\u2003Tarlo v\u2019s\u2003cyst\u2003does\u2003not\u2003enhance \u2003with\u2003gad olinium \u2003cont rast\u2003\nagents \u2003(Figs. \u200332-3\u2003and\u200332-4).\nSYRINGOMYELIA\nSyringomyelia \u2003refers \u2003to\u2003a\u2003hete rogeneous \u2003colle ction \u2003of\u2003condit ions\u2003char-\nacterized \u2003by\u2003the\u2003prese nce\u2003of\u2003abnor mal\u2003fluid-filled \u2003cavit ies\u2003within \u2003the\u2003\nspinal \u2003cord. \u2003The\u2003ter m\u2003syrinx \u2003is\u2003Greek \u2003for\u2003a\u2003cavit y\u2003of\u2003tubular \u2003shape. \u2003\nSyringomyelia \u2003was\u2003sugg ested \u2003in\u20031827 \u2003by\u2003Olli vier\u2003d\u2019Ange rs\u2003as\u2003a\u2003name \u2003\nfor\u2003cystic \u2003cavitations \u2003of\u2003the\u2003spinal \u2003cor d.38", "498443f1-1573-4a40-9c09-4ac9a914bd0e": "C,\u2002Coronal \u2002post-Gd \u2002fat-suppressed \u2002images \u2002more \u2002clearly \u2002\ndemonstrate \u2002the\u2002enhancing \u2002mass \u2002(long arrow) \u2002separate \u2002from \u2002the\u2002nonenhancing \u2002left\u2002optic \u2002nerve \u2002(short arrow). \u2002\nM,\u2002extraocular \u2002muscles. \u2002\nB\nM\nMM\nM\nCA\nFIG 20-22 \u2002 Axial \u2002T1-weighted \u2002MRI\u2002study \u2002shows \u2002optic \u2002glioma \u2002of\u2002bilateral \u2002\noptic \u2002nerves, \u2002with\u2002involvement \u2002of\u2002the\u2002chiasm \u2002(arrows) \u2002in\u2002a\u2002patient \u2002with\u2002\nneurofibromatosis.", "71a16a95-55bb-4929-a605-6f3e57f5be14": "Osteo ma\u2003is\u2003gene rally\u2003an\u2003incidental \u2003\nfinding \u2003and\u2003is\u2003the\u2003commo nest\u2003osseous \u2003tumor \u2003in\u2003the\u2003maxillofa cial\u2003\nregion. \u2003It\u2003is\u2003freq uently \u2003seen\u2003in\u2003the\u2003front oethmoid \u2003sinuses. \u2003It\u2003appear s\u2003as\u2003\na\u2003characteristic \u2003sharp, \u2003wel l-delineated \u2003scler otic\u2003lesion \u2003attache d\u2003by\u2003a\u2003\nbroad \u2003base\u2003or\u2003pedic le\u2003to\u2003the\u2003bone. \u2003It\u2003pro duces \u2003a\u2003comple te\u2003signal \u2003void\u2003\non\u2003all\u2003MR\u2003seque nces\u2003and\u2003may\u2003ofte n\u2003be\u2003ove rlooked \u2003owing \u2003to\u2003the\u2003back-\nground \u2003of\u2003sinus \u2003air.\nOdontogenic Cysts and Tumors\nOdontogenic \u2003cysts\u2003and\u2003tumor s\u2003that\u2003arise\u2003from \u2003the\u2003maxillary \u2003alve olar\u2003\nridge \u2003may\u2003exte nd\u2003into\u2003the\u2003maxillary \u2003sinus \u2003and\u2003prese nt\u2003as\u2003sinus \u2003\nmasses.71\u2003All\u2003of\u2003them \u2003are\u2003ver y\u2003wel l\u2003delineat ed\u2003at\u2003CT.\u2003The\u2003odo ntogenic \u2003\ncysts\u2003of\u2003significance \u2003to\u2003the\u2003sinonasal \u2003reg ion\u2003includ e\u2003the\u2003radicular \u2003cyst,\u2003\ndentigerous \u2003cyst,\u2003and\u2003odo ntogenic \u2003ker atocyst. \u2003The\u2003radicular \u2003cyst\u2003is\u2003\nseen\u2003in\u2003relation \u2003to\u2003a\u2003carious \u2003tooth \u2003and\u2003appear s\u2003as\u2003a\u2003wel l-defined \u2003\ncystic \u2003lesion \u2003bor dered \u2003by\u2003a\u2003thin\u2003rim\u2003of\u2003cor tical\u2003bone. \u2003Dent igerous \u2003\ncysts\u2003and\u2003odontogenic \u2003ker atocysts \u2003are\u2003more \u2003commo n\u2003in\u2003the\u2003man-\ndible. \u2003A\u2003dentigerous \u2003cyst\u2003is\u2003seen\u2003as\u2003a\u2003wel l-defined \u2003unilocular \u2003or\u2003mul-\ntilocular \u2003cyst\u2003in\u2003relat ion\u2003to\u2003the\u2003crow n\u2003of\u2003an\u2003unerup ted\u2003tooth; \u2003the\u2003\ncrown \u2003of\u2003the\u2003tooth \u2003pro jects\u2003into\u2003the\u2003cystic \u2003cavit y.\u2003An\u2003odo ntogenic \u2003FIG 23-27  Coronal CT image shows smooth expansion with ground-\nglass appearance of the walls of the ethmoid labyrinth on the right side \nand the right middle turbinate. Fibrous dysplasia. \nFIG 23-28  Axial CT shows fracture of the pterygoid plates bilaterally, \nposterolateral wall of both maxillary sinuses, anterior wall of right maxil -\nlary sinus, and the right zygomatic arch.", "92d2d1f6-4c6f-4075-8715-0c6fd600ef3c": "Radiographics \u2003\n21(5):1257\u20131273, \u20032001.\n342.\u2003Lawler \u2003LP ,\u2003Fishman \u2003EK:\u2003Ar teriovenous \u2003malfo rmations \u2003and\u2003syst emic \u2003\nlung\u2003supply: \u2003Ev aluation \u2003by\u2003mult idetector \u2003CT\u2003and\u2003thre e-dimensional \u2003\nvolume \u2003rendering. \u2003AJR Am J Roentgenol \u2003178(2):493\u2013495, \u20032002.\n343.\u2003Lee\u2003CH:\u2003The\u2003crazy-pa ving\u2003sign.\u2003Radiology \u2003243(3):905\u2013906, \u20032007.\n344.\u2003Lee\u2003PH,\u2003Car r\u2003DH,\u2003Rub ens\u2003MB,\u2003et\u2003al:\u2003Ac curacy \u2003of\u2003CT\u2003in\u2003pr edicting \u2003the\u2003\ncause \u2003of\u2003bronchiectasis. \u2003Clin Radiol \u200350(12):839\u2013841, \u20031995.\n345.\u2003Lee\u2003ES,\u2003Gotway \u2003MB,\u2003Re ddy\u2003GP ,\u2003et\u2003al:\u2003Earl y\u2003br onchiolitis \u2003ob literans \u2003\nfollowing \u2003lung\u2003tr ansplantation: \u2003Ac curacy \u2003of\u2003expir atory \u2003thin-sec tion\u2003CT\u2003\nfor\u2003diagnosis. \u2003Radiology \u2003216(2):472\u2013477, \u20032000.\n346.\u2003Lee\u2003KN,\u2003Le vin\u2003DL,\u2003We bb\u2003WR,\u2003et\u2003al:\u2003Pulmo nary\u2003alv eolar \u2003pr oteinosis: \u2003\nHigh-resolution \u2003CT,\u2003chest \u2003ra diographic, \u2003and\u2003funct ional \u2003co rrelations. \u2003\nChest \u2003111(4):989\u2013995, \u20031997.\n347.\u2003Lee\u2003KS,\u2003Kim\u2003TS,\u2003Fujimot o\u2003K,\u2003et\u2003al:\u2003Tho racic \u2003manifestat ion\u2003of\u2003We gener\u2019s \u2003\ngranulomatosis: \u2003CT\u2003findings \u2003in\u200330\u2003patie nts.\u2003Eur Radiol \u200313(1):43\u201351, \u2003\n2003.\n348.\u2003Lee\u2003KS,\u2003Pr imack \u2003SL,\u2003Staples \u2003CA,\u2003et\u2003al:\u2003Chr onic\u2003infiltr ative\u2003lung\u2003disease: \u2003\ncomparison \u2003of\u2003diagnost ic\u2003ac curacies \u2003of\u2003ra diography \u2003and\u2003low-\u2003and\u2003\nconventional-dose \u2003thin-sec tion\u2003CT.\u2003Radiology \u2003191(3):669\u2013673, \u20031994.", "17637e23-2026-4a16-ac08-57190f9b31d9": "PART II \u2003 CT \u2003and\u2003MR\u2003Imaging \u2003of\u2003the\u2003Whole \u2003Body 262\n248.\u2003Meyers \u2003SP ,\u2003Hir sch\u2003WL,\u2003Cur tin\u2003HD,\u2003et\u2003al:\u2003Cho ndrosarcomas \u2003of\u2003the\u2003skull \u2003\nbase: \u2003MR\u2003imaging \u2003feat ures.\u2003Radiology \u2003184(1):103\u2013108, \u20031992.\n249.\u2003Miller \u2003DC,\u2003Ho chberg \u2003FH,\u2003Har ris\u2003NL,\u2003et\u2003al:\u2003Patholo gy\u2003with\u2003clinical \u2003\ncorrelations \u2003of\u2003pr imary \u2003ce ntral \u2003ner vous\u2003syst em\u2003non-H odgkin\u2019s \u2003\nlymphoma. \u2003The\u2003Massa chusetts \u2003Gene ral\u2003Hospital \u2003exp erience \u20031958-1989. \u2003\nCancer \u200374(4):1383\u20131397, \u20031994.\n250.\u2003Mitsuya \u2003K,\u2003Nakas u\u2003Y,\u2003Ho riguchi \u2003S,\u2003et\u2003al:\u2003Pe rfusion \u2003we ighted \u2003magne tic\u2003\nresonance \u2003imaging \u2003to\u2003distinguish \u2003the\u2003re currence \u2003of\u2003metastat ic\u2003br ain\u2003\ntumors \u2003from \u2003ra diation \u2003necr osis\u2003afte r\u2003ste reotactic \u2003ra diosurgery. \u2003\u2003\nJ Neurooncol \u200399(1):81\u201388, \u20032010.\n251.\u2003Miwa \u2003K,\u2003Shinoda \u2003J,\u2003Yano \u2003H,\u2003et\u2003al:\u2003Discr epancy \u2003be tween \u2003lesion \u2003\ndistributions \u2003on\u2003methio nine\u2003PET\u2003and\u2003MR\u2003images \u2003in\u2003patie nts\u2003with\u2003\nglioblastoma \u2003mult iforme: \u2003Insig ht\u2003fro m\u2003a\u2003PET\u2003and\u2003MR\u2003fusion \u2003image \u2003\nstudy. \u2003J Neurol Neurosurg Psychiatry \u200375(10):1457\u20131462, \u20032004.\n252.\u2003Moffat \u2003BA,\u2003Che nevert \u2003TL,\u2003Law rence \u2003TS,\u2003et\u2003al:\u2003Func tional \u2003diffusion \u2003map: \u2003\nA\u2003noninvasive \u2003MRI\u2003bio marker \u2003fo r\u2003earl y\u2003str atification \u2003of\u2003clinical \u2003br ain\u2003\ntumor \u2003response. \u2003Proc Natl Acad Sci U S A \u2003102(15):5524\u20135529, \u20032005.\n253.\u2003Moller-Hartmann \u2003W,\u2003He rminghaus \u2003S,\u2003Kr ings\u2003T,\u2003et\u2003al:\u2003Clinical \u2003\napplication \u2003of\u2003pr oton\u2003magne tic\u2003reso nance \u2003spe ctroscopy \u2003in\u2003the\u2003diagnosis \u2003\nof\u2003intracranial \u2003mass \u2003lesions. \u2003Neuroradiology \u200344(5):371\u2013381, \u20032002.\n254.\u2003Monajati \u2003A,\u2003He ggeness \u2003L:\u2003Patt erns\u2003of\u2003ed ema\u2003in\u2003tumo rs\u2003vs.\u2003infarc ts:\u2003\nVisualization \u2003of\u2003whit e\u2003matte r\u2003pathwa ys.", "2841d45d-f6c9-4acd-8136-414b5b9801fe": "Venous \u2003varix \u2003rep resents \u2003abnor mal\u2003dilatation \u2003of\u2003\norbital \u2003veins. \u2003The\u2003supe rior\u2003ophthalmic \u2003vein\u2003is\u2003most \u2003ofte n\u2003affec ted.\u2003\nEtiologies \u2003includ e\u2003cong enital \u2003venous \u2003malfor mation \u2003or\u2003venous \u2003wall\u2003\nweakness; \u2003it\u2003can\u2003also\u2003occur \u2003in\u2003associatio n\u2003with\u2003intrao rbital \u2003or\u2003intra cra-\nnial\u2003arteriovenous \u2003malfor mation.\nFor\u2003evaluation \u2003of\u2003venous \u2003varix, \u2003CT\u2003is\u2003best\u2003per formed \u2003with\u2003cont rast\u2003\nenhancement, \u2003rep eated \u2003without \u2003and\u2003with\u2003the\u2003Valsalv a\u2003maneuv er65,72\u2003\n(Fig.\u200320-37). \u2003The\u2003varix \u2003is\u2003seen\u2003as\u2003a\u2003large \u2003tor tuous \u2003vein\u2003or\u2003lobulat ed\u2003\nmasslike \u2003confluence \u2003of\u2003small \u2003veins. \u2003Ther e\u2003is\u2003stro ng\u2003cont rast\u2003enhance -\nment, \u2003although \u2003hete rogeneity \u2003can\u2003be\u2003prese nt\u2003if\u2003thromb osis\u2003is\u2003prese nt.\u2003\nVenous \u2003varix \u2003enlarges \u2003significantly \u2003with\u2003the\u2003Valsalv a\u2003maneuv er,\u2003helping \u2003\ndifferentiate \u2003it\u2003from \u2003other \u2003enhancing \u2003lesions. \u2003CTA\u2003can\u2003also\u2003be\u2003used\u2003to\u2003\ndiagnose \u2003and\u2003map\u2003the\u2003anatomic \u2003course \u2003of\u2003an\u2003orb ital\u2003varix71\u2003(Fig.\u200320-38).\nHemangiomas.  Hemangiomas \u2003can\u2003be\u2003classified \u2003into\u2003two\u2003distinct \u2003\nentities: \u2003cavernous \u2003and\u2003capillary .5\u2003They \u2003are\u2003seen\u2003in\u2003differ ent\u2003age\u2003groups; \u2003\ncavernous \u2003hemangio mas\u2003are\u2003seen\u2003in\u2003young \u2003adults, \u2003most \u2003commo nly\u2003\nbetween \u2003the\u2003seco nd\u2003and\u2003fourth \u2003deca des\u2003of\u2003life,\u2003wher eas\u2003capillary \u2003hem-\nangiomas \u2003are\u2003seen\u2003in\u2003young \u2003pediat ric\u2003patients.FIG 20-35 \u2002 Carotid \u2002cavernous \u2002fistula. \u2002A,\u2002Coronal \u2002T1-weighted \u2002MRI\u2002study \u2002shows \u2002marked \u2002enlargement \u2002of\u2002the\u2002\nleft\u2002superior \u2002ophthalmic \u2002vein\u2002(arrow). \u2002B,\u2002Lateral \u2002digital \u2002subtraction \u2002angiogram \u2002shows \u2002fistulous \u2002communication \u2002\nbetween \u2002branches \u2002of\u2002the\u2002external \u2002carotid \u2002and\u2002the\u2002cavernous \u2002sinus. \u2002m,\u2002middle \u2002meningeal \u2002artery; \u2002F,\u2002fistula; \u2002\nc,\u2002cavernous \u2002sinus.", "aa9a1f8b-19fd-4342-af3a-6ca7c6400a81": "Similarly, \u2003factors \u2003that\u2003either \u2003increase \u2003signal \u2003from \u2003the\u2003meninges \u2003or\u2003\ndecrease \u2003signal \u2003from \u2003backg round \u2003tissues \u2003enhance \u2003the\u2003cont rast-to-noise \u2003\nratio \u2003(CNR) \u2003and\u2003there fore\u2003the\u2003conspicuit y\u2003of\u2003the\u2003enhancing \u2003meninges. \u2003\nDouble-dosing \u2003and\u2003triple-d osing \u2003of\u2003paramagne tic\u2003cont rast\u2003agents \u2003have\u2003\ndemonstrated \u2003impro ved\u2003det ection \u2003of\u2003parenc hymal \u2003lesions \u2003with\u2003MRI,72\u2003FIG 18-4  Subdural empyema. A and B, Enhanced axial CT images at the level of the falx cerebri show dural \nenhancement surrounding a subdural empyema. \nA B\nFIG 18-5  Superior sensitivity of MRI over CT in detection of meningeal disease: Pott\u2019s puffy tumor. \nA, Enhanced axial CT image at the level of an extracranial subperiosteal collection of pus. B, Enhanced axial \nMRI obtained after administration of gadolinium at the same level shows enhancement of the subjacent \ndura-arachnoid (arrows). Detection of this meningeal enhancement prompted a change of antibiotics to \nimprove CSF drug penetration. \nB A", "41c2634d-44cb-4945-8d33-056b71bd61e5": "Saunde rs,\u2003p\u20032.\n59.\u2003Ng\u2003SH,\u2003Chang \u2003TC,\u2003Ko\u2003SF,\u2003et\u2003al:\u2003Nasop haryngeal \u2003carcinoma: \u2003MRI\u2003and\u2003CT\u2003\nassessment. \u2003Neuroradiology \u200339:741\u2013746, \u20031997.\n60.\u2003Ng\u2003SH,\u2003Chang \u2003JT,\u2003Ko\u2003SF,\u2003et\u2003al:\u2003MRI\u2003in\u2003recur rent\u2003nasophar yngeal \u2003\ncarcinoma. \u2003Neuroradiology \u200341:855\u2013862, \u20031999.\n61.\u2003Ng\u2003SH,\u2003Chan \u2003SC,\u2003Yen\u2003TC,\u2003et\u2003al:\u2003Staging \u2003of\u2003untreat ed\u2003nasophar yngeal \u2003\ncarcinoma \u2003with\u2003PET/CT: \u2003Compar ison\u2003with\u2003con ventional \u2003imaging \u2003\nwork \u00adup.\u2003Eur J Nucl Med Mol Imaging \u200336(1):12\u201322, \u20032009.\n62.\u2003Norbash \u2003AM:\u2003Nasop harynx \u2003and\u2003dee p\u2003facial \u2003spaces. \u2003In\u2003Eldman \u2003RR,\u2003\nHesselink \u2003JR,\u2003Zlatkin \u2003MB,\u2003edito rs:\u2003Clinical magnetic resonance imaging ,\u2003\ned\u20032,\u2003Philadelphia, \u20031996, \u2003WB\u2003Saunde rs,\u2003pp\u20031079\u20131109.\n63.\u2003Offiah \u2003C,\u2003Hall\u2003E:\u2003Post\u00adtr eatment \u2003imaging \u2003appear ances \u2003in\u2003head \u2003and\u2003neck\u2003\ncancer \u2003patients. \u2003Clin Radiol \u200366(1):13\u201324, \u20032011.\n64.\u2003Ong\u2003CK,\u2003Chong \u2003VF:\u2003Imaging \u2003of\u2003per ineural \u2003sprea d\u2003in\u2003head \u2003and\u2003neck\u2003\ntumours. \u2003Cancer Imaging \u200310(SpecA):S92\u2013S98, \u20032010.\n65.\u2003Pfister \u2003DG,\u2003et\u2003al:\u2003Cance rs\u2003of\u2003the\u2003nasophar ynx.\u2003In\u2003Head and Neck Cancers. \nNCCN clinical practice guidelines in oncology ,\u2003ed\u20032,\u20032011, \u2003Natio nal\u2003\nComprehensive \u2003Cance r\u2003Netw ork\u2003(NCCN). \u2003Availab le\u2003at:\u2003<http://\nwww.nccn.org/professionals/physician_gls/f_guidelines.asp>.\n66.\u2003Radkowski \u2003D,\u2003McGill \u2003T,\u2003Healy \u2003GB,\u2003et\u2003al:\u2003Angiofib roma. \u2003Changes \u2003in\u2003\nstaging \u2003and\u2003treat ment. \u2003Arch Otolaryngol Head Neck Surg \u2003122(2):122\u2013129, \u2003\n1996.\n67.\u2003Rathore \u2003YS,\u2003Sinha \u2003S,\u2003Mahapatr a\u2003AK:\u2003Transse llar\u2003transsp henoidal \u2003\nencephalocele: \u2003A\u2003series \u2003of\u2003four\u2003cases. \u2003Neurol India \u200359(2):289\u2013292, \u2003\n2011.\n68.\u2003Righi \u2003S,\u2003Boffano \u2003P ,\u2003Pate ras\u2003D,\u2003et\u2003al:\u2003Thor nwaldt \u2003cysts.", "cf428388-04da-417d-add6-19f0013be4bc": "106.\u2003Provenzale \u2003JM,\u2003Al len\u2003NB:\u2003We gener \u2003gr anulomatosis: \u2003CT\u2003and\u2003MR\u2003\nfindings. \u2003AJNR Am J Neuroradiol \u200317(4):785\u2013792, \u20031996.\n107.\u2003Quint \u2003DJ,\u2003Elde vik\u2003OP ,\u2003Cohe n\u2003JK:\u2003Mag netic \u2003reso nance \u2003imaging \u2003of\u2003\nnormal \u2003meningeal \u2003enhanc ement \u2003at\u20031.5\u2003T.\u2003Acad Radiol \u20033(6):463\u2013468, \u2003\n1996.\n108.\u2003Raffin \u2003LS,\u2003Ba cheschi \u2003LA,\u2003Ma chado \u2003LR,\u2003et\u2003al:\u2003Diffusio n-weighted \u2003MR\u2003\nimaging \u2003of\u2003cyst ic\u2003lesions \u2003of\u2003neur ocysticercosis: \u2003A\u2003pr eliminary \u2003stud y.\u2003Arq \nNeuropsiquiatr \u200359(4):839\u2013842, \u20032001.\n109.\u2003Rath \u2003TJ,\u2003Hug hes\u2003M,\u2003Ar abi\u2003M,\u2003et\u2003al:\u2003Imag ing\u2003of\u2003ce rebritis, \u2003enc ephalitis, \u2003\nand\u2003brain \u2003abscess. \u2003Neuroimaging Clin N Am \u200322(4):585\u2013607, \u20032012.\n110.\u2003Rosenbaum \u2003ML,\u2003Ho ff\u2003JT,\u2003No rman \u2003D:\u2003De creased \u2003mor tality \u2003fro m\u2003br ain\u2003\nabscesses \u2003since \u2003the\u2003ad vent\u2003of\u2003co mputerized \u2003to mography. \u2003J Neurosurg \u2003\n49:658\u2013668, \u20031978.\n111.\u2003Rossi \u2003A:\u2003Imag ing\u2003of\u2003acu te\u2003disseminat ed\u2003enc ephalomyelitis. \u2003\nNeuroimaging Clin N Am \u200318(1):149\u2013161, \u2003ix,\u20032008.\n112.\u2003Saez-Llorens \u2003XJ,\u2003Umana \u2003MA,\u2003Odio \u2003CM,\u2003et\u2003al:\u2003Br ain\u2003abscess \u2003in\u2003infants \u2003\nand\u2003children. \u2003Pediatr Infect Dis J \u20038(7):449\u2013458, \u20031989.\n113.\u2003Safder \u2003S,\u2003Car penter \u2003JS,\u2003Ro berts \u2003TD,\u2003et\u2003al:\u2003The\u2003\u201cb lack\u2003tur binate\u201d \u2003sign:\u2003An\u2003\nearly \u2003MR\u2003imaging \u2003finding \u2003of\u2003nasal \u2003muc ormycosis. \u2003AJNR Am J \nNeuroradiol \u200331(4):771\u2013774, \u20032010.\n114.\u2003Samann \u2003PG,\u2003Schle gel\u2003J,\u2003Mul ler\u2003G,\u2003et\u2003al:\u2003Se rial\u2003pr oton\u2003MR\u2003spe ctroscopy \u2003\nand\u2003diffusion \u2003imaging \u2003findings \u2003in\u2003HIV-r elated \u2003her pes\u2003simplex \u2003\nencephalitis. \u2003AJNR Am J Neuroradiol \u200324(10):2015\u20132019, \u20032003.\n115.", "952fd7d4-649f-4ff6-bb71-7c3ab4f34f13": "CHAPTER 25\u2003 Larynx 737\nshowing \u2003the\u2003relat ionship \u2003betw een\u2003tumor \u2003and\u2003the\u2003later al\u2003aspec t\u2003of\u2003the\u2003\ntrue\u2003vocal \u2003fold.\nTumor \u2003can\u2003be\u2003distinguished \u2003readil y\u2003from \u2003the\u2003fat\u2003in\u2003the\u2003supr aglottic \u2003\nparaglottic \u2003space. \u2003The\u2003inter face\u2003betw een\u2003tumor \u2003and\u2003muscle \u2003at\u2003the\u2003true\u2003\nfold\u2003level\u2003is\u2003more \u2003difficult \u2003to\u2003visualiz e.\u2003MRI\u2003studies \u2003have\u2003the\u2003adv antage \u2003\nof\u2003better \u2003tissue \u2003differ entiation \u2003using \u2003various \u2003pulse \u2003seque nces, \u2003but\u2003this\u2003\nadvantage \u2003can\u2003be\u2003realize d\u2003only\u2003if\u2003the\u2003patient \u2003is\u2003able\u2003to\u2003cont rol\u2003motion \u2003\n(Fig.\u200325-10). \u2003In\u2003our\u2003expe rience \u2003the\u2003ability \u2003to\u2003opt imize \u2003the\u2003cont rast\u2003\ninjection \u2003with\u2003CT\u2003scanning \u2003may\u2003allow \u2003goo d\u2003differ entiation \u2003of\u2003the\u2003\ntumor \u2003from \u2003muscle, \u2003diminishing \u2003the\u2003soft\u2003tissue \u2003adv antage \u2003of\u2003MRI.\nMidline \u2003tumor \u2003can\u2003cross \u2003the\u2003leve l\u2003of\u2003the\u2003vent ricle\u2003to\u2003invol ve\u2003the\u2003\nanterior \u2003commissure. \u2003This\u2003area\u2003can\u2003be\u2003difficult \u2003to\u2003eval uate\u2003either \u2003by\u2003\ndirect \u2003visualization \u2003or\u2003by\u2003imaging. \u2003If\u2003there \u2003is\u2003dee p\u2003gro wth\u2003from \u2003the\u2003\nanterior \u2003commissure \u2003into\u2003the\u2003attachme nt\u2003of\u2003the\u2003cor d\u2003or\u2003through \u2003the\u2003\ncricothyroid \u2003membr ane,\u2003imaging \u2003may\u2003det ect\u2003tumor \u2003that\u2003is\u2003unappr eci-\nated\u2003clinically.\nAnterior \u2003growth \u2003from \u2003a\u2003supr aglottic \u2003carcinoma \u2003bring s\u2003the\u2003tumor \u2003\ninto\u2003the\u2003preepiglottic \u2003space \u2003(see\u2003Figs.\u200325-9\u2003and\u200325-10). \u2003The\u2003pre epiglot -\ntic\u2003space \u2003and\u2003paraglott ic\u2003space \u2003have\u2003a\u2003rich\u2003lymp hatic \u2003drainage, \u2003and\u2003\ntumor \u2003invasion \u2003height ens\u2003the\u2003conc ern\u2003reg arding \u2003nodal \u2003metastases. \u2003\nInvasion \u2003is\u2003easily \u2003appr eciated \u2003on\u2003axial\u2003imaging \u2003because \u2003the\u2003tumor \u2003is\u2003\ncontrasted \u2003against \u2003the\u2003fat.\u2003Such \u2003invol vement \u2003is\u2003not\u2003a\u2003cont raindication \u2003\nto\u2003a\u2003supraglottic \u2003larynge ctomy.", "46e4b3e2-8cfb-4f50-a86e-967fc553129a": "Dermoid \u2003cysts\u2003are\u2003the\u2003rarest \u2003of\u2003the\u2003cong enital \u2003neck\u2003\nlesions. \u2003Only \u20037%\u2003of\u2003all\u2003der moid \u2003tumor s\u2003occur \u2003in\u2003the\u2003neck. \u2003The\u2003majorit y\u2003\nof\u2003head \u2003and\u2003neck\u2003der moids \u2003occur \u2003in\u2003the\u2003orb it,\u2003nasal \u2003cavit y,\u2003or\u2003oral\u2003\ncavity. \u2003Dermoid cyst \u2003is\u2003a\u2003general \u2003ter m\u2003that\u2003includ es\u2003epide rmoid, \u2003\ndermoid, \u2003and\u2003ter atoid \u2003cysts. \u2003Most \u2003cer vical\u2003der moid \u2003cysts\u2003occur \u2003in\u2003the\u2003\nmidline \u2003or\u2003just\u2003off\u2003midline \u2003and\u2003are\u2003usuall y\u2003prese nt\u2003at\u2003birth \u2003(Fig.\u200324\u00ad31).\u2003\nIn\u2003contrast \u2003to\u2003thyr oglossal \u2003duct\u2003cysts, \u2003der moid \u2003cysts\u2003typical ly\u2003do\u2003not\u2003\nmove \u2003with\u2003swallow ing.\u2003A\u2003distinct \u2003imaging \u2003chara cteristic \u2003of\u2003a\u2003der moid \u2003\ncyst\u2003is\u2003the\u2003fat\u2003or\u2003fluid\u2003comp onents \u2003that\u2003result \u2003in\u2003ver y\u2003brig ht\u2003T2\u00adwe ighted \u2003\nsignal \u2003and\u2003a\u2003low\u2003to\u2003high\u2003T1\u00adwe ighted \u2003signal \u2003with\u2003an\u2003absence \u2003of\u2003cont rast\u2003\nenhancement. \u2003In\u2003CT\u2003imaging, \u2003the\u2003fatty\u2003parts \u2003of\u2003the\u2003cyst\u2003are\u2003hyp odense.29\nMasses of Inflammatory Origin\nIt\u2003is\u2003often \u2003difficult \u2003to\u2003det ermine \u2003clinicall y\u2003whethe r\u2003a\u2003patient \u2003with\u2003an\u2003\nerythematous, \u2003painful, \u2003and\u2003swolle n\u2003neck\u2003has\u2003a\u2003simple \u2003cel lulitis, \u2003an\u2003\ninfected \u2003retention \u2003cyst,\u2003a\u2003cer vical\u2003manifestatio n\u2003of\u2003a\u2003syste mic\u2003inflam \u00ad\nmatory \u2003disease \u2003(e.g., \u2003sarco idosis), \u2003or\u2003a\u2003pote ntially \u2003life\u00adthreat ening \u2003dee p\u2003\nneck\u2003abscess. \u2003With \u2003sect ional \u2003imaging, \u2003in\u2003many \u2003cases \u2003it\u2003is\u2003possible \u2003not\u2003\nonly\u2003to\u2003diagnose \u2003an\u2003abscess \u2003but\u2003also\u2003to\u2003differ entiate \u2003it.necrotic \u2003jugular \u2003chain \u2003lymp h\u2003nodes \u2003or\u2003cer vical\u2003abscesses \u2003on\u2003both\u2003CT\u2003\nand\u2003MRI.\nThyroglossal Duct Cyst.", "dff9376c-e8c8-4cc7-a7a7-f3c6efb36097": "Up\u2003to\u20035%\u2003of\u2003chor domas \u2003have\u2003metastatic \u2003disease \u2003to\u2003the\u2003lungs, \u2003\nbone, \u2003skin,\u2003or\u2003brain \u2003at\u2003initial \u2003prese ntation. \u2003In\u2003adv anced-stage \u2003chor do-\nmas,\u2003up\u2003to\u200365%\u2003of\u2003cases \u2003are\u2003metastatic.99,112\u2003With \u2003current \u2003treat ments, \u2003\nmost \u2003chordomas \u2003will\u2003recur \u2003or\u2003pro gress. \u2003Recur rence \u2003is\u2003due\u2003to\u2003subt otal\u2003\nexcision \u2003or\u2003violatio n\u2003of\u2003the\u2003tumor \u2003capsule \u2003with\u2003resultant \u2003seeding \u2003of\u2003\u2003\nthe\u2003surgical \u2003wound.153\u2003Thus, \u2003en\u2003bloc\u2003resec tion\u2003is\u2003the\u2003mainstay \u2003treat-\nment.145,234,243\u2003The\u2003role\u2003of\u2003radiat ion\u2003therap y\u2003is\u2003unclear.103\u2003Chordomas \u2003\nare\u2003insensitive \u2003to\u2003con ventional \u2003chemothe rapies.87,254\nPathophysiology.  In\u20031857, \u2003Virchow \u2003first\u2003describ ed\u2003the\u2003phy saliferous \u2003\ncells\u2014cells \u2003with\u2003cyto plasm \u2003repla ced\u2003by\u2003bubb le-like \u2003vacuoles\u2014that \u2003are\u2003\ncharacteristic \u2003of\u2003chor doma.250\u2003Strong \u2003evidence \u2003sugg ests\u2003that\u2003chor do-\nmas\u2003arise\u2003from \u2003notoc hordal \u2003remnants \u2003locate d\u2003in\u2003ver tebral \u2003bodies \u2003and\u2003\nthroughout \u2003the\u2003axial\u2003skele ton.115,218,230,247\u2003Chordomas \u2003have\u2003three \u2003histo -\nlogic \u2003variants: \u2003classical \u2003(con ventional), \u2003chondr oid,\u2003or\u2003dediff erentiated. \u2003\nDistinguishing \u2003chondr oid\u2003chor domas \u2003from \u2003chondr osarcomas \u2003histo -\nlogically \u2003can\u2003somet imes\u2003be\u2003difficult.117\nImaging.  Chordomas \u2003are\u2003usuall y\u2003midline \u2003expansile \u2003lesions \u2003with\u2003\nosseous \u2003destruction \u2003and\u2003soft\u2003tissue \u2003mass \u2003(Fig.\u200330-22). \u2003The\u2003ver tebral \u2003\nbody \u2003is\u2003most \u2003commo nly\u2003invol ved\u2003in\u2003spinal \u2003chor domas. \u2003Radio graphic \u2003\nfindings \u2003include \u2003calcifications \u2003(30%-70%), \u2003osteosc lerosis \u2003(43%-62%),", "7a3a28ee-52fb-4426-8d9b-5d7bd210c5ed": "Local \u2003curettag e\u2003almost \u2003alway s\u2003results \u2003in\u2003\nrecurrence.150,253\u2003Chondrosarcomas \u2003are\u2003gene rally\u2003resistant \u2003to\u2003chemo -\ntherapy \u2003and\u2003radiat ion\u2003therap y.188\nPathophysiology.  Most \u2003chondrosarcomas \u2003are\u2003primar y;\u2003howe ver,\u2003\nsecondary \u2003chondr osarcomas \u2003can\u2003arise\u2003from \u2003a\u2003pre existing \u2003benig n\u2003\nosseous \u2003or\u2003cartilag inous \u2003tumor \u2003(e.g., \u2003osteo chondroma).220\u2003The\u2003tumor \u2003\nproduces \u2003cartilag e\u2003that\u2003surr ounds \u2003and\u2003inva des\u2003the\u2003osseous \u2003matrix \u2003and\u2003\nfills\u2003marrow \u2003spaces. \u2003Chondr osarcoma \u2003histolog ic\u2003subt ypes\u2003includ e\u2003con-\nventional, \u2003mesench ymal, \u2003clear\u2003cel l,\u2003and\u2003dediff erentiated \u2003chondr osarco -\nmas.\u2003Most \u2003chondrosarcomas \u2003are\u2003of\u2003the\u2003con ventional \u2003subt ype,\u2003which \u2003\nare\u2003mostly \u2003low\u2003gra de.118,177\nImaging.  Radiographs \u2003of\u2003spinal \u2003chondr osarcoma \u2003typical ly\u2003show \u2003lyt ic\u2003\nor\u2003expansile \u2003osseous \u2003destr uction, \u2003usuall y\u2003arising \u2003from \u2003the\u2003poste rior\u2003\nelements.177,188,197\u2003Ring\u2003and\u2003arc\u2003calcifications \u2003of\u2003chondr oid\u2003matrix \u2003min-\neralization \u2003are\u2003prese nt\u2003in\u2003up\u2003to\u200370%\u2003of\u2003patients232\u2003(Figs. \u200330-25 \u2003and\u2003\n30-26A).\nInvolvement \u2003of\u2003adja cent\u2003ver tebral \u2003bodies \u2003through \u2003the\u2003disk\u2003or\u2003exte n-\nsion\u2003to\u2003adjacent \u2003ribs\u2003may\u2003be\u2003seen.197\u2003On\u2003CT,\u2003these \u2003tumor s\u2003are\u2003usuall y\u2003\nhypodense \u2003to\u2003skele tal\u2003muscle \u2003because \u2003of\u2003the\u2003water \u2003cont ent\u2003of\u2003chon -\ndroid188\u2003(see\u2003Fig.\u200330-26A). \u2003Some times \u2003the\u2003chondr oid\u2003calcification \u2003may\u2003\nbe\u2003amorphous, \u2003making \u2003some \u2003chondr osarcomas \u2003difficult \u2003to\u2003distinguish \u2003\nfrom \u2003osteoblastic \u2003tumor s.177\nThe\u2003high\u2003water \u2003cont ent\u2003of\u2003chondr osarcomas \u2003make \u2003them \u2003hyp oin-\ntense \u2003on\u2003T1-\u2003and\u2003hyp erintense \u2003on\u2003T2-weig hted\u2003images.154,188\u2003Mineral -\nFIG 30-25  Cervical chondrosarcoma. Frontal radiograph shows \nosseous destruction of the right C5-C6 facets with associated ill-defined \nsoft tissue calcifications.", "52cff6ee-ec13-409c-8d03-e8cb3a45b6c3": "S ubsecond \u2003spir al \u2003data \u2003\nacquisition \u2003p ermits \u2003t emporal \u2003r esolution \u2003o n \u2003the \u2003o rder \u2003o f\u2003220 \u2003t o \u2003300 \u2003\nmilliseconds, \u2003d epending \u2003o n \u2003the \u2003scanne r \u2003man ufacturer. \u2003T hese \u2003t emporal \u2003\nresolutions \u2003e nable \u2003mo re \u2003e xaminations \u2003t o \u2003b e \u2003scanne d \u2003w ithin \u2003a \u2003sing le \u2003\nbreath \u2003hold \u2003and \u2003incr ease \u2003the \u2003r ange \u2003o f\u2003anat omy \u2003that \u2003can \u2003b e \u2003c overed \u2003in \u2003\na\u2003sing le \u2003a cquisition. \u2003T his \u2003imp roves \u2003the \u2003p erformance \u2003o f\u2003c linical \u2003ap plica-\ntions \u2003s uch \u2003as \u2003CT \u2003ang iography, \u2003w hich \u2003r equires \u2003p recise \u2003t iming \u2003o f\u2003a \u2003c on-\ntrast\u2003b olus \u2003inje ction \u2003and \u2003r apid \u2003a cquisition \u2003d uring \u2003the \u2003ar terial \u2003p hase. \u2003\nFast\u2003data \u2003a cquisition \u2003can \u2003also \u2003imp rove \u2003the \u2003z-axis \u2003r esolution \u2003f or \u2003a \u2003g iven \u2003\nstudy \u2003b y \u2003c overing \u2003the \u2003same \u2003amount \u2003o f\u2003anat omy \u2003in \u2003the \u2003same \u2003t ime \u2003w ith \u2003\nthinner \u2003slic es \u2003and/o r \u2003w ith \u2003o versampling \u2003at \u2003lo w \u2003pit ch.\nMultidetector-Row Designs.  Multidetector-row \u2003scanne rs \u2003ar e \u2003mo-\ntivated \u2003b y \u2003the \u2003d esire \u2003t o \u2003c over \u2003larg e \u2003r egions \u2003o f\u2003anat omy \u2003in \u2003sho rt \u2003t imes \u2003\nwith\u2003fine \u2003sampling \u2003alo ng \u2003the \u2003z-axis \u2003o f\u2003the \u2003pat ient.\u2003I n \u2003ear ly \u2003scanne rs \u2003\nwith\u2003o nly \u2003a \u2003sing le \u2003data \u2003a cquisition \u2003c hannel \u2003(sing le \u2003slic e),\u2003the \u2003b eam \u2003\nwidth \u2003dir ectly \u2003d etermined \u2003the \u2003c overage \u2003as \u2003w ell \u2003as \u2003the \u2003imag e \u2003thic kness \u2003\n(spatial \u2003r esolution). \u2003W ith \u2003the \u2003d evelopment \u2003o f\u2003fast,\u2003stab le,\u2003c ompact \u2003\nelectronics, \u2003it \u2003b ecame \u2003p ossible \u2003t o \u2003b uild \u2003a \u2003D AS \u2003that \u2003c ould \u2003sim ultane -\nously \u2003a cquire \u2003and \u2003st ore \u2003m ultiple \u2003imag es.", "03c37dbe-4d69-4e39-98ea-b7e75d232054": "Ne uroblastomas \u2003\nalso\u2003have\u2003a\u2003tendency \u2003to\u2003cross \u2003the\u2003midline.most \u2003benign \u2003neur ogenic \u2003tumo rs\u2003are\u2003asymp tomatic, \u2003the\u2003de velopment \u2003\nof\u2003pain\u2003often \u2003indicates \u2003malignant \u2003tr ansformation.\nOn\u2003CT\u2003or\u2003MRI, \u2003malignant \u2003tumo rs\u2003of\u2003ner ve\u2003sheath \u2003or igin\u2003ty pically \u2003\nmanifest \u2003as\u2003post erior \u2003mediast inal\u2003masses \u2003large r\u2003than\u20035\u2003cm\u2003in\u2003diamet er.\u2003\nAlthough \u2003benign \u2003and\u2003malignant \u2003neur ogenic \u2003tumo rs\u2003cannot \u2003be\u2003diffe r-\nentiated \u2003with\u2003ce rtainty, \u2003findings \u2003that\u2003sug gest\u2003malignancy \u2003incl ude\u2003a\u2003\nsudden \u2003change \u2003in\u2003size\u2003of\u2003a\u2003pr eexisting \u2003mass \u2003or\u2003the\u2003de velopment \u2003of\u2003\nheterogeneous \u2003signal \u2003inte nsity \u2003on\u2003MRI\u2003(caused \u2003by\u2003necr osis\u2003and\u2003FIG 38-78  Neurofibroma. A, Axial T1-weighted MRI shows a lobular mass (arrowheads) extending into the \nintervertebral foramina. V, vertebral body. B, Axial gadolinium-enhanced MRI shows homogeneous enhance -\nment within the mass (arrowheads). V, vertebral body.\nVV\nA B A B\nFIG 38-79  Plexiform neurofibromas in a woman with type I neurofibro -\nmatosis. Coronal noncontrast CT shows plexiform neurofibromas along \nthe course of nerves within the posterior mediastinum (arrowheads).", "cb5e1000-2c28-47cb-bbb8-960d21e74aff": "18-25). \u2003In\u2003cases \u2003of\u2003suspe cted\u2003asept ic\u2003meningit is,\u2003per forming \u2003MRI\u2003after\u2003\nadministration \u2003of\u2003paramagne tic\u2003cont rast\u2003medium \u2003may\u2003help\u2003pre vent\u2003\ndelays \u2003in\u2003diagnosis.45\nNoninfectious Inflammatory Meningitis\nNoninfectious \u2003gran ulomatous \u2003disease \u2003can\u2003also\u2003invol ve\u2003the\u2003meninges. \u2003\nApproximately \u20035%\u2003of\u2003patients \u2003with\u2003sarco idosis \u2003have\u2003neurolo gic\u2003mani -\nfestations; \u2003of\u2003those, \u2003the\u2003most \u2003commo n\u2003sign\u2003is\u2003that\u2003of\u2003cranial \u2003nerv e\u2003\npalsies.153\u2003Gd-enhanced \u2003MRI\u2003is\u2003the\u2003study \u2003of\u2003choic e\u2003to\u2003docume nt\u2003men-\ningeal \u2003involvement \u2003and\u2003may\u2003show \u2003either \u2003the\u2003pia\u2003mater\u2013SAS \u2003or\u2003the\u2003\ndura-arachnoid \u2003patter n\u2003(see\u2003Fig.\u200318-14).146,147,179\u2003Striking \u2003thicke ning\u2003of\u2003\nthe\u2003meninges \u2003may\u2003also\u2003be\u2003demo nstrated. \u2003Sarc oid\u2003was\u2003prese nt\u2003in\u200331%\u2003\nof\u200337\u2003patients \u2003with\u2003chro nic\u2003meningit is\u2003of\u2003unknown \u2003etiolo gy\u2003examined \u2003\nwith\u2003enhanced \u2003MRI\u2003and\u2003meningeal \u2003biopsy \u2003and\u2003as\u2003such\u2003was\u2003the\u2003most \u2003\nfrequent \u2003cause \u2003of\u2003chro nic\u2003meningit is\u2003in\u2003that\u2003series.29\nMeningeal \u2003abnor mality \u2003may\u2003also\u2003occur \u2003in\u2003Weg ener\u2019s \u2003gran ulomato -\nsis135\u2003(Fig.\u200318-26). \u2003Thick ened \u2003nodular \u2003meninges \u2003on\u2003both\u2003enhance d\u2003CT\u2003\nand\u2003MRI\u2003in\u2003a\u2003patient \u2003with\u2003Weg ener\u2019s \u2003gran ulomatosis \u2003wer e\u2003rep orted \u2003by\u2003\nTishler \u2003and\u2003colleagues.156\u2003The\u2003imaging \u2003featur es\u2003reflec t\u2003the\u2003histopatho -\nlogic \u2003findings \u2003of\u2003dural \u2003and\u2003brain \u2003biopsies \u2003that\u2003rev ealed \u2003gran ulomatous \u2003FIG 18-23  Coccidioidomycosis. Axial T1-weighted image demon -\nstrates diffuse meningeal enhancement within the suprasellar cistern \nin a patient with coccidioidomycosis diagnosed with lumbar puncture. \nFIG 18-24  Lyme disease. Sagittal T1-weighted images of the lumbar \nspine before (A) and after ( B) administration of intravenous gadolinium \ndemonstrate thick linear enhancement of the spinal conus and all nerve roots of the cauda equina in a patient with Lyme disease. \nA B", "a2980349-29dd-4ac7-b3be-63d221aa68a7": "PART II \u2003 CT \u2003and\u2003MR\u2003Imaging \u2003of\u2003the\u2003Whole \u2003Body 216\nFIG 9-39  Lipoblastic meningioma. Axial T1-weighted ( A) and T2-weighted (B) MRIs demonstrate a curvilinear \nfocus of T1 hyperintensity in the far right lateral temporooccipital convexity (black and white arrows).  The \nremainder of this dural-based extracerebral tumor cannot be clearly distinguished from the adjacent com -\npressed brain parenchyma on the T1-weighted noncontrast image. The lesion (arrow) is also barely discern -\nible on the fast T2-weighted image (B). Following IV gadolinium (C), the tumor, which is based on the most \nlateral aspect of the right leaf of the tentorium, enhances intensely on T1-weighted imaging, except for the focus of lipid storage (arrow). \nA\nCB", "dc44aa85-e517-4a54-b7da-94663a6eb281": "11C\u2003MET \u2003is,\u2003howe ver,\u2003limited \u2003by\u2003short \u2003tra cer\u2003half-life \u2003(20\u2003minut es),\u2003\nrequiring \u2003an\u2003on-site \u2003cyclot ron,\u2003which \u2003pre cludes \u2003gene ralized \u2003use.275\u2003FIG 9-78  Recurrent glioblastoma in a patient with a history of left temporal glioblastoma. A, On contrast-\nenhanced T1-weighted MRI following resection and chemoradiation therapy, a recurrent heterogeneously \nenhancing lesion within and adjacent to the resection cavity is seen. B to E, Multiparametric 18F FDG \nPET/MRI performed to differentiate between progressive/recurrent neoplasm and radiation change. Axial PET (B) and PET/MRI ( C) images demonstrate FDG uptake above background along the peripheral (enhanc -\ning) portion of the lesion. DSC MR perfusion rCBV map coregistered with contrast-enhanced T1-weighted MRI (D) demonstrates peripheral increased lesional rCBV in a pattern similar to FDG uptake ( B and C). \nE, DCE T1-weighted MRI K\ntrans map demonstrates corresponding increased permeability. Findings are sug -\ngestive of recurrent/progressive glioblastoma. \nA B C\nD E", "9deac49a-7be1-4cd2-b0c6-2a4c0d3e6f4d": "80.\u2003Maas \u2003A,\u2003Hukk elhoven \u2003C,\u2003Mar shall\u2003L,\u2003et\u2003al:\u2003Pr ediction \u2003of\u2003out come \u2003in\u2003\ntraumatic \u2003brain \u2003injur y\u2003with\u2003co mputed \u2003to mographic \u2003char acteristics: \u2003\u2003\nA\u2003comparison \u2003be tween \u2003the\u2003co mputed \u2003to mographic \u2003classificat ion\u2003and\u2003\ncombinations \u2003of\u2003co mputed \u2003to mographic \u2003pr edictors. \u2003Neurosurgery \u2003\n57(6):1173\u20131182, \u20032005.\n81.\u2003Maas \u2003AIR,\u2003Sto cchetti \u2003N,\u2003Bul lock\u2003R:\u2003Mo derate \u2003and\u2003sev ere\u2003tr aumatic \u2003\nbrain \u2003injury \u2003in\u2003ad ults.\u2003Lancet Neurol \u20037(8):728\u2013741, \u20032008.\n82.\u2003Macpherson \u2003B,\u2003Ma cPherson \u2003P ,\u2003Je nnett \u2003B:\u2003CT\u2003ev idence \u2003of\u2003intr acranial \u2003\ncontusion \u2003and\u2003hae matoma \u2003in\u2003re lation \u2003to\u2003the\u2003pr esence, \u2003site\u2003and\u2003ty pe\u2003of\u2003\nskull \u2003fracture. \u2003Clin Radiol \u200342(5):321\u2013326, \u20031990.\n83.\u2003Mannion \u2003RJ,\u2003Cr oss\u2003J,\u2003Br adley \u2003P ,\u2003et\u2003al:\u2003Me chanism-based \u2003MRI\u2003\nclassification \u2003of\u2003tr aumatic \u2003br ainstem \u2003injur y\u2003and\u2003its\u2003re lationship \u2003to\u2003\noutcome. \u2003J Neurotrauma \u200324(1):128\u2013135, \u20032007.\n84.\u2003Marmarou \u2003A,\u2003Sig noretti \u2003S,\u2003Fat ouros \u2003P ,\u2003et\u2003al:\u2003Mit ochondrial \u2003injur y\u2003\nmeasured \u2003by\u2003pr oton\u2003magne tic\u2003reso nance \u2003spe ctroscopy \u2003in\u2003sev ere\u2003head \u2003\ntrauma \u2003patients. \u2003Acta Neurochir Suppl \u200395:149\u2013151, \u20032005.\n85.\u2003Marmarou \u2003A,\u2003Sig noretti \u2003S,\u2003Fat ouros \u2003PP ,\u2003et\u2003al:\u2003Pr edominance \u2003of\u2003ce llular \u2003\nedema \u2003in\u2003traumatic \u2003br ain\u2003swe lling\u2003in\u2003patie nts\u2003with\u2003sev ere\u2003head \u2003injur ies.\u2003\u2003\nJ Neurosurg \u2003104(5):720\u2013730, \u20032006.\n86.\u2003Marquez \u2003de\u2003la\u2003Plata \u2003CD,\u2003Yang \u2003FG,\u2003Wang \u2003JY,\u2003et\u2003al:\u2003Diffusio n\u2003te nsor\u2003\nimaging \u2003biomarkers \u2003fo r\u2003tr aumatic \u2003axo nal\u2003injur y:\u2003Anal ysis\u2003of\u2003thre e\u2003\nanalytic \u2003methods. \u2003J Int Neuropsychol Soc \u200317(01):24\u201335, \u20032011.\n87.", "c0200280-c24c-4f0e-aaea-dea568d37972": "REFERENCES\n1.\u2003Adams \u2003HP ,\u2003Jr,\u2003Be ndixen \u2003BH,\u2003Kap pelle\u2003LJ,\u2003et\u2003al:\u2003Classificat ion\u2003of\u2003sub type\u2003\nof\u2003acute \u2003ischemic \u2003str oke.\u2003Definit ions\u2003fo r\u2003use\u2003in\u2003a\u2003mult icenter \u2003clinical \u2003\ntrial.\u2003TOAST. \u2003Tr ial\u2003of\u2003Org\u200310172 \u2003in\u2003Acu te\u2003Str oke\u2003Tr eatment. \u2003Stroke \u2003\n24(1):35\u201341, \u20031993.\n2.\u2003Aho\u2003K,\u2003Har msen \u2003P ,\u2003Hatano \u2003S,\u2003et\u2003al:\u2003Ce rebrovascular \u2003disease \u2003in\u2003the\u2003\ncommunity: \u2003Res ults\u2003of\u2003a\u2003WHO \u2003col laborative \u2003stud y.\u2003Bull World Health \nOrgan \u200358(1):113\u2013130, \u20031980.\n3.\u2003Albers \u2003GW,\u2003Caplan \u2003LR,\u2003Easto n\u2003JD,\u2003et\u2003al:\u2003Tr ansient \u2003ische mic\u2003attac k\u2014\nProposal \u2003for\u2003a\u2003new\u2003definit ion.\u2003N Engl J Med \u2003347(21):1713\u20131716, \u20032002.\n4.\u2003Albers \u2003GW,\u2003Thi js\u2003VN,\u2003We chsler \u2003L,\u2003et\u2003al:\u2003Mag netic \u2003reso nance \u2003imaging \u2003\nprofiles \u2003predict \u2003clinical \u2003resp onse\u2003to\u2003earl y\u2003re perfusion: \u2003The\u2003diffusion \u2003and\u2003\nperfusion \u2003imaging \u2003ev aluation \u2003fo r\u2003unde rstanding \u2003str oke\u2003ev olution \u2003\n(DEFUSE) \u2003stud y.\u2003Ann Neurol \u200360(5):508\u2013517, \u20032006.\n5.\u2003Asato \u2003R,\u2003Okumur a\u2003R,\u2003Ko nishi \u2003J:\u2003\u201cFo gging \u2003eff ect\u201d\u2003in\u2003MR\u2003of\u2003ce rebral \u2003\ninfarct. \u2003J Comput Assist Tomogr \u200315(1):160\u2013162, \u20031991.\n6.\u2003Augustin \u2003M,\u2003Bamme r\u2003R,\u2003Simb runner \u2003J,\u2003et\u2003al:\u2003Diffusio n-weighted \u2003\nimaging \u2003of\u2003patie nts\u2003with\u2003suba cute\u2003ce rebral \u2003ische mia:\u2003Co mparison \u2003\u2003\nwith\u2003conventional \u2003and\u2003co ntrast-enhanced \u2003MR\u2003imaging .\u2003AJNR Am J \nNeuroradiol \u200321(9):1596\u20131602, \u20032000.\n7.\u2003Ay\u2003H,\u2003Furie \u2003KL,\u2003Sing hal\u2003A,\u2003et\u2003al:\u2003An\u2003ev idence-based \u2003causati ve\u2003\nclassification \u2003syst em\u2003fo r\u2003acu te\u2003ische mic\u2003str oke.\u2003Ann Neurol \u200358(5):688\u2013\n697,\u20032005.\n8.\u2003Ay\u2003H,\u2003Koroshetz \u2003WJ,\u2003Be nner\u2003T,\u2003et\u2003al:\u2003Tr ansient \u2003ische mic\u2003attac k\u2003with\u2003\ninfarction: \u2003A\u2003unique \u2003syndro me?", "adca4345-26e9-4f0d-83ae-e3783ecaa0c1": "Schwannoma.  Schwannoma \u2003is\u2003a\u2003benig n\u2003(WHO \u2003gra de\u2003I)\u2003encapsu -\nlated \u2003tumor \u2003that\u2003arises \u2003from \u2003Schwann \u2003cel ls\u2003of\u2003nerv e\u2003sheaths \u2003of\u2003cranial \u2003\nand\u2003spinal \u2003nerv es.\u2003It\u2003is\u2003estimate d\u2003to\u2003acc ount \u2003for\u2003betw een\u20035%\u2003and\u200310%\u2003\nof\u2003primary \u2003intra cranial \u2003neoplasms \u2003and\u2003for\u2003nearly \u200330%\u2003of\u2003intraspinal \u2003\ntumors.47\nIntracranial \u2003schwanno mas\u2003occur \u2003in\u2003all\u2003age\u2003groups, \u2003but\u2003the\u2003peak\u2003\nincidence \u2003is\u2003in\u2003the\u2003fourth \u2003through \u2003seve nth\u2003deca des\u2003of\u2003life.\u2003Ther e\u2003is\u2003a\u2003\ndistinct \u2003sex\u2003pre dilection, \u2003with\u2003a\u2003female-t o-male \u2003ratio \u2003of\u20032\u2003:\u20031,\u2003although \u2003\nno\u2003such\u2003predilection \u2003exists \u2003in\u2003reg ard\u2003to\u2003spinal \u2003schwanno mas.47\nBy\u2003far\u2003the\u2003most \u2003commo n\u2003site\u2003of\u2003intra cranial \u2003invol vement \u2003is\u2003the\u2003\nsuperior \u2003vestibular \u2003divisio n\u2003of\u2003the\u2003eighth \u2003cranial \u2003nerv e.241\u2003Trigeminal \u2003\nnerve \u2003schwannomas \u2003are\u2003much \u2003less\u2003common, \u2003with\u2003facial, \u2003tr ochlear, \u2003and\u2003\nabducens \u2003nerve \u2003tumor s\u2003only\u2003rare ly\u2003rep orted. \u2003Only \u2003the\u2003first\u2003(olfact ory)\u2003\nand\u2003second \u2003(opt ic)\u2003cranial \u2003nerv es\u2003lack\u2003Schwann \u2003cel l\u2003sheaths \u2003and\u2003are\u2003\ntherefore \u2003not\u2003pote ntial\u2003sites\u2003of\u2003orig in.\u2003The\u2003clinical \u2003prese ntation \u2003varies \u2003\naccording \u2003to\u2003the\u2003site\u2003of\u2003orig in.\u2003Vestib ular\u2003schwanno ma\u2003(also \u2003called \u2003\nacoustic neuroma \u2003or\u2003neurinoma )\u2003typically \u2003presents \u2003with\u2003sympt oms\u2003of\u2003\na\u2003mass \u2003in\u2003the\u2003cer ebellopontine \u2003angle, \u2003including \u2003tinnitus, \u2003sensor ineural \u2003FIG 9-32  Medulloblastoma of the anteroinferior right cerebellar hemisphere in a 26-year-old patient. A, Axial \nT2-weighted MRI demonstrates a poorly circumscribed mass with a heterogeneous signal pattern in the \nanteroinferior portion of the right cerebellar hemisphere. Irregular areas of pronounced hyperintensity (arrow) \nare interspersed in a mildly hyperintense background that likely represents surrounding edema. The tumor extends medially into the inferior vermis. B, After IV gadolinium the tumor demonstrates homogeneous \ncontrast enhancement with well-circumscribed margins (arrow). Punctate intratumoral hypointensities rep -\nresent enlarged vascular channels and/or focal calcifications. \nA B", "46c7118c-dc21-4947-b8a5-a9da206ba927": "S imilarly \u2003the \u2003c hemical \u2003c omposition \u2003o f\u2003\nsolids \u2003s uch \u2003as \u2003r enal \u2003calculi \u2003can \u2003b e \u2003p robed \u2003w ith \u2003m ultiple \u2003x-r ay \u2003e nergies \u2003\nto\u2003assess \u2003the \u2003c ontent \u2003and \u2003c omposition \u2003o f\u2003calculi \u2003ha ving \u2003similar \u2003p hysical \u2003\ndensities.\nThe\u2003most \u2003p romising \u2003ap plications \u2003f or \u2003d ual-energy \u2003and \u2003sp ectral \u2003CT \u2003\ncapabilities \u2003ar e \u2003v irtual \u2003no ncontrast \u2003( VNC) \u2003e xams, \u2003io dine \u2003q uantifica -\ntion,\u2003and \u2003calci um \u2003q uantification. \u2003D ual-energy/spectral \u2003r econstructions \u2003\ncan\u2003also \u2003p revent \u2003b eam \u2003har dening \u2003ar tifacts \u2003and \u2003r elated \u2003e rrors \u2003in \u2003att enu-\nation \u2003q uantification \u2003(HU \u2003v alues).\nThere \u2003ar e \u2003se veral \u2003c ommercially \u2003a vailable \u2003CT \u2003scanne r \u2003d esign \u2003imple -\nmentations \u2003that \u2003p rovide \u2003o ptions \u2003f or \u2003d ual-energy \u2003o r \u2003sp ectral \u2003CT \u2003\nscanning.through \u2003the \u2003pat ient.\u2003Of\u2003c ourse \u2003the \u2003d ensity \u2003and \u2003w idth \u2003o f\u2003a \u2003pat ient\u2019s \u2003\nbody \u2003can \u2003v ary \u2003g reatly \u2003w ithin \u2003a \u2003r egion \u2003o f\u2003int erest, \u2003esp ecially \u2003w hen \u2003scan-\nning\u2003an \u2003e ntire \u2003b ody \u2003r egion \u2003(o r \u2003m ultiple \u2003r egions). \u2003U sing \u2003a \u2003sing le \u2003fix ed \u2003\nmAs\u2003v alue \u2003d oes \u2003not \u2003a chieve \u2003the \u2003ne eded \u2003o ptimization; \u2003so me \u2003anat omy \u2003\nwill\u2003ne cessarily \u2003b e \u2003d epicted \u2003w ith \u2003ina dequate \u2003imag e \u2003q uality \u2003o r \u2003e xposed \u2003\nto\u2003e xcess \u2003r adiation \u2003in \u2003this \u2003ap proach.\nAutomated \u2003t ube \u2003cur rent \u2003mo dulation \u2003(A TCM)30\u2003is\u2003a\u2003t ool \u2003t o \u2003a ddress \u2003\nthis\u2003c hallenge. \u2003I deally \u2003A TCM \u2003can \u2003b e \u2003use d \u2003t o \u2003o ptimize \u2003the \u2003scanning \u2003\nparameters \u2003in \u2003r eal \u2003t ime \u2003so \u2003that \u2003ea ch \u2003pat ient \u2003is \u2003e xposed \u2003t o \u2003j ust \u2003e nough \u2003\nradiation \u2003t o \u2003p roduce \u2003a \u2003diag nostic-quality \u2003imag e\u2014and \u2003no \u2003mo re.", "580a95ae-ef54-497f-9617-daef9e35772d": "Imaging \u2003is\u2003also\u2003valuab le\u2003for\u2003treat ment \u2003planning. \u2003\nAccurate \u2003delineation \u2003of\u2003target \u2003volume \u2003with\u2003MRI\u2003as\u2003wel l\u2003as\u2003PET/CT \u2003\nresults \u2003in\u2003more \u2003pre cise\u2003deli very\u2003of\u2003RT\u2003and\u2003indirec tly\u2003impro ves\u2003local\u2003\ncontrol \u2003and\u2003disease \u00adspe cific\u2003surv ival.36\u2003Imaging \u2003can\u2003also\u2003pro vide\u2003pro g\u00ad\nnostic \u2003indicator s.\u2003The\u2003most \u2003impor tant\u2003pro gnostic \u2003crite rion\u2003pre dictive \u2003\nof\u2003outcome \u2003and\u2003surv ival\u2003in\u2003NPC \u2003was\u2003CT\u00adde rived \u2003primar y\u2003tumor \u2003\nvolume \u2003greater \u2003than\u200350\u2003mL\u2003during \u2003RT\u2003planning.8\nResponse assessment and surveillance.  The\u2003NCCN \u2003guidelines \u2003\nrecommend \u2003a\u2003baseline \u2003scan\u2003to\u2003be\u2003obtaine d\u2003within \u20036\u2003months \u2003of\u2003comple \u00ad\ntion\u2003of\u2003chemoradiation \u2003in\u2003patients \u2003with\u2003T3\u00ad4\u2003and/or \u2003N2\u00ad3\u2003disease. \u2003\nFurther \u2003imaging \u2003is\u2003only\u2003rec ommended \u2003\u201cas\u2003indicated \u2003based \u2003on\u2003signs/\nsymptoms.\u201d65\nResponse \u2003assessment \u2003can\u2003be\u2003per formed \u2003either \u2003with\u2003MRI\u2003or\u2003PET/\nCT,\u2003with\u2003equivalent \u2003rep orted \u2003accur acy\u2003for\u2003det ection \u2003and\u2003restaging .19\u2003\nCT\u2003has\u2003inferior \u2003soft\u2003tissue \u2003resolu tion\u2003to\u2003differ entiate \u2003betw een\u2003posttr eat\u00ad\nment \u2003changes \u2003and\u2003residual \u2003or\u2003recur rent\u2003disease. \u2003A\u2003baseline \u2003posttr eat\u00ad\nment \u2003MRI\u2003scan\u2003is\u2003usuall y\u2003per formed \u2003at\u20032\u2003to\u20033\u2003months \u2003after\u2003therap y\u2003\nbecause \u2003it\u2003is\u2003per ceived \u2003to\u2003be\u2003valuab le\u2003for\u2003det ecting \u2003subc linical \u2003residual \u2003^Note: \u2002Mucosal \u2002extension \u2002to\u2002lingual \u2002surface \u2002of\u2002epiglottis \u2002from \u2002primary \u2002tumors \u2002of\u2002base \u2002tongue \u2002or\u2002vallecula \u2002does \u2002not\u2002constitute \u2002invasion \u2002of\u2002larynx.*Note: \u2002Parapharyngeal \u2002extension \u2002denotes \u2002posterolateral \u2002extension \u2002of\u2002tumor.\n+Midline \u2002nodes \u2002are\u2002considered \u2002ipsilateral \u2002nodes.\n++Supraclavicular \u2002zone \u2002or\u2002fossa \u2002is\u2002relevant \u2002to\u2002the\u2002staging \u2002of\u2002nasopharyngeal \u2002carcinoma \u2002and\u2002is\u2002the\u2002triangular \u2002region \u2002originally \u2002described \u2002by\u2002Ho.", "26921a02-661f-4c38-a077-f4b448a89430": "The\u2003magnitud e\u2003is\u2003known \u2003as\u2003the\u2003mean diffusivity \u2003(MD) \u2003\nand\u2003is\u2003mathematical ly\u2003equi valent \u2003to\u2003the\u2003ADC \u2003obtaine d\u2003from \u2003a\u2003\u2003\nconventional \u2003DWI \u2003study .\u2003The\u2003direc tionality \u2003is\u2003known \u2003as\u2003fractional \nanisotropy \u2003(FA).\nIn\u2003a\u20032006 \u2003publicatio n,\u2003Stadlbaue r\u2003et\u2003al.323\u2003used\u2003DTI\u2003to\u2003ret rospec -\ntively \u2003correlate \u2003changes \u2003in\u2003FA\u2003and\u2003MD\u2003with\u2003the\u2003deg ree\u2003of\u2003tumor \u2003cel l\u2003\ninfiltration \u2003det ermined \u2003histolog ically. \u2003Histo pathologic \u2003findings \u2003of\u200377\u2003\nMRI-guided \u2003ster eotactic \u2003biopsies \u2003in\u200320\u2003glioma \u2003patients \u2003wer e\u2003cor related \u2003\nwith\u2003the\u2003FA\u2003and\u2003MD\u2003values \u2003found \u2003at\u2003the\u2003biopsy \u2003sites. \u2003FA\u2003was\u2003found \u2003to\u2003\nbe\u2003inversely \u2003cor related \u2003to\u2003per cent\u2003tumor \u2003infiltrat ion\u2003and\u2003was\u2003found \u2003\u2003\nto\u2003be\u2003better \u2003than\u2003MD\u2003for\u2003assessment \u2003and\u2003delineat ion\u2003of\u2003tumor \u2003\u2003\ninfiltration. \u2003For\u2003low\u2003tumor \u2003cel l\u2003numbe rs\u2003as\u2003shown \u2003in\u2003Figure \u200317-14, \u2003\u2003\nthe\u2003logarithmic \u2003reg ression \u2003lines\u2003showe d\u2003a\u2003stro ng\u2003decr ease\u2003in\u2003FA\u2003(see\u2003\nFig.\u200317-14A) \u2003and\u2003an\u2003increase \u2003in\u2003MD\u2003(see\u2003Fig.\u200317-14B) \u2003follo wed\u2003by\u2003an\u2003\nasymptotic \u2003plateauing \u2003tre nd\u2003for\u2003high\u2003tumor \u2003cel l\u2003numbe r.\u2003Fro m\u2003these \u2003\nfindings, \u2003the\u2003invest igators \u2003hyp othesized \u2003that\u2003their \u2003findings \u2003\u201crefle ct\u2003\u2003\nthe\u2003infiltrative \u2003invasio n\u2003mechanism \u2003of\u2003gliomas \u201d\u2014namely, \u2003initial \u2003rCBV \u2003of\u20033.70\u2003in\u2003tumor \u2003vs.\u20030.98\u2003in\u2003normal \u2003tissue. \u2003In\u2003the\u2003per ienhancing \u2003\nabnormal-appearing \u2003reg ion\u2003containing \u2003tumor \u2003and\u2003ede ma\u2003(2),\u2003the\u2003nor-\nmalized \u2003mean \u2003Cho/NAA \u2003was\u2003found \u2003to\u2003be\u20033.3\u2003and\u2003Cho/Cr \u2003was\u20031.76,\u2003the\u2003\nmean \u2003tumor \u2003ADC \u2003value \u2003was\u20030.92\u2003\u00b1\u20030.17\u2003\u00d7\u200310\u22123\u2003mm2/sec,\u2003and\u2003mean \u2003\ntumor \u2003rCBV \u2003was\u20031.68\u2003\u00b1\u20030.41.", "d2105014-4b31-477c-84c3-dfd8847ec2b1": "CHAPTER 12 \u2003 Cerebral \u2003Aneurysms \u2003and\u2003Cerebrovascular \u2003Malformations 407\nFIG 12-75  A, Non\u2013contrast-enhanced axial CT image illustrating an enlarged superior ophthalmic vein (arrow) \nin a patient with a traumatic carotid cavernous fistula. B, Noncontrast axial T1-weighted MRI of an enlarged \nsuperior ophthalmic vein (arrow) in a different patient with a traumatic carotid cavernous fistula. C, Same \npatient as in B, illustrating dilated compartments with increased flow in the left cavernous sinus (arrow) on \nthe same axial T1-weighted scan owing to the carotid cavernous fistula. D, Catheter left carotid cerebral \nangiogram, lateral view, of the patient in B and C, documenting the rapid flow from the left internal carotid \nartery to the adjacent cavernous sinus (long arrow) and the enlarged superior ophthalmic vein (short arrow). \nA\nD CB\nchanging \u2003appear ance\u2003of\u2003clot\u2003dep ending \u2003on\u2003its\u2003age\u2003(see\u2003Fig.\u200312-79). \u2003\nContrast \u2003enhancement \u2003may\u2003make \u2003visualizat ion\u2003of\u2003lept omeningeal \u2003and\u2003\nmedullary \u2003fistula \u2003vascular \u2003pathology \u2003more \u2003readil y\u2003appare nt\u2003than\u2003on\u2003\nnoncontrast \u2003images.204,218\u2003Diminished \u2003ADC \u2003values \u2003with\u2003diffusion-\nweighted \u2003imaging \u2003(DWI) \u2003may\u2003be\u2003absent \u2003unless \u2003venous \u2003ischemia \u2003or\u2003\ninfarction \u2003are\u2003prese nt139\u2003(Fig.\u200312-78). \u2003SWI\u2003is\u2003best\u2003for\u2003visualizing \u2003abnor -\nmal\u2003draining \u2003veins139\u2003(see\u2003Fig.\u200312-78). \u2003MRV \u2003can\u2003be\u2003useful \u2003to\u2003define \u2003\npatent, \u2003occluded, \u2003or\u2003stenot ic\u2003dural \u2003sinuses; \u2003howe ver,\u2003if\u2003a\u2003TOF\u2003instead \u2003\nof\u2003a\u2003PC\u2003sequence \u2003is\u2003used, \u2003clot\u2003can\u2003mimic \u2003flowing \u2003bloo d.\u2003MRA \u2003can\u2003\nillustrate \u2003dilated \u2003suppl ying\u2003arte ries\u2003and\u2003high\u2003flow\u2003within \u2003the\u2003dural \u2003sinus \u2003\nor\u2003draining \u2003cor tical\u2003or\u2003medul lary\u2003veins78,290;\u2003however, \u2003the\u2003typical \u2003small \u2003AVFs \u2003may\u2003be\u2003subtle \u2003if\u2003the\u2003more \u2003easily \u2003appr eciated \u2003findings \u2003of\u2003intra cra-\nnial\u2003hemorrhage, \u2003ede ma,\u2003or\u2003infarct ion\u2003are\u2003not\u2003prese nt.\nMRI\u2003and\u2003MRA \u2003are\u2003notor ious\u2003for\u2003missing \u2003uncomplicat ed\u2003dural \u2003AVFs \u2003\nunless \u2003enlarged \u2003suppl ying\u2003arte ries\u2003or\u2003the\u2003venous \u2003drainage \u2003into\u2003dilated \u2003\ncortical \u2003or\u2003medul lary\u2003veins \u2003are\u2003demo nstrated.78,97,426\u2003Venous \u2003varices \u2003may\u2003\nalso\u2003be\u2003identified \u2003(Fig.\u200312-77).", "61a9e198-77e1-4466-8401-55ab6a5fb8af": "CHAPTER 15 \u2003 Neurodegenerative \u2003Disorders 475\nsubtypes \u2003are\u2003chara cterized \u2003by\u2003an\u2003abnor mal\u2003accum ulation \u2003of\u2003prot eins82:\u2003\nmicrotubule-associated \u2003prot ein\u2003tau\u2003(MAPT), \u2003TAR\u2003DNA-b inding \u2003\nprotein \u2003(TDP) \u200343,\u2003and\u2003fused \u2003in\u2003sarco ma\u2003prot ein\u2003(FUS). \u2003FTLD-tau, \u2003\nFTLD-TDP , \u2003and\u2003FTLD-FUS \u2003rep resent \u200345%, \u200350%, \u2003and\u20035%\u2003of\u2003all\u2003FTLD \u2003\ncases, \u2003respectively, \u2003at\u2003postmo rtem \u2003examinatio n.\nThe\u2003designation \u2003of\u2003pro bable \u2003bvFTD \u2003by\u2003the\u2003rev ised\u2003diagnostic \u2003cri-\nteria111\u2003restricts \u2003diagnosis \u2003to\u2003patients \u2003with\u2003demo nstrable \u2003functio nal\u2003\ndecline \u2003and\u2003typical \u2003neuro imaging \u2003findings, \u2003including \u2003frontal \u2003and/or \u2003\ntemporal \u2003atrophy, \u2003and\u2003hyp operfusion \u2003or\u2003hyp ometabolism \u2003on\u2003PET\u2003\u2003\nor\u2003SPECT.\nStructural \u2003MRI\u2003studies \u2003showe d\u2003that\u2003classic \u2003bvFTD \u2003prese nts\u2003\u2003\nwith\u2003a\u2003combination \u2003of\u2003medial \u2003frontal, \u2003orb ital-insular \u2003and\u2003anter ior\u2003\ntemporal \u2003cortical \u2003atro phy12,114,119\u2003(Fig.\u200315-4). \u2003Such \u2003an\u2003atro phy\u2003patter n\u2003\ncan\u2003be\u2003readily \u2003appr eciated \u2003on\u2003cor onal\u2003T1-weig hted\u2003MRI\u2003scans \u2003(knife-\nedge\u2003atrophy) \u2003(see\u2003Fig.\u200315-4). \u2003The\u2003MTL \u2003is\u2003more \u2003affec ted\u2003anter iorly\u2003\n(i.e.,\u2003the\u2003amygdala \u2003is\u2003more \u2003affec ted\u2003than\u2003the\u2003hippo campus \u2003and\u2003pos-\nterior \u2003hippocampus \u2003ofte n\u2003appear s\u2003normal).", "abc8a04f-de03-4ab9-a95c-8307663d9f92": "Positron Emission Tomography.  PET\u2003with\u2003the\u2003ra diotracer \u2003\n18F-fluorodeoxyglucose \u2003(FDG) \u2003co mplements \u2003CT\u2003and\u2003MRI\u2003in\u2003ev alua-\ntion\u2003of\u2003pleural \u2003and\u2003chest \u2003wall\u2003malignancies. \u2003PET\u2003allo ws\u2003fo r\u2003ev aluation \u2003\nof\u2003metabolic \u2003ac tivity \u2003of\u2003tumo r,\u2003whic h\u2003co ncentrates \u2003FDG \u2003to\u2003a\u2003gr eater \u2003\ndegree \u2003than\u2003nor mal\u2003tiss ue.\u2003This\u2003ty pe\u2003of\u2003assessment \u2003is\u2003useful \u2003in\u2003the\u2003\ncontext \u2003of\u2003pr etreatment \u2003planning, \u2003staging ,\u2003and\u2003fol low-up. \u2003Fur ther-\nmore, \u2003different \u2003tumo r\u2003sub types \u2003hav e\u2003show n\u2003diffe rences \u2003in\u2003FDG \u2003\navidity\u2014for \u2003example, \u2003mor e\u2003indole nt\u2003epithe lioid\u2003mesothelio ma\u2003te nds\u2003\nto\u2003be\u2003less\u2003metab olically \u2003ac tive\u2003than\u2003mor e\u2003agg ressive \u2003sarc omatoid \u2003meso -\nthelioma.45\u2003Poor \u2003spatial \u2003resol ution \u2003of\u2003PET\u2003is\u2003large ly\u2003co mpensated \u2003fo r\u2003\nby\u2003co-registration \u2003with\u2003CT\u2003(PET -CT). \u2003Hy brid\u2003PET -CT\u2003syst ems\u2003that\u2003are\u2003\ncapable \u2003of\u2003performing \u2003PET\u2003and\u2003CT\u2003in\u2003a\u2003single \u2003session \u2003hav e\u2003co me\u2003into\u2003\nwidespread \u2003use.45\nIntegrated \u2003PET-CT \u2003is\u2003sup erior \u2003to\u2003PET\u2003and\u2003CT\u2003alone \u2003in\u2003the\u2003diagno -\nsis\u2003and\u2003staging \u2003of\u2003thor acic\u2003malignancies. \u2003Imp ortantly, \u2003PET -CT\u2003is\u2003sup e-\nrior\u2003in\u2003identifying \u2003patie nts\u2003with\u2003oc cult\u2003metastases \u2003and\u2003unrese ctable \u2003\ntumors.45\u2003PET-CT \u2003is\u2003also\u2003ve ry\u2003useful \u2003fo r\u2003distinguishing \u2003malignancy \u2003\nfrom \u2003atelectasis, \u2003infe ction, \u2003and\u2003other \u2003be nign\u2003pr ocesses45\u2003(Fig.\u200339-6).\nPathology\nApical Pleural Cap.", "58b9dd9a-62e2-40a0-b1d8-fc6e9737ab4f": "Cancer \u200360:3080\u20133082, \u20031987.\n82.\u2003Jaeckle \u2003K,\u2003Kr ol\u2003G,\u2003Posne r\u2003J:\u2003Ev olution \u2003of\u2003co mputed \u2003to mographic \u2003\nabnormalities \u2003in\u2003lep tomeningeal \u2003metastases. \u2003Ann Neurol \u200317(1):85\u201389, \u2003\n1985.\n83.\u2003Janss \u2003A,\u2003Galetta \u2003S,\u2003Fr eese\u2003A,\u2003et\u2003al:\u2003Sup erficial \u2003side rosis\u2003of\u2003the\u2003ce ntral \u2003\nnervous \u2003system: \u2003Mag netic \u2003reso nance \u2003imaging \u2003and\u2003patholog ical\u2003\ncorrelation. \u2003J Neurosurg \u200379:756\u2013760, \u20031993.\n84.\u2003Jennings \u2003M,\u2003Slatkin \u2003N,\u2003D\u2019A ngelo \u2003M,\u2003et\u2003al:\u2003Ne oplastic \u2003mening itis\u2003as\u2003the\u2003\npresentation \u2003of\u2003oc cult\u2003pr imitive \u2003neur oectodermal \u2003tumo rs.\u2003J Child \nNeurol \u20038:306\u2013312, \u20031993.\n85.\u2003Johnson \u2003B,\u2003Fr am\u2003E:\u2003Ce rebral \u2003ve nous \u2003oc clusive \u2003disease. \u2003Patho physiology, \u2003\nclinical \u2003manifestat ions,\u2003and\u2003imaging .\u2003Neuroimaging Clin N Am \u2003\n2:769\u2013783, \u20031992.\n86.\u2003Kallmes \u2003D,\u2003Gr ay\u2003L,\u2003Glass \u2003J:\u2003Hig h-dose \u2003ga dolinium-enhanced \u2003MRI\u2003fo r\u2003\ndiagnosis \u2003of\u2003mening eal\u2003metastasis. \u2003Neuroradiology \u200340:23\u201326, \u20031998.\n87.\u2003Kelly \u2003A,\u2003Zimme rman \u2003R:\u2003Hea d\u2003tr auma: \u2003co mparison \u2003of\u2003MR\u2003and\u2003\nCT\u2013Experience \u2003in\u2003100\u2003patie nts.\u2003AJNR Am J Neuroradiol \u20039:699\u2013708, \u2003\n1988.\n88.\u2003Kilgore \u2003D,\u2003Br eger\u2003R,\u2003Daniels \u2003D,\u2003et\u2003al:\u2003Cr anial \u2003tiss ues:\u2003No rmal\u2003MR\u2003\nappearance \u2003afte r\u2003intr avenous \u2003injec tion\u2003of\u2003Gd-DTPA. \u2003Radiology \u2003\n160:757\u2013761, \u20031986.\n89.\u2003Kioumehr \u2003F,\u2003Dadse tan\u2003M,\u2003Fe ldman \u2003N,\u2003et\u2003al:\u2003Post contrast \u2003MRI\u2003of\u2003the\u2003\ncranial \u2003meninges: \u2003Le ptomeningitis \u2003ve rsus\u2003pac hymeningitis. \u2003J Comput \nAssist Tomogr \u200319:713\u2013720, \u20031995.\n90.\u2003Kirkpatrick \u2003J:\u2003Ne urologic \u2003infe ctions \u2003due\u2003to\u2003bac teria, \u2003fungi, \u2003and\u2003\nparasites.", "30caf8c5-cf29-4a56-a743-fa0487d4ff95": "PART II \u2003 CT \u2003and\u2003MR\u2003Imaging \u2003of\u2003the\u2003Whole \u2003Body 710\noropharyngeal \u2003cancer ,\u2003and\u2003inflammator y\u2003lesions \u2003and\u2003also\u2003use\u2003it\u2003to\u2003\ncomplement \u2003the\u2003diagnostic \u2003eval uation \u2003of\u2003tumor s\u2003with\u2003pres umed \u2003bone \u2003\ndestruction. \u2003The\u2003relat ive\u2003low\u2003cost\u2003of\u2003CT\u2003examinatio ns,\u2003its\u2003wide \u2003avail\u00ad\nability, \u2003the\u2003short \u2003examinatio n\u2003time, \u2003and\u2003the\u2003high\u00adqualit y\u2003multiplanar \u2003\nimaging \u2003provided, \u2003as\u2003wel l\u2003as\u2003the\u2003higher \u2003sensiti vity\u2003and\u2003specificit y\u2003\nregarding \u2003nodal \u2003invol vement \u2003in\u2003malignant \u2003neoplasms, \u2003are\u2003indisputable \u2003In\u2003most \u2003patients, \u2003especial ly\u2003in\u2003dev eloped \u2003countr ies,\u2003CT\u2003and\u2003MRI\u2003are\u2003\nperformed \u2003for\u2003diagnosing \u2003and\u2003staging \u2003of\u2003neck\u2003masses. \u2003In\u2003the\u2003pediat ric\u2003\npopulation, \u2003ultraso nography \u2003has\u2003a\u2003special \u2003role\u2003in\u2003follo w\u00adup\u2003of\u2003nodal \u2003\nmasses.73\u2003Whether \u2003CT\u2003or\u2003MRI\u2003is\u2003the\u2003primar y\u2003imaging \u2003modality \u2003\ndepends \u2003on\u2003the\u2003institu tion,\u2003although \u2003head \u2003and\u2003neck\u2003radiolo gists\u2003tend\u2003\nto\u2003use\u2003CT\u2003for\u2003imaging \u2003of\u2003laryngeal \u2003cancer ,\u2003hyp opharyngeal \u2003cancer ,\u2003FIG 24-9  Normal axial anatomy at the level of the cricoid cartilage and inferior cornua of the thyroid cartilage. \nA, CT scan. The asymmetry in the diameters of the internal jugular veins is a normal variant. B, T1-weighted \nMRI. 1, Sternocleidomastoid muscle; 2, thyroid gland; 3, internal carotid artery; 4, internal jugular vein; 8, \ntrapezius muscle; 9, longus colli muscle. \n42\n33\n91\n934\n8\n841\nA B\nFIG 24-10  Nodal chains of the neck. (Modified from Reede DL, Bergeron RT: CT of cervical lymph nodes. \nJ Otolaryngol 11:411, 1982.)\nParotid nodes\nOccipital nodes\nMastoid nodes\nJugulodigastric nodeFacial nodes\nSubmandibular nodes\nSubmental nodes\nExternal carotid artery\nInternal jugular chain\n(common carotid artery, internal\njugular vein, vagus nerve)\nAnterior jugular chainSpinal accessory nerve\nGreater auricular nerve\nSpinal accessory chain\nExternal jugular vein\nTransverse cervical chain", "3758729c-bada-480f-a435-1cdb54cfd8c8": "The\u2003intent \u2003of\u2003such\u2003a\u2003gra ding\u2003syste m\u2003is\u2003to\u2003\npredict \u2003therapeutic \u2003risk\u2003and\u2003outc ome, \u2003and\u2003its\u2003applicatio n\u2003is\u2003fairly \u2003\nsimple; \u2003the\u2003details \u2003of\u2003many \u2003AVMs \u2003are\u2003not\u2003comple tely\u2003explained \u2003by\u2003this\u2003\nclassification \u2003syste m,\u2003howe ver.\u2003A\u2003newe r\u2003cond ensed \u2003classificatio n\u2003syste m\u2003\ncombines \u2003grades \u2003I\u2003and\u2003II\u2003and\u2003gra des\u2003IV\u2003and\u2003V,\u2003leaving \u2003gra de\u2003III\u2003\nunaltered.388\nImaging Evaluation\nComputed Tomography.  CT\u2003imaging \u2003of\u2003the\u2003brain \u2003should \u2003be\u2003per-\nformed \u2003without \u2003and\u2003with\u2003cont rast\u2003to\u2003eval uate\u2003for\u2003intra cranial \u2003hemor -\nrhage \u2003and\u2003to\u2003visualiz e\u2003the\u2003abnor mal\u2003intra vascular \u2003cont rast\u2003within \u2003the\u2003\nAVM. \u2003AVMs \u2003demo nstrate \u2003a\u2003focal \u2003colle ction \u2003of\u2003isointe nse\u2003to\u2003slightly \u2003\nhyperintense \u2003vessels \u2003on\u2003nonenhanc ed\u2003scans \u2003but\u2003may\u2003be\u2003unremar kable \u2003without \u2003the\u2003administr ation \u2003of\u2003a\u2003cont rast\u2003agent \u2003(Fig.\u200312-46). \u2003Acut e\u2003\nhemorrhage \u2003is\u2003wel l\u2003docume nted\u2003when \u2003prese nt22\u2003(Fig.\u200312-47). \u2003Occa -\nsionally, \u2003mass \u2003effe ct,\u2003surr ounding \u2003ede ma,\u2003calcification \u2003(25%-30% \u2003of\u2003\ncases), \u2003or\u2003adjacent \u2003brain \u2003atro phy\u2003may\u2003be\u2003ident ified.215\u2003IV\u2003contrast \u2003\nenhancement \u2003is\u2003essential \u2003for\u2003ident ifying \u2003the\u2003typical \u2003\u201cbag\u2003of\u2003wor ms\u201d\u2003\nappearance \u2003of\u2003a\u2003brain \u2003AVM \u2003(see\u2003Fig.\u200312-46) \u2003as\u2003we ll\u2003as\u2003its\u2003enlarge d\u2003sup-\nplying \u2003arteries \u2003and\u2003draining \u2003veins.\nMagnetic Resonance Imaging.  MRI\u2003examination \u2003is\u2003for\u2003the\u2003most \u2003\npart\u2003superior \u2003to\u2003CT\u2003for\u2003ident ifying \u2003and\u2003eval uating \u2003cer ebral \u2003AVMs. \u2003MRI\u2003\nnot\u2003only\u2003outlines \u2003the\u2003nidus \u2003and\u2003per mits\u2003eval uation \u2003of\u2003its\u2003size\u2003but\u2003also\u2003\nidentifies \u2003supplying \u2003arte ries\u2003and\u2003draining \u2003veins. \u2003A\u2003clust er\u2003of\u2003vessels \u2003of\u2003\nvariable \u2003signal \u2003intensit ies,\u2003dep ending \u2003on\u2003the\u2003imaging \u2003seque nces\u2003used, \u2003\ncharacterizes \u2003the\u2003AVM \u2003nidus.", "e8dbed0b-d3bb-414d-aaf8-35e0973416c2": "PART II \u2003 CT \u2003and\u2003MR\u2003Imaging \u2003of\u2003the\u2003Whole \u2003Body 734\nFIG 25-4 \u2002 View \u2002from \u2002above, \u2002looking \u2002down \u2002at\u2002the\u2002skeletonized \u2002larynx. \u2002\nThe\u2002thyroarytenoid \u2002muscle \u2002(M)\u2002is\u2002seen \u2002stretching \u2002from \u2002the\u2002arytenoid \u2002\n(A)\u2002to\u2002the\u2002thyroid \u2002cartilage. \u2002C,\u2002cricoid. \u2002The\u2002arrow \u2002indicates \u2002the\u2002point \u2002\nwhere \u2002paraglottic \u2002spread \u2002of\u2002tumor \u2002is\u2002expected \u2002to\u2002intersect \u2002the\u2002lateral \u2002\nvocal \u2002fold.\u2002The\u2002opposite \u2002side\u2002shows \u2002the\u2002vocal \u2002ligament \u2002stretching \u2002from \u2002\nthe\u2002vocal \u2002process \u2002of\u2002arytenoid \u2002to\u2002the\u2002thyroid \u2002cartilage. \u2002(From \u2002Curtin \u2002HD:\u2002\nMR\u2002and\u2002CT\u2002of\u2002the\u2002larynx. \u2002In\u2002Thrall \u2002JH,\u2002editor: \u2002Current practice of \nradiology ,\u2002ed\u20023,\u2002St.\u2002Louis, \u20021994, \u2002Mosby.)\nA\nCM\ndeserves \u2003special \u2003attent ion\u2003in\u2003a\u2003discussion \u2003of\u2003larynx \u2003imaging. \u2003The\u2003thy-\nroarytenoid \u2003muscle \u2003(TAM) \u2003stre tches \u2003from \u2003the\u2003aryt enoid \u2003cartilag e\u2003to\u2003\nthe\u2003inner \u2003surface \u2003of\u2003the\u2003anter ior\u2003thyr oid\u2003cartilag e\u2003(Fig.\u200325-4; \u2003see\u2003Fig.\u2003\n25-2). \u2003This\u2003muscle \u2003paralle ls\u2003the\u2003true\u2003fold\u2003and\u2003makes \u2003up\u2003the\u2003bulk\u2003of\u2003the\u2003\ntrue\u2003vocal \u2003fold.\u2003The\u2003chara cteristic \u2003shape \u2003of\u2003this\u2003muscle \u2003allow s\u2003ident ifi-\ncation \u2003of\u2003the\u2003true\u2003vocal \u2003fold\u2003leve l\u2003at\u2003imaging.\nThe\u2003cricothyroid \u2003and\u2003thyr ohyoid \u2003membr anes\u2003span\u2003the\u2003great er\u2003part\u2003\nof\u2003the\u2003intervals \u2003betw een\u2003the\u2003crico id\u2003cartilag e,\u2003thyr oid\u2003cartilag e,\u2003and\u2003\nhyoid \u2003bone \u2003and\u2003rep resent, \u2003along \u2003with\u2003the\u2003cartilag es,\u2003the\u2003oute r\u2003limits \u2003of\u2003\nthe\u2003larynx. \u2003Notabl y\u2003the\u2003cricoth yroid \u2003membr ane\u2003is\u2003consid ered\u2003to\u2003be\u2003\nincomplete \u2003later al\u2003to\u2003the\u2003anter ior\u2003midline.\nTwo\u2003membranes \u2003are\u2003found \u2003just\u2003dee p\u2003to\u2003the\u2003mucosa.", "825f6b7d-041d-4274-bbec-9f0477bf3bc0": "12-19), \u2003glob ular\u2003or\u2003\nelongated \u2003areas \u2003of\u2003cont rast\u2003enhance ment284\u2003or\u2003a\u2003similarly \u2003shaped \u2003filling \u2003\ndefect \u2003within \u2003a\u2003colle ction \u2003of\u2003bloo d\u2003(Fig.\u200312-20), \u2003variab le\u2003calcification \u2003\ninvolving \u2003the\u2003aneurysm\u2019s \u2003walls, \u2003and\u2003clot\u2003within \u2003large r\u2003aneur ysms \u2003char-\nacterize \u2003cerebral \u2003aneury sms.143\u2003Larger \u2003cerebral \u2003aneury sms\u2003are\u2003typical ly\u2003\nmore \u2003easily \u2003ident ifiable \u2003because \u2003of\u2003their \u2003conspicuous \u2003size,\u2003but\u2003they\u2003are\u2003\nalso\u2003often \u2003identified \u2003by\u2003the\u2003prese nce\u2003of\u2003inter nal\u2003clot\u2003and\u2003per ipheral \u2003wall\u2003\ncalcifications, \u2003especial ly\u2003in\u2003giant \u2003aneury sms\u2003(>25\u2003mm\u2003in\u2003diamete r)\u2003\n(Fig.\u200312-21). \u2003Giant \u2003aneury sms\u2003are\u2003most \u2003commo nly\u2003ident ified\u2003in\u2003\nmiddle-aged \u2003wome n;\u2003are\u2003typical ly\u2003locate d\u2003in\u2003the\u2003extr adural \u2003carotid \u2003\nartery, \u2003the\u2003middle \u2003cer ebral \u2003arte ry\u2003bifurcat ion,\u2003or\u2003the\u2003basilar \u2003summit; \u2003\nand\u2003usually \u2003manifest \u2003with\u2003mass \u2003effe ct\u2003but\u2003can\u2003prese nt\u2003as\u2003subara chnoid \u2003\nhemorrhage.52,196\u2003Any\u2003large \u2003aneury sm\u2003can\u2003pro duce \u2003mass \u2003effe ct\u2003on\u2003adja-\ncent\u2003brain \u2003or\u2003cranial \u2003nerv es\u2003(see\u2003Fig.\u200312-19). \u2003CT\u2003is\u2003exc ellent \u2003for\u2003iden-\ntifying \u2003skull \u2003base\u2003erosio n\u2003due\u2003to\u2003large \u2003or\u2003giant \u2003aneury sms,\u2003especial ly\u2003if\u2003\nthin\u2003sections \u2003(\u22643\u2003mm) \u2003are\u2003obtaine d.FIG 12-15  A, CT scan illustrating acute subarachnoid hemorrhage (arrow) centered in the expected location \nof a right posterior communicating aneurysm, confirmed on two contiguous sagittal reconstructed CTA \nimages (B and C, arrows). \nAB\nC", "3d93f327-8303-465c-aa03-61469f4bbfe4": "CHAPTER 39 \u2003 Disease \u2003of\u2003the\u2003Pleura, \u2003Chest \u2003Wall, \u2003and\u2003Diaphragm 1129\ndemonstrate \u2003the\u2003fascicular sign, \u2003with\u2003heterogeneous \u2003low\u2003signal \u2003inte n-\nsity\u2003in\u2003a\u2003ringlike \u2003patte rn.\u2003The\u2003ner ve\u2003of\u2003or igin\u2003may\u2003be\u2003ide ntifiable. \u2003\nDegeneration\u2014manifested \u2003as\u2003myx oid\u2003cyst ic\u2003chang e,\u2003hemo rrhage, \u2003cal-\ncification, \u2003and\u2003fibr osis\u2003if\u2003pr esent\u2014is \u2003mor e\u2003co mmon \u2003in\u2003sch wannomas \u2003\nthan\u2003in\u2003neurofibromas. \u2003Bio psy\u2003is\u2003painful \u2003ow ing\u2003to\u2003intr insic\u2003inner va-\ntion115\u2003(Fig.\u200339-42).\nNeurofibromas \u2003may\u2003oc cur\u2003in\u2003isolatio n\u2003or\u2003in\u2003neur ofibromatosis \u2003ty pe\u2003\n1\u2003(NF1). \u2003Most \u2003affe cted\u2003patie nts\u2003pr esent \u2003be tween \u2003the\u2003ages\u2003of\u200320\u2003and\u200340.\u2003\nTypically, \u2003neurofibromas \u2003or iginate \u2003fro m\u2003spinal \u2003ner ve\u2003ro ots\u2003and\u2003may\u2003be\u2003\nlocalized \u2003(most \u2003co mmon), \u2003diffuse, \u2003or\u2003plexif orm. \u2003Plexif orm\u2003tumo rs\u2003Schwannomas \u2003are\u2003be nign\u2003ner ve\u2003sheath \u2003tumo rs\u2003that\u2003arise\u2003fro m\u2003\nspinal \u2003nerve \u2003ro ots\u2003or\u2003inte rcostal \u2003ner ves.\u2003The y\u2003te nd\u2003to\u2003be\u2003slow\u2003gr owing \u2003\nand\u2003are\u2003most \u2003co mmonly \u2003see n\u2003in\u2003young \u2003to\u2003middle-ag ed\u2003ad ult\u2003patie nts.\u2003\nSmall \u2003lesions \u2003are\u2003we ll\u2003circumscr ibed, \u2003bu t\u2003large r\u2003lesions \u2003may\u2003be\u2003mor e\u2003\nlobulated. \u2003Scallo ping\u2003rathe r\u2003than\u2003er osion \u2003of\u2003adj acent \u2003bo nes\u2003is\u2003ty pical. \u2003\nThe\u2003usual \u2003CT\u2003app earance \u2003of\u2003sch wannoma \u2003is\u2003a\u2003homo geneous \u2003mass \u2003\u2003\nthat\u2003is\u2003iso-\u2003or\u2003slightl y\u2003hy poattenuating \u2003to\u2003musc le.\u2003A\u2003less\u2003co mmon \u2003\nappearance \u2003is\u2003a\u2003cyst\u2003with\u2003fibr ous\u2003walls, \u2003co ntaining \u2003smalle r\u2003nod ules.\u2003\nSchwannomas \u2003te nd\u2003to\u2003be\u2003isoint ense\u2003on\u2003T1-\u2003and\u2003mark edly\u2003hy perin -\ntense \u2003on\u2003T2-we ighted \u2003images, \u2003with\u2003av id\u2003enhanc ement. \u2003Tumo rs\u2003may\u2003FIG 39-42  A, PA radiograph of a patient with a neurogenic tumor in the left posterior mediastinum.", "46a6fb41-bbf8-4a37-871c-0416ba31db28": "AJNR Am J Neuroradiol \u200320:117\u2013123, \u20031999.\n227.\u2003Meyerhoff \u2003DJ,\u2003Blo omer \u2003C,\u2003Car denas \u2003V,\u2003et\u2003al:\u2003Elev ated\u2003sub cortical \u2003\ncholine \u2003metabolites \u2003in\u2003co gnitively \u2003and\u2003clinical ly\u2003asymp tomatic \u2003HIV+\u2003\npatients. \u2003Neurology \u200352:995\u20131003, \u20031999.\n228.\u2003Michaelis \u2003T,\u2003He lms\u2003KD,\u2003Me rboldt \u2003W,\u2003et\u2003al:\u2003First\u2003obse rvation \u2003of\u2003\nscyllo-inositol \u2003in\u2003pr oton\u2003NMR \u2003spe ctra\u2003of\u2003human \u2003br ain\u2003in\u2003vit ro\u2003and\u2003in\u2003\nvivo.\u2003Paper \u2003pr esented \u2003at\u2003Ann ual\u2003Me eting \u2003of\u2003the\u2003So ciety\u2003of\u2003Mag netic \u2003\nResonance \u2003in\u2003Me dicine, \u2003Be rlin,\u20031992.\n229.\u2003Michaelis \u2003T,\u2003Me rboldt \u2003KD,\u2003Br uhn\u2003H,\u2003et\u2003al:\u2003Absol ute\u2003co ncentrations \u2003of\u2003\nmetabolites \u2003in\u2003the\u2003ad ult\u2003human \u2003br ain\u2003in\u2003vi vo:\u2003Quantificat ion\u2003of\u2003\nlocalized \u2003proton \u2003MR\u2003spe ctra.\u2003Radiology \u2003187:219\u2013227, \u20031993.\n230.\u2003Michaelis \u2003T,\u2003Vid een\u2003J,\u2003Linsey \u2003MS,\u2003et\u2003al:\u2003Ce rebral \u2003abno rmalities \u2003in\u2003end\u2003\nstage \u2003renal \u2003disease. \u2003Pap er\u2003pr esented \u2003at\u2003the\u2003Se cond \u2003Ann ual\u2003Me eting \u2003of\u2003\nthe\u2003Society \u2003of\u2003Mag netic \u2003Reso nance \u2003in\u2003Me dicine, \u2003San\u2003Fr ancisco, \u20031994, \u2003\u2003\np\u2003306.\n231.\u2003Miller \u2003B:\u2003A\u2003re view\u2003of\u2003che mical \u2003issues \u2003in\u20031H\u2003NMR \u2003spectroscopy: \u2003\nN-acetyl-aspartate, \u2003creat ine\u2003and\u2003choline. \u2003NMR Biomed \u20034:47\u201352, \u20031991.\n232.\u2003Miller \u2003BL,\u2003Mo ats\u2003R,\u2003Shonk \u2003T,\u2003et\u2003al:\u2003Alzhe imer\u2003disease: \u2003De piction \u2003of\u2003\nincreased \u2003cerebral \u2003my oinositol \u2003with\u2003pr oton\u2003MR\u2003spe ctroscopy. \u2003Radiology \u2003\n187:433\u2013437, \u20031993.\n233.\u2003Mishra \u2003AM,\u2003Gup ta\u2003RK,\u2003Jag gi\u2003RS,\u2003et\u2003al:\u2003Role\u2003of\u2003diffusion-w eighted \u2003\nimaging \u2003and\u2003in\u2003vi vo\u2003pr oton\u2003magne tic\u2003reso nance \u2003spe ctroscopy \u2003in\u2003the\u2003\ndifferential \u2003diagnosis \u2003of\u2003ring-e nhancing \u2003intr acranial \u2003cyst ic\u2003mass \u2003lesions.", "82550bb8-fd02-428f-8f7d-b8c8cb5807d7": "J Neurosurg \u200376(4):705\u2013709, \u20031992.\n398.\u2003Van\u2003Lae re\u2003K,\u2003Ce yssens \u2003S,\u2003Van\u2003Cale nbergh \u2003F,\u2003et\u2003al:\u2003Dir ect\u2003co mparison \u2003of\u2003\n18F-FDG \u2003and\u200311C-methio nine\u2003PET\u2003in\u2003susp ected \u2003re currence \u2003of\u2003glio ma:\u2003\nSensitivity, \u2003inte r-observer \u2003var iability \u2003and\u2003pr ognostic \u2003val ue.\u2003Eur J Nucl \nMed Mol Imaging \u200332(1):39\u201351, \u20032005.\n399.\u2003Vates \u2003GE,\u2003Chang \u2003S,\u2003Lambo rn\u2003KR,\u2003et\u2003al:\u2003Gliomat osis\u2003ce rebri: \u2003A\u2003re view\u2003of\u2003\n22\u2003cases. \u2003Neurosurgery \u200353(2):261\u2013271, \u20032003.\n400.\u2003Vazquez \u2003E,\u2003Luca ya\u2003J,\u2003Cast ellote \u2003A,\u2003et\u2003al:\u2003Ne uroimaging \u2003in\u2003pe diatric \u2003\nleukemia \u2003and\u2003ly mphoma: \u2003Diff erential \u2003diagnosis. \u2003Radiographics \u2003\n22(6):1411\u20131428, \u20032002.\n401.\u2003Venkatesh \u2003SK,\u2003Gup ta\u2003RK,\u2003Pal\u2003L,\u2003et\u2003al:\u2003Spe ctroscopic \u2003increase \u2003in\u2003choline \u2003\nsignal \u2003is\u2003a\u2003nonsp ecific \u2003mark er\u2003fo r\u2003diffe rentiation \u2003of\u2003infe ctive/\ninflammatory \u2003fro m\u2003neo plastic \u2003lesions \u2003of\u2003the\u2003br ain.\u2003J Magn Reson \nImaging \u200314(1):8\u201315, \u20032001.\n402.\u2003Verma \u2003N,\u2003Co wperthwaite \u2003MC,\u2003Bur nett\u2003MG,\u2003et\u2003al:\u2003Diff erentiating \u2003tumo r\u2003\nrecurrence \u2003fro m\u2003tr eatment \u2003necr osis:\u2003A\u2003re view\u2003of\u2003neur o-oncologic \u2003\nimaging \u2003strategies. \u2003Neuro Oncol \u200315(5):515\u2013534, \u20032013.\n403.\u2003Vuori \u2003K,\u2003Kankaanr anta\u2003L,\u2003Hakkine n\u2003A-M, \u2003et\u2003al:\u2003Lo w-grade \u2003glio mas\u2003and\u2003\nfocal \u2003cortical \u2003de velopmental \u2003malfo rmations: \u2003Diff erentiation \u2003with\u2003\nproton \u2003MR\u2003spe ctroscopy. \u2003Radiology \u2003230(3):703\u2013708, \u20032004.\n404.\u2003Warren \u2003KE,\u2003Fr ank\u2003JA,\u2003Bla ck\u2003JL,\u2003et\u2003al:\u2003Pr oton\u2003magne tic\u2003reso nance \u2003\nspectroscopic \u2003imaging \u2003in\u2003childr en\u2003with\u2003re current \u2003pr imary \u2003br ain\u2003tumo rs.\u2003\nJ Clin Oncol \u200318(5):1020\u20131026, \u20032000.\n405.", "4129f170-b855-4762-9387-d021e1f974a5": "PART II \u2003 CT \u2003and\u2003MR\u2003Imaging \u2003of\u2003the\u2003Whole \u2003Body 774\nneurofibromas \u2003are\u2003infiltrat ive\u2003with\u2003ill\u00addefine d\u2003margins. \u2003Fro m\u20035%\u2003to\u2003\n13%\u2003of\u2003plexiform \u2003neurofib romas \u2003underg o\u2003malignant \u2003deg eneration.11\nSchwannomas \u2003are\u2003encapsulat ed\u2003tumor s\u2003attache d\u2003to\u2003or\u2003surr ounded \u2003\nby\u2003a\u2003nerve. \u2003They \u2003are\u2003comp osed\u2003of\u2003two\u2003typ es\u2003of\u2003tissues: \u2003cel lular\u2003Anto ni\u2003\ntype\u2003A\u2003and\u2003less\u2003cel lular\u2003Anto ni\u2003typ e\u2003B\u2003tissue. \u2003They \u2003are\u2003almost \u2003neve r\u2003\nassociated \u2003with\u2003neurofib romatosis \u2003typ e\u20031\u2003and\u2003rare ly\u2003underg o\u2003malig \u00ad\nnant\u2003change.11\nNeurofibromas \u2003can\u2003be\u2003seen\u2003at\u2003any\u2003age,\u2003but\u2003schwanno mas\u2003most \u2003\ncommonly \u2003prese nt\u2003betw een\u200320\u2003and\u200350\u2003years \u2003of\u2003age,\u2003with\u2003occasio nal\u2003\noccurrences \u2003in\u2003childhoo d.\u2003Neur ofibromas \u2003are\u2003usuall y\u2003asympt omatic, \u2003\nwhereas \u2003schwannomas \u2003are\u2003ofte n\u2003painful \u2003and\u2003tend er.\u2003The\u2003pain\u2003may\u2003be\u2003\nlocalized \u2003or\u2003radicular \u2003in\u2003nature \u2003and\u2003associate d\u2003with\u2003paresthesias.11\nImaging Findings.  The\u2003imaging \u2003appear ance\u2003of\u2003per ipheral \u2003nerv e\u2003\nsheath \u2003tumors \u2003dep ends\u2003on\u2003their\u2003histolog ic\u2003comp osition, \u2003and\u2003as\u2003a\u2003result \u2003\nneurofibromas \u2003and\u2003schwanno mas\u2003may\u2003be\u2003indistinguishable \u2003by\u2003imaging. \u2003\nSolitary \u2003neurofibromas \u2003and\u2003schwanno mas\u2003prese nt\u2003as\u2003wel l\u00addefine d\u2003\nlobulated \u2003masses \u2003and\u2003tend\u2003to\u2003cross \u2003fascial \u2003planes. \u2003They \u2003can\u2003appear \u2003as\u2003\nisointense \u2003masses \u2003to\u2003muscle, \u2003with\u2003rare\u2003calcification \u2003and\u2003variab le\u2003\nenhancement \u2003on\u2003CT.\u2003Some \u200373%\u2003of\u2003solitary \u2003or\u2003plexifo rm\u2003neurofib ro\u00ad\nmas\u2003demonstrate \u2003relat ively\u2003decr eased \u2003atten uation \u2003bef ore\u2003and\u2003after\u2003\u2003\ncontrast \u2003administration \u2003on\u2003CT.\u2003Schwanno mas\u2003enhance \u2003more \u2003homog e\u00ad\nneously \u2003with\u2003either \u2003iodinate d\u2003cont rast\u2003or\u2003gad olinium.", "435d8828-8b37-4e77-8285-e086c9a3ad64": "Acta Neurochir (Wien) \u2003146(3):257\u2013263, \u20032004.\n30.\u2003Feldmann \u2003E,\u2003Gandy \u2003S,\u2003Bec ker\u2003R,\u2003et\u2003al:\u2003MRI\u2003demo nstrates \u2003desce nding \u2003\ntranstentorial \u2003herniat ion.\u2003Neurology \u200338(5):697\u2013701, \u20031988.\n31.\u2003Feuerman \u2003T,\u2003Wac kym\u2003P ,\u2003Gade \u2003G,\u2003et\u2003al:\u2003Value \u2003of\u2003skull \u2003radio graphy, \u2003head \u2003\ncomputed \u2003tomographic \u2003scanning, \u2003and\u2003admission \u2003for\u2003obser vation \u2003in\u2003\ncases \u2003of\u2003minor \u2003head \u2003injury .\u2003Neurosurgery \u200322(3):449\u2013453, \u20031988.\n32.\u2003Finfer \u2003SR,\u2003Cohen \u2003J:\u2003Sev ere\u2003traumat ic\u2003brain \u2003injury .\u2003Resuscitation \u2003\n48(1):77\u201390, \u20032001.\n33.\u2003Firsching \u2003R,\u2003Woisc hneck \u2003D,\u2003Diedr ich\u2003M,\u2003et\u2003al:\u2003Early \u2003magnet ic\u2003resonanc e\u2003\nimaging \u2003of\u2003brainst em\u2003lesions \u2003after\u2003seve re\u2003head \u2003injury .\u2003J Neurosurg \u2003\n89(5):707\u2013712, \u20031998.\n34.\u2003Galloway \u2003NR,\u2003Tong \u2003KA,\u2003Ashwal \u2003S,\u2003et\u2003al:\u2003Diffusion-w eighted \u2003imaging \u2003\nimproves \u2003outc ome\u2003pre diction \u2003in\u2003pediat ric\u2003traumat ic\u2003brain \u2003injury .\u2003\u2003\nJ Neurotrauma \u200325(10):1153\u20131162, \u20032008.\n35.\u2003Garnett \u2003MR,\u2003Cad oux-Hudson \u2003TAD, \u2003Styles \u2003P:\u2003How \u2003useful \u2003is\u2003magnet ic\u2003\nresonance \u2003imaging \u2003in\u2003pre dicting \u2003seve rity\u2003and\u2003outc ome\u2003in\u2003traumat ic\u2003\nbrain \u2003injury? \u2003Curr Opin Neurol \u200314(6):753\u2013757, \u20032001.\n36.\u2003Gennarelli \u2003T:\u2003Mec hanisms \u2003of\u2003brain \u2003injury .\u2003J Emerg Med \u200311(Suppl \u2003\n1):5\u201311, \u20031993.\n37.\u2003Gentry \u2003LR,\u2003Gode rsky\u2003JC,\u2003Thompso n\u2003B:\u2003MR\u2003imaging \u2003of\u2003head \u2003trauma: \u2003\nReview \u2003of\u2003the\u2003distrib ution \u2003and\u2003radio pathologic \u2003featur es\u2003of\u2003traumat ic\u2003\nlesions. \u2003AJR Am J Roentgenol \u2003150(3):663\u2013672, \u20031988.\n38.\u2003Gentry \u2003LR,\u2003Gode rsky\u2003JC,\u2003Thompso n\u2003B,\u2003et\u2003al:\u2003Prosp ective \u2003compar ative\u2003\nstudy \u2003of\u2003intermediate-field \u2003MR\u2003and\u2003CT\u2003in\u2003the\u2003eval uation \u2003of\u2003closed \u2003head \u2003\ntrauma.", "d6782977-1d62-4af6-8c12-cef19bae265b": "CHAPTER 35 \u2003 Congenital \u2003Abnormalities 917\nFIG 35-8  Lipomyeloschisis. A, Sagittal T1 image best demonstrates the T1-hyperintense large lipoma (*) \nextending through a wide spinal dysraphic defect (black arrow) to the subcutaneous fat. B, The terminal \nplacode-lipoma interface lies within the spinal canal (white arrow). The subarachnoid space ventral to the \nplacode is not expanded. Note the mild hydromyelia that not infrequently complicates spinal cord \ntethering. \nA* *\nB\nFIG 35-9  Posterior meningocele. One-day-old with prenatal diagnosis of lumbosacral meningocele. A, Sagit-\ntal T1 image shows a wide lumbosacral spinal dysraphic defect with a meningocele sac herniating at this site (*). The cord is low lying (arrow) and tethered at the site of attachment of the meningocele. B, Axial T2 \nat the level of the meningocele (*) demonstrates the low-lying conus in the spinal canal (arrow). \nC, Sagittal T2 image demonstrates a nerve (arrow) herniated in the meningocele (*) (surgically confirmed). \nA B*\n**\nC", "6f67c8df-f53a-43f8-96cf-c0fa25290e3e": "PART II \u2003 CT \u2003and\u2003MR\u2003Imaging \u2003of\u2003the\u2003Whole \u2003Body 824\n41.\u2003Iizuka \u2003H,\u2003Iizuka \u2003Y,\u2003Koba yashi \u2003R,\u2003et\u2003al:\u2003Chara cteristics \u2003of\u2003idiopathic \u2003\natlanto-axial \u2003subl uxation: \u2003A\u2003compar ative\u2003radio graphic \u2003study \u2003in\u2003patients \u2003\nwith\u2003an\u2003idiopathic \u2003etiolo gy\u2003and\u2003those \u2003with\u2003rheumat oid\u2003arthrit is.\u2003Eur \nSpine J Off Publ Eur Spine Soc Eur Spinal Deform Soc Eur Sect Cerv \nSpine Res Soc \u200322:54\u201359, \u20032013.\n42.\u2003Insko \u2003EK,\u2003Gra cias\u2003VH,\u2003Gupta \u2003R,\u2003et\u2003al:\u2003Utilit y\u2003of\u2003flexion \u2003and\u2003exte nsion \u2003\nradiographs \u2003of\u2003the\u2003cer vical\u2003spine \u2003in\u2003the\u2003acut e\u2003eval uation \u2003of\u2003blunt \u2003\ntrauma. \u2003J Trauma \u200353:426\u2013429, \u20032002.\n43.\u2003Jackson \u2003RS,\u2003Banit \u2003DM,\u2003Rhyne \u2003AL,\u20033rd,\u2003et\u2003al:\u2003Upp er\u2003cer vical\u2003spine \u2003\ninjuries. \u2003J Am Acad Orthop Surg \u200310:271\u2013280, \u20032002.\n44.\u2003Jain\u2003VK:\u2003Atlanto axial\u2003dislocatio n.\u2003Neurol India \u200360:9\u201317, \u20032012.\n45.\u2003Joaquim \u2003AF,\u2003Pate l\u2003AA:\u2003Thor acolumbar \u2003spine \u2003trauma: \u2003Eval uation \u2003and\u2003\nsurgical \u2003decision-making. \u2003J Craniovertebral Junction Spine \u20034:3\u20139, \u20032013.\n46.\u2003Jones \u2003C,\u2003Jazay eri\u2003F:\u2003Evol ving\u2003standards \u2003of\u2003pra ctice\u2003for\u2003cer vical\u2003spine \u2003\nimaging \u2003in\u2003trauma: \u2003A\u2003ret rospective \u2003rev iew.\u2003Australas Radiol \u200351:420\u2013425, \u2003\n2007.\n47.\u2003el-Khoury \u2003GY,\u2003Kathol \u2003MH,\u2003Daniel \u2003WW: \u2003Imaging \u2003of\u2003acut e\u2003injuries \u2003of\u2003\nthe\u2003cervical \u2003spine: \u2003Value \u2003of\u2003plain \u2003radio graphy, \u2003CT,\u2003and\u2003MR\u2003imaging. \u2003\nAJR Am J Roentgenol \u2003164:43\u201350, \u20031995.\n48.\u2003Khurana \u2003B,\u2003Sheehan \u2003SE,\u2003Sodic kson \u2003A,\u2003et\u2003al:\u2003Traumat ic\u2003thora columbar \u2003\nspine \u2003injuries: \u2003What \u2003the\u2003spine \u2003surge on\u2003wants \u2003to\u2003know. \u2003Radiogr Rev Publ \nRadiol Soc N Am Inc \u200333:2031\u20132046, \u20032013.\n49.", "e2091619-4d41-454a-bd9b-2771d4181c24": "The\u2003CCR \u2003criteria \u2003are\u2003used\u2003to\u2003eval uate\u2003patients \u2003who\u2003are\u2003alert\u2003and\u2003in\u2003\nstable \u2003condition \u2003wher e\u2003spinal \u2003injury \u2003is\u2003suspe cted; \u2003patients \u2003are\u2003categ o-\nrized \u2003into\u2003high- \u2003or\u2003low-risk \u2003groups. \u2003High-r isk\u2003patients \u2003are\u2003older \u2003than\u2003\n65\u2003years, \u2003present \u2003with\u2003the\u2003prese nce\u2003of\u2003paresthesia, \u2003or\u2003have\u2003a\u2003histor y\u2003of\u2003\na\u2003dangerous \u2003mechanism \u2003of\u2003injury ,\u2003including \u2003falls\u2003from \u2003an\u2003elev ation \u2003\ngreater \u2003than\u20033\u2003fee t\u2003or\u20035\u2003stairs, \u2003axial\u2003load\u2003to\u2003the\u2003head, \u2003motor \u2003vehic le\u2003\ncollision \u2003at\u2003spee ds\u2003great er\u2003than\u2003100\u2003km/hour \u2003(62\u2003miles/h \u2003[mph]) \u2003or\u2003\nrollover \u2003or\u2003ejec tion,\u2003a\u2003collisio n\u2003invol ving\u2003a\u2003motor ized\u2003recr eational \u2003\nvehicle, \u2003or\u2003a\u2003bicyc le\u2003collisio n.\u2003Indicato rs\u2003of\u2003low\u2003risk\u2003are\u2003simple \u2003rear-e nd\u2003\nmotor \u2003vehicle \u2003collisio n,\u2003a\u2003patient \u2003in\u2003the\u2003sitting \u2003positio n\u2003in\u2003the\u2003emer -\ngency \u2003department, \u2003ambulatio n\u2003at\u2003any\u2003time, \u2003dela yed\u2003onset \u2003of\u2003neck\u2003pain, \u2003\nand\u2003absence \u2003of\u2003midce rvical \u2003tend erness. \u2003No\u2003imaging \u2003is\u2003necessar y\u2003for\u2003\npatients \u2003fulfilling \u2003low\u2003risk-fac tor\u2003crite ria\u2003who\u2003are\u2003able\u2003to\u2003act ively\u2003rotate \u2003\nthe\u2003neck\u200345\u2003deg rees\u2003from \u2003left\u2003to\u2003right.99,100\u2003Similarly, \u2003meta-analy sis\u2003of\u2003\n14\u2003studies \u2003including \u2003NEXUS \u2003and\u2003CCR \u2003crite ria\u2003indicates \u2003that\u2003asymp -\ntomatic \u2003patients \u2003without \u2003a\u2003distra cting \u2003injury \u2003who\u2003maintain \u2003a\u2003full\u2003range \u2003\nof\u2003motion \u2003of\u2003the\u2003cer vical\u2003spine \u2003can\u2003be\u2003cleare d\u2003without \u2003radio graphic \u2003\nevaluation, \u2003with\u2003a\u2003sensiti vity\u2003of\u200398%\u2003and\u2003negat ive\u2003pre dictive \u2003value \u2003of\u2003\n99.8%.7\nIMAGING MODALITIES\nPlain Radiographs\nThree-view \u2003plain \u2003radio graphs\u2014anteroposterior \u2003(AP), \u2003cross-table \u2003\nlateral, \u2003and\u2003odo ntoid \u2003view s\u2014offer \u2003a\u2003fast\u2003and\u2003low-cost \u2003imaging \u2003opt ion\u2003\nbut\u2003should \u2003only\u2003be\u2003used\u2003when \u2003the\u2003suspicion \u2003of\u2003injury \u2003is\u2003low.", "bf689911-1e7d-4752-8ef4-fccb503f444b": "12-37 \u2003and\u200312-38). \u2003Issues \u2003have\u2003bee n\u2003raised \u2003reg arding \u2003\nclip-to-clip \u2003variab ility,\u2003distor tion\u2003of\u2003the\u2003aneury sm\u2003clip\u2003during \u2003surgical \u2003\napplication, \u2003manufac turer \u2003liability ,\u2003warnings \u2003from \u2003the\u2003U.S.\u2003Foo d\u2003and\u2003\nDrug \u2003Administration \u2003(FDA) \u2003reg arding \u2003rotatio nal\u2003and\u2003translat ional \u2003\naneurysm \u2003clip\u2003motion \u2003in\u2003a\u2003magnet ic\u2003field, \u2003and\u2003the\u2003necessit y\u2003of\u2003insti-\ntutional \u2003assurance \u2003that\u2003all\u2003aneury sm\u2003clips\u2003be\u2003MRI\u2003compat ible.192\u2003Many \u2003\nfacilities \u2003have\u2003denie d\u2003MRI\u2003to\u2003patients \u2003with\u2003cer ebral \u2003aneury sm\u2003clips, \u2003helpful \u2003in\u2003differ entiating \u2003the\u2003patent \u2003lumen \u2003from \u2003mural \u2003thromb us4\u2003(see\u2003\nFig.\u200312-31).\nAn\u2003alternative \u2003pulse \u2003seque nce\u2003is\u2003phase-co ntrast \u2003(PC) \u2003MRA, \u2003which \u2003\nhas\u2003excellent \u2003backg round, \u2003susce ptibility \u2003artifa ct,\u2003and\u2003stagnant \u2003bloo d\u2003\nsuppression \u2003and\u2003may\u2003help\u2003image \u2003in-plane \u2003flow\u2003and\u2003slow\u2003flow, \u2003two\u2003\ncauses \u2003of\u2003flow\u2003saturat ion\u2003deg radation \u2003of\u2003TOF\u2003MRA.101,165\u2003It\u2003can\u2003be\u2003\ncombined \u2003with\u2003cardiac \u2003gating \u2003using \u2003elec trocardiogram \u2003leads \u2003or\u2003per iph-\neral\u2003photoplethysmography \u2003to\u2003create \u2003cine-PC \u2003MRA, \u2003a\u2003tec hnique \u2003that\u2003\nhas\u2003been \u2003used\u2003to\u2003docume nt\u2003a\u2003great er\u2003pulsatility \u2003change \u2003in\u2003aneury sm\u2003\nsize\u2003with\u2003ruptured \u2003than\u2003with\u2003unrupt ured\u2003aneury sms.\u2003PC\u2003MRA \u2003has\u2003\npoorer \u2003spatial \u2003resolu tion,\u2003dep ends\u2003on\u2003a\u2003prescr ibed\u2003velo city-encoding \u2003\ngradient \u2003with\u2003the\u2003pote ntial\u2003for\u2003aliasing, \u2003can\u2003be\u2003alter ed\u2003by\u2003comple x\u2003flow, \u2003\nand\u2003requires \u2003longe r\u2003imaging \u2003and\u2003pro cessing \u2003times \u2003than\u2003TOF\u2003MRA.165\u2003\nAlthough \u2003PC\u2003MRA \u2003may\u2003ident ify\u2003few er\u2003aneury sms\u2003than\u2003TOF\u2003MRA,182,266\u2003\nthe\u2003slow\u2003flow\u2003within \u2003fusifor m\u2003aneury sms\u2003may\u2003be\u2003bett er\u2003imaged \u2003with\u2003\nPC\u2003MRA.", "92f89bd5-4301-4e5b-bbb3-1b4dd5f4e6bc": "384 Gastrointestinal Imaging: The Requisites\nDiaphragmatic Eventration\nDiaphragmatic eventration is not actually a hernia, but rather a \ncongenital elevation of one side of an intact diaphragm, creating a space above the normally situated diaphragm that becomes filled by the bowel. It is quite common, usually small ( Fig. 10-4) but \noccasionally large (Fig. 10-5), and asymptomatic in most cases. In the newborn, however, it can cause respiratory distress.\nDiaphragmatic Rupture\nDiaphragmatic rupture is a tear of the diaphragm and is usually traumatic. Given that abdominal pressure is higher than chest pressure, the bowel often herniates through the diaphragmatic rent, which may sometimes be sufficient to cause symptomatic compression of the lungs or heart. The diagnosis is usually made by multiplanar CT or MRI (Figs. 10-6 and 10-7), although oral contrast material injected through a nasogastric tube should dem-onstrate herniated bowel contents in the chest. Most traumatic diaphragmatic hernias require surgical repair.\nPNEUMOPERITONEUM\nAlthough pneumoperitoneum is sometimes referred to as \u201cfree air,\u201d the gas is generally not \u201cair,\u201d but rather carbon dioxide inserted from laparoscopic procedures or bowel gas that is present in an extraluminal location. The gas may resemble air, however, for a short while after open laparotomy procedures. The presence of pneumoperitoneum may therefore be a benign postsurgical finding or may represent more sinister causes secondary to bowel ischemia or perforation ( Box 10-1). The detection of pneumoperi -\ntoneum is important and sometimes critical because it may be the only imaging sign of bowel perforation. Its detection, however, can be challenging (especially on plain radiograph) but is more likely when the x-ray beam is tangential to the location of the gas, which rises to the most nondependent part of the abdomen. Therefore, on an upright view the gas is most likely to be identi -\nfied under the diaphragm (Fig. 10-8), but on an anteroposterior view the gas may not be appreciated because the x-ray beam does not pass tangential to it. Pneumoperitoneum in the lateral or sagittal plane is better appreciated with computed tomography (CT), which demonstrates the extraluminal gas against the ante-rior abdominal wall (Fig. 10-9). Smaller volumes of pneumoperi-toneum can be quite subtle to detect on plain radiograph ( Fig. \n10-10), and a lateral chest view may be required before small vol -\numes of gas are identified (Fig. 10-11). The most sensitive plain radiograph procedure is the left decubitus (right side up) view of the right upper quadrant, where as little as 1 mL of extralumi-nal gas can be detected between the liver margin and diaphragm. This procedure is rarely performed, primarily because CT is a far \nB\n A\nFigure 10-4. Plain posteroanterior ( A) and lateral chest radiograph ( B) in a 66-year-old woman with right hemidiaphragmatic elevation caused by slight \neventration (arrows).\nFigure 10-5. Posteroanterior chest radiograph in an 83-year-old woman \nwith a large left diaphragmatic eventration with elevation of the splenic \nflexure (arrow), which remains in the abdomen.", "beb38a84-3c7d-4d50-85c7-7055f6d3c5fd": "Stomach  63\nthe more common adenocarcinoma. MAL T lymphoma most com -\nmonly affects the stomach and represents a low-grade B-cell lym -\nphoma. Because of its low grade, it can be difficult to detect with \neither CT or PET . It is heavily associated with H. pylori, which \nis thought to be causative as a result of the chronic inflammatory reaction induced in the infected stomach. T reatment and eradica -\ntion of gastric H. pylori are often curative.\nAt imaging, there are various presentations of gastric lym -\nphoma, including a large ulcerating lesion, multiple polypoid lesions (with or without ulceration), or an infiltrating mass that can result in a linitis plastica appearance (Figs. 2-72, 2-73, and 2-74). These features can usually be observed on CT, but dif-ferentiation from other malignant diagnoses is sometimes diffi -\ncult because of similar appearance on imaging. CT will readily demonstrate extragastric extension or remote adenopathy and hepatosplenomegaly.\nPosttransplant lymphoproliferative disorder (PTLD) occurs \nas a complication after prolonged immunosuppression, mostly among transplant recipients. It is due to an uncontrolled prolif -\neration of B cells infected with Epstein-Barr virus (EBV) and the disease; therefore it has similarities with Burkitt lymphoma. The disease can respond to the cessation of the immunosuppressive therapy, although some patients progress to typical non-Hodg-kin B-cell lymphoma. Extranodal involvement is much more common than nodal involvement and affects the GI tract most commonly, typically the small bowel, then the colon, stomach, duodenum, and esophagus in descending frequency. Most other abdominal organs can also be involved, including the lung and central nervous system. Implanted allografts can also succumb to disease (e.g., liver, renal, heart/lung).\nImaging features in the bowel are similar to other GI lym-\nphoma, including circumferential wall thickening (sometimes marked) and aneurysmal luminal dilatation. Characteristically, the disease ulcerates and then perforates far more frequently than other types of lymphoma.Burkitt Lymphoma\nThis is a B-cell lymphoma first described as an EBV-mediated lymphoma endemic to central Africa. This virally induced tumor (Epstein-Barr* ) most often involves the maxilla in younger adults \nand children, but colonic involvement, particularly of the ascend-ing colon, is well recognized. Other forms of Burkitt lymphoma include the sporadic type, again mediated by EBV , and more commonly produce ileocecal lymphoma. A third variant, termed immunodeficiency-associated Burkitt lymphoma (a variant of posttrans-plant lymphoproliferative disease), occurs in immunosuppressed patients, particularly those with human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) but also those taking immunosuppressive drugs.\nMetastases\nMetastatic disease to the stomach is usually focal and small but can occasionally be larger, particularly with melanoma. These classically result in a bull\u2019s-eye mucosal lesion (although simple mucosal masses are also recognized) that appears as a circular metastatic mucosal deposit with a central ulcerated depression (see Fig. 2-17). On UGI examination, contrast will collect in the \nulcer crater in the supine position if the lesion is on the posterior wall or conversely on the anterior wall if the patient is in the prone position. These are often multiple and most commonly seen in melanoma, breast cancer, and lung cancer.\nBreast cancer and lymphoma can also cause a linitis plastica \nappearance, infiltrating along the gastric wall rather than produc -\ning discrete mucosal masses (Fig. 2-75). Other primary malignan-cies (e.g., ovarian and pseudomyxoma peritonei) can envelop the stomach with metastatic deposits and give the appearance of linitis plastica (Fig. 2-76).", "cac1cba9-09e9-4300-abc9-58ae9254523d": "328 Gastrointestinal Imaging: The Requisites\nit is unlikely to be a Murphy sign and therefore not acute chole -\ncystitis. However, since this test is often poorly performed, the \nsign is not necessarily elicited when acute cholecystitis is present.\nLess commonly, patients are referred for CT because the clini -\ncal symptoms may not localize specifically to the gallbladder or the referring physician may not specifically suspect cholecystitis. Features on contrast-enhanced CT include a distended gallblad -\nder with enhancement of a circumferentially thickened wall and pericholecystic inflammatory changes (\u201cfat stranding\u201d) in the adjacent peritoneal fat (Fig. 8-36). Gallstones may or may not be identified, depending on their calcium content.\nNuclear scintigraphy with \n99mT c hepatobiliary iminodiacetic \nacid (HIDA), now rarely performed because of the accuracy of US, has high specificity for the diagnosis of acute cholecystitis. Injected isotope is readily excreted into the biliary system, and a normally functioning gallbladder is usually identified at 1 hour. If no gallbladder is observed after 4 hours (because of cystic duct obstruction), a diagnosis of acute cholecystitis is made, assum -\ning that there are accompanying clinical symptoms and signs (Fig. 8-36). Early in the injection (i.e., in the arterial phase), the \n hyperemic gallbladder wall may demonstrate increased activity \nand a \u201crim sign\u201d may be observed, representing a crescentic band of isotope activity in the adjacent inflamed hepatic parenchyma, but this sign is less specific and rarely identified. MRI is rarely performed to evaluate for the diagnosis of acute cholecystitis but will demonstrate MR-equivalent findings to contrast-enhanced CT, with a distended gallbladder and a thickened enhancing wall, and most likely the offending gallstone will be identi -\nfied. Pericholecystic inflammatory change will be manifest as increased T2 signal.\nThe complications of acute cholecystitis include gallbladder \ngangrene and perforation with pericholecystic abscess or gas in the gallbladder wall or lumen (Figs. 8-37 and 8-38). Once the gall-bladder has been perforated, a positive Murphy sign is less likely because the gallbladder is no longer distended. The features of a perforated gallbladder are best imaged by CT, demonstrating the extent of pericholecystic abscess formation.\nChronic cholecystitis results from repetitive episodes of sub-\nacute cholecystitis caused by the presence of stones but usually is not sufficiently symptomatic to make the patient seek urgent medical care. The symptoms are mild to moderate intermittent pain in the right upper quadrant. There is sometimes biliary colic when the gallstone becomes temporarily impacted in the gall -\nbladder neck, but not long enough to cause the sequelae of full-blown acute cholecystitis. The repetitive milder inflammatory episodes ultimately cause fibrosis, thickening, and contraction of the gallbladder, such that it becomes shrunken and compacted with stones ( Figs. 8-9 and 8-10 ). At that point an increasing num -\nber of more painful episodes may develop, precipitating medical attention and subsequent cholecystectomy.\nA B\nFigure 8-35.  A and B, Sagittal US in a 29-year-old woman with a distended gallbladder, slight wall thickening, and intramural gallbladder lucencies ( long \narrow) caused by acute cholecystitis. There is an impacted stone at the gallbladder neck (short arrow). The patient had a positive sonographic Murphy sign.\nA\n B C\nFigure 8-36. Axial ( A) and coronal contrast-enhanced CT ( B) and HIDA scan ( C) in a 30-year-old man with an inflamed gallbladder. Pericholecystic \nedema (large white arrows ) and wall thickening are due to acute cholecystitis. On HIDA scan there is no gallbladder filling ( small black arrow ) of T c at 60 \nminutes because of an obstructed cystic duct. Isotope passes into the duodenum directly (arrowhead  ).", "a3eef9ac-3568-45a1-8097-7bd0d1b11b7b": "Liver 279\ncharacteristic feature is the \u201cwater lily\u201d sign, representing the \nwalls of a dead or dying cyst ( Fig. 6-155) that collapses within the \nlarger cystic complex. The cyst wall may enhance, similar to other infected abscesses.\nThe major risk from hepatic hydatid cyst infection is rupture, \nwhich can be fatal if into the lungs or peritoneum. Percutane -\nous aspiration, however, is not contraindicated unless the wall is calcified because of difficulty penetrating the cyst wall. Rarely, hydatid cysts are large enough to cause obstructive jaundice. The diagnosis is readily made with an accompanying history and serological testing. Similar to that of amebic abscess, the diagnosis may not be made until an aspirate is cultured or ana -\nlyzed microscopically. T reatment is with antiparasitic medica -\ntion and aspiration for smaller lesions or catheter placement for larger lesions.\nHepatic Schistosomiasis\nOf the three main schistosomal species ( Schistosoma hematobium, \nS. japonicum, and S. mansoni), S. mansoni is most likely to infect \nthe liver. The life cycle involves an intermediate freshwater snail host (asexual reproductive stage) and humans as the definitive host for sexual reproduction. Eggs excreted by humans release miracidia that infest the intermediate host, a freshwater snail, where they evolve into cercariae, which are released back into the water. These penetrate the skin of human bathers and are transported to the lungs and heart, then to the mesenteric venous system, and finally come to reside in periportal venules. Host immune response can result in parasitic death with granu -\nlomatous formation and subsequent fibrosis, resulting in cirrho-sis (particularly centrally) and portal hypertension. Because the disease is endemic in countries with endemic hepatitis B and C, the two diseases often exacerbate the complications of each other, and the complications of cirrhosis are more profound and develop earlier.\nThe imaging findings are periportal edema and fibrosis, mainly \nat the porta hepatis, but as with other cirrhoses the liver is gener -\nally irregular in shape. Capsular and hepatic septal calcification can be identified, characteristic of schistosomal infection, and there may be linear hyperdense strands of fibrotic tissue, giv -\ning a so-called turtle-backed appearance (Fig. 6-157). Secondary effects of portal hypertension are common (mesenteric varices, splenomegaly, and ascites).\nHEPATIC CALCIFICATIONS (BOX 6-8)\nCalcified granulomas from TB are common worldwide but rarer outside endemic countries (Fig. 6-158). In the United States, his-toplasmosis is more common and even endemic in some areas. T ypically, caseating granulomas heal with small, punctate areas of calcification, sometimes throughout the liver (and also spleen). The calcification in TB is often coarser than that seen with his -\ntoplasmosis. Sarcoidosis, a noncaseating granulomatous disease, can also develop multiple, small, punctate, calcified areas within the hepatic parenchyma. Other infections that can lead to hepatic calcification include wall calcification in treated abscess (e.g., pyogenic, amebic, and hydatid disease).\nMalignant calcification within the liver is usually secondary \nto mucinous metastatic disease (e.g., from the colon, ovary, or pancreas) (Fig. 6-105). Very rarely, osteosarcoma can metastasize and calcify within the liver ( Fig. 6-159). Hepatic calcification also \noccurs in primary liver tumors. HCC calcification is uncommon but definitely recognized and is observed far more often (up to 30%) in fibrolamellar HCC (Fig. 6-160). Rarer hepatic primary tumors, including hemangioendotheliomas, hamartomas, and hepatoblastomas, can also calcify (Fig. 6-135). Hamartoma, a rare hepatic benign tumor, can demonstrate calcification (Fig. 6-161). Very rarely, benign large hemangiomas also calcify.\nHematomas, particularly if subcapsular, are prone to calcifica -\ntion. Other capsular calcification can occur with diffuse peritonitis (particularly meconium peritonitis).", "ea586baa-a379-4f6a-9860-2163010a16b6": "210 Gastrointestinal Imaging: The Requisites\nAppendicitis\nThe appendix is an important factor in disease because of its \npropensity to be obstructed by a fecalith, usually close to its ori -\nfice. A fecalith is a small fecal concretion that often calcifies and may become quite large ( Fig. 5-152). The obstructed appendix \nbecomes distended with secreted appendiceal mucous, which is then secondarily infected, resulting in appendicitis. The wall thickens because of inflammatory edema and hyperemia. When the appendiceal caliber (overall diameter) is \u22656 mm (mural thick -\nness, >2 mm), acute appendicitis can be diagnosed with a sensi -\ntivity of 100% but lower specificity, which rises to close to 100% when the diameter is \u22657 mm. Patients typically report perium -\nbilical pain moving to the right lower quadrant with rebound tenderness (McBurney* point). Despite these classic clinical findings, the diagnosis is notoriously difficult to make. Up to 50% of patients referred for surgery before the CT era were found to have either a normal appendix or another pathologic finding. However, since US in children and CT in adults became used routinely to evaluate for suspected appendicitis, few patients are now referred unnecessarily for surgery.\n*Charles McBurney (1845-1913), American surgeon.\nB\n A\nFigure 5-153. T ransverse ( A) and sagittal (B) US images in a 16-year-old girl with appendicitis demonstrating thickened walls ( arrow) with an overall \ndiameter (small arrows) of 9 mm.\nFigure 5-152. Axial contrast-enhanced CT in a 51-year-old woman \nwith a large fecalith ( arrow) that caused localized mucosal inflammation \nrather than appendicitis.Plain radiography may demonstrate a fecalith in approximately \n10% of patients, with possible ileus in the setting of acute appen -\ndicitis. US, the investigation of choice in children, demonstrates a noncompressible appendix dilated \u22657 mm in diameter with tenderness directly over the inflamed appendix (McBurney sign), which may also show increased Doppler* flow, although this is not necessary to make the diagnosis ( Fig. 5-153). A fecalith is fre -\nquently identified as an echogenic focus with posterior acoustic shadowing. Perforation and abscess formation are seen as a com-plex fluid collection, with or without gas.\nIn adults, CT is the investigation of choice with a sensitivity \nand specificity approaching 100% ( Fig. 5-154). The optimal tech-\nnique is under debate, with some institutions recommending rec -\ntal contrast for better delineation of the cecum and appendix, but most protocols use only oral and IV contrast media (providing the patient can tolerate this). The dilated appendix (\u2265 7 mm in diam-\neter) should be identified, and the fecalith is frequently identi -\nfied (Fig. 5-154). There is mucosal enhancement after IV contrast administration, and usually periappendiceal inflammatory change (fat-stranding) or fluid is seen, although this is variable (Figs. 5-154 and 5-155). The cecal tip often demonstrates secondary thicken -\ning, termed a \u201ccecal bar,\u201d best observed with CT protocols using rectal contrast medium. Once perforation occurs, CT demonstrates the extraluminal collection of gas and pus ( Fig. 5-156). Appendi-\nceal perforation can lead to a localized walled-off abscess, but more extensive peritonitis may also occur. Appendicitis undiagnosed or left untreated carries high morbidity and mortality rates.\nThe imaging diagnosis of appendicitis is not always so straight-\nforward. US evaluation may be compromised from overlying adi -\npose tissue, bowel gas, and abdominal pain. Therefore CT has a higher sensitivity for the detection of an inflamed appendix (close to 100% vs. 85%). Despite this, close attention to regional anat -\nomy may be required to identify the inflamed appendix, which can be buried between loops of small bowel, some of which may not be opacified adequately with oral contrast agent. The associ -\nated periappendiceal inflammatory change (stranding) may oblit -\nerate the normal fat planes between tissues, making evaluation of normal anatomy more challenging ( Fig. 5-156). The inflamed \nappendix may also not be in the expected location, as explained previously.", "3ca8bb8b-4f86-4c70-8b3a-f7ba0468477e": "Liver 265\nB\n A\nFigure 6-119. A and B, Axial non-contrast-enhanced CT in a 56-year-old woman with a left lobe HCC that has large hypodense fat elements ( arrows).\nB\n C\n A\nFigure 6-120. Axial arterial ( A), PVP (B), and delayed (C) contrast-enhanced CT in a 79-year-old woman with a cirrhotic liver and a segment V HCC \n(arrows) that demonstrates arterial enhancement, a capsule at PVP , and contrast washout on delayed imaging. There is a focus on intratumoral fat ( curved \narrow) and abdominal ascites.\nA\n BB\n C\nF\n E\n D\nFigure 6-121. Axial fat-saturated T2-weighted ( A), fat-saturated T1-weighted ( B), AP ( C), PVP ( D), and hepatobiliary postcontrast MRI, and B500 \nDWI (E) and ADC maps ( F) in a 63-year-old woman with a dysplastic nodule ( arrows) that has low T2 signal, unlike an HCC, which would show moder -\nate to high T2 signal. It does not demonstrate hepatocyte activity on delayed hepatobiliary agent imaging.", "d608ca87-9f40-48ad-b734-701ed9072260": "200 Gastrointestinal Imaging: The Requisites\nperforation is imminent and is often a surgical emergency. This \nis discussed in more detail earlier in the chapter. The causes are mostly inflammatory or infectious, including IBD, certain bacte -\nrial or viral pathogens, or ischemic bowel.\nScleroderma\nScleroderma is a multisystemic autoimmune disease that com -\nmonly affects any aspect of the GI tract and progressively leads to atonic bowel and dilatation. This is caused by collagen depo-sition in the muscularis mucosae layer of the affected bowel with smooth muscle atrophy and fibrosis. The colon ultimately becomes functionless and can be grossly dilated.\nChagas Disease\nOften acute and self-limiting, Chagas disease can proceed to a chronic, sometimes debilitating and fatal disease. Chagas dis -\nease is caused by the parasite T rypansoma cruzi, which can cause \nchronic neuronal inflammation and destruction of the myenteric plexus, leading to an atonic viscus that usually affects the esopha -\ngus or colon. This can cause marked distention of the esophagus or colon, with the latter at risk of volvulus. The GI symptoms are often secondary to the more serious effects of a dilated cardiomy -\nopathy and heart failure.\nCystic Fibrosis\nCystic fibrosis has a number of GI complications, mostly resulting from the viscous mucoid inspissated material that occupies the small and large bowel. These include meconium ileus, intussus -\nception, and appendicitis. The colon can also become occupied by the viscoid material, leading to meconium ileus equivalent syndrome, which resembles meconium ileus and predominantly affects the cecum and ascending colon. Colonic strictures have also been reported in children because of a submucosal fibrosis, termed \u201cfibrosing colopathy.\u201d In some patients a colitis-type picture with wall thickening and pericolonic inflammation (fat-stranding) develops and can be difficult to distinguish from IBD (Fig. 5-129). Patients with cystic fibrosis are at a slight increased risk of adenocarcinoma in the small or large bowel ( Fig. 5-130), \nalthough there is dispute as to whether this simply reflects the expected normal frequency of cancer in the general population.\nIdiopathic Intestinal Pseudoobstruction\nIdiopathic intestinal pseudoobstruction is a congenital or acquired rare disorder usually observed in children. Patients have repeti -\ntive symptoms and signs of large bowel obstruction in the absence of a mechanical cause. Congenital causes are extremely rare and are caused by myopathic or neuropathic disease and associated with other dilated structures (i.e., megaureters). The secondary or acquired form is more common because of a variety of metabolic, infectious, endocrinological, muscular, and neuropathic disorders.\nExtracolonic Causes of Colonic Stricture\nAdjacent inflammatory disease (e.g., pancreatitis) or abscess for -\nmation anywhere along the length of the bowel (i.e., secondary to tuboovarian abscess or appendiceal abscess) may cause localized stricture formation from the secondary inflammatory change.\nMalignant invasion of the colonic serosa, usually via direct \nperitoneal spread, may cause localized stricture formation and marked spasm ( Fig. 5-125). Other malignant causes are secondary \nto direct colonic invasion from adjacent malignancy (Fig. 5-126).\nMechanical Large Bowel Obstruction\nIn common with mechanical obstruction in any viscera or ves -\nsel, the cause of mechanical large bowel obstruction can be outside the bowel (extraluminal), within the bowel wall (muco -\nsal or submucosal), or within the bowel lumen (intraluminal) (T able 5-9). The imaging appearances vary according to the \ncause. Extraluminal obstruction generally causes a smooth, shallow, angled stricture, unless caused by hernia or volvu-lus, where the stricture is tight and abrupt. Intramural causes produce a more obtuse angled filling defect within the bowel lumen, whereas mucosal strictures generally produce sharply marginated strictures, either polypoid or shouldering (abrupt transition between normal mucosa and stricture) (see Chapter 1). Mechanical obstruction is often assessed initially with the abdominal plain radiography to determine whether the large \nC\n A\n B\nFigure 5-128.", "ffe8804b-c4e1-48a1-87e8-2f574d58d10f": "100 Gastrointestinal Imaging: The Requisites\nMUCOSAL SMALL BOWEL ABNORMALITIES\nSmall bowel mucosal or fold thickening has numerous causes, \nand even the most experienced GI radiologist will probably struggle to remember them all when challenged ( T able 4-1). This \nis compounded by the fact that many of the causes are rare and that the mucosal fold thickening can be further subdivided into uniform versus irregular (or nodular) thickening. Furthermore, these different types of mucosal thickening can be difficult to differentiate from one another, and sometimes a single diagnosis can manifest with both regular and irregular fold thickening.\nCrohn Disease\nCrohn * disease is also known as regional or terminal ileitis. It is thought \nto be an autoimmune disease, although so far there is no known definitive causative agent. It has widespread manifestations, mainly of the GI tract, resulting in inflammatory changes from the mouth to the anus, but most commonly in the small intestine, particularly the terminal ileum. Hence, it is known as an inflammatory bowel disease (along with ulcerative colitis) and is a transmural process and charac -\nterized by noncaseating granulomas during histological examination . \nIt is primarily a disease of the West and has a bimodal presentation, either in the early 20s or in the 50s. Symptoms are mainly abdominal pain and diarrhea, weight loss, fever, and melena. T ypically the disease is intermittent in up to 80% of patients, with approximately 20% hav -\ning only a single attack. Up to 50% of patients have recurrent disease even after surgery, usually in the proximal portion of small bowel that remains. Patients are also at increased risk of adenocarcinoma devel -\noping in the inflamed areas , in both the small bowel and colon, and \ntherefore regular endoscopic screening is recommended in patients with Crohn disease. Crohn disease is associated with systemic clinical \n*Burrill B. Crohn (1884-1983), American gastroenterologist.disease of uveitis, episcleritis, seronegative spondyloarthropathy, ery-thema nodosum, pyoderma gangrenosum, and gallstone formation (because of poor absorption of bile salt from terminal ileal disease).\nPatients are typically between ages 15 and 25 when they have \ntheir first clinical attack. In the acute phase of the disease, there is mural thickening with mucosal edema and fine ulceration, leading to spasm and luminal narrowing. As the acute phase worsens, the ulcers may deepen and create fistulas with the adjacent small or large bowel. Further disease progression yields fibrotic changes and small bowel stricture formation. Specific signs of Crohn disease are \u201cskip lesions,\u201d representing alternating areas of normal bowel (small or large) and affected segments, and \u201ccobblestoning,\u201d representing areas  \nof mucosal ulceration separated by regions of more normal mucosa.\nThe diagnosis can be made by capsule endoscopy or colonos -\ncopy by passing the scope through the ileocecal valve into the terminal ileum and recognizing inflammatory ulcerative changes that will strongly suggest the diagnosis, which can be confirmed with ileal biopsy. Imaging, however, plays a key role in the diag -\nnosis because the disease usually demonstrates highly character -\nistic imaging features, particularly in the small bowel ( T able 4-2). \nIt is one of the few remaining major indications for SBFT, which should identify either the acute or more chronic changes of the disease.", "e3386c28-df2b-4b45-be3e-f7e413096160": "Small Bowel 113\nVasculitis\nA range of autoimmune disease, such as systemic lupus erythe -\nmatosus, Churg-Strauss syndrome, and granulomatosis with poly -\nangiitis, causes small bowel edema through vasculitis. The small \nbowel is often affected, given the rich mesenteric vascular sup -\nply, which can affect both small and large vessels (arteries and veins). The inflammatory effect on small mesenteric vessels leads \nto localized ischemia with small bowel wall and mucosal thicken -\ning, which is often widespread (Figs. 4-49 and 4-50).\nIdiopathic Thrombocytopenia\nIdiopathic thrombocytopenia (ITP) is a disease characterized by platelet depletion from antibody destruction, predominantly in the spleen, which, when severe, can cause widespread hemor -\nrhage in different organs, including the small or large bowel. In the small bowel, the features are of submucosal bleeding with thickened, crowded picket fence\u2013like folds, similar to other causes of intramural small bowel hemorrhage.\nSmall Bowel Varices\nSmall bowel varices are rare but can produce a smooth submuco -\nsal serpiginous defect similar to that seen in esophageal varices.\nIschemic Enteritis\nIschemic enteritis can be acute (with sudden onset of abdominal pain, diarrhea, and vomiting) or chronic with symptoms of intestinal \nA\n B\nFigure 4-49. Coronal ( A) and axial ( B) contrast-enhanced CT in a 29-year-old woman with mesenteric hyperermia ( large arrrow), thickened ileum \n(small arrow), and mural stratification (curved arrow) from acute systemic lupus erythematosus.\nB\n A\nFigure 4-50. Axial ( A) and coronal ( B) contrast-enhanced CT in a 60-year-old woman with marked diffuse small bowel wall thickening ( arrows) due to \nChurg-Strauss disease (autoimmune vasculitis).", "58dbb54c-c577-4f7d-99c0-fe6e7b8edde3": "Liver 221\n(OOP) imaging (or other fat-suppression techniques, e.g., Dixon), \nT2, and postcontrast T1 (with or without fat saturation) images. Most of these sequences are now considerably faster than those of previous MRI generations. The normal liver typically demonstrates a slightly higher T1-weighted signal and slightly lower T2-weighted signal when compared with those of the spleen. Most biliary and vascular structures are of low signal on T1-weighted images, but bile, in particular, is of high signal of T2-weighted images, hence its use in magnetic resonance cholangiopancreatography (MRCP).\nFat-Suppression Techniques\nSimple fat-suppression techniques (performed on both T1 and T2 sequences) are available for all MRI scanners and null out signal in voxels with high fatty content. These techniques are most useful when evaluating disease in anatomical locations with a large amount of normal fat (e.g., peritoneum) because the result-ing fat signal loss increases the contrast of any abnormal tissue with inherent higher signal (e.g., inflammatory and many benign or malignant masses that demonstrate enhancement after the administration of IV contrast agents). Furthermore, they can be used to evaluate abnormalities with substantial fatty components (fatty liver, dermoid cysts, adrenal myelolipoma, and adenomas). Alternatively, fat-containing tissue can be evaluated with IP and OOP chemical shift MRI or Dixon fat-suppression techniques, and inversion recovery sequences are also available (Fig. 6-7).\nMagnetic Resonance Imaging Contrast Agents\nThe three main classes of MRI contrast agents are extracellu -\nlar, hepatobiliary, and mononuclear phagocytic (formerly reticu -\nloendothelial). Extracellular agents are the most common and include gadopentetate dimeglumine (Gd-DTPA). These agents behave similarly to iodinated contrast agents used in CT . They circulate freely in the extracellular spaces before being excreted predominantly in the kidneys. As with contrast-enhanced CT, the detection and characterization of liver lesions depend on the differential arterial or portal venous enhancement of liver lesions or lack of enhancement compared with that of normal hepatic parenchyma.\nHepatobiliary agents are specifically absorbed by hepatocytes \nand partially excreted in bile and the kidneys (Fig. 6-8), so detec-tion and characterization of lesions depend on whether they retain hepatocyte function (e.g., focal nodular hyperplasia [FNH], some well-differentiated hepatocellular carcinoma [HCC]) or not (hemangiomas, metastases, and cysts). These agents include manganese-based mangafodipir trisodium (Mn-DPDP) and gadolinium-based gadoxetate disodium (Gd-EOB-DTPA) and \nA\n B\nFigure 6-5. Axial PVP ( A) and delayed-phase ( B) contrast-enhanced CT in a 52-year-old woman with hemangioma. The lesion ( arrows) demonstrates \nperipheral nodular enhancement that fills in on delayed imaging, characteristic of the hemangioma.\nA\n B\n C\nFigure 6-6. A through C, Virtual noncontrast CT . The original contrast-enhanced image (A) demonstrates a small segment VIII liver lesion (arrow) that \ncan be identified on the virtual noncontrast image (arrow). The true noncontrast image (C) is shown for comparison.", "cb441f88-2576-4b0f-a780-f410d0409823": "278 Gastrointestinal Imaging: The Requisites\nA\n B\nFigure 6-154. Axial ( A) and coronal (B) contrast-enhanced CT in a 51-year-old man with amebic liver abscess (arrows).\nB\n A\nFigure 6-155. Axial ( A) and coronal (B) contrast-enhanced CT in a 7-year-old boy with hydatid disease of the liver and spleen with daughter cysts \n(arrow) and a \u201cdrooping lily\u201d sign (small arrows).\nFigure 6-156.  Axial contrast-enhanced CT in a 67-year-old woman with \na calcified mass due to prior hydatid infection and cyst \u201cdeath\u201d (arrow).\nFigure 6-157. Axial contrast-enhanced CT in a 19-year-old man with a \nfibrotic \u201cturtle-backed\u201d liver as a result of chronic schistosomiasis.", "8c9ca39b-0450-46af-a9e1-2d20c3deb119": "Liver 275\nB\nA\nFigure 6-144. Axial ( A) and coronal ( B) contrast-enhanced CT in a \n76-year-old with bacterial endocarditis and multiple hepatic septic emboli \n(arrows).\nFigure 6-145. Axial contrast-enhanced CT in a 19-year-old man with a \ncomplex hypodense mass in segment V because of bacterial abscess. Peripheral hypodense areas ( arrow) are commonly identified secondary to \nthe associated hepatic inflammatory response.\nFigure 6-146. Axial contrast-enhanced CT in a 27-year-old with Bar-\ntonella infection (cat-scratch disease) of the liver and spleen as evidenced by muliple low-density abscesses in the liver and spleen.\nFigure 6-147. Axial contrast-enhanced CT in a 73-year-old man with a \nlarge, thick-walled loculated hepatic abscess.\nFigure 6-148. Axial contrast-enhanced CT in a 66-year-old man with \nmultiple hepatic gas-fluid levels owing to multiple abscesses.", "3edb902f-e335-49e6-ac6d-620eae25a1d9": "66 Gastrointestinal Imaging: The Requisites\nnoncontractile stomach without recognizable mucosal folds, usu-\nally starting at the antrum and progressing proximally (see Figs. \n2-34, 2-35, 2-64, 2-65, 2-74, and 2-76 ). In general, it does not \nextend distally to cross the pylorus. At CT, the stomach lumen is narrowed (particularly in the antrum), with thickened infiltrated tumor in the gastric wall (see Figs. 2-64, 2-73, and 2-74). Associ-ated regional lymphadenopathy and distant metastases are read -\nily observed with the appropriate CT technique.Gastric Outlet Obstruction\nThere are both benign and malignant causes of gastric outlet obstruction (T able 2-8). Most of the benign gastric causes result in outlet obstruction through fibrosis as a consequence of the healing phases. The most common benign cause is a result of chronic peptic ulcer disease, but as described earlier, this is less prevalent and responds well to antibiotics, so it is now relatively rare.\nMore common are malignant causes, the most prevalent being \ngastric cancer (Fig. 2-79) (often scirrhous type) and pancreatic adenocarcinoma (see Fig. 2-63). Both can infiltrate along the gas -\ntric wall, causing antral constriction and outlet obstruction. Lym -\nphoma, like that elsewhere in the GI tract or pancreaticobiliary system, tends not to be obstructive but rather mass-like without mechanically constrictive effects. However, if very large, it may ultimately cause outlet obstruction.\nGastric Bezoar\nGastric bezoars are composed of plant and vegetable matter (phy -\ntobezoar) or hair (trichobezoar), the first being more common and more likely to cause associated ulcer disease from local abrasion. In general, bezoars do not obstruct unless they are large and act with a ball-valve effect. They are more common after gastric reconstructive surgery when there is a smaller stomach lumen. T richobezoars tend to be much larger than phytobezoars at pre-sentation, when they are filled with hair and food residue and are typically black in color ( Figs. 2-80 and 2-81 ). Patients often have \nan underlying psychiatric diagnosis.\nThe persimmon bezoar is a unique bezoar noted in Native \nAmericans after unripened fruit from the persimmon tree has been eaten. After ingestion, it coagulates with gastric acid into a gelati -\nnous mass, sometimes leading to gastric outlet obstruction.\nOther bezoars include lactobezoars, which consist of solidi -\nfied undigested milk, and pharmacobezoars, which consist of undigested and accumulated multiple medications. Other for -\neign object bezoars include swallowed drug-filled condoms, typically seen in smugglers, that get lodged in the gastric antrum and pylorus. Rarely, other nondescript foreign objects are swallowed by children or by institutionalized and psychiatric  \npatients.\nAt imaging, there may be a soft tissue mass noted on plain radi -\nography, but a UGI will readily identify a mottled complex mass \nB\n A\nFigure 2-79. Plain abdominal radiography ( A) and axial contrast-enhanced CT (B) in a 69-year-old man with gastric outlet obstruction and a distended \nstomach (small arrows) due to an antral gastric cancer (large arrow).table 2-7 Causes of Linitis Plastica (Leather-Bottle) Stomach\nMalignant Benign\nGastric carcinoma\nLymphomaMetastases (breast, lung)Eosinophilic gastroenteritisCrohn diseaseT uberculosis, syphilisCaustic ingestionSarcoidosisZollinger-Ellison syndrome \n(multiple ulcers)\n \ntable 2-8 Causes of Gastric Outlet Obstruction\nCongenital Pyloric stenosis\nMechanical BezoarDiaphragmatic herniaVolvulus\nInflammatory Peptic ulcer diseasePancreatitisCrohn disease\nInfection T uberculosisSyphilis\nCorrosives Linitis plastica\nMalignancy CarcinomaLymphoma\nRadiation therapy Radiation stricture", "87998a1b-c6ea-4a46-8cc0-710781304b04": "56 Gastrointestinal Imaging: The Requisites\nbut they may appear as generally smooth, rounded hypervascu-\nlar masses after the administration of intravenous (IV) contrast material (Fig. 2-55).\nGastric Varices\nThe dilated submucosal gastric vein, like its esophageal equiva -\nlent, can cause life-threatening hemorrhage. It can be secondary to portal venous hypertension but is more commonly associated with splenic vein thrombosis (i.e., pancreatic malignancy, pancreatitis, thrombotic disorders).\nDiagnosis is usually made by EGD, but on UGI series,  there \nis fold-thickening typically in the fundus because of the dilated submucosal vessels (Fig. 2-56). The diagnosis is usually associ -\nated with esophageal varices and may only be visualized with the patient in the prone or supine position that creates enough venous distention to be visible on UGI series . The varices are \nusually far better visualized by CT than UGI (Fig. 2-57).Gastric Carcinoma\nGastric carcinoma is the third most common GI malignancy after colonic and pancreatic carcinoma. It arises from the gas -\ntric mucosa (it is slightly more common in the gastric fundus), and most gastric carcinomas are adenocarcinomas (95%). It is more common in men, and risk factors include H. pylori infec-\ntion, alcohol, smoking, pernicious anemia, chronic atrophic gastritis, adenomatous polyps, M\u00e9n\u00e9trier disease, prior gastric surgery (Billroth II), salted and smoked food (especially fish), and foods with high nitrite or nitrate content. Gastric atrophy and carcinoma are associated, but because mild gastric atrophy is common in the elderly, it is not certain whether there is any cause and effect. Therefore it is not unusual for antral and body carcinomas to be associated with gastric atrophy, probably as a simple result of aging. Patients with severe atrophic changes (i.e., those with pernicious anemia), however, are definitely at risk for the development of gastric carcinoma and should be \nB\n A\nFigure 2-48. Axial ( A) and coronal ( B) CT in a 44-year-old man with a smooth intraluminal submucosal filling defect at the gastric fundus ( arrows) due \nto a GIST .\nAB\nFigure 2-49. Axial ( A) and coronal (B) CT in a 55-year-old woman with a transmural gastric mass with ulceration (arrows) due to a benign GIST .", "41c5c495-145f-4f5d-8a4b-2d04868c518d": "26 Gastrointestinal Imaging: The Requisites\nEpidermolysis Bullosa\nEpidermolysis bullosa is similar to pemphigoid with multiple small \nesophageal bullae that form in the upper esophagus in conjunction with epidermal disease. These ulcerate and result in strictures on healing, with either tight focal strictures or longer tapered strictures (Figs. 1-63 and 1-64 ). There is a small risk of malignant degeneration.\nTylosis\nT ylosis is a rare autosomal dominant disease characterized by hyperkeratinization of the palms of the hands (and sometimes the soles of the feet) with a high risk for squamous esophageal carcinoma (approximately 95% of patients aged 70 years) second -\nary to esophageal leukoplakia and dysplasia. In the esophagus, focal, small, nonspecific ulcerations can occur along any length of the esophagus, stomach, and small bowel. In the colon, it can pro-duce a colitis similar to ulcerative colitis and is one of the poten -\ntial causes of a toxic megacolon (see \u201cThumb-Printing and T oxic Megacolon\u201d in Chapter 5).\nGlycogenic Acanthosis\nGlycogenic acanthosis is a condition typically seen in the elderly, characterized by small (2 to 10 mm), multiple, disparate, plaque-like mucosal lesions throughout the esophagus, which can be numerous or scattered ( Figs. 1-43 and 1-65 ). These are filled with \nglycogen deposits, hence their name. Diagnosis is benign, and it is usually detected incidentally and is mostly asymptomatic.\nEctopic Gastric Mucosa\nGastric heterotopia (or ectopic mucosa) in the upper esophagus is present in about 4% of patients and is usually asymptomatic, unlike Barrett esophagus. Ectopic gastric mucosa  can produce \nsmall, ring-like indentations of the esophagus, usually at the level of the thoracic inlet.\nFigure 1-62. UGI series in a 49-year-old woman with pemphigoid and a \ntight stricture (arrow) with a barium \u201cjet\u201d caudally.\nFigure 1-63. Oblique UGI swallow of the upper esophagus in a 59-year-\nold woman with a tight stricture ( arrow) due to epidermolysis bullosa. \nThe appearance is not dissimilar to pemphigoid.\nFigure 1-64. UGI in a 49-year-old woman with an upper esophageal \nstricture (arrow) due to epidermolysis bullosa.", "cae5e488-f40c-43bc-8877-faadfe4a32f0": "250 Gastrointestinal Imaging: The Requisites\ndiagnosis. For instance, steatotic livers at US can alter the usual \nlesion echo characteristics because the liver parenchyma is rela -\ntively echogenic compared with that of normal. Therefore hem -\nangiomas may appear hypoechoic relative to the hyperechoic \nbackground liver rather than the normal  situation, which is the \nconverse (Fig. 6-80). Further imaging with CT may not demon -\nstrate all the classic features of hemangioma ( Fig. 6-81), and an \nMRI might ultimately be required to demonstrate all the classic features (Fig. 6-82). As previously discussed, however, it should be remembered that the a priori chance that these atypical lesions are malignant in a patient without malignant disease is very small. In general, the use of multiple methods to fully characterize atypical lesions is reserved for the patient who has an underlying malignancy, and metastatic liver disease must be excluded before a decision of which therapy to offer the patient.\nSclerosing hemangiomas are particularly challenging because \nthey may not enhance at all (since the vascular spaces are \n sclerosed) and at MRI the features may be of intermediate signal \non T2-weighted imaging, suggesting the lesion may be malignant (Fig. 6-83). The diagnosis may ultimately require percutaneous biopsy, particularly if definitive characterization is required in a patient with an extrahepatic malignancy to rule out metastatic disease. Although biopsy of a hemangioma should be avoided when possible, percutaneous biopsy with thin aspirate needles is \nA\nCDB\nFigure 6-78. Axial T2 ( A), postcontrast arterial ( B), PVP ( C), and delayed T1-weighted ( D) fat-saturated MRI in a 35-year-old man and a giant hem -\nangioma. The lesion is relatively T2 bright and demonstrates typical peripheral nodular enhancement ( arrows) that steadily \u201cfills in\u201d from arterial to \ndelayed-phase imaging but not completely.\nAB\nFigure 6-79.  Axial T2-weighted ( A) and delayed postcontrast T1-weighted ( B) fat-saturated MRI in a 50-year-old woman with a giant hemangioma with \nperipheral nodular enhancement (arrowheads) and a T2 bright, nonenhancing scar (arrow).", "9f795c88-51e7-47b0-9154-afa495edc34b": "402 Gastrointestinal Imaging: The Requisites\nureters, resulting in hydronephrosis. Because of its inflammatory \nnature, retroperitoneal fibrosis in the acute phase may demon -\nstrate intense uptake at FDG-PET (Fig. 10-66). Diffuse retro-peritoneal lymphadenopathy from lymphoma can appear similar and may also demonstrate increased uptake on PET imaging, but the retroperitoneum is often not the only site of disease and therefore it can be differentiated from retroperitoneal fibrosis (Fig. 10-67).Extramedullary Hematopoiesis\nExtramedullary hematopoiesis refers to ectopic hematopoi -\nesis outside the bony medulla. It is therefore associated with conditions causing bone marrow displacement, particularly myelofibrosis but also congenital hemolytic anemias and thal-assemia. Patients are usually asymptomatic, but mediastinal, retroperitoneal, or pelvic sites of hematopoiesis can develop  \nB\nCDA\nFigure 10-62. Axial contrast-enhanced PET/CT in a 40-year-old man with follicular lymphoma with abdominal lymphadenopathy ( A; arrows), which \nare fluorodeoxyglucose avid (B; small arrows). After chemotherapy, there is still residual, but less, disease seen on CT ( C; arrowheads) but complete \nresponse seen on PET (D).\nFigure 10-63. Axial contrast-enhanced CT in a 56-year-old woman \nwith colon cancer and a single discrete retroperitoneal 2.3-cm lymph node \n(arrow).\nFigure 10-64. Axial contrast-enhanced CT in a 66-year-old woman \nwith colon cancer and multiple ill-defined retroperitoneal nodes ( arrows).", "23530c02-ce49-4ea0-b21e-57d9f9ef38f8": "Radiographics 28(1):119-134, 2008; doi: 10.1148/rg.281075058.\nHeffernan E J et al: Recurrent pyogenic cholangitis: from imaging to intervention. \nAJR 192(1):W28-35, 2009.\nHoeffel C  et al: Normal and pathologic features of the postoperative biliary tract  \nat 3D MR cholangiopancreatography and MR imaging. Radiographics 26(6): 1603-1620, 2006; doi: 10.1148/rg.266055730.\nJutras J A: Hyperplastic cholecystoses. AJR 83:795-827, 1960.\nKiewiet J JS\n et al: A systematic review and meta-analysis of diagnostic performance \nof imaging in acute cholecystitis. Radiology, July 12, 2012; Published online. doi: 10.1148/radiol.12111561.\nKim J H\n et al: MR cholangiography in symptomatic gallstones: diagnostic accuracy \naccording to clinical risk group. Radiology 224(2):410-416, 2002; Published online May 17, 2002, doi: 10.1148/radiol.2241011223.\nKim J H\n et al: CT findings of cholangiocarcinoma associated with recurrent \n pyogenic cholangitis. AJR 187:1571-1577, 2006; doi: 10.2214/AJR.05.0486 .\nKim J Y et al: Differentiation between biliary cystic neoplasms and simple cysts of \nthe liver: accuracy of CT . AJR 195:1142-1148, 2010; doi: 10.2214/AJR.09.4026.\nKim J Y et al: Spectrum of biliary and nonbiliary complications after lapatoscopic \ncholecystectomy: radiologic findings. AJR 191(3):783-789, 2008.\nKim O H et al: Imaging of the choledochal cyst. Radiographics 15:69-88, 1995 .\nKim S J et al: Peripheral mass\u2013forming cholangiocarcinoma in cirrhotic liver. AJR \n189:1428-1434, 2007; doi: 10.2214/AJR.07.2484.\nKnowlton J Q et al: Imaging of biliary tract inflammation: an update. AJR \n190(4):984-992, 2008.\nKumar A  et al: Carcinoma of the gallbladder: CT findings in 50 patients. Abdom \nImaging 19:304-310, 1994.\nLee W J et al: Radiologic spectrum of cholangiocarcinoma: emphasis on unusual \nmanifestations and differential diagnoses. Radiographics 21:S97-S116, 2001. Spec No.\nLevy A D\n et al: Caroli\u2019s disease: radiologic spectrum with pathologic correlation. \nAJR 179(4):1053-1057, 2002.\nFigure 8-81. T echnetium 99m HIDA imaging in a 67-year-old with \nfever and perihepatic and peritoneal fluid confirmed as biliary in origin \n(arrows).\nFigure 8-82. T ransverse US in a 55-year-old man with recent percuta -\nneous gallbladder placement. Irregular hyperechoic intraluminal mass (arrow) is due to gallbladder hemorrhage.", "1324acb5-ea09-4e09-bbef-636fe2d73acc": "60 Gastrointestinal Imaging: The Requisites\nA\n B\n C\nFigure 2-63. UGI series ( A) and axial (B) and coronal (C) contrast-enhanced CT in a 67-year-old woman with marked antral narrowing ( arrows) due to \nantral linitis plastica from gastric adenocarcinoma.\nA\n B\n C\nFigure 2-62. Barium swallow, axial contrast-enhanced CT, and PET in a 66-year-old woman with a cardial tumor extending into the lower esophagus \n(A; arrowhead) and metastatic lymph nodes (B; arrows) with uptake on PET (C; arrows).\nAB C\nFigure 2-61. Axial contrast-enhanced CT ( A and B) and PET ( C) in a 62-year-old man with mural thickening of the gastric body ( large arrows) due to \nadenocarcinoma, which demonstrates marked FDG uptake (small arrow).", "12a00ddf-19b9-4996-a6ad-b33486667323": "Antispasmodics are useful in this regard to reduce motility and spasm temporarily. Even in a high-quality examination with good bowel cleansing and a well-distended colon, the detection of small polyps can be challenging for the less experienced. Regardless of whether a single-contrast or DCBE technique is performed, close scrutiny during the fluoro -\nscopic phase is required and any suspect lesion should be analyzed in multiple planes (with spot images) to increase the diagnostic confidence of lesion detection and subsequent characterization. Given that BE has been largely superseded by other techniques for the detection of colonic neoplastic lesions (most notably by direct optical colonoscopy, which also permits immediate biopsy results of any detected lesion, and to some extent by CTC), BE will most likely be reserved for other specific indications such as evalua-tion of postoperative patients with either barium or water-soluble  \ncontrast media depending on the clinical circumstance.\nComputed Tomography\nImaging of mural disease in the colon is largely performed via computed tomography (CT), which enables visualization of transmural processes (e.g., Crohn disease). Mucosal abnormali -\nties are generally better observed at DCBE, optical, or virtual CT colonoscopy, but inflammatory colonic mucosa shows a variable degree of enhancement after the administration of intravenous (IV) contrast material, which can be helpful in evaluating the acu-ity and extent of colonic disease. CT also offers the opportunity to evaluate for any associated mesenteric concomitant disease (e.g., pericolonic inflammation or \u201cfat-stranding\u201d) or for regional lymph nodes, as might be seen with Crohn disease or malignancy. In general, the administration of oral contrast material to outline the colonic lumen is warranted, although water-based compounds may help show mucosal hyperemia better after the administra -\ntion of IV contrast medium.\nIt is important for the radiologist to evaluate the whole colon \ncarefully at CT performed for other indications because in busy practices incidental colonic malignancies are occasion -\nally detected. Sometimes small tumors are difficult to detect because of colonic spasm, feces, or a collapsed colon. The ileo -\ncecal valve is a particularly difficult area to evaluate because there is often the spurious appearance of colonic wall thicken -\ning. Inevitably, some patients who have been referred for opti -\ncal colonoscopy to confirm disease seen on CT turn out to have normal findings.\nMagnetic Resonance Imaging\nIn general, MRI has been less useful for evaluating the bowel and colon, although fast single-shot, fat-saturated scanning techniques are now being used to evaluate colonic disease. The technique (sometimes also referred to as MR enterography) is particularly useful for evaluating younger patients with chronic colonic disease (e.g., ulcerative colitis or Crohn disease) to avoid the potentially large lifetime radiation burden they might incur if serial imaging were performed by CT . MRI is also highly effective in evaluat -\ning rectal extension of tumor and is now routinely performed in many centers to help determine if patients require chemotherapy or radiation (chemoradiation) preceding surgical removal.\nPositron Emission Tomography\nPositron emission tomography (PET scanning) has little role in the evaluation of the colon itself, although rectal tumors Chapter  5\nColon and Appendix", "dd941da8-881d-408b-acc3-8f80e5ec237d": "Peritoneum , retroPeritoneum , and mesentery  397\nFigure 10-47. Axial contrast-enhanced CT in an 83-year-old woman \nwith diffuse peritoneal ascites and crowding of small bowel caused by \nmetastatic ovarian cancer.\nFigure 10-48.  Axial contrast-enhanced CT in a 64-year-old woman with a \nsoft tissue metastatic deposit ( arrow) in Morison pouch from ovarian cancer.\nFigure 10-49. Axial contrast-enhanced CT in a 56-year-old man with \nseveral omental nodules (arrow) representing gastric cancer metastases.\nFigure 10-50. Axial contrast-enhanced CT in a 48-year-old woman \nwith diffuse omental \u201ccaking\u201d (arrows) and ascites caused by metastatic gastric cancer.\nB A\nFigure 10-46. Axial ( A) and coronal (B) contrast-enhanced CT in a 61-year-old woman with metastatic ovarian cancer that characteristically \u201cscallops\u201d \nthe liver capsule (arrows). There is widespread malignant ascites.", "e36a5a6f-8dc7-4d81-8b74-5ff2ab128c22": "Colon and appendix  205\nFecal Impaction\nFecal impaction is usually caused by poor dietary habits (poor \nfluid intake, low roughage); inactivity; antispasmodic drugs, including narcotics; and anticholinergic medications. Profound constipation occurs in some institutionalized and psychiatric patients. In children, the causes may be psychological or due to congenital anomalies. Patients usually report constipation, but some may also report encopresis, which is overflow diarrhea around the fecal obstruction.\nThe imaging findings are usually straightforward, with fecal \nimpaction, sometimes severe, noted on plain radiography ( Fig. \n5-139). Fecal impaction also is commonly identified at CT .\nStercoral Ulcer\nSometimes fecal impacted stool causes abrasive damage to the colonic mucosa, ischemia, and ulceration. Stercoral ulceration most commonly occurs in the rectum, but when constipation is severe, it can be identified in the more proximal colon (Fig. 5-140).\nGallstone Ileus (see Chapter 4)\nThe pericholecystic inflammation from chronic cholecystitis can sometimes create fistulae between adjacent viscera, usually the \nFigure 5-138. Axial noncontrast CT in a 71-year-old woman with mild \nsigmoid thickening and pericolonic edema or stranding associated with a \nlinear density (arrow), found to be a chicken bone at surgery.\nA\n B\n C\nFigure 5-139. Plain abdominal radiograph ( A) and axial ( B) and coronal ( C) contrast-enhanced CT in a 45-year-old man with upper sigmoid Crohn \nstricture (arrow) and gross fecal impaction due to chronic obstruction.\nA\n B\nFigure 5-140. Axial ( A) and coronal ( B) contrast-enhanced CT in a 53-year-old woman with left colonic stool ball ( arrows) with colonic wall thickening \ndue to abrasive inflammation.", "a8b09a88-4bd8-4827-9b6f-e4526f1e1b51": "214 Gastrointestinal Imaging: The Requisites\nloss of hepatic reserve and inability to metabolize the vasoac -\ntive hormones sufficiently. Because benign lesions are small, \nthey are almost never identified with CT unless they induce appendicitis (Fig. 5-164), but the primary malignant lesion can occasionally be identified at CT as an enhancing small mass in the expected location (see Chapter 4). They usually metasta-size to the regional mesenteric lymph nodes and produce a local desmoplastic reaction, represented by spiculated mesenteric soft tissue thickening similar to that seen with other metastatic carcinoids (i.e., terminal ileum).\nCrohn Disease (see Chapter 4)\nPrimary appendiceal Crohn disease is rare. It is more common in younger patients and isolated to the appendix in most cases. It usually presents with symptoms and signs of appendicitis and is therefore diagnosed only after appendectomy. Surgical removal is usually uncomplicated with Crohn disease limited to the appen -\ndix, but if Crohn disease is elsewhere, recurrent disease is com -\nmon. Appendiceal Crohn disease is most commonly part of more florid disease (Fig. 5-165); up to 50% of affected appendices are in patients with colonic disease.\nAppendiceal Stump\nAfter appendectomy, a residual appendiceal remnant known as an appendiceal stump may protrude into the cecal base and be identified at BE ( Fig. 5-166). It is most likely secondary to \na granulomatous reaction to retained suture material. It is usu -\nally of no clinical significance except the knowledge of its exis -\ntence. Adenocarcinoma development within the stump has been reported, and because the lesions can appear similar to colonic adenomatous polyps, patients are typically referred for optical colonoscopy.\nFigure 5-161. Axial contrast-enhanced CT in a 77-year-old man with a \ncomplex solid and cystic ( arrow) mass in the region of the appendix proven \nto be a malignant mucocele.\nA\n B\nFigure 5-162. Axial ( A) and coronal (B) contrast-enhanced CT in a 56-year-old man with pseudomyxoma peritonei. There is widespread metastatic \nspread of mucous material throughout the peritoneum, compressing bowel and scalloping the liver (arrows).", "e98b211a-c6b5-4e2d-8aac-acb2a2d61db5": "", "717b437d-ed8d-471f-a815-473cae45077b": "186 Gastrointestinal Imaging: The Requisites\nTable 5-6 Colonic Polyps\nType Malignant Potential Subtype\nAdenoma Yes Spontaneous (common)\nCongenital (uncommon)Mismatch repair cancer \nsyndrome (T urcot)\nHereditary nonpolyposis \ncolorectal cancer (Lynch syndrome)\nFamilial polyposisGardner syndrome\nHamartoma Yes Juvenile polyposisPeutz-Jeghers syndromeCronkhite-Canada syndrome\nHyperplastic No\nInflammatory No Usually secondary to \nulcerative colitis\n \nFigure 5-83. DCBE in a 53-year-old man with a tubular adenoma \n(arrow) with a short stalk (short arrow).\nFigure 5-84. DCBE in a 59-year-old man with a tubulovillous ( arrow) \npolyp in the ascending colon. The stalk is observed originating from the lateral wall (small arrow).\nFigure 5-85. DCBE in a 64-year-old woman with a \u201cMexican hat\u201d sign \nfrom a polyp observed end on ( arrow). Surgical clips from prior surgery are \nvisualized.\nB\nA\nFigure 5-86. A and B, CTC in a 53-year-old woman with a tubular \ncolonic polyp (arrows).", "ec0347b8-5d69-4d57-a24b-26e763326e1c": "Colon and appendix  181\ndense within the pool (negative shadow), and they do not show \nfluid levels when the patient is upright, as do diverticula. Very large diverticula are termed \u201cgiant diverticula.\u201d They are uncom-mon, but characteristic on plain radiography or CT (Fig. 5-69).\nAlthough simple diverticula are of little significance for the \nmajority of patients, some may develop diverticulitis in a mode similar to the development of appendicitis in the appendix. A stool pellet becomes impacted in a diverticulum and sets up a local inflammatory reaction and often a microperforation. The resulting inflammatory changes lead to colonic spasm with luminal narrowing, wall thickening, and pericolonic edema (stranding) (Figs. 5-70 and 5-71 ). These findings can be subtle \nFigure 5-67. DCBE in a 55-year-old man with a colonic polyp and \nbowler hat sign ( long arrow). The apex of the bowler hat points toward the \ncolonic lumen (short arrow).\nFigure 5-68. DCBE in a 70-year-old woman and a bowler hat sign \n(arrow), where its apex points out from the colonic lumen ( short arrow), \nconsistent with a diverticulum.\nA\nBB\nFigure 5-69.  Plain abdominal radiograph ( A) and axial contrast-enhanced \nCT (B ) in a 70-year-old man with a rounded, gas-filled central abdominal \nstructure (arrows) due to a giant diverticulum.\nFigure 5-70. BE in a 66-year-old woman with diverticular disease and \nspasm (arrow) in the lower descending colon due to diverticulitis.", "c6353dc1-d23e-46f9-9e1e-98d759fedca3": "68 Gastrointestinal Imaging: The Requisites\nScleroderma can cause neuromuscular destruction and subse -\nquent atonic stomach, similar to its manifestations elsewhere in \nthe GI tract. Chronic intestinal pseudoobstruction, a very rare entity affecting the neuromuscular plexuses throughout the bowel, can cause an atonic stomach and gastric dilatation. Other neurogenic conditions of central or peripheral neuropathies (syph -\nilis, poliomyelitis, diabetes) can also result in chronic gastric atony.\nPostsurgical Stomach\nA Billroth* I, or B1, is simply the removal of the pylorus and end-to-end anastomosis of the stomach to the duodenum. A Billroth II, or B2, operation involves antrectomy and a side-to-side anas -\ntomosis of the jejunum to the greater curvature of the stomach. The afferent limb consists of the duodenum, which is now a blind ending (with preservation of the normal bile duct anatomy) and a variable length of jejunum. The efferent loop, into which gas -\ntric contents should preferentially empty, is the distal component of the side-to-side anastomosis ( Fig. 2-83). If stomach contents \npreferentially empty into the afferent limb, then afferent loop syndrome can develop (see later in chapter).\nFor the prevention of bile reflux into the stomach, which can \ncause severe gastritis, a modification of the Billroth II technique involves creation of a Roux\n\u2020-en-Y anastomosis. In this instance, \nthe afferent duodenal limb is still a blind ending with a normal insertion of the bile duct, but it is inserted into the efferent jeju -\nnal limb distal to the gastrojejunal anastomosis. This loop may be brought to the gastric remnant anterior to the transverse meso -\ncolon (antecolic) or posteriorly (retrocolic), with the latter having a shorter loop, which is thought to more closely match normal physiological conditions. The Roux-en-Y anastomosis is also used for hepaticojejunostomy and choledochojejunostomy and is increasingly commonly with gastric bypass surgery.\n*Theodor Billroth (1829-1894), German surgeon.\n\u2020C\u00e9sar Roux (1857-1934), Swiss surgeon.COMPLICATIONS OF GASTRIC SURGICAL \nPROCEDURES\nThere are numerous complications to gastric surgery, and they can be divided into early and late ( T able 2-9). Some complica-\ntions (infection and hemorrhage) are common to most surgical procedures.\nFigure 2-82. Coronal conrast-enhanced CT in a 71-year-old woman with \ngastric atonic dilatation.\nFigure 2-83. UGI series in a 56-year-old woman who underwent a nor -\nmal Roux-en-Y gastric bypass opereation. There is a choledochojejunos -\ntomy with the afferent limb (large arrow) and normal reflux of contrast \ninto the bile ducts. The efferent limb (small arrow) is of normal caliber.\ntable 2-9 Complications of Gastric Surgical Procedures\nEarly\nLeakage Usually at anastomotic site; fistula may \nresult\nInfection Common to many surgical procedures\nHemorrhage Common to many surgical procedures\nAnastomotic stricture Usually edema\nEsophageal dysmotility Surgical trauma to esophagus\nIleus Common in many abdominal surgical \nprocedures.\nLateGastroparesisAnastomotic stricture Fibrosis\nT umor\nMarginal ulcer formation Gastric acid effect on jejunal mucosa\nGastric cancer\nObstruction Gastric outlet obstruction; adhesions; \ninternal hernia intussusception\nMalabsorption Dumping syndrome\nBezoarsAfferent loop syndrome", "9b00ef78-1c9b-4872-89b8-ac60da769733": "40 Gastrointestinal Imaging: The Requisites\nmeasurements that exceed 15 mm longitudinally and 3 mm in \ndiameter of a single wall on transverse images ( Fig. 2-3). T reat-\nment is by a pyloromyotomy and is usually curative.\nThe adult version (hypertrophic pyloric stenosis) is poorly \nunderstood and is frequently associated with peptic ulcer dis -\nease, which suggests that it is acquired rather than congenital. The findings are similar to those in the neonate with an elongated pyloric channel (up to three times the normal length) and a cir -\ncumferential mass-like effect within the pylorus, seen by either EGD or contrast studies. Adult pyloric stenosis should be dis -\ntinguished from prolapsed gastric antral folds that are transient at fluoroscopic evaluation and do not obstruct the gastric outlet.\nGastric Diverticulum\nGastric diverticula can be congenital or acquired, and fundal or antral in location. The fundal diverticulum is usually congenital and the most common of the gastric diverticula. It is positioned posteriorly at the cephalad margin of the lesser curve, close to the inferomedial aspect of the GE junction. It is usually asymp -\ntomatic and of no clinical significance, unless it is large whereby stasis and delayed gastric emptying have been recognized. Fun-\ndal diverticula can also ulcerate and bleed, and gastric carcinoma \nhas been recognized in the diverticulum.\nGastric diverticula are mostly identified on CT because barium \nexaminations are performed less often. They are readily identi-fiable, although they are sometimes mistaken for the left adre -\nnal gland on CT, particularly if there is no oral contrast medium within them ( Fig. 2-4). Close observation should confirm a con -\nnection to the stomach lumen, and a gas/fluid level should clinch the diagnosis ( Fig. 2-4). When a UGI series is performed, gas and \ncontrast should outline the diverticulum outside the confines of the normal gastric wall (Fig. 2-5).\nAntral diverticula are acquired and are usually small, projecting \noutward from the antral greater curvature, giving a collar-button appearance; they are sometimes mistaken for a benign gastric ulcer. They may be associated with previous gastric ulcer disease but generally have none of the other features that are usually associated with ulcer disease, including collars and fold thicken -\ning. Antral diverticula are also associated with pancreatitis, gastric outlet obstruction, and malignancy.\nA\n B\nFigure 2-2. Abdominal plain radiograph ( A) and UGI series ( B) in a 4-week-old boy demonstrating gross gastric dilatation ( arrows) and a bird-beak \nappearance to the gastric outlet.\nAB C\nFigure 2-3. Ultrasound views of the stomach and pylorus in a 5-week-old boy with gastric distention as evidenced by hyperechoic gas in a fluid-filled \nstomach (A; arrow) and pyloric lengthening (B; arrow) and thickening (C; arrow).", "cd8f7c68-8aa7-41a0-b873-a5716c42d75c": "Small Bowel 131\nAB\nFigure 4-87. Axial ( A) and coronal (B ) contrast-enhanced CT in a 52-year-old man with a circumferential terminal ileal mass ( arrows) due to a \nGIST . The appearances can be similar to some forms of lymphoma.\nB\n A\nCC\n D\nFigure 4-88. Axial ( A, C, and D) and coronal (B) contrast-enhanced CT in a 55-year-old man with a 1.8-cm terminal ileal mass (large arrows) due to \ncarcinoid tumor. There are a spiculated mesenteric metastasis (arrowhead ) and hypervascular liver metastases (small arrows) in a fatty liver.", "705e6fab-a9b2-4660-8bd6-a0e4216aafb1": "168 Gastrointestinal Imaging: The Requisites\ndistribution of the colonic changes ( Fig. 5-37). Severely affected \npatients show colonic pneumatosis as the gas permeates the \ndamaged mucosa, which can then enter the mesenteric venous system and be recognized as mesenteric venous gas (particularly at CT) and ultimately intrahepatic portal venous gas. Occasion-ally, ischemia occurs proximal to an obstructing colonic stricture, such as colonic adenocarcinoma. The obstruction causes marked distention of the proximal colon, compromising its vascular sup -\nply or directly invading mesenteric vasculature (Fig. 5-38).\nReversible Ischemic Colitis\nReversible ischemic colitis is sometimes referred to as jogger\u2019s or runner\u2019s colitis because it is observed in otherwise healthy patients in whom colitis develops (with pain and diarrhea, which is rarely bloody) either during or soon after long-distance run -\nning and resolves shortly after termination of the exercise. The mechanism of injury is poorly understood but is a nonocclusive ischemia thought to be caused by low mesenteric flow states from arterial shunting to extremity musculature away from the mesen -\ntery combined with marked dehydration. Both the superior and \nA\n B\nFigure 5-30.  Axial ( A) and coronal ( B) noncontrast CT in a 44-year-old man with transverse colonic thickening ( arrows) due to graft-versus-host disease.\nFigure 5-31.  Axial contrast-enhanced CT in a 58-year-old man with recent \nright colectomy for colon adenocarcinoma and now with a chemotherapy-\ninduced pancolitis (arrows).\nFigure 5-32. Axial contrast-enhanced CT in a 56-year-old woman with \na pancolitis (arrows) secondary to quinones therapy.\nB\nA\nFigure 5-33.  Plain abdominal radiograph ( A) and axial contrast-enhanced \nCT (B ) in a 17-year-old male adolescent undergoing chemotherapy with \ncecal mural thickening (arrows) due to typhlitis.", "8857a022-80a3-4540-857d-65283794e14c": "Spleen 301\nThorotrast\nThe presence of Thorotrast is now rarely identified because its \nuse as an intravascular angiographic contrast agent was termi-nated in the 1950s following the discovery that its alpha-emitting particles could lead to malignancies (mainly splenic angiosar -\ncoma). It was readily sequestered by the mononuclear phagocytic system, mainly the liver and spleen, resulting in hyperdense organs (particularly the spleen). Thorotrast in the spleen sets up a chronic reactive process, ultimately leading to fibrosis and splenic contraction (Fig. 7-28).SPLENIC MASS LESIONS\nSplenic mass lesions can be classified as either single or multiple, benign (T able 7-1) or malignant (T able 7-2) lesions. Benign and malignant primary splenic lesions tend to be single, whereas met -\nastatic and infectious lesions are multiple.\nBenign Splenic Lesions\nGaucher Disease\nGaucher disease types 1 and 3 can survive into adulthood and \nusually lead to hepatosplenomegaly caused by accumulation of \nFigure 7-26. Axial contrast-enhanced CT in a 39-year-old woman with \nsickle cell disease and a small spleen ( arrow) resulting from repeated \nthrombotic episodes.\nFigure 7-27. Axial noncontrast CT in a 44-year-old woman with sickle \ncell disease and a small calcified \u201cshrunken\u201d spleen ( arrow). The stomach \nis filled with oral contrast material (arrowheads  ).\nFigure 7-28. Axial contrast-enhanced CT in a 79-year-old man with \nprevious Thorotrast contrast agent administration and a hyperdense \nspleen (arrow), representing sequestered Thorotrast.\nTable 7-1 Benign Splenic Lesions\nType Etiology Single Multiple\nCyst PseudocystEpithelioid++++++\nInfection Bacterial abscessFungalMycobacterialParasiticYeast+++++++++++++++++\nInfarction InfarctionHematoma++++\nNeoplasm HemangiomaHamartomaLittoral cell angiomaLymphangiomaSANTPEComaInflammatory pseudotumorEpithelioid granulomaChondromaMyxomaOsteoma+++++++++++++++++++\u2212\u2212\u2212\u2212\u2212\u2212\u2212\nInfiltrative Granuloma (sarcoid)Gaucher disease++++++\n \nPEComa, Perivascular epitheliod cell tumor; SANT, sclerosing angiomatoid nodular \ntransformation.", "7fe01f03-fd4f-44ac-9121-b984f78702de": "Liver 223\nmotion. Tissues with high cellularity (e.g., tumors) demonstrate \nlittle Brownian motion and are termed \u201crestricted,\u201d whereas predominantly water-based tissues (e.g., simple cysts) are termed \u201cnonrestricted.\u201d The strength of the diffusion weighting can be altered by increasing diffusion-weighted b values, which alters the signal output from these tissues. Because water molecules generally demonstrate restricted diffusion in solid lesions, they travel less distance from the time of the original pulse sequence to the rephrasing gradient, which leads to higher signal at higher diffusion-weighted b values (because the water molecules can easily be rephased by the diffusion-weighted gradient) ( Fig. \n6-11). In general, free-moving water (as in cystic lesions) dem-onstrates reduced signal on higher diffusion-weighted b values (the rephasing pulse) because the freely moving water molecules have traveled farther and are harder to rephase (Fig. 6-12).\nThe degree of proton motion in capillaries and tissues can be \nmeasured and quantified as the apparent diffusion coefficient (ADC). A slope can be plotted that represents the ADC, which, in turn, represents each voxel\u2019s diffusion value. T ypically, the ADC is displayed pictorially as a parametric map on an axial image on which a region of interest can be placed to measure a mean ADC within the area selected. An ADC map can also reflect the signal intensities of a tissue obtained at the different b values across a range of voxels. Malignant lesions tend to demon -\nstrate little or no signal on ADC maps ( Fig. 6-11), whereas benign \nlesions (less water restriction) show higher signal ( Fig. 6-12).  \nAB\nFigure 6-10. A, Axial hepatobiliary agent fat-saturated contrast-enhanced MRI and subtraction image in a 74-year-old man with cirrhosis and question-\nable area of enhancement in segment V (arrow). B, Subtraction images confirm enhancement in a new HCC (arrow).\nB\n C\n A\nFigure 6-11. Axial T2-weighted ( A), B500 (B), and ADC (C) DWI in a 73-year-old man with multiple liver metastases (arrows). The lesions are bright \non T2-weighted and B500 imaging but dark on ADC maps.\nA BC\nFigure 6-12. Axial arterial-phase hepatobiliary agent T1-weighted ( A) MRI and B500 ( B) and ADC ( C) maps in a 57-year-old woman with focal \nnodular hyperplasia. There is mild arterial enhancement (arrows) and slight increased signal on DWI and ADC maps.", "5cac1334-4448-4e45-b988-7bee745ddeba": "288 Gastrointestinal Imaging: The Requisites\nAAB\nFigure 6-180. Axial ( A) and coronal ( B) contrast-enhanced CT in a 70-year-old man with a linear hypodense appearance of the liver ( arrows) secondary \nto previous mediastinal radiation.\nB A\nFigure 6-181.  A and B, Axial delayed post\u2013hepatobiliary agent contrast-enhanced MRI of the liver in a 53-year-old woman with a hepatic defect following \nproton beam therapy (arrows).\nhemorrhage and infarction from the immediate procedure, the \nmost common complication is stenosis from intimal fibroplasia in the hepatic vein. The direction of blood flow is best evalu -\nated by Doppler US. Normal venous flow is hepatofugal, but in obstruction or stenosis the flow is slow (peak velocity <35 cm/s), absent, or hepatopetal or there may be increased flow at the point of anastomosis (>50 cm/s).\nHepatic Radiation\nGiven the size of the liver in the upper abdomen, it is not surpris -\ning that this organ is often in the radiation field in the treatment of upper abdominal malignancies, most often in combination with chemotherapy (chemoradiation) before curative surgical resection is attempted. If the liver is within the radiation field, it may show acute radiation changes as a discrete area of hypoatten -\nuation at CT, typically with linear margins corresponding to the margins of the radiation field ( Fig. 6-180). More recently, proton \nbeam therapy has been used for the primary treatment of some hepatic malignancies, which leaves characteristic wedge-shaped defects within the irradiated field (Fig. 6-181).SuggeSted  ReadingS\nAbikhzer G  et al: Altered hepatic metabolic activity in patients with hepatic \nsteatosis on FDG PET/CT . AJR 196:176-180, 2011.\nAcunas B  et al: Hydatid cyst of the liver: identification of detached cyst lining on \nCT scans obtained after cyst puncture. AJR 156:751-752, 1991.\nAgnello F  et al: High-b-value diffusion-weighted MR imaging of benign \nhepatocellular lesions: quantitative and qualitative analysis. Radiology \n262(2):511-519, 2012.\nAhrar K  et al: Percutaneous radiofrequency ablation of renal tumors: technique, \ncomplications, and outcomes. J Vasc Interv Radiol 16(5):679-688, 2005.\nAsayama Y  et al: Delayed-phase dynamic CT enhancement as a prognostic factor \nfor mass-forming intrahepatic cholangiocarcinoma. Radiology 238(1):150-155, 2006.\nBahl M\n et al: Liver steatosis: investigation of opposed-phase T1-weighted liver \nMR signal intensity loss and visceral fat measurement as biomarkers. Radiology 249(1):160-166, 2008.\nBargellini I\n et al: Hepatocellular carcinoma: CT for tumor response after \ntransarterial chemoembolization in patients exceeding Milan criteria\u2014selection parameter for liver transplantation. Radiology 255(1):289-300, 2010.\nBasaran C\n et al: Fat-containing lesions of the liver: cross-sectional imaging findings \nwith emphasis on MRI. AJR 184(4):1103-1110, 2005.\nBeaty SD  et al: T eaching file: incidental hepatic mass. AJR 190:S62-S64, 2008 .\nBerrocal T  et al: Pediatric liver transplantation: a pictorial essay of early and late \ncomplications. Radiographics 26(4):1187-1209, 2006.", "3ac029c7-2fa3-42ca-b0ff-ede386f4808d": "Liver 283\nPortal Venous Gas\nThe finding of portal venous gas on plain radiograph, US, or CT \nrarely represents an innocent condition (unless the patient has had recent gastrointestinal surgery or endoscopic investigation). Usu-ally the finding is a secondary sign of more serious disease else-where and denotes violation of the small and large bowel mucosal barrier by instrumentation, ischemia, infection, or perforation. Alternatively, gas may originate from gas-forming organisms in infected thrombophlebitis in the mesenteric tributaries, usually itself a manifestation of bacterial seeding from the large bowel.\nIn general, the diagnosis of portal venous gas should be straight -\nforward. It should be distinguished from intrahepatic biliary gas, which is almost always benign and more central in location, since it is present mainly in the larger left and right main biliary radicals (Fig. 6-166). Gas, being nondependent, rises to the most supe-rior location, and in the supine position the left biliary radicals are generally more anterior than those in the right, so biliary gas is more commonly identified in the left lobe. Furthermore, bile flows toward the hepatic hilum, keeping the gas relatively central (i.e., downstream to flowing bile). Conversely, portal venous gas follows the centrifugal flow of venous blood away to the periph -\nery of the liver. Gas is located in the most nondependent location and is therefore most commonly present in the peripheral right and left lobes (Fig. 6-167).\nHepatic Infarction\nBecause of the dual hepatic blood supply, hepatic parenchymal necrosis is uncommon and usually requires disruption of both portal and arterial blood supply. Causes are usually iatrogenic (surgery, interventional imaging procedures) or traumatic. Patients undergoing liver transplant are particularly suscep -\ntible. Other causes include hypercoagulable states, vasculitis, or infections. On noncontrast CT, there is a hypoattenuating, usually wedge-shaped defect, although more central, rounded, low-density regions are also recognized. As necrosis progresses, gas formation can be seen within the affected regions. On contrast-enhanced CT, the infarcted regions are generally geo -\ngraphical in appearance and either fail to enhance or demon -\nstrate patchy enhancement because of formation of collaterals (Fig. 6-168).\nHEPATIC TRAUMA\nIn addition to iatrogenic causes (particularly interventional imag -\ning procedures), hepatic trauma is most commonly a result of blunt trauma from motor vehicle injury and secondarily from penetrat -\ning injuries (knife wound or gunshot). CT is the preferred imaging method, particularly because other organs can be assessed simul -\ntaneously. A laceration without significant hemorrhage is identi -\nfied as a linear, hypodense, hepatic lesion ( Fig. 6-169). Areas of \nacute hemorrhage are identified as hyperdense regions on noncon -\ntrast CT and may even be hyperdense on contrast-enhanced CT if clotted, often in a subcapsular location ( Fig. 6-170). There may \nbe hemoperitoneum, the appearance of which varies from simple fluid to frank blood depending on the stage of bleeding. The degree of hemorrhage within and outside of the liver is generally more profound with hepatic laceration, which itself can be seen as a fracture within the hepatic parenchyma ( Fig. 6-171). Areas \nof hepatic infarction are recognized as wedge-shaped hypodense defects. Pseudoaneurysm can be either an acute or a chronic complication.\nA\nB\nFigure 6-167.  Sagittal US ( A) and axial noncontrast CT ( B) in a \n67-year-old patient with portal venous gas. At US, there is echogenic \nnondependent shadowing, and the gas is in the most nondependent lobe at CT (arrows).\nFigure 6-168. Axial contrast-enhanced CT in a 31-year-old man with \nright hepatic gas ( small arrow) due to infarction secondary from emboliza -\ntion of a bleeding hepatic adenoma. There is also hepatic hemorrhage and hemorrhagic ascites (arrows).", "9c8e2f83-f701-4d9a-9e69-cb7bad84cb1e": "84 Gastrointestinal Imaging: The Requisites\nchronic findings can be seen at the same time ( Fig. 3-27). Occasion-\nally the ulcers can be very large, known as giant duodenal ulcers,  and \nmay mimic the configuration of the bulb itself, potentially lead-\ning the radiologist to think that the ulcer is a normal bulb. There should, however, be no duodenal folds within the ulcer itself, and there is persistent pooling of contrast rather than the contrast pass-ing on down the duodenum from the normal peristaltic waves.\nThe most serious complication is perforation caused by trans -\nmural penetration of the ulcer, which mainly occurs into the peri -\ntoneum because most (95%) bulbar ulcers are on the anterior wall. Less commonly, retroperitoneal perforation occurs from the rarer posterior wall ulcers. Subtle perforation may require CT analysis with lung \u201cwindow\u201d contrast settings; otherwise, subtle extralu-minal gas may be missed. Perforation can also cause severe hem -\norrhage with profuse hematemesis or melena. The ulcer itself is often not identified at CT, but the diagnosis is strongly suggested by duodenal mucosal thickening and periduodenal inflammation (stranding), fluid, and gas (Fig. 3-28). Sometimes there is profuse gas that can be both intraperitoneal and extraperitoneal (Fig. 3-29).\nThickened Duodenal Folds\nDuodenal mucosal thickening is generally not confined to the bulb unless it is due to peptic ulcer disease. There are several \nFigure 3-27. UGI series in a 66-year-old woman with proximal duode -\nnal narrowing and distortion ( large arrow) caused by healing from chronic \nduodenal ulcer disease. A tiny acute ulcer is also present (small arrow).\nA\n B\nFigure 3-28.  Axial CT in a 60-year-old woman with duodenal perforation as evidenced by mucosal thickening ( A; arrow) and periduodenal fluid \n(A; small arrow) and pockets of extraluminal gas (B; curved arrow).\nB\n A\nFigure 3-29. Axial ( A) and coronal (B) contrast-enhanced CT in a 62-year-old woman with a perforated duodenal ulcer and diffuse retroperitoneal and \nperitoneal gas (arrows).", "b765ef88-8c28-448f-9a2e-d0067862bdb1": "Colon and appendix  159\nin a counterclockwise direction, but many failures of full rotation \noccur, resulting in various degrees of colonic malrotation. The cecum and ascending colon may fail to fixate to their normal posi -\ntion in the right side of the abdomen, becoming quite mobile and at risk for volvulus or torsion. Most malrotations, even when complete with the colon residing in the left side of the abdomen, are asymptomatic.\nInflammatory Colonic Disease\nColitis\nColonic and rectal inflammatory disease has multiple causes \n(T able 5-1), of which some are self-limiting, others produce life-long morbidity, and some are potentially fatal.\nUlcerative Colitis\nUlcerative colitis (UC), like Crohn disease, is an inflammatory bowel disease (IBD), but unlike Crohn disease, its intestinal manifestations are limited to the colonic mucosa. It can, how-ever, present with widespread additional clinical manifestations in the mouth (aphthous ulcers), eyes (iritis, uveitis, and episcle -\nritis), musculoskeletal system (arthritis, ankylosing spondylitis, and sacroileitis), skin (erythema nodosum and pyoderma gan-grenosum), and biliary tree (primary sclerosing cholangitis). It is a disease usually found in young adults (although symptoms may persist for many years), and symptoms may include pain, diarrhea, and rectal bleeding. UC in its milder forms can be confused with irritable bowel syndrome. UC is familial, being more common in first-degree relatives; is thought to be autoim -\nmune in origin; and is treated as such with immunosuppressive therapy.The colonic mucosal disease always starts in the rectum and \nextends proximally to a variable degree, sometimes affecting the whole colon (pancolitis) and sometimes even a short segment of ileum, so-called backwash ileitis. The extent of colonic involve -\nment typically directs the symptoms and seriousness of the dis -\nease. Some patients have only one short episode confined to the rectum, and others have recurring disease, sometimes with a life-threatening toxic megacolon. This usually necessitates aggres -\nsive medical or surgical therapy, often requiring an emergency total colectomy as the diffusely involved colonic mucosa becomes so thickened, friable, and distended that perforation is imminent.\nThe imaging features depend on the stage of the disease ( T able \n5-2), and many of these features are shared by Crohn disease  \n(T able 5-3). They can sometimes be identified by plain abdomi -\nnal radiography as thickened haustra, particularly when caused by a pancolitis (Fig. 5-5). Severe disease can almost certainly be recognized on plain radiography as can toxic megacolon, with marked colonic distention resulting from ileus (Fig. 5-6) and wall and mucosal thickening (Fig. 5-7). The wall thickening is some-times referred to as \u201cthumb-printing\u201d because of the polypoid soft tissue nature of the mucosal edema and thickening. BE dem -\nonstrates typical features but has largely been replaced by optical colonoscopy for diagnosis. When BE is performed, the features depend on the severity and acuity of disease. In acute disease a variable length of colon (starting in the rectum) shows a granular mucosal pattern representing edema and ulcer formation, some -\ntimes of the whole colon (Fig. 5-8), which may also affect the last few centimeters of the terminal ileum (\u201cbackwash ileitis\u201d) (Fig. 5-9). \u201cCollar-button ulcer\u201d formation has been described, which represents acute ulceration of the colon with submucosal extension (Fig. 5-10), with further ulceration prevented by the Table 5-1 Colitis\nClassification Type Etiology Typical Features\nInflammatory bowel disease Ulcerative colitis Variable colitis extending proximally from rectum\nCrohn disease Variable\u2014skip lesions or pancolitis\nIschemic Emboli or low-flow states Watershed areas\u2014splenic flexure\nRadiation Dose dependent Usually pelvic\nInfectious Viral Norwalk Diffuse colitis\nRotavirus Diffuse colitis\nE. coli Often severe, predominantly transverse colon\nCMV Pancolitis in immunosuppressed patients\nHerpes Rectosigmoid region\nBacterial Shigella sp. Ileocecal region \u00b1 lymphadenopathy\nSalmonella sp.", "c39179bb-cc8f-4bce-938e-daec550731ba": "Pancreas  353\nthickened and spiculated duodenal and gastric folds representing \nsecondary edematous transmural enteric changes (Fig. 9-20). On US the pancreas can appear enlarged with a heterogeneous echo texture mixed with prominent hypoechoic regions ( Fig. 9-21), \nalthough contrast-enhanced CT is usually performed to evalu -\nate pancreatitis. Not all patients with clinical and biochemical pancreatitis have abnormal CT findings, although the majority of patients show abnormalities to a variable degree. The pancreas is typically enlarged, sometimes focally, with effacement of the normal indented pancreatic border combined with peripancreatic edematous changes (Fig. 9-22). The latter can be severe with widespread edema throughout the retroperitoneal space, produc -\ning single or multiple acute fluid collections ( Fig. 9-23). Some-\ntimes pancreatic adenocarcinoma has a similar appearance, and a useful CT sign is preservation of perivascular fat planes (unlike pancreatic adenocarcinoma, in which they are often obliterated), which strongly favors a benign diagnosis ( Fig. 9-24). The reverse \nis not always true in that the peripancreatic inflammation in severe pancreatitis can sometimes obliterate this fat plane. Unless contraindicated, contrast-enhanced CT is administered to evalu -\nate the vascular viability of the pancreatic parenchyma. Pancreatic necrosis is recognized by single or multiple focal hypodensities (or diffuse depending on the severity) surrounded by normally enhancing pancreas (Fig. 9-25). These hypodensities represent the hypovascularized or nonvascularized pancreatic parenchyma, which has been destroyed by the acute inflammatory process. Depending on the degree of pancreatic necrosis, it may be termed necrotizing pancreatitis if more than 50% of the gland is involved.\nDocumentation of pancreatic necrosis is critical because it \nplaces the patient in a much higher risk category than those with simple fluid collections. Necrotic areas can also become infected, which has an even higher mortality rate. Surgical debridement is the treatment of choice. Necrosis is usually associated with pan -\ncreatic and peripancreatic fluid collections ( Figs. 9-23 through \n9-25). There may be evidence of acute fluid collections in the retroperitoneum, which may also become infected and form an abscess. If contrast material is not administered, the pancreas is typically diffusely hypodense. MRI also demonstrates an enlarged gland with areas of necrosis that fail to enhance after IV administration of contrast medium. The terminology used in pancreatitis is defined in T able 9-1.\nThe severity of acute pancreatitis can be staged by contrast-\nenhanced CT ( T able 9-2) and corresponds reasonably closely to \nthe clinical course. When the percentage of gland necrosis is also included (0 to 30%, 30% to 50%, >50%), a CT severity index can be calculated, which corresponds even more closely to the clini -\ncal course (T able 9-3). However, the CT severity index does not always match the clinical course, and therefore its use in clinical practice is variable. The most important CT finding is pancreatic necrosis, which markedly increases morbidity and mortality rates associated with disease. Acute hemorrhagic pancreatitis is a par -\nticularly severe form of pancreatitis with, as its name suggests, hemorrhage within the pancreas (which might not be recognized \nFigure 9-19. CT scout view in a 43-year-old man with distended trans -\nverse colon (small arrows) and a colon cut-off sign (arrow).\nFigure 9-20. Upper GI series in a 66-year-old man with a \u201cpuckered\u201d \nappearance to the greater curvature of the stomach ( arrows) caused by \ninflammation from pancreatitis.\nFigure 9-21. T ransverse US in a 17-year-old male with acute pancreatitis, \ndemonstrating an edematous, heterogeneously enlarged pancreas ( arrows) \nwith anterior peripancreatic fluid (small arrow).\nFigure 9-22. Axial contrast-enhanced CT in a 37-year-old man with \nhypertriglyceridemia-induced pancreatitis. The liver is markedly fatty, \nand pancreatic enlargement without necrosis ( small arrow) and diffuse \nperipancreatic inflammation (large arrow) are present.", "f839f199-aa88-4b63-a16f-51b46037db57": "Pancreas  361\nso that it is sometimes difficult to differentiate changes due \nto tumor from those due to pancreatitis. The local extension into the peripancreatic fat can abut and then surround key vascular structures, particularly the superior mesenteric artery (Fig. 9-44) or vein and sometimes both (Fig. 9-45). The supe-\nrior mesenteric vein (SMV), however, is often compressed by tumor mass effect as it courses through the pancreas rather than becoming invaded and encased (Fig. 9-46). Multiplanar images can offer better depiction of the relationship of the tumor to the adjacent vessels ( Fig. 9-47) and are often used to determine \nsurgical resectability of the mass. Local invasion of splenic, celiac, and mesenteric vessels may preclude operability but will depend on the local surgical expertise. T umors with more than 50% encasement of the SMV or portal vein ( Figs. 9-46 through \n9-48) are generally unresectable, although some surgeons are more aggressive and have shown some success with up to 75% circumferential encasement. Splenic vein invasion is not a con -\ntraindication to surgery. Celiac axis (celiac or hepatic artery or both) and superior mesenteric artery encasement greater than 25% is generally unresectable (Figs. 9-45 through 9-47). Splenic and gastroduodenal artery encasement is not a contraindication to surgery. T umors with distant metastases, which are common in pancreatic cancer because of its late presentation, are unre-sectable. However, it is becoming increasingly apparent that some newer neoadjuvant therapies (e.g., FOLFIRINOX with or without radiation therapy) cause a dramatic reduction in tumor size and residual perivascular soft tissue changes now represent fibrosis rather than active tumor. Radiologists should therefore hesitate before assuming inoperability in these patients ( Fig. \n9-49). Contrast-enhanced CT has a high predictive value (close to 100%) for unresectability but only 75% to 80% for tumor resectability. Hence, when the CT features suggest unresect -\nability, the radiologist is usually correct. The converse is not true, as a number of tumors deemed resectable by CT turn out not to be. Pancreatic positron emission tomography (PET)/CT does not usually add value to the diagnosis of the primary tumor because of variable fluorodeoxyglucose uptake ( Fig. 9-50), but \nit can sometimes be useful to evaluate extrapancreatic disease, particularly regional adenopathy.\nFigure 9-43. Axial pancreatic-phase contrast-enhanced CT in a 78-year-\nold man with an adenocarcinoma of the midpancreatic body (large arrow) \nwith upstream pancreatic duct dilatation ( small arrow) and peripancreatic \nextension of tumor. The tumor has extended to encase the celiac axis (thin arrows), rendering the patient inoperable.\nFigure 9-44. Axial pancreatic-phase contrast-enhanced CT in a 73-year-\nold woman with soft tissue encasement by pancreatic adenocarcinoma of the superior mesenteric artery ( arrows), but the superior mesenteric vein is \nunaffected (small arrow). This patient was inoperable.\nFigure 9-45. Axial contrast-enhanced CT in a 71-year-old with pancre -\natic adenocarcinoma and almost complete encasement of the superior mesenteric artery ( large arrow) and approximately 50% of the superior \nmesenteric vein (small arrow), which has lost its normal ovoid shape. This \npatient proved inoperable.\nFigure 9-46. Axial pancreatic-phase contrast-enhanced images in a \n66-year-old woman with a 1.5-cm subtle hypodense mass in the junction of the head and uncinate that abuts the superior mesenteric vein between the 6 and 11 o\u2019clock positions with effacement of the normal fat plane (arrows) but preservation of vessel caliber. This patient was operable.", "d8f9a218-3bae-4da1-955b-c5dc933f7a95": "10 Gastrointestinal Imaging: The Requisites\nchest along with the gastric cardia (Fig. 1-22). Therefore, the GE \njunction lies in the chest with the herniated gastric fundus lying alongside and to the left of the lower esophagus.\nAlthough hernias are best appreciated by UGI series, they are \nfrequently visualized incidentally by CT, which will demonstrate a dilated lower esophagus (actually represents the gastric cardia in the chest) in the lower chest with a variable proportion of mesenteric fat surrounding the herniated stomach ( Fig. 1-23). Consequently, \nthere is a slight widening of the diaphragmatic hiatus (>15 mm).  \nA paraesophageal hernia can also be appreciated with the herniated cardia lying alongside the lower esophagus (Fig. 1-24).\nEXTRAMURAL ESOPHAGEAL IMPRESSIONS\nExtramural esophageal impressions cause smooth and obtuse impressions on the esophagus similar to the extramural masses throughout the GI tract. Most causes are benign ( T able 1-1). \nExternal malignant masses may ultimately distort the mucosal contour but only after transmural metastatic invasion.\nPostcricoid Impression\nAlso known as postcricoid defect of pharyngeal venous plexus, postcricoid impression is common and not pathological, and it is caused by redundant hypopharyngeal mucosa overlying the cen-tral pharyngeal venous plexus positioned approximately at the \nFigure 1-22. UGI series in an 86-year-old woman with a sliding hernia \nwith the GE junction in the chest ( large arrow) and paraesophageal hiatal \nhernia (small arrow).\nB\n A\nFigure 1-23. Axial ( A) and coronal (B) contrast-enhanced CT in a 77-year-old woman with a sliding hiatal hernia (arrows).\nA\n B\n C\nFigure 1-24. UGI swallow ( A) and axial (B) and coronal (C) noncontrast CT in a 60-year-old woman with a combined sliding and paraesophageal her -\nnia (arrows). At CT the GE junction is in the chest.", "fc8e01f0-33da-4d4d-8e02-8bdf727f86fc": "246 Gastrointestinal Imaging: The Requisites\nB\n A\n C\nFigure 6-68. Sagittal US ( A) and PVP ( B) and delayed ( C) contrast-enhanced CT in a 46-year-old woman with a cavernous hemangioma. It is hyper -\nechoic at US ( arrow) with through-transmission ( arrowheads). At PVP CT, there is peripheral nodular enhancement ( arrows) and the lesion is almost \nisodense to the liver in the delayed phase because of contrast fill-in (curved arrow).\nFigure 6-69. Axial arterial-phase contrast-enhanced CT in a 33-year-old \nman with a 1.5-cm hypervascular lesion ( arrow) in segment VII as a result \nof a \u201cflash-filling\u201d capillary hemangioma.\nFigure 6-70. Arterial-phase contrast-enhanced CT in a 41-year-old \nwoman with a 1.5-cm hypervascular segment VI lesion ( arrow) resulting \nfrom focal nodular hyperplasia.\nFigure 6-71. Axial arterial-phase contrast-enhanced MRI in a 36-year-\nold woman with a 1.5-cm segment VII hypervascular lesion ( arrow) result-\ning from hepatic adenoma.\nFigure 6-72. Axial arterial-phase contrast-enhanced CT in a 57-year-old \nman with a 1-cm segment VIII hypervascular mass ( arrow) that represents \nhepatocellular carcinoma. Associated esophageal varices are present \n(small arrow).", "3e124fa9-74f4-45fa-ae2b-615949b7aefe": "150 Gastrointestinal Imaging: The Requisites\ncholangiopancreatography (ERCP). Jejunal and ileal diverticula \noccur in about 2% of the elderly population and typically along the mesenteric border from a site of weakness at the point where mesenteric vessels penetrate the bowel wall. They are often multiple and large, particularly in the jejunum (Figure 4-135). Their main significance is that bacterial overgrowth within the diverticula can occur, feeding off the stagnant food that accumu-lates within them. Bacterial overgrowth can cause a malabsorp -\ntion syndrome with diarrhea (especially steatorrhea), pain, and bloating. The diverticula are relatively easy to identify at SBFT or enteroclysis but are harder to identify at CT, being confused with adjacent loops of small bowel. However, close scrutiny of the small bowel should identify them as partially contrast- or air-filled, circular or ovoid strictures without valvulae conniven -\ntes (Fig. 4-136). Occasionally, enteroliths can form within them and, similar to the appendix, can become inflamed and present acutely, sometimes with perforation.\nPseudodiverticula\nInflammatory conditions such as Crohn disease and scleroderma can distort the bowel to such an extent that the small bowel has the appearance of a diverticulum, hence the term pseudodivertic-\nula or sacculations (Figs 4-28 and 4-137). Other false diverticula \nFigure 4-134. Axial contrast-enhanced CT in a 55-year-old man with \nsmall bowel obstruction due to a phytobezoar (arrow).\nFigure 4-135. SBFT in a 68-year-old man with several jejunal diver -\nticula (arrow).\nAB\nFigure 4-136. Axial ( A) and coronal (B) contrast-enhanced CT in a 75-year-old man with multiple jejunal diverticula (arrows) and diverticulitis as \nevidenced by mesenteric inflammation (stranding).\nFigure 4-137. SBFT in a 63-year-old woman with Crohn disease and \nterminal ileal pseudosacculation (arrows).", "40e4bd53-952e-4562-910d-aced2771882c": "Colon and appendix  165\nGraft-Versus-Host Disease\nGraft-versus-host disease usually develops after allogeneic bone \nmarrow transplantation (and rarely thymic transplantation) and is caused by immunological destruction of host tissue, characterized on histological examination by apoptosis, a form of cell death. This disease particularly affects the GI tract but also the liver and dermis. In the colon there are nonspecific features of colitis with bowel wall and mucosal thickening, often involving the whole colon as a pancolitis (Fig. 5-30).\nDrug-Induced Colitis\nDrugs can cause colitis via various mechanisms, including direct mucosal necrosis, ischemia, lymphocytic colitis, and a particular form, pseudomembranous colitis (see page 174). Direct colitis may be secondary to some sorbitol enema formulations and chemother -\napeutic regimens (Fig. 5-31). Ischemic colitis may manifest after the administration of drugs that cause thrombosis (e.g., oral contra -\nceptive pill) or spasm (e.g., cocaine and amphetamines). Lympho -\ncytic colitis is of uncertain etiology and is associated with some H\n2 \nblockers and cholesterol-lowering agents. At imaging, the colitis is nonspecific with a variable length of colonic thickening (which may be in a vascular territorial distribution if caused by ischemia) with or without pericolonic edema, depending on the severity (Fig. 5-32).\nTyphlitis\nSometimes known as neutropenic colitis because it is an acute inflammatory condition (mainly of the terminal ileum, cecum, and ascending colon), typhlitis is identified in patients with \nB\n A\nFigure 5-21. A, BE in a 36-year-old woman with numerous apthous ulcers (arrows) in the left colon from Crohn disease. B, Magnified view of apthous \nulcers (arrow) in the distal transverse colon.\nA B\nFigure 5-22. Axial fat-saturated postcontrast T1-weighted images in a 22-year-old woman with focal Crohn disease of the ascending colon ( A, arrows). \nB, Coronal view demonstrates mucosal enhancement and mural thickening (arrow).", "a7a5f197-d3e9-44fd-a873-78e56dd4b2fc": "Small Bowel 151\ncan be created surgically from bowel anastomoses. Lymphoma \noften invades and destroys the bowel myenteric plexuses lead -\ning to aneurysmal dilation of the small bowel, sometimes with a diverticulum-like configuration.\nPneumatosis Intestinalis\nPneumatosis intestinalis can be idiopathic and asymptomatic in approximately 15% of cases. The gas in the bowel wall is typi-cally cystic and present in both the small and large bowel ( Fig. \n4-138). The findings are better observed at CT, particularly on \u201clung window\u201d contrast settings (Fig. 4-139). Obstructive airways disease, if severe, can cause retroperitoneal air, peritoneal air, and pneumatosis intestinalis as leaked air from ruptured lung alveoli tracks into the abdomen through diaphragmatic defects.\nHowever, many causes are far more sinister, usually because \nof bowel ischemia or inflammatory perforation. Pneumatosis resulting from ischemia is often preterminal, and gas may be seen tracking up the mesenteric veins and into the portal hepatic veins (Fig. 4-140). Infections with gas-forming organisms also carry a high mortality.\nPneumatosis can also be seen with infectious enteritides or \ninflammatory bowel disease, especially if associated with multi-ple mucosal ulcers ( Fig. 4-141). Occasionally gross bowel disten -\ntion proximal to an obstruction can also demonstrate gas within the bowel wall. Other causes include iatrogenic instrumentation, particularly from catheter insertion or enteric anastomoses.\nFistulae and Sinuses\nA fistula is an abnormal connection between two epithelium-lined organs. A sinus is a blind-ending cavity or sac. Fistulas and sinuses often have the same underlying causes ( T able 4-13). Fis-\ntulas are best observed at SBFT, which may identify a subtle track of contrast connecting the small bowel loop to an adjacent enteric or colonic loop or to the bladder or skin ( Fig. 4-142). However, \nthe retrograde catheter injection of water-soluble contrast media may be required for fistulas that emerge onto the skin, because this has a greater chance of identifying the fistulous track and its origin. Enteroenteric or enterocolic fistulas can be identified at CT as two contiguous viscera that are drawn together within an inflammatory mass (Fig. 4-143).\nFigure 4-138. Plain abdominal radiograph in a 78-year-old man demon -\nstrating ill-defined small bowel due to small bowel pneumatosis. The \ncause was idiopathic.\nAB\nFigure 4-139. Axial ( A) and coronal (B) contrast-enhanced CT (set to lung windows) in a 46-year-old woman with diffuse small bowel pneumatosis \n(arrows) secondary to kinase inhibitor capozatinib.\nFigure 4-140. Axial CT on \u201clung window\u201d contrast settings with small \nbowel pneumatosis secondary to ischemia (arrow).", "dc3b2a92-d977-4b89-aeee-a458a26117e1": "Peritoneum , retroPeritoneum , and mesentery  385\nA C\n B\nFigure 10-6. Axial ( A and B) and coronal (C) noncontrast CT in a 78-year-old woman who was recently involved in a motor vehicle accident. She has \nleft diaphragmatic rupture (large arrows) and herniation of the splenic flexure (small arrows) into the chest, causing lung compression (arrowheads).\nB\n A\nFigure 10-7. Axial ( A) and coronal ( B) contrast-enhanced CT in a 29-year-old man who was recently involved in a motor vehicle accident and has left \ndiaphragmatic rupture and splenic herniation into the chest (arrows).\n Box 10-1. Causes of Pneumoperitoneum\nIATROGENIC\nPostsurgeryPostlaparoscopyEndoscopyPeritoneal hemodialysisBarium enema\nPERFORATED VISCUS\nBowel obstruction (e.g., volvulus)Ischemia (e.g., obstructed hernia)Peptic ulcer diseaseDiverticulitisAppendicitisColitis (e.g., Crohn, infectious)MalignancySteroids\nPNEUMATOSIS\nINTRATHORACIC\nPneumomediastinumPneumothorax\nFigure 10-8.  Upright plain abdominal radiograph in a 51-year-old woman \nwho recently underwent abdominal surgery. A large pneumoperitoneum \nis best appreciated in the most nondependent part under the diaphragms (arrows).", "32dc4038-bdc3-467b-9e61-05ed44534567": "110 Gastrointestinal Imaging: The Requisites\nAngioneurotic Edema\nAngioneurotic edema is congenital (autosomal dominant hereditary \nangioneurotic edema) or acquired and is the result of a specific aller -\ngen or drug. It is potentially life threatening because of airway edema and obstruction. In an acute attack, there is marked elevation of bra -\ndykinin and mast cell tryptase with deficiency of complement fac -\ntors and C1 esterase, resulting in widespread vasodilatation. These potent vasodilators produce widespread interstitial edema and in the small bowel diffuse small bowel mucosal edema ( Fig. 4-43). Drug-\ninduced angioedema is increasingly recognized, particularly that caused by angiotensin-converting enzyme (ACE) inhibitors (African Americans are more susceptible). ACE inhibitors, which prevent bradykinin metabolism in susceptible individuals, accumulate sys-temically and causes the angioedema ( Fig. 4-44).\nWaldenstr\u00f6m Macroglobulinemia\nWaldenstr\u00f6m* macroglobulinemia, also known as lymphoplasma -\ncytic lymphoma with excessive B-cell proliferation, is predom-inantly in the bone marrow and lymph nodes. There are large \n*Jan G. Waldenstr\u00f6m (1906-1996), Swedish oncologist.concentrations of the paraprotein IgM in the peripheral blood, which is readily identified by electrophoresis. The IgM prolifera -\ntion can cause hyperviscosity in the intestinal lymphatics, leading to intestinal malabsorption. Imaging features are nonspecific with mucosal thickening, similar to lymphangiectasia or hypoprotein-emic states. There may be associated retroperitoneal adenopathy due to the lymphoproliferative disorder.\nHemorrhage\nIntramural hemorrhage from any cause typically causes uniform small bowel mucosal thickening with the valvulae conniventes having a \u201cpicket fence\u201d or \u201cstacked coin\u201d appearance on SBFT and nonspecific mucosal and submucosal thickening at CT, which may be hyperdense depending on disease acuity ( Figs. 4-45 and \n4-46). It is generally impossible to differentiate the causes by imaging, so clinical history is the key to the diagnosis once the abnormality is identified. Hemorrhages can result from several causes, listed in T able 4-3.\nHenoch-Sch\u00f6nlein Purpura\nHenoch-Sch\u00f6nlein purpura (HSP) disease usually affects chil -\ndren and young adults. It is of uncertain etiology, generally fol -\nlows viral or bacterial infections, and causes symptoms such as hemorrhagic skin rash, joint and abdominal pain, and melena. It is due to a systemic vasculitis that results from immune complex \nFigure 4-39. SBFT in a 61-year-old woman with a long ileal stricture \nand mucosal thickening (arrows) due to GVHD.\nFigure 4-40.  Axial contrast-enhanced CT in a 44-year-old man  with dif-\nfuse small bowel narrowing and mucosal hyperemia (arrow) due to GVHD.\nFigure 4-41. SBFT in a 55-year-old man with a long ileal stricture \n(arrows) resulting from prior GVHD.\nFigure 4-42.  Axial noncontrast CT in a 43-year-old man with mastocytosis \nand multiple intraabdominal nodes (arrow). There is associated spleno-\nmegaly (curved arrow) and ascites.", "b1bdc9e2-a9a6-427f-b0b4-7d7d0d96592a": "Peritoneum , retroPeritoneum , and mesentery  403\nand can be mistaken for lymphadenopathy or other malignant \nmasses (Fig. 10-68).\nAbdominal Wall Hemorrhage\nHemorrhage in the abdominal wall musculature is a relatively common event in patients receiving anticoagulant therapy. How-ever, it may be traumatic (blunt injury or surgery) or caused by excessive coughing or sometimes pregnancy. At imaging, the diagnosis is usually straightforward with a hyperdense mass in the affected musculature ( Fig. 10-69), which may demonstrate a \nhematocrit level (Fig. 10-70).\nPropylene (Prolene) Plug\nPropylene (Prolene) plug is a nonabsorbable material that is used to \u201cfill\u201d the hernial orifice and thus prevent hernial recurrence. Its appearance at CT imaging should be recognized (Fig. 10-71) and not confused with other, more sinister soft tissue masses. It is usually identified based on the appropriate history and expected location of the plug.\nAlloDerm Spacers\nAlloDerm spacers are a patented human tissue matrix (acellular human dermis) increasingly used in patients undergoing radia -\ntion or proton beam therapy. The cadaveric human tissue sepa -\nrates vital normal anatomical strictures from the radiation portal. AlloDerm has also been used for graft repair, breast reconstruc-tive surgery, and hernia repairs. Its appearances are characteristic at CT with a multilayered, sometimes whorled appearance of the dermal collagen matrix ( Fig. 10-72). The spacer involutes after \na period of time and can be mistaken for a soft tissue mass and \nFigure 10-65. Axial contrast-enhanced CT in a 23-year-old woman \nwith tuberculosis and multiple hypodense retroperitoneal lymph nodes \n(arrows).\nB A\nFigure 10-66. A, Axial contrast-enhanced CT in a 44-year-old woman with idiopathic retroperitoneal fibrosis and a soft tissue mass that envelops the \naortic bifurcation and inferior vena cava ( large arrow). There is right ureter dilatation ( small arrow) caused by inflammatory involvement more caudally. \nB, The disease is fluorodeoxyglucose avid at PET (arrowhead  ).\nFigure 10-67.  Axial contrast-enhanced CT in a 44-year-old woman with \nretroperitoneal lymphoma ( large arrow) with appearances similar to retro-\nperitoneal fibrosis. There are, however, smaller nodes in the mesentery (small arrow).\nFigure 10-68. Axial contrast-enhanced CT in a 48-year-old woman \nwith extramedullary hematopoiesis in the pelvis ( large arrows). There is a \nfibroid uterus (small arrow).", "62ec0620-c7dd-4679-8fc7-1d7945190b3a": "39\nNORMAL ANATOMY\nThe stomach begins at the gastric cardia (the portion that en -\nvelops the lower esophagus) and ends  after the pylorus. It consists \nof a fundus, body, lesser and greater curvature, antrum, and pylorus. \nIt has three layers of smooth muscle (outer longitudinal, middle circular, and inner oblique), with gastric rugae (or folds) within. The mucosa is lined by columnar epithelium, within which are numerous mucus- and acid-producing glands. Gastric folds are usually prominent when the stomach is collapsed but are effaced when it is distended. With good double-contrast technique, the normal lower antrum often has a smaller reticulated mucosal appearance, known as areae gastricae (Fig. 2-1).\nA contrast (usually barium) examination of the stomach used \nto be one of the most common imaging examinations before the advent of computed tomography (CT) and endoscopy. It is now rarely performed as a first-line investigation to evaluate for gas -\ntric disease. However, knowledge of good upper gastrointestinal (UGI) barium examination technique is still required, particularly because it can detect and characterize most lesions. Small pol -\nyps and mucosal lesions are unlikely to be detected by CT, and unless endoscopy is performed, they will be missed.\nBarium examination of the stomach usually follows initial \nexamination of the esophagus (see Chapter 1 ). T o promote gas -\ntric and duodenal bulb distention, some investigators inject small doses of anticholinergics or glucagon to induce a gastric and duodenal atonic state. Whether or not this is used, the examination of the stomach should not be delayed once the gas granules are swallowed and the initial views of the esophagus with the patient in the upright position have been performed. The patient is immediately placed recumbent to prevent the contrast material from spilling into the duodenum, which usu -\nally obscures the stomach, rendering the test inadequate. Once recumbent, the patient is then turned several times to encour -\nage the coating of the mucosa with barium. The sequence of spot radiographs then varies according to institutional prefer -\nence. Initially, a supine view (to provide an overview of the gas -\ntric anatomy) is followed by fundal views, with the patient in the right-side down lateral position (the fundus will be maximally distended with air in this position). After the patient is turned to the supine position (the patient turns to the left), views of the body can be obtained. The patient is then turned to the right anterior oblique position (i.e., the gastric antrum is uppermost) to obtain antral and duodenal bulb views (these regions, being nondependent, will be maximally distended with gas). If there is inadequate coating, the patient is then turned supine again to further coat the antrum and returned to the right anterior oblique position to achieve adequate antral coating and duodenal coat-ing. Further views of the esophagus can now be obtained with low-density (thin) barium with the patient in the prone oblique position, and the patient can be evaluated for hiatal hernia and gastroesophageal reflux disease (GERD). These results may be elicited with the patient in a slight T rendelenburg * position, and \ngravity is used to provoke the GE junction. The patient is finally turned to the prone position for the evaluation of the antrum and duodenum bulb with compression views. The antral and duodenal bulb anatomy is variable, and the patient may need to be rotated in different obliquities or even lateral positions to view them en face.\n*Friedrich T rendelenburg (1844-1924), German surgeon.CT is not a suitable technique for the examination of muco-\nsal disease, unless there is marked gastritis or mucosal lesions are sufficiently large to be visualized. CT is, however, useful when gastric perforation is suspected. The technique is mostly reserved for evaluating primary and secondary gastric tumors and extragastric inflammatory conditions such as pancreatitis. Mag -\nnetic resonance imaging (MRI) has little role in the evaluation of gastric disease.\nPositron emission tomography (PET) and PET/CT are increas -\ningly used to evaluate gastric malignancy, particularly for local and distant metastases.", "99002e13-e3fb-4a5e-8dba-81a9a52ca882": "266 Gastrointestinal Imaging: The Requisites\nbetween the two ( Fig. 6-121). A highly characteristic feature of \nHCC is delayed contrast washout from the lesion ( Fig. 6-122), \nwhich helps differentiate HCC from benign lesions. On MRI the \nlesions may have variable T1-weighted appearances, but they are usually hyperintense on T2-weighted imaging. Degeneration of a dysplastic nodule is suggested by an area of increased T2 signal within a region of low T2 signal (dysplastic nodules are usually hypointense on T2-weighted imaging) ( Fig. 6-123). Contrast-\nenhanced MRI shows brisk, intense enhancement with delayed washout, again characteristic of HCC (Fig. 6-122). More diffuse or metastatic lesions are generally easier to diagnose, given their multifocal nature, particularly when observed in a patient with cirrhosis (Fig. 6-124). Larger tumors may invade the portal vein and can be differentiated from nontumorous thrombus by subtle enhancement within the thrombus ( Fig. 6-125). Larger lesions \nmay also demonstrate a central scar and therefore need to be dif -\nferentiated from other lesions with a central scar, including hem -\nangioma, FNH, fibrolamellar HCC, and some metastases ( Fig. \n6-126). Differentiation from other hepatic tumors (FNH) is also aided by the use of hepatobiliary contrast agents, although some well-differentiated HCCs retain hepatocellular function. Poorly differentiated tumors, however, do not retain hepatocellular function and therefore are hypointense on delayed postcontrast imaging (Fig. 6-127), similar to metastatic disease.\nFibrolamellar Hepatocellular Carcinoma\nFibrolamellar hepatocellular carcinoma occurs in noncirrhotic liv -\ners, typically in younger patients. Histologically they are quite different from HCC, usually less aggressive, and potentially cur -\nable. Their imaging features have some similarity to those of \nA\nB\nFigure 6-122. Axial arterial ( A) and delayed ( B) post-contrast-enhanced \nMRI in a 54-year-old with two foci of HCC that washed out on delayed \nimaging (arrows).\nFigure 6-123. Axial T2-weighted MRI in a 66-year-old man with a pre -\ndominantly hypointense dysplastic nodule ( arrow), with an area of T2 \nincreased signal resulting from malignant degeneration to HCC ( small \narrow).\nAA\nB\nFigure 6-124. Axial arterial ( A) and delayed (B) contrast-enhanced CT \nin a 57-year-old with cirrhosis with a multifocal enhancing HCC ( arrows) \nthat washes out on delayed imaging. There are ascites and esophageal varices (small arrow), as well as enhancing tumor thrombus in the IVC (curved arrow). The main hepatic mass also causes biliary obstruction.", "2b9d5653-832d-452b-862c-0c3d00b05c0e": "114 Gastrointestinal Imaging: The Requisites\nangina (postprandial abdominal pain), weight loss, vomiting, and \ndiarrhea. Acute forms usually result from vascular occlusion (emboli, thrombosis), which can be arterial or venous, although the former is far more common. However, up to 30% of acute ischemic events are nonocclusive. Given that acute ischemia carries a high mortality if it is left untreated (50% to 90%), most patients should be considered a surgical emergency to rescue the affected bowel from infarction and necrosis. Patients with cardiac disease are particularly susceptible to mesenteric ischemia because the combined effect of poor cardiac output and vascular stenosis can result in marked low-flow mesen-teric vascular states. Other causes of ischemic enteritis are listed in T able 4-4 and can be inflammatory or caused by the cytotoxic vascu -\nlar effects of radiation or drugs.\nPlain radiographs often demonstrate an ileus and thickened \nbowel wall if severe. In delayed cases, intramural gas can be iden -\ntified, representing profound ischemia as intraluminal gas perme-ates the mucosa and then through the bowel wall and subsequently into the mesenteric venous system and liver in advanced cases. A small bowel follow-through examination, which is now rarely per -\nformed, will demonstrate thickening and crowding of the valvulae conniventes (\u201cstacked coin\u201d appearance) caused by submucosal edema and hemorrhage (Fig. 4-51). It usually heals by stricture formation, which is generally \u201cfixed\u201d at SBFT (Fig. 4-52).A multitude of findings can be demonstrated at CT, which is the \ninvestigation of choice. This requires contrast-enhanced CT, which should include arterial and venous phases to evaluate both the arterial and venous supply. This may identify arterial occlusive dis -\nease in the superior mesenteric artery or superior mesenteric vein. Because of the low-flow states, the small bowel mucosa enhances poorly and the bowel wall is thickened. There is a propensity for submucosal hemorrhage, which is identified as high-density mate -\nrial in the bowel wall at CT . The surrounding small bowel mesentery is edematous (stranding), and the affected bowel will demonstrate mucosal and mural thickening (Fig. 4-53). Severe ischemia will ulti-mately cause small bowel infarction, which at CT can be recognized as an area of poorly enhancing or nonenhancing bowel, which has an ominous \u201cdusky\u201d appearance, usually with adjacent edema ( Fig. \n4-54). Pneumatosis may also develop in severe cases with gas in the bowel wall, mesenteric vessels, or hepatic portal venous system (Fig. 4-55). The finding of intraluminal or mesenteric gas may be \nsubtle and only be appreciated by viewing CT images with \u201clung windows\u201d contrast settings to maximize the contrast between the gas and surrounding soft tissues (Fig. 4-55).\nShock Bowel\nShock bowel is reversible ischemic small bowel, usually caused by hypovolemic states. The transitory hypoperfusion results in dif -\nfuse bowel wall thickening and characteristic increased mucosal enhancement due to the capillary low-flow states combined with increased vascular permeability induced by the ischemia (Fig. 4-56).\nAmyloidosis\nAmyloidosis is a systemic disease caused by the deposit of amyloid proteins. There are multiple designations of amyloid, depend -\ning on the protein type. For instance, AL is amyloid light chain, seen in multiple myeloma and can also be classified as primary amyloidosis. Other forms are familial (ATTR protein deposition). Secondary amyloidosis (AA protein deposition) is due to protein production from chronic, particularly infective, disease (e.g., bron-chiectasis). Amyloid can deposit almost anywhere, including the heart, lungs, joints, brain, skin, and GI tract. Disease in the small bowel is often due to ischemia resulting from amyloid deposition within submucosal vessels.", "cc2a5088-28cb-4d71-996c-921b80329f23": "284 Gastrointestinal Imaging: The Requisites\nA\nB\nFigure 6-171. Axial ( A) and coronal ( B) contrast-enhanced CT in a \n30-year-old man after a motor vehicle injury, which demonstrates a frac -\ntured liver (arrows), hemorrhage, and pseudoaneurysm formation (small \narrows).\nFigure 6-169. Coronal contrast-enhanced CT in a 27-year-old woman \nwith a linear hypodense defect caused by a liver laceration (arrow).\nFigure 6-170. Axial noncontrast CT in a 55-year-old man with recent \ntrauma and liver laceration and a sliver of hyperdense acute blood sur -\nrounding the liver margin (arrow).\nPOSTOPERATIVE LIVER\nLiver Transplant\nThe most common procedure is the orthotopic liver transplant, \nin which an allograft from a cadaveric donor wholly or partly replaces the diseased liver, or in the case of living donor allografts, the right lobe is given to adult recipients and the left lobe to child recipients. The procedures are understandably complex, involv -\ning anastomoses of biliary and vascular structures. Imaging plays a crucial postoperative role in evaluating both the normal state and postoperative complications.\nDeteriorating liver function requires early imaging, usually \nwith US to exclude a mechanical cause (refer to Box 6-11 and \nT able 6-7), in particular whether there is normal main, right, and left hepatic arterial flow. This is usually best evaluated by Dop -\npler US to document absent flow (occlusion) or reduced flow (high-grade stenosis, hepatic edema, hypotension). Normal US findings include a low-resistance waveform best evaluated by the semiquantitative resistive index (RI), with normal values ranging from 0.5 to 0.7. Normal portal venous waveform is of continuous hepatopetal flow, whereas hepatic venous waveforms are phasic and secondary to variations in cardiac pulsations. Hepatic arte -\nrial occlusion (usually complete thrombosis) shows no flow or a tardus-parvus pattern with arterial collateral formation (RI <0.5 and acceleration time >80 msec) (Fig. 6-172). Hepatic arterial ste-nosis shows a prolonged systemic acceleration Doppler waveform and an RI of <0.5. At the site of anastomosis there is increased peak velocity of >2 m/s.\nPortal vein complications are less common than those of the \nhepatic artery and include thrombosis and stenosis, best evalu-ated by US, which may demonstrate an intraluminal filling defect (thrombus) or no Doppler flow or both. Other complications, including evidence of hepatic infarction, bile leak, hemorrhage, and abscess, are usually diagnosed with CT . Biliary strictures or leaks can be confirmed by contrast medium injection via the T -tube placed perioperatively or by endoscopic retrograde chol -\nangiopancreatography and, less commonly, transhepatic chol-angiography. Biliary strictures can be caused by anastomotic or secondary rejection, ischemia, infection, or recurrent sclerosing cholangitis (in patients with that underlying disease). Other rare complications include recurrent HCC or PTLD. The latter occurs in approximately 5% of patients within the first year after liver transplantation. It is precipitated by aggressive immunosuppres -\nsion that causes unregulated B-cell proliferation (often associated with Epstein-Barr virus) and development of B-cell lymphoma.", "f7d63980-5762-40d4-979f-6a25ec27b512": "Pancreas  375\nMost IPMNs are asymptomatic, occurring in elderly men in \nthe head and uncinate of the pancreas (Fig. 9-86) (approximately \n55%), with a minority (10%) in the tail. The remainder (35%) are multiple and diffusely located throughout the pancreas ( Fig. 9-87). \nMost are small and cyst like, but main duct variants simply cause duct dilatation owing to excessive mucin production. Main duct IPMNs can involve either the entire duct or a segment ( Fig. 9-88). \nThey are more frequently detected by MRCP because of the high T2 mucin signal characteristics ( Fig. 9-88), and side branch lesions \ncan often be observed to communicate with the main pancreatic duct (Figs. 9-86 and 9-87).\nThe lesions are premalignant, with up to 25% showing hyper -\nplastic features, 50% showing dysplastic features, and 25% showing frank adenocarcinoma. Malignant degeneration is more common in main duct tumors than in side branch lesions, and features include presence or development of a solid mass, pan -\ncreatic duct dilatation greater than 10 mm, mucin calcification, and polypoid main duct lesions ( Fig. 9-89). Therefore annual \nfollow-up is recommended for incidentally detected IPMNs, especially if the patient is younger. Follow-up should ideally be performed with MRCP rather than CT because of better contrast characteristics and avoidance of ionizing radiation. The management of small IPMNs, particularly the more common side branch lesions, in the elderly is more challenging given that they are relatively common and the risk of malignant degenera -\ntion may be small. Less frequent monitoring is therefore some-times practiced.\nFigure 9-86. Axial contrast-enhanced CT in a 79-year-old man with two \n8-mm cystic lesions in the uncinate ( arrows) consistent with side branch \nIPMNs.\nFigure 9-87. MRCP in a 74-year-old man demonstrating three small \nside branch IPMNs (arrows).\nB\nAA\nFigure 9-88. Axial contrast-enhanced CT ( A) and MRCP (B) in an \n80-year-old woman with a main duct IPMN and dilatation of a segment of \nthe main pancreatic duct in the head (arrows).\nFigure 9-89. Axial contrast-enhanced CT in a 78-year-old man with a \nmalignant IPMN demonstrates a multicystic complex mass (arrows) and a soft tissue mass projecting into the duodenum (arrowhead\n ).", "6230ff00-f163-482f-b361-c2934987026f": "Stomach  71\nwould require urgent surgery ( Fig. 2-96). Alternatively, the band \ncan be too \u201cloose\u201d so that the stomach is not constricted and early \nsatiety does not occur. This can be adjusted by tightening the band, assuming it has not slipped distal to its intended position.\nNissen Fundoplication\nNissen * fundoplication is an open or laparoscopic surgical pro -\ncedure, used to treat GERD, that involves creating a gastric fun-dal wrap (usually 360 degrees) around the lower esophagus to strengthen the lower esophageal sphincter (see Chapter 1). The procedure is generally effective, although complications of dyspha-gia, dumping syndrome, achalasia, and a difficulty with belching are recognized. The major complication is loosening of the wrap, with patients having recurrent symptoms of GERD (Fig. 2-97).\n*Rudolph Nissen (1896-1981), Swiss surgeon.\nA\n B\nFigure 2-88. Axial ( A) and coronal ( B) contrast-enhanced CT in a 47-year-old woman after a Whipple procedure and an obstructed afferent loop ( large \narrow) with secondary biliary dilatation (small arrow).\nEsophagus\nExtrude d\nstomach\nRoux limbProximal\npouch\nFigure 2-89.  Schematic representation of a Roux-en-Y bariatric operation. \nThere is a small proximal gastric pouch and larger extruded gastric remnant.Gastric slee veEsophagus\nExtrude d\nstomach\nFigure 2-90. Schematic representation of a sleeve gastrectomy.\nFigure 2-91. Axial contrast-enhanced CT in a 33-year-old woman with \na leak after bariatric surgery with extraluminal gas ( large arrow) and fluid \n(small arrow).", "10237474-9dfc-46c2-8258-d28508f19a32": "204 Gastrointestinal Imaging: The Requisites\na pathological lesion acts as a lead point, unlike ileoileal intussus -\nception, which is often transitory and of little significance. Both \nbenign (Fig. 5-100) and malignant lesions ( Fig. 5-106) can act as \nthe lead point ( Fig. 5-100). The diagnosis can be made with BE \nbut is now almost always made with CT imaging in adults, but US in children. In children, ileocolic or colocolic intussusception can often be reduced without surgery by using rectal air or water, monitored fluoroscopically or by US, whereas surgery is generally required in adult forms.\nForeign Bodies\nForeign bodies are usually ingested orally, either accidentally or purposely, and should be visualized by BE or CT, particularly if metallic. Some undigested medication tablets can occasionally be identified and show their expected shape. Rectal foreign bod-ies are sometimes rectally self-inserted and may require general anesthesia or surgery or both for removal. Sharp foreign bodies may perforate the mucosa (Fig. 5-138).\nA\n B\nFigure 5-136. Plain radiograph of the abdomen ( A) and coronal ( B) contrast-enhanced CT in a 76-year-old man with sigmoid volvulus and marked \ndistention of the sigmoid that points to the right upper quadrant (arrows) with large bowel obstruction of the remaining colon.\nFigure 5-137. Axial noncontrast CT in a 71-year-old man with an obtu -\nrator hernia. The colon has herniated through the right pelvic wall ( arrows).Table 5-10  Causes of Colonic Pneumatosis\nType Disease\nPrimary pneumatosis Pneumatosis cystoides coli\nLarge bowel obstruction Volvulus\nNeoplastic obstruction\nPulmonary disease Chronic obstructive airways diseaseAsthmaCystic fibrosis\nInflammatory disease Inflammatory bowel diseaseInfectious colitis (especially pseudo-\nmembranous and CMV colitis)\nDiverticulitis\nVascular Ischemia (embolus or atheroma)Vasculitis (SLE, polyangiitis)\nNeoplastic Malignancies (carcinoma, lymphoma)Direct metastatic invasion\nT rauma Iatrogenic (colonoscopy)Enema studiesSelf-induced trauma\nDrugs Chemotherapy (colitis)Steroids\nGraft-versus-host disease Posttransplantation\n \nCMV, Cytomegalovirus, SLE, systemic lupus erythematosus.", "5f2de309-bb7f-4563-a819-16aa4636ee09": "90 Gastrointestinal Imaging: The Requisites\nthan 2 cm. Most are tubular with tubulovillous and villous being \nless common ( Fig. 3-47). Patients usually have GI bleeding or \nobstructive symptoms from intussusception. Adenomatous polyps are more readily recognized at UGI rather than at CT as an irreg -\nular polypoid mass, usually close to the duodenal bulb or medial aspect of the second part of the duodenum (Fig. 3-48). Occasionally they appear as a more solid mass (Fig. 3-49).Hyperplastic polyps are rare benign epithelial sessile polyps, \nusually small and multiple within the duodenum. They are far less common than gastric hyperplastic polyps.\nFamilial polyposis, Peutz-Jeghers syndrome (hamartomatous \npolyps), Cronkhite-Canada syndrome, and Cowden\u2019s disease (see Chapter 5) can all demonstrate duodenal polyposis, although at contrast fluoroscopy, it is not possible to distinguish them. Usu -\nally a family history or other manifestations of the disease (e.g., mucocutaneous pigmentation in Peutz-Jeghers syndrome) are a clue to the diagnosis.\nDuodenal Carcinoma\nDuodenal carcinomas are rare, although they are the most com -\nmon malignant duodenal tumors. They develop from the ade -\nnoma-carcinoma sequence (see Chapter 5), so all duodenal adenomas should be considered premalignant. Other predispos -\ning factors include familial polyposis syndromes, particularly Gardner syndrome. They present with upper abdominal pain, nausea, vomiting, and malignant symptoms of weight loss and anemia. At imaging, they have characteristic features similar to adenocarcinoma elsewhere in the GI tract. Most are in the mid to distal duodenum and present with an irregular intraluminal mass (with or without ulceration) or an apple core appearance, especially if presenting late ( Figs. 3-50 and 3-51 ). Malignancy is \nconfirmed if there is associated regional lymphadenopathy.\nFigure 3-46. Axial contrast-enhanced CT in a 42-year-old man with an \neccentric 2.5-cm duodenal mass (arrow) caused by carcinoid.\nB\n A\nFigure 3-47. Coronal ( A) and axial (B) contrast-enhanced CT in a 72-year-old man with a filling defect in the second part of the duodenum ( arrows) \ncaused by a duodenal villous adenoma.\nBB\n AA\nFigure 3-48. Axial ( A) and coronal (B) contrast-enhanced CT in a 55-year-old woman with circumferential duodenal wall thickening (arrows) due to \nan adenoma.", "cb98692a-3656-483c-b013-293f570a6edf": "Small Bowel 147\nAB\nFigure 4-127. SBFT examination ( A) and coronal CT (B) in a 20-year-old man with a terminal ileal stricture (arrows) due to Crohn disease.\nAB\nFigure 4-128. Axial ( A) and coronal (B) contrast-enhanced CT in a 54-year-old man with a transient ileal intussusception. The intussusceptum ( long \narrows) is surrounded by mesenteric fat within the intussuscipiens (short arrows).\nAt CT, there is evidence of a thickened gallbladder wall that \nadheres to the duodenum. There is often gas in the gallbladder \nand common bile duct due to the fistula between the duodenum and gallbladder. There is small bowel dilatation, with the offend-ing gallstone identified at or near the ileocecal valve (Fig. 4-130).\nForeign Bodies\nIngested foreign bodies usually pass via the rectum asymptom -\natically but can become lodged within the small bowel, particu -\nlarly at its narrowest point at, or near, the ileocecal valve ( Fig. \n4-131). Larger material may cause more proximal obstruction (Fig. 4-132). The most commonly ingested foreign bodies are \nfruit pits (e.g., peach, prune), but more bizarre objects can be found, particularly in psychiatric patients. Many are identified on plain radiographs if metallic (Fig. 4-133). Drug dealers can transport their drugs by packing narcotics into condoms and swallowing them. Sometimes the load is sufficient to cause obstruction. They can usually be identified on plain radiographs as oval opacities, possibly with air surrounding them (double condom sign). These can be fatal if they rupture, causing a mas -\nsive drug overdose. Iatrogenic material can become dislodged (e.g., parts of feeding tubes) and migrate down the GI tract and may sometimes cause obstruction (see Fig. 4-131).\nSmall Bowel Bezoars\nSmall bowel bezoars are uncommon, and like stomach bezoars, can be caused by the overingestion of vegetable matter (phy-tobezoar), which, when severe, can lead to SBO. The diagnosis can be made at SBFT with an appearance of an irregular mass with barium interspersed among the vegetable matter. At CT, it may be harder to identify the specific cause of SBO unless large enough, although the obstruction itself is readily identi-fied (Fig. 4-134).\nDiverticula\nThe most common small bowel diverticulum is in the duode -\nnum (see Chapter 2) and is of no significance except for causing difficulties with ampullary cannulation at endoscopic retrograde", "ac37685a-8292-4cc3-85c1-fb83f0ec4d59": "Even though they secrete glu -\ncagon, glucagonomas often present late and large, and up to 80% are metastatic to the liver or regional lymph nodes at the time of diagnosis. They are usually located in the body and tail of the pancreas ( Fig. 9-64). Clinical findings are secondary to the \nelevated glucagon levels and include diabetes mellitus, anemia, weight loss, hypoaminoacidemia, and a characteristic necrolytic migratory erythema.\nVIPoma\nVIPomas secrete vasoactive intestinal polypeptide (VIP) from delta-1 islet cells, producing the WDHA (or WDHH) syndrome of watery diarrhea, hypokalemia, and achlorhydria and hypovo -\nlemia. Up to 50% are malignant, and most occur in the body and tail of the pancreas. Like other pancreatic neuroendocrine tumors at imaging, they are hypervascular and most likely to be detected during arterial-phase imaging (Fig. 9-65).\nSomatostatinoma\nSomatostatinomas are the rarest of the islet cell tumors, with excess somatostatin produced from delta islet cells. Most are malignant, cause diarrhea and weight loss, and can be confused with VIPomas. At imaging, they are also relatively large and hypervascular and \n*Robert Milton Zollinger (1903-1992), American surgeon; Edwin H. Ellison \n(1918-1970), American surgeon.Table 9-6 Features of Pancreatic Neuroendocrine Tumors\nType Location Cell Type Hormone Malignancy Clinical Findings\nInsulinoma Pancreas \u03b2 Insulin 10% Hypoglycemia\nGastrinoma Pancreas, duodenum, \nstomach\u03b1-1 Gastrin 60% Zollinger-Ellison syndrome\nGlucagonoma Pancreas \u03b1-1 Glucagon 80% Diabetes mellitus, necrolytic migratory \nerythema\nVIPoma Pancreas \u03b4-1 VIP 50% WDHA syndrome\nSomatostatinoma Pancreas, chest, brain \u03b4 Somatostatin 60%-70% Diarrhea, weight loss\n \nWDHA, Watery diarrhea, hypokalemia, and achlorhydria.\nFigure 9-52. Axial arterial-phase contrast-enhanced CT in a 54-year-old \nman with a 2-cm enhancing mass in the pancreatic head ( large arrow) that \nrepresents a functioning insulinoma. An additional hypervascular liver \nmass is in segment II of the liver (small arrow).", "aea8a6d0-6417-4b88-afce-ddf67a6e3694": "356 Gastrointestinal Imaging: The Requisites\nBB\n A\nFigure 9-28. Axial ( A) and coronal (B) contrast-enhanced CT in a 44-year-old woman with a 10-cm well-contained encapsulated fluid collection \n(arrows) representing a pancreatic pseudocyst.\nB A\nFigure 9-29. Axial T2-weighted ( A) and coronal T1-weighted ( B) fat-saturated postcontrast MRI in a 53-year-old man with a 5-cm pancreatic \npseudocyst (arrows).\nFigure 9-30. Plain abdominal radiograph and axial contrast-enhanced \nCT in a 47-year-old woman with chronic pancreatitis and diffuse pancre -\natic calcification ( arrows). A plastic biliary stent ( small arrow) is present \nbecause of an inflammatory biliary stricture.\nFigure 9-31. Axial contrast-enhanced CT in a 42-year-old man with an \nacute episode of chronic pancreatitis, demonstrating diffuse pancreatic cal -\ncification (large arrow), peripancreatic inflammatory changes ( small arrow), \nand a focally enlarged pancreatic duct ( arrowhead  ). Splenomegaly is caused \nby chronic splenic vein thrombosis.", "0fa7935f-3d23-4bd4-903a-b903bc2290bd": "338 Gastrointestinal Imaging: The Requisites\na spectrum of disease with hyperplastic cholecystosis and par -\nticularly cholesterolosis. Gallbladder polyps have also been \nrecognized in Peutz-Jeghers (hamartomatous polyps) (see Chapter 4) and familial adenomatous polyposis (adenomatous polyps) (see Chapters 4 and 5). At US, they are recognized by a small intraluminal nonshadowing sessile mass, which helps to differentiate them from gallstones ( Fig. 8-62). The presence \nof cholesterol is indicated by echogenicity within the polyp (without shadowing). Differentiation from tumefactive sludge is usually possible because sludge is typically mobile, larger, and irregular in contour. Furthermore, color Doppler flow can be observed in some larger polyps. If the polyp is sufficiently large (>5 mm), it can be identified with CT . Smaller polyps can be identified with T2-weighted MRI because of the superior contrast resolution between the high-signal bile and low-signal polyp.\nMost polyps are asymptomatic and benign, but they are con-\nsidered to have premalignant potential, although this is not fully substantiated. Polyps up to 1 cm are serially imaged to determine any increase in size that might indicate malignant transformation to cholangiocarcinoma. When polyps are larger than 1 cm (and especially if >1.5 cm), cholecystectomy is usually indicated to exclude cholangiocarcinoma (Fig. 8-63). Some surgeons remove polyps smaller than 1 cm because of this risk.\nBiliary Intraductal Papillary Mucinous Neoplasm\nBiliary intraductal papillary mucinous neoplasm (IPMN) causes both intrahepatic and extrahepatic biliary duct dilatation when mucin is secreted from papillary mucinous epithelial cells lining the ducts. Therefore a discrete mass may not be present. Bili -\nary IPMN is far less commonly observed than IPMN of the pan -\ncreatic duct. Patients present with intermittent pain, fever, and jaundice. The diagnosis is suggested when ERCP demonstrates multiple intraluminal mucinous filling defects, with or without an associated mass. US, CT, and MRI usually show diffuse (and sometimes grossly enlarged) bile ducts filled with hypodense mucinous material (Fig. 8-64).\nB\n A\nFigure 8-62. Sagittal US ( A) and axial T2-weighted fat-saturated MRI (B) in a 49-year-old woman with several gallbladder polyps (arrows).\nBB\n A\nFigure 8-63. Coronal ( A) and axial (B) contrast-enhanced CT in a 56-year-old woman with a small fundal polypoid mass ( arrows) that was early gall-\nbladder carcinoma at cholecystectomy.", "13955f7f-aa8b-496a-8695-6f62bb0e1c67": "Liver 273\nFigure 6-139. Axial arterial-phase contrast-enhanced CT in a 56-year-\nold man with cirrhosis and right portal vein thrombosis and a hyperdense \nwedge-shaped area on the right hepatic lobe ( arrows) and prominent right \nhepatic artery (small arrow) resulting from arterial shunting.\nB\nA\nFigure 6-140. Axial ( A) and sagittal ( B) contrast-enhanced CT in a \n76-year-old man with prior hepatic surgery and now with an arteriovenous fistula with early right portal vein enhancement (arrows).\nB\nA\nFigure 6-141. Axial ( A) and coronal ( B) CT in a 66-year-old man with \nPVP thrombosis (short arrow) and cavernous transformation of the portal vein (arrows).\nenhancement of the portal venous area in question, typically \nwedge shaped. Most often, this is caused by cirrhosis and is trans-sinusoidal. This phenomenon can also unmask the presence of a small, as yet unrecognized metastasis that has created an arte-rioportal shunt and a wedge-shaped hypervascular area beyond it. HCCs frequently cause arterioportal shunting either within the primary tumor or as a result of treatment with radiofrequency ablation. T ransplexal shunting is caused by arterial blood shunting to peribiliary venous plexuses and is typically seen in the perihilar region. This is less common and occurs with cirrhosis and portal vein obstruction. Hepatic arterial blood is abnormally diverted directly into the portal venous system at the level of the main \nvessels, sinusoids, or peribiliary venules. Causes are  posttraumatic \n(particularly after interventional imaging procedures) or sponta -\nneous in cirrhosis, but shunts can also be secondary to benign (hemangioma) and malignant (HCC) hepatic tumors (Fig. 6-140).\nEvidence that a shunt is present at contrast-enhanced CT \nor MRI can be visualized as early (arterial phase) portal venous opacification, either of the larger portal veins or as isolated seg -\nmental or subsegmental enhancement. The latter is usually iden-tified by a small, rounded, or oval blush, which is evidence of early portal opacification, not dilated arterial structures. Other features include a peripheral wedge-shaped area of enhancement (as in THIDs as high-pressure arterial blood is pumped into the segmental or subsegmental portal structures). Most shunts are not visible and are isodense by the time of portal venous scan -\nning. Shunts in the setting of cirrhosis can be hard to differenti-ate from small HCCs, and close interval follow-up is indicated to exclude an enlarging tumor.", "59f636b2-c1ff-43b5-9f83-02545a1ae15a": "392 Gastrointestinal Imaging: The Requisites\nwith constriction or retraction of the mesentery, often with \ncalcification (Fig. 10-27). It should be differentiated from mesenteric metastases from carcinoid, which can have similar appearances (Fig. 10-28).\nMesenteric Adenitis\nInflammation of the mesenteric nodes is not uncommon. It is usually nonspecific and recognized on CT as a number of slightly enlarged mesenteric lymph nodes associated with inflammatory fat changes (fat stranding) ( Fig. 10-29). It is most \noften idiopathic but can be bacterial (Fig. 10-30) or tubercu-lous (Fig. 10-31). Reactive adenitis can also occur with small or large bowel infections or inflammatory bowel disease (see Chapter 4).\nMesenteric Fat Necrosis\nMesenteric fat necrosis is often referred to as an omental infarct and simply represents arterial disruption of a small area of mes -\nentery, leading to infarction. It is most commonly identified in obese elderly patients and in those who have had recent abdomi-nal surgery. Patients present with acute abdominal pain, which \nB\n A\nFigure 10-27. Axial ( A) and coronal (B) contrast-enhanced CT in a 73-year-old woman with a calcified mesenteric mass (large arrows) with mesenteric \nretraction (small arrow) caused by retractile mesenteritis.\nFigure 10-28. Axial contrast-enhanced CT with a right lower quadrant \nmass representing carcinoid ( large arrow) and a mesenteric desmoplastic \nreaction and associated colonic thickening (small arrows).\nFigure 10-29. Axial contrast-enhanced CT in a 56-year-old man with \nseveral slightly enlarged mesenteric nodes ( large arrow) and inflammatory \nfat changes resulting from mesenteric adenitis.\nFigure 10-30.  Axial contrast-enhanced CT in a 61-year-old man with a \nnumber of enlarged right lower quadrant mesenteric nodes ( arrows) due to \nbacterial mesenteric adenitis.", "7023c830-1409-44d4-8c36-44a7ee7d4be0": "Stomach  49\nnausea, vomiting, diarrhea, and weight loss. Findings include \ngastric erosions, ulceration, and diffuse infiltration with mucosal \nthickening and nodularity, particularly of the distal stomach and proximal small bowel. The latter findings can be difficult to dis -\ntinguish from other causes of gastric and small bowel thickening, including Crohn disease, Zollinger-Ellison syndrome, and lym -\nphoma. Chronic disease can present with a constricted antral and gastric body, secondary to fibrosis, which is difficult to distinguish from other causes of linitis plastica.\nCrohn Disease (see Chapters 4 and 5)\nCrohn disease is usually associated with Crohn disease elsewhere in the small bowel and colon and typically demonstrates aphthous ulceration when involving the stomach (see Fig. 2-16). Crohn dis -\nease represents a transmural process with submucosal lymphoid \nfollicular proliferation with the ulceration of the overlying mucosa \nFigure 2-25. UGI series of the stomach demonstrating a malignant gas -\ntric ulcer. There is a central pooling of barium in the gastric ulcer sur -\nrounded by fused and clubbed mucosal folds (arrow).\nFigure 2-26. UGI series in a 70-year-old woman with a radiolucent halo \n(large arrow) due to a Carman meniscus sign that surrounds a central \nmaliginant ulcer crater (small arrow).\nFigure 2-27. UGI series in a 72-year-old man with a healing gastric \nulcer. Radiating folds (arrow) converge on the previous ulcer.\nFigure 2-28. UGI series in a 59-year-old man with antral deformity \n(arrow) due to chronic scarring from peptic ulcer disease.\nFigure 2-29. UGI series in a 48-year-old woman with Zollinger-Ellison \nsyndrome and repetitive antral ulceration with chronic stricture and resid -\nual ulcers (arrow).", "bbfba4d3-0823-43d8-a6ea-97b52ea60c69": "306 Gastrointestinal Imaging: The Requisites\nSplenic Hamartoma\nHamartomas are uncommon vascular tumors of the spleen that \nare usually an incidental finding. They are generally hyper -\nechoic on US and can be difficult to visualize. On CT they appear similar to hemangiomas, although the enhancement tends to be more heterogeneous with variable filling-in toward the center on delayed images ( Fig. 7-45). They can therefore \nbe difficult or impossible to differentiate from hemangiomas by imaging. On MRI they are often isointense on T1-weighted imaging and slightly hyperintense on T2-weighted images (Fig. 7-45). As with CT, they generally show peripheral nodu -\nlar enhancement and variable centripetal filling-in of contrast material. Similar to hemangiomas, they can also show areas of calcification.\nSplenic Lymphangioma\nSplenic lymphangiomas are rare and classically of low density at CT, sometimes cyst like, with thin walls and sharp margins, often in a subcapsular location. The walls may demonstrate curvilinear calcifications. Fine internal septa are frequently seen ( Fig. 7-46) \nand are better identified after the administration of IV contrast agent or with MRI.\nLittoral Cell Angioma\nLittoral cell angiomas are rare benign vascular splenic tumors aris -\ning from littoral cells in the red pulp sinuses. They can be as large as 6 to 8 cm and are often multiple. They appear hypodense on noncontrast CT imaging and demonstrate irregular enhancement after administration of IV contrast material ( Fig. 7-47). They may \nbecome relatively isodense with the spleen on delayed imaging, which makes differentiation from splenic hamartomas and hem -\nangiomas difficult because they can show similar features. Usu -\nally the diagnosis can be made only by percutaneous biopsy or splenectomy.\nSclerosing Angiomatoid Nodular \nTransformation\nSclerosing angiomatoid nodular transformation (SANT) is a rare \nbenign vascular tumor composed of multiple red pulp nodules made from endothelial cells interspersed with fibrous bands, sometimes with a central scar. At imaging, unless the scar is identified, there are no particular identifying features. The tumors are typically hypodense but may demonstrate some peripheral enhancement and, like hemangiomas and hamarto -\nmas, can become isodense with the spleen on delayed imaging (Fig. 7-48).\nFigure 7-43. Sagittal US in a 36-year-old woman with a 3.5-cm hyper -\nechoic splenic mass (arrows) representing a hemangioma.\nFigure 7-42. Axial contrast-enhanced CT in a 39-year-old man with an \nill-defined, 3.5-cm splenic mass (arrows) due to an epithelioid granuloma.\nA\nB\nFigure 7-41. PET imaging in two patients with splenic sarcoid, one \nwith diffuse and marked FDG uptake ( A, arrow), the other with discrete \nsubtle areas of uptake (B, small arrows).", "27eeb38f-edb4-497d-8775-60da727a4628": "218\nThe liver, as the largest and most complex organ in the abdo -\nmen, can present with diverse abnormalities. The most common \nclinical conundrum is the characterization of single or multiple hepatic lesions, primarily into benign or malignant disease, but there are many diffuse infiltrative diseases, some of which are dif-ficult to evaluate with imaging, particularly in their early phases. However, modern imaging techniques offer the ability to char -\nacterize many, if not most, hepatic disorders, particularly if com -\nbined with the relevant clinical history. Indeed, as with imaging of other organs, a relevant clinical history is critical for the radiolo -\ngist as he or she attempts to differentiate abnormalities into their disease categories. For instance, the presence of hepatic cystic lesions on computed tomography (CT) in an otherwise healthy 30-year-old is almost always benign, but similar CT findings in a 70-year-old woman with known ovarian cancer may mean meta -\nstatic disease. Furthermore, collateral biochemical, pathological, microbiological, and hematological data are often crucial in reach -\ning the correct imaging diagnosis. As elsewhere, prior imaging is of utmost importance. In the clinical scenario outlined above, the presence of a cystic liver lesion in the 70-year-old woman many years before her ovarian cancer diagnosis would normally signify a benign cyst. Conversely, the presence of a new cystic lesion when compared with prior imaging would indicate a metastasis.\nThe liver is classically divided into eight lobes, or segments, \naccording to the Couinaud* system (Fig. 6-1), and determination of lesion location can be critical if surgical resection is being con -\nsidered. Each segment has portal veins, hepatic arteries, and bile ducts, and each drains into individual lobar hepatic veins ( T able \n6-1). The middle hepatic vein divides the liver into right and left lobes. The left lobe is then further subdivided by the left hepatic vein into medial (segment IV\u2014sometimes further subdivided into segments IVa and IVb) and lateral components (segments II and III) (Figs. 6-1 and 6-2). Segments II and III are in turn sepa-rated by the left portal vein, with segment II above and segment III below (Figs. 6-1 and 6-2). The right hepatic vein subdivides the right lobe into anterior and posterior segments with the right portal vein further dividing these into upper and lower segments (Figs. 6-1 and 6-2). Segment VIII is upper anterior, segment VII is upper posterior, segment V is lower anterior, and segment VI is lower posterior. Segment I, or the caudate lobe, is posterior.\nThe liver has a dual blood supply, with approximately 80% sup -\nplied from the portal vein and 20% from the hepatic artery, and blood freely circulates into the extravascular spaces. An under -\nstanding of this paradigm is important in planning appropriate contrast-enhanced imaging protocols because different diseases have different enhancement characteristics depending on the source of their primary blood supply.\nIMAGING METHODS\nAll imaging methods, from plain radiograph to positron emission tomography (PET), have a role in hepatic imaging. However, the majority of hepatic abnormalities are not only detected, but also characterized, by means of cross-sectional imaging.\nPlain Radiograph and Fluoroscopy\nAlthough infrequently used as a primary imaging tool, the plain radiograph is still useful to assess prosthetic positioning, \n*Claude Couinaud (1922-2008), French surgeon.Chapter  6\nLiver   \nIVC\nIVCPortal ve inHepatic ve ins\nV\nVIVIIVIIIII\nIII\nIIVa\nIVb\nFigure 6-1. Schematic representation of hepatic Couinaud segments.intrahepatic gas, and occasionally calcification and hepatomegaly. Conventional fluoroscopy is still the primary method of choice for performing most interventional hepatic therapeutic procedures.\nUltrasound\nHepatic evaluation by ultrasound (US) is now considered less optimal than CT or magnetic resonance imaging (MRI), par -\nticularly in the United States, although the use of Doppler * \nharmonic and US contrast imaging has shown some advantages. However, these are not in wide clinical use. US still has a critical role in the evaluation of cirrhosis and infiltrative disease, some specific liver lesions, and some interventional procedures. US is highly operator dependent and requires extensive training, and perhaps for these reasons CT and MRI have often superseded it in clinical practice, at least in the United States.", "ffc5b5db-05da-4713-b35e-ee2b763599c9": "28 Gastrointestinal Imaging: The Requisites\nWestern Europe and the United States, there has been a marked \nincrease over the last generation in adenocarcinomas so that they now account for nearly 50% of esophageal tumors in some stud -\nies. Other tumors are very rare (T able 1-6). Approximately 20% occur in the upper esophagus, 50% in the middle, and 30% in the lower esophagus. The staging is listed in T able 1-7.\nThe findings at UGI examination depend on the timing of the \ndiagnosis. Early findings may demonstrate small sessile polyps or plaque-like lesions, although with adenocarcinoma, there is usually an associated Barrett esophagus with small plaque-like lesions or more marked irregularity along the Barrett stricture (see Fig. 1-51). Later presentations produce larger lesions, which \ninfiltrate along the length of affected esophagus, with a shelf-like abrupt transition from normal to abnormal esophageal mucosa (not dissimilar to its colonic adenocarcinoma \u201capple core\u201d coun -\nterpart), with resultant luminal stricture formation (Fig. 1-67). The mucosa is distorted, blunted, or destroyed, and nodular masses can arise, which can ulcerate ( Fig. 1-68). Other lesions \ncan present as flat ulcers surrounded by an edematous rim. A rarer type is varicoid carcinoma, whereby the neoplasm extends sub -\nmucosally along a length of esophagus, giving the appearance of varicosities or thickened folds (see Fig. 1-33). The mucosal folds \nmay not be as smooth as those in esophageal varices, and this result gives a clue to the diagnosis. The patient may not have a history of cirrhosis. Some gastric adenocarcinomas invade the lower esophagus and extend a few centimeters above the GE junction (Fig. 1-69). At UGI examination, it can be difficult to know for certain whether these tumors are primarily esophageal extending to the GE junction or vice versa, and the diagnosis may only be made at endoscopy and biopsy.\nAt CT, the primary tumor can be harder to identify unless it is \nlarge, particularly if the esophagus is undistended and empty of oral contrast medium. However, CT is far superior to UGI exami -\nnation for the identification of any local extension, including regional lymphadenopathy ( Fig. 1-70). In stages I and II and early \nTable 1-7 Staging of Esophageal Carcinoma\nStage Disease Extension\n0 Carcinoma in situ\nI Lamina propria/submucosa\nIIA T ransmural but not further extension\nIIB T ransmural and regional lymph nodes\nIII Regional lymph nodes (or other nodes), invasion of \nadjacent structures\nIVB Regional or other nodes\nIVB Regional or other nodes and distant metastases\n \nB A B\nFigure 1-67. UGI swallow ( A) and axial contrast-enhanced CT (B) of the lower esophagus in a 68-year-old man with marked mucosal irregularity  \n(A; arrow) typical of esophageal carcinoma. The lesion is less evident on CT, with eccentric wall thickening (B; arrow).Table 1-6 Esophageal Carcinoma\nType Frequency\nSquamous Worldwide, 90%; Western Europe/\nUnited States, 50%\nAdenocarcinoma Worldwide, 5%-10%; Western \nEurope/United States, 35%-50%\nSpindle cell carcinoma <1%\nCarcinosarcoma <1%\nPrimary malignant melanoma <1%\nOat cell carcinoma <1%", "b893db48-585e-416e-91ba-745140fe3e38": "2 Gastrointestinal Imaging: The Requisites\npressure. This action may elicit either the hiatal hernia or reflux \nand perhaps be the answer to the patient\u2019s symptoms. In this position, the normal longitudinal mucosal relief images are also observed, and this observation may permit variceal visualization. Finally, the stomach and duodenum should be briefly evaluated in case the patient\u2019s symptoms are due to disease in these organs.\nIf the patient\u2019s symptom is upper dysphagia, then antero -\nposterior (AP) and lateral views of the upper esophagus are taken immediately after the ingestion of the effervescent granules. While the patient drinks the barium, the radiolo-gist both observes and performs rapid sequence images (3 to 4 per second) because the barium usually passes through the esophagus too fast for the radiologist to time the exposure cor -\nrectly. Therefore functional information (i.e., a cricopharyn-geus spasm) and morphological disease can be obtained at the same time.\nThe use of nonionic water-soluble contrast medium, instead \nof barium, is warranted when there is any risk of aspiration or esophageal leak. Although barium is inert and not toxic if inhaled, it may remain within bronchi for an extended period of time. Ionic contrast medium within the bronchi is hyperos-molar and can cause pulmonary edema and generally should not be used for esophageal examination. Barium is also toxic within the mediastinum and peritoneum, hence the use of nonionic contrast medium if esophageal perforation is suspected. Water-soluble contrast medium, which is less dense than barium, may not identify small leaks. If no initial leak or aspiration is identi -\nfied, it is then prudent to follow the examination with denser barium, which may identify a small, contained leak. Even if there is some leakage of barium in these circumstances, it will likely be small, given that water-soluble contrast medium failed to identify any leakage.\nContrast studies of the esophagus (including any viscus) \nare often effective at characterizing the nature of the lesion or abnormality. Extrinsic (extraluminal) masses tend to displace the bowel because of their mass effect and demonstrate shal -\nlow, or obtuse, margins on contrast studies ( Fig.1-2). Masses that \noriginate in the submucosa (or have an intramural origin ) tend \nto demonstrate sharper, less obtuse margins ( Fig. 1-2). Mucosal \nmasses tend to demonstrate acute margins, sometimes pedun -\nculated and sometimes with a stalk. Furthermore, the intralu -\nminal contrast appearances can suggest malignancy or benignity because malignant lesions tend to demonstrate abrupt, sharp margins that are usually irregular (sometimes termed shouldering) and are often short ( Fig. 1-2). Benign lesions, on the other hand, \ndemonstrate smoother borders with little irregularity, although some larger lesions may ulcerate as they outgrow their vascular supply. These rules of thumb generally apply to the entire gas -\ntrointestinal (GI) tract.\nComputed Tomography\nComputed tomography (CT), although still important in the evaluation of esophageal disease, is not the investigation tech -\nnique of choice for most diseases unless the patient has esopha -\ngeal malignancies for which it is used for staging purposes. CT can also be used to evaluate extraluminal or submucosal masses that may impinge on the esophagus because these cannot be observed directly by barium or endoscopic studies. It is also used to evaluate traumatic conditions of perforation, which are iatro -\ngenic, traumatic, or spontaneous. Ideally the patient is asked to drink a cup of contrast material immediately before the CT to delineate the lumen.\nMagnetic Resonance Imaging\nMagnetic resonance imaging (MRI) has even fewer applications in the esophagus given that respiratory motion artifacts are com -\nmon when the chest is evaluated with MRI, although it may serve to evaluate mediastinal and paraesophageal abnormalities when CT is not indicated.\nEndoscopic Ultrasound\nEndoscopic ultrasound has a role in evaluation of submucosal esophageal masses but is rarely performed. Ultrasound has little use otherwise in the esophagus.\nNuclear Medicine\nNuclear medicine still has a role in the functional examina-tion of esophageal motility and reflux disorder, particularly in children.", "9b7f4c93-57bd-4721-b087-77c8ab191016": "Small Bowel 141\nA\n C\n B\nFigure 4-109. Axial ( A and B) and coronal (C) contrast-enhanced CT in an 81-year-old man with massive herniation ( arrow) of small and large bowel \nthrough a right inguinal hernia.\nAB\nFigure 4-110. Coronal ( A) and axial (B) noncontrast CT in an 80-year-old woman with herniation of the appendix through a right-sided femoral hernia \n(arrows), also known as Amyand hernia. (Claudius Amyand 1680-1740, British surgeon.)\nAB\nFigure 4-111.  A and B, Coronal contrast-enhanced CT in a 59-year-old woman with small bowel obstruction due to an obstructing right inguinal \nhernia (arrows).", "8b987f19-c2d2-4b03-951f-1101bba3b50d": "Further disease progression yields fibrotic changes and small bowel stricture formation. Specific signs of Crohn disease are \u201cskip lesions,\u201d representing alternating areas of normal bowel (small or large) and affected segments, and \u201ccobblestoning,\u201d representing areas  \nof mucosal ulceration separated by regions of more normal mucosa.\nThe diagnosis can be made by capsule endoscopy or colonos -\ncopy by passing the scope through the ileocecal valve into the terminal ileum and recognizing inflammatory ulcerative changes that will strongly suggest the diagnosis, which can be confirmed with ileal biopsy. Imaging, however, plays a key role in the diag -\nnosis because the disease usually demonstrates highly character -\nistic imaging features, particularly in the small bowel ( T able 4-2). \nIt is one of the few remaining major indications for SBFT, which should identify either the acute or more chronic changes of the disease. CT is also highly informative and often diagnostic and TaBle 4-1 Small Bowel Fold Thickening\nType Disease Fold Thickening\nInflammatory Crohn disease\nZollinger-Ellison syndromeAdjacent inflammatory diseaseBeh\u00e7et diseaseUlcerative ileojejunitisVasculitisIrregularIrregularRegular/irregularIrregularIrregularUniform\nAutoimmune Lactose intoleranceCeliac diseaseT ropical sprueEosinophilic enteritisGraft-versus-host diseaseMastocytosisAngioneurotic edemaWaldenstr\u00f6m  \nmacroglobulinemiaUniformUniformUniformIrregular/uniformIrregularUniform/irregularUniform/irregularUniformUniform\nVascular Intramural hemorrhageIschemiaRadiationShock bowelPortal hypertensionVascular infarctionCongestive heart failureHypoproteinemiaUniformUniform/irregularUniformUniformUniformUniformUniformUniform\nCongenital LymphangiectasiaAbetalipoproteinemiaAngioneurotic edemaUniformUniformUniform\nInfection Whipple diseaseBacterial, viral, fungal \nprotozoal, parasitic infectionsIrregularIrregular\nNeoplastic LymphomaEndometriosisIrregularIrregular\n TaBle 4-2 Small Bowel Imaging Findings of Crohn Disease\nImaging Finding Mechanism and Terminology Figure\nMesenteric \nhyperemiaVasa recta hyperemia  \n(comb sign)4-8\nMucosal and \nmuscularis enhancementHyperemic response 4-9 to 4-11\nMural  \nthickeningT ransmural inflammatory \nchange\nMural stratification\u2014target \nsign4-12 to 4-15\nUlcers Aphthous (target lesions)Cobblestoning (longitudinal \nand transverse)4-16 and 4-17\nSinus, fistula, and \nfissure formationDeep inflammatory response, \nulceration and penetration through wall; trefoil appearance with fistula4-18 to 4-20\nAbscess Secondary infection from  \ndeep penetrating ulceration4-21\nLymphoid \nhyperplasiaSmall (up to 3 mm) nodular \nmucosal lesions; immune response4-22\nLymphadenopathy Mesenteric adenopathy 4-23\nStricture String sign\u2014edema,  \nulceration, or fibrosis4-24 and 4-25\nSegmental \nnarrowingSkip lesions from fibrosis 4-26\nPseudopolyps Postinflammatory filiform; \nislands of normal mucosa surrounded by ulcerations4-27\nSacculations Antimesenteric border \n(increased intraluminal pressure)4-28\nFat-halo sign on \nCTSubmucosal fat surrounded  \nby soft tissue, mucosa, serosa, muscularis propria4-29\nMalignant \ntransformationMural enhancement, wall \nthickening4-30\n \nCT, Computed tomography.", "424105a5-b0d8-49e1-a965-ced506318120": "*Abraham Vater (1684-1751), German anatomist.\n\u2020Paul Langerhans (1847-1888), German pathologist.Because of the excellent contrast characteristics of T2-weighted \nimaging, pancreatic duct anomalies (either main duct or side branch) are best imaged noninvasively with magnetic resonance cholangiopancreatography (MRCP), although greater anatomical detail will require endoscopic retrograde cholangiopancreatogra -\nphy (ERCP) and, in some circumstances, therapeutic intervention (i.e., pancreatic stent).\nCONGENITAL ANOMALIES\nA brief understanding of pancreatic embryology is necessary to understand congenital pancreatic anomalies. The pancreas is formed by fusion of the ventral and dorsal buds of the embry -\nonic foregut. The ventral bud is originally two buds that fuse early and form to the right of the developing duodenum, while the dorsal bud lies to the left ( Fig. 9-1). The midgut (which \nincludes the duodenum) then rotates clockwise, and the ventral bud rotates along with it and fuses with the dorsal pancreatic bud from behind. The fused pancreas now lies completely to the left of the duodenum. The dorsal duct (duct of Santorini*) from the original dorsal bud now drains the tail, body, and upper head and for a while drains into the minor papilla. The ventral duct (from the original ventral bud), also known as duct of Wirsung,\n\u2020 drains \nthe lower head and uncinate into the major papilla along with the  \ncommon bile duct. Normally, the ventral and proximal dorsal ducts fuse to form the main pancreatic duct, which drains into the major papilla (papilla of Vater). The remaining distal remnant of the dorsal duct usually regresses and drains into the accessory duct of Santorini.\nAnnular Pancreas\nAnnular pancreas is a rare anomaly resulting from abnormal or failed rotation of the ventral bud and/or rotation of the duodenum embryologically (Fig. 9-2) such that the bud fails to achieve its position to the left of the duodenum and instead forms a partial or complete ring of pancreatic tissue around the second part of the duodenum. It can also result when the bifid ventral ducts encir -\ncle the duodenum rather than fuse together. Many patients are asymptomatic, but annular pancreas can present early in child -\nhood because it is commonly associated with other congenital atretic anomalies, including those of the esophagus, duodenum, and anus. Furthermore, the resulting ring can cause duodenal strictures, which if severe can be recognized in the neonate because of copious vomiting from duodenal obstruction, often requiring surgery to remove the stricture. Presentation in adults is usually after repeated episodes of epigastric pain, early satiety, and vomiting from subacute duodenal obstruction.\nThe diagnosis was formerly made with an upper gastrointesti -\nnal (GI) series, in which the second part of the duodenum appears strictured to a variable degree depending on the degree of the anomaly and associated with loss of the normal duodenal fold pat -\ntern (Fig. 9-3). Depending on the degree of stricture formation, the proximal duodenum may be distended or dilated. However, annular pancreas is now detected primarily by CT because of its increased use. The CT findings are characteristic of pancreatic tissue passing to the right and encircling the second part of the duodenum, which is sometimes better visualized on multiplanar imaging (Fig. 9-4). The diagnosis can also be made with ERCP that shows the ventral duct (Wirsung) completely encircling the \n*Giovanni Domenico Santorini (1681-1737), Italian anatomist.\n\u2020Johann Georg Wirsung (1600-1643), German physician.Chapter  9\nPancreas", "d79405c4-6031-4a67-8e3b-e1464fd12f7c": "360 Gastrointestinal Imaging: The Requisites\nB\nA\nFigure 9-39. Axial ( A) and coronal ( B) contrast-enhanced CT in a \n76-year-old man with a large pancreatic adenocarcinoma having a central \nhypodense necrotic area ( large arrows). The tumor also obstructs the duo -\ndenum (small arrows).\nFigure 9-40. Axial reformatted contrast-enhanced CT in a 60-year-old \nman with a subtle 2-cm uncinate mass (large arrow) that obstructs the pancreatic duct (small arrow).\nAA\nB\nFigure 9-41. Axial contrast-enhanced CT ( A) and ERCP ( B) in a \n53-year-old man with chronic pancreatitis and a new pancreatic head mass caused by adenocarcinoma (large arrow). A stricture is present in the lower bile duct (small arrow), as well as calcification (arrowheads).\nFigure 9-42. MRCP in a 61-year-old with dilated pancreatic and biliary \nducts (double-duct sign) (arrows) resulting from an obstructing pancreatic adenocarcinoma.", "c4ea6fad-ef11-4278-8dee-6d0a750c94a5": "Liver 239\nBudd-Chiari Syndrome\nBudd-Chiari syndrome consists of abdominal pain, hepatomeg -\naly, and ascites secondary to lobar or segmental hepatic venous \nocclusion. A primary form is due to outflow obstruction, mainly idiopathic, but can also be secondary to congenital venous webs, trauma, and infections, especially tuberculosis (TB). Secondary forms are usually thrombotic, either at the hepatic venous outflow or within the hepatic central hepatic veins as a result of external venous compression by adjacent hepatic tumors, chemotherapy or radiation, or hypercoagulable states.\nPresentation may be acute or chronic depending on the cause. \nAcute presentation may be fulminant with hepatomegaly and hepatic failure. On noncontrast CT the liver is enlarged and the hepatic veins are attenuated and hyperdense secondary to the thrombus. There are usually associated splenomegaly and asci-tes. Contrast-enhanced CT demonstrates a characteristic \u201cflip-flop\u201d enhancement pattern with early central liver enhancement (particularly in the caudate lobe and region surrounding the IVC) and decreased peripheral enhancement that reverses on the late PVP with peripheral enhancement and central relative lack of enhancement (Fig. 6-50) as a result of portal and sinusoidal stasis. Parenchymal enhancement in both acute and chronic pre-sentations can also mimic the imaging findings of passive venous congestion (Fig. 6-51), with a diffusely heterogeneous \u201cnutmeg\u201d or mosaic-type pattern of parenchymal enhancement. Other fea -\ntures of chronic presentation include hepatic atrophy, sometimes with imaging appearances of cirrhosis (irregular contour, regener -\native nodules), and usually hypertrophy of the caudate lobe ( Fig. \n6-52). The intrahepatic IVC and hepatic veins are attenuated and barely visible. Intrahepatic arterioportal shunting is frequently present.\nVenoocclusive Disease\nVenoocclusive disease usually results from the toxic effects on hepatic sinusoidal endothelium of high-dose chemotherapy, particularly when used with stem cell transplantation, when it is also known as sinusoidal obstruction syndrome. Less often, it occurs after ingestion of some plant alkaloids. The hepatic venules become occluded from inflammation and fibrosis. The clinical effect from the increased intrahepatic sinusoidal pressure leads to portal venous hypertension with hepatomeg-aly, portal hypertension, varices, splenomegaly, and ascites (Fig. 6-53).\nAmyloidosis\nAmyloid proteins, particularly monoclonal immunoglobulin light chains (AL-type) from primary systemic amyloidosis, accumulate within multiple organs (many within the abdomen and pelvis). Diffuse hepatic and splenic protein deposition causes hepato-splenomegaly (Fig. 6-54).\nB\nA\nFigure 6-50. Axial arterial ( A) and PVP ( B) postcontrast fat-saturated \nMRI in a 43-year-old woman with Budd-Chiari syndrome. There is early \ncentral arterial enhancement (arrows) and late peripheral enhancement (small arrows) (flip-flop effect).\nFigure 6-51. Axial contrast-enhanced CT in a 41-year-old woman with \nBudd-Chiari syndrome and a mosaic enhancement pattern to the liver. Note the attenuated IVC (arrow).\nFigure 6-52. Coronal contrast-enhanced CT in a 49-year-old woman \nwith Budd-Chiari cirrhosis and characteristic enlargement of the caudate lobe (arrow). There is also abdominal ascites.", "f7e3a7ae-bb8f-4a28-809c-1e4d54bbd16e": "258 Gastrointestinal Imaging: The Requisites\nA\nB\nFigure 6-97. Axial delayed postcontrast hepatobiliary agent MRI ( A) in \na 69-year-old man with a small caudate lobe metastasis ( arrow), confirmed \nat intraoperative US (B) (small arrow).\nFigure 6-98. Sagittal US in a 59-year-old woman with predominantly \nhypoechoic breast cancer metastases (arrow) with \u201cbull\u2019s-eye\u201d appear -\nances. Box 6-7. Hypervascular Hepatic Metastases\nNeuroendocrine (from any site)\nRenalMelanomaSarcomaThyroidHepatocellular carcinomaChoriocarcinomaSome breast metastases\nB\nA\nFigure 6-99. Axial arterial ( A) and PVP ( B) contrast-enhanced CT in a \n42-year-old woman with metastatic pancreatic neuroendocrine tumor. \nThe hypervascular lesions (arrows) are identified only during the arterial phase.\nFigure 6-100. Axial PVP contrast-enhanced CT in a 66-year-old woman \nwith multiple metastases from colon cancer.of most lesions >5 mm. Some metastatic lesions follow the same \nenhancement pattern as their \u201cparent\u201d primary malignancy and enhance predominantly in the arterial phase ( Box 6-7). The \nknowledge that the patient has one of these underlying malig -\nnancies necessitates both arterial and PVP imaging because many of these lesions, particularly if small, can be detected only during the arterial phase ( Figs. 6-3 and 6-99 ). Hepatic metastases, which", "5d730ce7-ef90-40bf-a25d-2648e13eeaa6": "1The esophagus extends from the lower pharynx at the upper \nesophageal sphincter to \nthe lower esophageal sphincter at  \nthe esophageal vestibule, or phrenic ampulla, just above the gastroesophageal (GE) junction. It consists of inner circular and outer longitudinal muscle layers. There is striated (voluntary) muscle for the upper third and smooth muscle for the lower two thirds, and the esophagus has no serosal covering at any point. It is lined by squamous columnar epithelium throughout. The course of the esophagus is normally indented by the aortic arch, left main bronchus, and left atrium.\nThe esophageal vestibule, or phrenic ampulla, is normally \nslightly distended ( Fig. 1-1). At the upper end of the vesti -\nbule is a slight narrowing, or A-ring, caused by smooth muscle (internal esophageal sphincter), which can be normal or may cause slight dysphagia if hypertrophied. The B-ring is at the GE junction itself (at the lower end of the vestibule, also known as phrenic ampulla) and is not seen unless a hiatal her -\nnia is present. The Z line may be seen as a slight narrowing at the lower end of the phrenic ampulla and represents the epithelial junction between the esophagus (squamous) and stomach (columnar) and will not be seen unless a hiatal hernia is present. Dysphagia will not occur unless the B ring in the lower esophagus is less than 12 to 13 mm, when it is known as a Schatzki*  ring (see discussion later in chapter).\nTECHNIQUES\nOral Contrast Studies\nAlthough cross-sectional imaging techniques are critical for the evaluation of malignant esophageal disease for staging pur -\nposes, most esophageal abnormalities are too small and fine to  \nbe accurately evaluated by them. Contrast examination of the\n \nesophagus (usually with barium) is an appropriate tool for the evaluation of most esophageal disease, but the radiologist\u2019s role has been greatly diminished since the advent and routine use of direct optical endoscopy. However, given that the barium swal-low and upper gastrointestinal (UGI) studies can be exquisite tools for the assessment of both morphological (gross appear -\nance of the pharynx, esophagus, GE junction) and functional esophageal abnormalities (pharyngeal function, esophageal dysmotility, gastroesophageal reflux disease [GERD]), radiolo -\ngists should still be familiar with their use and imaging findings.\nA UGI swallow examination is best performed with both \nsingle- and double-contrast techniques. Before beginning the examination, the radiologist should further question the patient about his or her symptoms and history. The information gleaned from the patient can offer clues and greater specificity about what the radiologist might expect, and the radiologist might then modify or tailor the examination accordingly. At this point, the radiologist should explain the procedure to the patient because compliance is crucial to obtain an optimal examina -\ntion. For instance, after the initial ingestion of effervescent gas granules, the patient should try as best as possible to refrain from eructation, which might defeat the purpose of performing a double-contrast examination. Maximal esophageal and gastric \n*Richard Schatzki (1901-1992), American radiologist.distention provides better images and therefore a greater abil -\nity to detect subtle disease. In \nthe upright position, the patient \nthen ingests the gas granules, followed by a small sip of water to aid rapid swallowing. The goal is to prevent the granules from \u201cfizzing\u201d in the mouth, which reduces their distensive effect in the esophagus and stomach. The patient then swallows a cup of high-density (\u201cthick\u201d) barium, at which point images are taken of the gas-distended esophagus and small mucosal abnormali -\nties can be identified. If any abnormality is identified at this point, multiple tangential views should be taken to allow the radiologist to evaluate the lesion in more detail once the exami -\nnation is finished. T oo often, inadequate oblique and tangential views are taken, resulting in the lesion being visible in a limited plane, which may make formal diagnosis difficult or even impos -\nsible.", "7625fc96-cd8f-4c81-b3e2-6f2fbcf5a574": "esophagus  31\noften causes less ulceration; rather, it may produce a more smooth-\ntapered, achalasia-like appearance.\nESOPHAGEAL MOTILITY DISORDERS\nNormal Peristalsis\nPeristalsis is a complex neuromuscular and involuntary event involving a primary peristaltic wave that is initiated at the moment of swallowing that propels the food bolus caudally with progres -\nsive stripping (or propulsive) waves. This wave is soon followed by the secondary peristaltic wave that results from esophageal distention by the food bolus and is a locally initiated propulsive wave in the area immediately adjacent to the food bolus. Under normal conditions, the result is a smooth, wave-like contraction from upper to lower esophagus. T ertiary contractions are nonpro-pulsive, random, and disorganized contractions observed more often in the elderly. Dysmotility disorders are caused by dispa-rate causes but are probably most common after stroke, given its frequency in the population (T able 1-8).\nNeurogenic Dysmotility\nCentral or peripheral neuropathies can affect esophageal peristalsis and lead to major dysmotility. It is not uncommon after stroke for the patient to have swallowing difficulties, often with aspiration and its consequent complications. Other causes are listed in T able \n1-8. Many of these causes can be sufficiently debilitating that the patient will ultimately require enteral or parenteral feeding; many patients require the placement of gastric or jejunal feeding tubes.\nScleroderma\nThis autoimmune and chronic systemic disease of uncertain eti -\nology affects the skin, lungs, heart, kidneys, and central nervous system (CNS), and commonly affects the GI tract (second most common manifestation after the skin). It is part of the CREST (calcinosis, Raynaud* phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia) syndrome. Within the GI tract, the esophagus is most commonly affected (approximately 90% of cases), although small bowel involvement is also common (50%). There is a progressive smooth muscular atrophy secondary to the chronic fibrosing process that affects the lower two thirds of the esophagus (the upper third is striated muscle). The bowel progressively loses function and becomes dilated with the loss of normal peristaltic activity (Fig. 1-75). The resulting fibrosis leads to esophageal widening and distention rather than stricture for -\nmation, although GERD is common because the GE junction is typically widely patent. The resulting ulceration can cause stric -\nture formation and even a Barrett esophagus. Dermatomyositis can give similar dysmotility appearances to scleroderma.\nAchalasia\nAchalasia is a smooth muscle motility disorder of the lower esoph-agus that can be primary or secondary. Primary achalasia is a dis -\nease, usually starting in young adulthood, that affects the lower esophagus because of a reduction in myenteric ganglia in Auer -\nbach\n\u2020 (or myenteric) plexus that provide motor function to the \nlower esophageal sphincter. The lower esophageal sphincter then fails to relax, with the proximal esophagus steadily dilating over months and years as it attempts to propel food through the stric -\ntured lower esophagus. Clinically, the resulting stasis can lead to halitosis, aspiration, and secondary infection with candidiasis. It is also a premalignant condition with the risk of secondary squa -\nmous carcinoma development, although the diagnosis can be dif -\nficult because the patient has a long history of dysphagia and a small tumor can be easily missed for surrounding food debris.\nSevere forms can even be recognized on a plain chest radiograph \nwith a posterior mediastinal fluid-filled dilated esophagus, which should be confirmed with UGI examination or ultimately EGD because biopsy of the affected esophageal segment confirms the disease. Esophageal dysmotility at UGI examination varies from mild to almost the complete absence of peristalsis in severe forms. A diffusely dilated esophagus is typically identified as a tight stricture at the GE junction with a \u201crat-tailed\u201d or \u201cbird-beak\u201d \n*Maurice Raynaud (1834-1881), French internal medicine physician.\n\u2020Leopold Auerbach (1828-1897), German anatomist.\nFigure 1-74.", "d6cac6b3-fed3-43ae-b362-9d211061af63": "Pancreas  371\nwith multiple internal septa and calcification of the wall and \nsepta. Giant cell carcinomas rarely metastasize, so the prognosis is usually good in these patients if the primary tumor is removed surgically.\nCYSTIC PANCREATIC MASSES\nCystic Pancreatic Neoplasms\nApproximately 90% of cystic pancreatic neoplasms are benign, with the remaining malignant 10% arising predominantly arising from mucinous tumors. Many lesions appear similar at imaging, however, and the challenge for the radiologist is to determine which lesions need to be monitored more closely than others. With modern imaging techniques, it is possible to differentiate many by their location, size, and internal architecture along with the sex and age of the patient (Box 9-3 and T able 9-7). However, some lesions can be identified only by endoscopic US and biopsy or complete surgical removal.\nSimple Pancreatic Cysts\nSimple pancreatic cysts are uncommon and may be congenital in origin, since they are more commonly seen in neonates. At imaging, they are usually thin walled and less than 2 cm, without septa, mural nodules, or thickening, and are therefore innocent (Fig. 9-74). They are usually single but can be multiple. Up to 10% of patients with adult polycystic kidney disease show simple pancreatic cysts, as do 50% of patients with von Hippel-Lindau * \ndisease (Fig. 9-75). Pancreatic cysts can also be seen in patients with Beckwith-Wiedemann syndrome.\nPancreatic Enteric Duplication Cyst\nPancreatic enteric duplication cysts are rare and most commonly found in children. They are usually incidental but can present with complications of pancreatitis and therefore can be confused \n*Eugen von Hippel (1867-1939), German ophthalmologist; Arvid Vilhelm Lindau \n(1892-1958), Swedish pathologist.with pancreatic pseudocyst. They are, however, usually well cir -\ncumscribed and cystic in appearance and tend to be larger than \nsimple cysts (Fig. 9-76).\nPancreatic Cystosis\nIn patients with cystic fibrosis, the pancreas typically becomes fatty replaced (Figs. 9-13 and 9-14 ) or less commonly calcified. \nIn some patients, however, pancreatic epithelial cysts develop because some exocrine function remains, but their ducts are blocked by the viscous inspissated secretions ( Fig. 9-77). The \nolder the individual is, the more likely these cysts are to develop.\nSerous Microcystic Pancreatic Neoplasm\nSerous microcystic pancreatic neoplasms are of uncertain cause but are considered benign. Their walls consist of cuboidal epi-thelium and secrete glycogenic-type material. They are more common in women (4:1) and in patients with von Hippel-Lindau disease. They are much less common than mucinous tumors and account for approximately 15% of cystic pancreatic neoplasms. They are difficult to differentiate from other cystic neoplasms, particularly when small, but as they enlarge, these neoplasms may show characteristic features (T able 9-7). They are usually discov-ered incidentally but if large can produce symptoms of bowel or biliary duct obstruction.\nAt imaging, the lesion is usually well circumscribed and posi -\ntioned in the pancreatic head. Multiple small (<2 cm, often  \n<1 cm) lace-like cysts are identified, giving them their well-known \u201choneycomb\u201d and microcystic appearance (seen in approximately 90% of serous cystadenomas) ( Fig. 9-78). \nApproximately 10% show larger cysts and are termed oligocys -\ntic or macrocystic (not to be confused with macrocystic muci-nous cysts). The cyst walls may enhance and show a central scar, which can calcify, a useful differentiating feature from muci -\nnous tumors ( Fig. 9-79). The tumor typically does not cause  Box 9-3.", "9abba457-bdf5-4ebd-abbb-1052a070c038": "308 Gastrointestinal Imaging: The Requisites\nA\n B\nFigure 7-46. Sagittal US ( A) and axial ( B) contrast-enhanced CT in a 38-year-old woman with splenic lymphangioma. US demonstrates an ill-defined, \nsmall, complex, cyst-like structure ( arrows) with internal septa. CT demonstrates low-density complex cysts with the septa barely visible ( small arrows).\nA\n B\nFigure 7-47. Axial ( A) and coronal (B) contrast-enhanced CT in a 66-year-old woman with multiple hypodense splenic lesions ( arrows) that proved to \nbe littoral cell angiomas.\nA\n B\nFigure 7-48. Axial portal venous phase ( A) and delayed (B) contrast-enhanced CT in a 48-year-old woman with a 4-cm heterogeneously enhancing \nmass (arrows) representing a sclerosing angiomatoid nodular transformation (SANT) that is almost isodense with the spleen on delayed imaging. There \nis a small central nonenhancing scar (small arrows).", "922ea653-b475-4d82-907d-359f336ef683": "Pancreas  351\nECTOPIC PANCREAS\nThe true incidence of ectopic pancreas is unknown, but some \nfigures put the incidence surprisingly at 10% of the population, although the condition is rarely seen in clinical practice. Ectopic pancreas is also known as pancreatic rest or aberrant pancreas. Small areas of pancreatic tissue come to \u201crest\u201d in an ectopic position, usually in the distal gastric antrum along the greater curvature or near the pancreatic ampulla in the second portion of the duodenum. They can, however, be detected in more dispa -\nrate locations, including other intestinal locations and even the pelvis, liver, and spleen.\nPatients are usually asymptomatic, but ectopic pancreas can \ncause gastric or duodenal hemorrhage and, if large enough, bili-ary obstruction or even small bowel intussusception. Rests that are identified at imaging are usually in the expected location of the stomach or duodenum and found mostly with upper GI series because they are too small to be identified by cross-sectional imag -\ning techniques (although they may be inferred from the presence of a small hypodense and cystic mass). The characteristic appear -\nance is of a 1- to 2-cm submucosal mass, either round or eccentric in shape, sometimes lobular, with a central pit or depression that fills with contrast material in the dependent position.\nFATTY PANCREATIC REPLACEMENT\nFatty pancreatic replacement can be a normal aging process as the pancreas becomes increasingly atrophic and fatty replaced (Fig. 9-12).Cystic Fibrosis\nCystic fibrosis is an autosomal-recessive disease with a number of abdominal complications, including diffuse pancreatic insuffi -\nciency when severe. The pancreatic tissue becomes largely fatty replaced, sometimes with small cystic change. On US the fatty change is hyperechoic, but on CT the pancreas is partially replaced by fat (Fig. 9-13) or may not be seen at all, the fatty replacement merging into the surrounding retroperitoneal fat ( Fig. 9-14). Other \nfeatures may include small bowel dilatation and cecal thickening (see discussion in Chapters 4, on the small bowel, and 5, on the colon). The pancreas in cystic fibrosis can also become diffusely calcified or undergo cystosis (see later in the chapter).\nUneven Lipomatosis\nFatty pancreatic replacement can be either diffuse ( Fig. 9-15) or \nfocal, termed \u201cuneven\u201d (Fig. 9-16). It is of little clinical signifi-cance, except that it has been associated with pancreas divisum and can be confused with a pancreatic neoplasm. Fat-suppressed MRI can be helpful in distinguishing between the two.\nPancreatic Lipomatous Pseudohypertrophy\nPancreatic lipomatous pseudohypertrophy is of unknown but possibly congenital origin, causes pancreatic hypertrophy with \nFigure 9-12. Axial noncontrast CT in a 79-year-old woman with an  \nage-related atrophic fatty-replaced pancreas ( small arrows) that has tiny \npunctate calcifications (arrows).\nFigure 9-13. Axial contrast-enhanced CT in a 24-year-old woman with \na partially fatty-replaced pancreas ( arrow) resulting from cystic fibrosis. \nThe pancreatic head and uncinate are normal ( small arrow).\nFigure 9-14. Axial noncontrast CT in a 39-year-old man with cystic \nfibrosis and complete pancreatic fatty replacement (arrows).\nFigure 9-15. T ransverse US of the pancreas in a 44-year-old woman \nwith diffuse echogenicity (arrows) secondary to a fatty pancreas.", "20a18302-bea1-4a29-9b01-5169bf5977a7": "Small Bowel 135\nWithin the GI tract, the esophagus is most commonly affected \n(approximately 90% of cases), although small bowel involve -\nment occurs in approximately 50% of cases. There is a progres -\nsive smooth muscular atrophy of the small bowel wall resulting \nfrom a chronic fibrosing process. The bowel becomes variably functionless and dilated with loss of normal peristaltic activity. The atonic small bowel can also encourage the proliferation of bacteria that are not usually present, resulting in a malabsorp -\ntive pattern. Other features of progressive small bowel changes, which can also occur in the colon, are wide-mouthed diverticula or sacculations, which also harbor bacteria, and these can further exacerbate the malabsorptive pattern. Ultimately, if the fibrosis is severe enough, permanent small bowel dilatation occurs and the mucosal folds are crowded together resulting in the clas-sic hidebound appearance, which can be recognized by SBFT examination (Fig. 4-97).Chagas Disease\nChagas*  disease is caused by the protozoan T rypanosoma cruzi,  \nwhich is endemic in Central and South America. In those regions, it is estimated that approximately 10 million people are infected, most of them being asymptomatic. The disease is trans -\nferred to humans via the reduviid bug, which becomes infected with T . cruzi by feeding on the blood of infected humans. The \nbugs infect other humans by defecating into the bites they cause. In the acute phase, it can be recognized by the Roma\u00f1a\n\u2020 sign, \nwhich is periorbital redness and swelling that appear after the reduviid bug has bitten. Despite treatment, the infection may enter a chronic phase, with most patients being asymptomatic, \n*Carlos Chagas (1879-1934), Brazilian physician.\n\u2020Cec\u00edlio Roma\u00f1a (1899-1997), Argentinean epidemiologist and physician.\nFigure 4-95. Abdominal plain radiograph in a 77-year-old woman with \ndistended small and large bowel due to adynamic ileus.\nAB C\nFigure 4-96. Plain abdominal radiograph ( A) and axial ( B) and coronal ( C) contrast-enhanced CT in a 71-year-old man with adynamic ileus and obvious \ndilated small bowel on CT but little evidence on plain radiograph.\nFigure 4-97. Barium SBFT in a 39-year-old woman with scleroderma \nand dilated small bowel and crowded mucosal folds with a hidebound \nappearance (arrow), characteristic of the disease.", "edbd1d71-776d-4bc2-9ec1-902629d36c29": "54 Gastrointestinal Imaging: The Requisites\nCowden\u2019s* disease (multiple hamartoma syndrome) results in \nwidespread GI hamartomas with thyroid and breast masses.\nInflammatory Fibroid Polyps\nInflammatory fibroid polyps are also known as eosinophilic granulomas because of their histological concentration of eosino-philic cells (not to be confused with eosinophilic gastritis). On imaging they appear as a smooth-walled mucosal mass with or without ulceration, usually in the distal stomach. They are usually asymptomatic.\nBenign Intramural Gastric Tumors\nBenign intramural gastric tumors include gastrointestinal stromal  \ntumors (GIST s), lipomas, lymphangiomas, hemangiomas, \n*Cowden\u2019s disease. Named after the first described patient.schwannomas, and neurofibromas. A GIST is a nonepithelial sarcoma and the most common submucosal mesenchymal tumor throughout the GI tract, with 70% occurring in the stomach, 20% in the small bowel, and approximately 10% in the esophagus. They usually grow slowly and are mostly benign, but when they are large, they can become malignant and metastasize to distant organs. They are thought to arise from the interstitial cells of Cajal*  (responsible for peristaltic regulatory function) and express \nthe c-kit (CD117) receptors, which can be detected by immu -\nnohistochemistry. GIST s are part of the Carney\n\u2020 triad of gastric \nGIST, functioning extraadrenal paraganglioma, and a pulmonary chondroma.\n*Santiago Ram\u00f3n y Cajal (1852-1934), Spanish pathologist.\n\u2020J. Aidan Carney, American pathologist.\nFigure 2-42. UGI series in a 60-year-old woman with a featureless \nstomach due to atrophic gastritis. There is also a small antral polyp \n(arrow).\n Box 2-2. Benign Gastric Masses\nPolyps (hyperplastic, adenomatous, hamartoma, inflamma-\ntory fibroid)GISTHemangiomaLipomaNeurofibromaParagangliomaEctopic pancreasCarcinoid\nGIST, Gastrointestinal stromal tumor.\n Box 2-3. Malignant Gastric Masses\nCarcinomaLymphomaGISTMetastasesKaposi sarcoma\nGIST, Gastrointestinal stromal tumor.\nFigure 2-43. UGI series in a 47-year-old woman with multiple gastric \nmucosal lesions (arrows) due to hyperplastic polyps.\nFigure 2-44. UGI in a 54-year-old man with a lesser curve smooth \nmucosal filling defect (arrow) due to a gastric adenomatous polyp.", "94369c7b-7bdd-4448-99a8-ca5649bdcdbe": "Liver 247\ndiffusion-weighted imaging may be unhelpful in the character -\nization of hemangiomas. Often they show increased DWI signal, \nthe reverse of what one would expect for a benign lesion. This is probably best explained by the slow-flowing blood within these lesions. Protons, therefore, do not travel far between the initial DWI and subsequent rephasing pulse, which therefore appear restricted. However, they are usually bright on the ADC maps, which serve to confirm the benign nature of the mass (Fig. 6-77).\nGiant hemangiomas (>10 cm) usually demonstrate peripheral \nnodular enhancement but typically do not fully \u201cfill in\u201d on delayed imaging (Fig. 6-78). Many demonstrate a central scar that does not enhance (Fig. 6-79), which can be confused with some hepatocel -\nlular and fibrolamellar carcinomas. Their T2 signal characteristics are typically not as bright as smaller hemangiomas but should still be significantly brighter than malignant lesions. The central scar is typically hyperintense (Fig. 6-79).\nGiven the frequency of hemangiomas in the population, it is not \nsurprising that a number demonstrate atypical imaging patterns on a particular imaging method and that further characterization with another method may be required. For instance, the peripheral enhancement may not be classically nodular at contrast-enhanced CT or MRI, or the signal characteristics on T2-weighted MRI may not be sufficiently high to diagnose hemangioma confidently. More than one imaging method may therefore be required. When using multiple methods, it is important to evaluate all the imaging characteristics of the hemangioma from all the images acquired. One method may demonstrate one or two of the classic features of a hemangioma, but another might show other features. By col -\nlating all the imaging findings from the different tests, it should be possible to make a definitive diagnosis in the majority of cases. Sometimes three methods may be required to make the formal \nFigure 6-73. Axial arterial-phase contrast-enhanced CT in a 71-year-old \nman with a 1-cm hypervascular mass ( arrow) that is a carcinoid metastasis.\nB A\nC D\nFigure 6-74. Axial noncontrast ( A), arterial ( B), PVP ( C), and delayed-phase contrast-enhanced ( D) CT in a 61-year-old man with a segment VII hem -\nangioma. The lesion is just visible at noncontrast CT, and there is early peripheral arterial enhancement (arrows), nodular peripheral PVP enhancement \n(small arrow), and almost complete \u201cfilling-in\u201d with contrast material on delayed imaging (thin arrow). This highly characteristic enhancement pattern is diagnostic for hemangioma.", "dacd62cc-7115-41f3-974a-9ba23b81e496": "332 Gastrointestinal Imaging: The Requisites\nPrimary Sclerosing Cholangitis\nPrimary sclerosing cholangitis (PSC) is a chronic disease of the \nextrahepatic and intrahepatic bile ducts that causes progressive and diffuse biliary duct inflammation and stricture formation, often termed either arborized (or \u201cpruned tree\u201d) or bead like. Cholestasis ensues with the formation of multiple small segmen -\ntal ectatic bile ducts. PSC is most likely autoimmune in origin because of the presence of numerous circulating autoantibodies and because up to 80% of patients also have ulcerative colitis. It is also, however, associated with Crohn disease and other autoim -\nmune diseases, including autoimmune pancreatitis and thyroid -\nitis. In most patients it appears before the age of 45 years, and the disease is usually unrelenting with progression through fibrosis and biliary cirrhosis, which may ultimately require liver trans -\nplantation, even though PSC is known to recur in the allograft. There is also an approximate 10% chance that cholangiocarci-noma will develop.\nThe diagnosis is best made with good biliary ductal opacifica -\ntion, and therefore ERCP (or transhepatic cholangiography) is the imaging method of choice ( Fig. 8-48). Segmental strictures are \nfound in the extrahepatic ducts but are most commonly observed \nC\n B\n A\nFigure 8-45. MRCP ( A) and axial (B) and coronal (C) contrast-enhanced CT in a 58-year-old woman with adenomyomatosis and a CT \u201crosary sign\u201d \nwith several tiny stones ( arrows) lodged within the Rokitansky-Aschoff sinuses and the \u201cstring of pearls\u201d sign ( arrowhead) and fundal constriction ( curved \narrow) at MRCP .\nB\n A\nFigure 8-46. Sagittal US ( A) and axial contrast-enhanced CT (B) in a 44-year-old woman with a fundal gallbladder constriction ( arrows) caused by \nadenomyomatosis.\nFigure 8-47. T ransverse US in a 48-year-old woman with ring-down \nartifacts (arrow) in a \u201cstrawberry\u201d gallbladder.", "73004dbd-2cab-4379-a8d8-9b0645815f14": "242 Gastrointestinal Imaging: The Requisites\nAB\nC\n D\nFigure 6-58. Axial noncontrast ( A) and arterial (B), PVP ( C), and delayed ( D) contrast-enhanced CT in a 70-year-old man with multiple hepatic cysts. \nThe cysts have a water density <10 HU and demonstrate no enhancement in any phase.\nFigure 6-59. Axial T2-weighted MRI with several T2 hyperintense \nliver cysts in both the left and right lobes.\nFigure 6-60. Coronal contrast-enhanced CT in a 57-year-old man with \na large cystic mass caused by biliary cystadenoma. Simple hepatic cysts \nare unlikely to reach such size. There is a further smaller cystadenoma in the dome of the liver.homogeneous, low-density mass, with typical densities of <10 \nHounsfield Units (HU), that generally does not enhance after administration of IV contrast medium (Fig. 6-58). Slight enhance-ment may occur (similar to simple renal cysts), but generally <10 HU. On MRI, simple cysts are represented by low T1 and high T2 signal (Fig. 6-59). Cysts are often multiple, but numerous cysts are more likely associated with polycystic kidney disease (Fig. 6-16).\nOn occasion, simple cysts can be confused with other diagnoses. \nBiliary cystadenomas can appear cystic on cross-sectional imaging (Fig. 6-60), but they are usually large and contain internal septa. Biliary hamartomas appear cystic, but they are usually small and numerous (Fig. 6-61). Some metastases are predominantly cystic", "319b074a-1a53-40ee-a4f7-2cb372e4362b": "Garg PK  et al: Subcutaneous and breast metastasis from asymptomatic gallbladder \ncarcinoma. Hepatobiliary Pancreat Dis Int 8(2):209-211, 2009.\nGayer G  et al: Foreign objects encountered in the abdominal cavity at CT . \nRadiographics 31(2):409-428, 2011.\nGeorge C  et al: Computed tomography appearances of sclerosing encapsulating \nperitonitis. Clin Radiol 62(8):732-737, 2007.\nHanbidge AE  et al: US of the peritoneum. Radiographics 23(3):663-684, 2003. \ndiscussion 684-685.\nHarshen R  et al: Pseudomyxoma peritonei. Clin Oncol (R Coll Radiol) 15(2):73-77, \n2004.\nB\nC D\nA\nFigure 10-72. Axial ( A and C) and coronal (B and D) contrast-enhanced CT in a 53-year-old man with cholangiocarcinoma ( large arrows) and AlloDerm \nspacers (small arrows). Recent placement demonstrates serpiginous formation but later appears as a soft tissue density, mimicking a mass and recurrent \ndisease (arrowheads).\nFigure 10-73. Axial contrast-enhanced CT in a 22-year-old woman \nwith a curvilineal density ( large arrow) in the pelvis and associated abscess \n(small arrow) caused by a gossypiboma from a retained surgical sponge.", "725156ff-8aff-48a8-a217-217721297a82": "Colon and appendix  161\nrelatively impermeable bowel wall. This sign is three times as \ncommon in UC as in Crohn disease. Pseudopolyp formation, which can also be recognized in Crohn disease, can occur with more chronic disease and represents areas of reparative mucosa between areas of ulceration (Fig. 5-11). As the disease progresses, the affected length of colon becomes featureless and shortened, termed \u201clead piping\u201d (Fig. 5-12).\nThe presence and extent of disease are more readily evaluated \nby CT than by contrast enema, whose features also mirror the clinical disease. These include bowel wall thickening and luminal narrowing with a variable amount of pericolonic edema and mes -\nenteric vascular hyperemia (Fig. 5-13). The degree of inflamma-tion may be reflected by \n18F-fluorodeoxyglucose (FDG) uptake at \nPET imaging (Fig. 5-13). Mural stratification or double-halo sign, which is common with an acute presentation, is a nonspecific sign for inflammatory bowel disease representing hyperemic mucosa and serosa with intervening submucosal edema (Fig. 5-14). If the acute disease worsens, the mucosa becomes progressively thick -\nened and inflamed (Fig. 5-15), which can ultimately lead to a toxic megacolon, whose CT features include a distended colon with profusely thickened mucosal tissue, sometimes referred to as an \u201caccordion pattern\u201d (see Fig. 5-52).\nMore chronic features of the disease at CT are similar to those \nobserved at BE with colonic shortening and luminal fibrotic nar -\nrowing. However, CT may identify widening of the presacral fat space and a characteristic \u201cfat halo\u201d sign consisting of inner mucosal and outer muscularis enhancement with a nonenhanc-ing middle submucosal ring. This ring is composed of increased \nFigure 5-9. Single-contrast BE with nodular mucosal irregularity ( small \narrow) due to acute ulcerative colitis. There is associated fold thickening \n(arrow) in the terminal ileum due to backwash ileitis.\nFigure 5-10. Single-contrast BE in a 30-year-old woman with ulcerative \ncolitis and multiple \u201ccollar button\u201d ulcers (arrow).\nFigure 5-11. DCBE in 38-year-old man with chronic ulcerative colitis \nand filiform polyp formation (arrow).\nFigure 5-12. DCBE in a 41-year-old woman with chronic ulcerative \ncolitis and diffuse colonic lead-piping. There is also a descending colon benign inflammatory stricture (arrow).", "b104a099-ee99-4b23-b56c-846c17cc290c": "376 Gastrointestinal Imaging: The Requisites\nCystic Pancreatic Neuroendocrine Tumors\nSome PNET s are predominantly cystic ( Figs. 9-60 and 9-62 ), \nwhether functioning or nonfunctioning. Larger nonfunctioning \nPNET s may undergo central necrosis and appear cystic at pre -\nsentation (Fig. 9-90).Acinar Cell Tumor\nAcinar cell tumors are usually heterogeneous, but some are \n predominantly cystic and can be confused with other pancre -\natic cystic neoplasms ( Fig. 9-91). These tumors are, however, \nextremely rare, and the diagnosis may be made only after biopsy or surgery.\nCystic Teratoma of the Pancreas\nCystic teratomas of the pancreas are extremely rare. They usually present late and large and are discovered because of their mass effect on adjacent organs. They tend to be homogeneous and uni-form with a rounded, smooth-walled mass, sometimes with rim calcification, but like teratomas elsewhere, they can present with fat, soft tissue, and coarse calcification.\nPancreatic Lymphangioma\nPancreatic lymphangioma, a very rare presentation of lymphan -\ngioma, is usually identified in the neck or axilla, retroperitoneum, or mesentery. Similar to lymphangiomas elsewhere, pancreatic lymphangiomas are multicystic with thin septa and uniformly hypodense cyst contents.\nSolid and Papillary Epithelial Neoplasm\nSolid and papillary epithelial neoplasms (SPENs), also known as solid and pseudopapillary neoplasms, papillary cystic carcinoma tumors, papillary epithelial neoplasms, and Frantz * tumors, \nare composed of epithelial tissue. These tumors are rare, more common in younger women (90%; often non-Caucasians), and usually large at initial imaging presentation because of their indolent growth pattern. At imaging they are usually located in the pancreatic body and tail. They show complex solid and cystic masses (with or without calcification) and a well-defined capsule, which often avidly enhances. They can therefore appear similar to other cystic pancreatic neoplasms, particularly mucinous tumors ( Fig. 9-92). Internal hemorrhage is common \nbecause they are highly vascular masses, which can be observed after administration of IV contrast medium, helping to differ -\nentiate the lesion from mucinous tumors ( Fig. 9-93). Despite \nthese rather alarming imaging features, only 10% are malignant. \n*Virginia Kneeland Frantz (1896-1967), American surgical pathologist.\nFigure 9-90. Axial contrast-enhanced CT in a 57-year-old man with a \n9-cm complex predominantly low-density necrotic mass ( arrows) repre-\nsenting a nonfunctioning pancreatic neuroendocrine tumor.\nB\nA\nFigure 9-91. Axial ( A) and coronal ( B) contrast-enhanced CT in a \n65-year-old man with a 4-cm complex cystic mass in the head of the pan -\ncreas (arrows) owing to acinar cell carcinoma.\nFigure 9-92. Axial contrast-enhanced CT in a 17-year-old woman with \nan 8-cm complex cystic mass (arrow) representing a solid and papillary \nepithelial neoplasm of the pancreas, not dissimilar to mucinous pancreatic neoplasms.", "1c666047-533b-4a93-ae59-37dfb08c4765": "Stomach  55\nSubmucosal intramural gastric tumors, including GIST s, all \nhave similar imaging findings at upper GI ( Fig. 2-47). They appear \nwith a well-defined border en face, but with a smooth intralumi -\nnal projection in profile (side-on), with the characteristic obtuse \nborders (although this finding is variable depending on the size of the tumor), with similar CT appearances ( Figs. 2-27 and 2-48). \nSome may ulcerate, particularly if larger, which can be seen as a bull\u2019s-eye or target lesion (barium pooling in the ulcer crater sur -\nrounded by a halo) (Fig. 2-49). If they are larger than 2 cm, they are best evaluated by contrast-enhanced CT, where they demon -\nstrate the features of an intramural mass, which usually extends beyond the confines of the stomach wall. Sometimes, they appear as a predominantly extragastric mass and demonstrate heteroge -\nneous enhancement, with areas of necrosis and ulceration if larger (Fig. 2-50). Calcification is recognized in up to 25% of cases.\nLipomas and lymphangiomas can change shape on compres-\nsion because of their soft nature (Fig. 2-51). Lipomas typically occur in the gastric antrum and can prolapse into the duodenum. They can be diagnosed by their fatty density on CT ( Fig. 2-52). \nHemangiomas of the stomach are rare, are usually multiple, and are recognized with associated venous vascular calcification. They are associated with Bean* syndrome (or blue rubber bleb nevus syndrome) and autosomal dominant disease. Patients often have multiple GI hemangiomas, usually in the stomach, that often bleed. Other mesenchymal tumors cannot be differentiated by CT or UGI series and generally require removal for final diag -\nnosis (Fig. 2-53).\nDuplication Cysts\nDuplication cysts occur anywhere along the GI tract and are rare in the stomach. They are smooth-walled submucosal filling defects, usually along the greater curvature. They may commu -\nnicate with the stomach and therefore fill with contrast media at fluoroscopy, giving a large diverticulum-like appearance.\nEctopic Pancreas\nEctopic pancreas is usually asymptomatic, although it can bleed occasionally. Some reports state it occurs in up to 10% of patients, but the incidence in clinical practice is likely to be much lower. The submucosa of the gastric antrum or proximal duodenum is the most common site, but its presence in the esophagus to the ileum has been described. Classically, the ectopic pancreas con-tains small, smooth-filling defects, with a central umbilication that represents a rudimentary pancreatic duct (Fig. 2-54).\nCarcinoid\nCarcinoids are rare in the stomach and are usually benign. Most probably go undetected, but when they are larger, they may ulcerate and bleed and may therefore be sometimes confused with gastric carcinoma. They are not commonly detected by CT, \n*William B. Bean (1909-1989), American physician.\nFigure 2-45. UGI in a 44-year-old man with Gardner syndrome and \nmultiple gastric adenomatous polyps.\nFigure 2-46. UGI series in a 38-year-old man with several small hamar -\ntomatous polyps (arrow).\nFigure 2-47. UGI in a 38-year-old woman demonstrating a smooth, \nrounded submucosal mass (arrow) that proved to be a benign GIST .", "682c984f-de88-4d30-9b08-ee9becd50f17": "76\nNORMAL ANATOMY\nThe duodenum is classified into four parts. The first is the duode -\nnal bulb, which is intraperitoneal before it passes posteriorly into \nthe second part, or C-sweep, which is retroperitoneal and fixed. This second part starts at the superior duodenal flexure and ends at the inferior duodenal flexure. The third part, also retroperitoneal, extends transversely from the inferior duodenal flexure to a point where it starts to ascend at the fourth part to its end at the ligament of T reitz.*  The duodenum also has four layers: the mucosa, sub -\nmucosa, inner circular, and outer longitudinal muscle. The mucosa is lined with multiple mucus-secreting Brunner\n\u2020 glands, most of \nwhich occur in the proximal duodenum and which can enlarge to cause Brunner gland hypertrophy (see later in chapter). The sec-ond part of the duodenum contains two papillae on its medial bor -\nder, the minor papilla (Santorini\n\u2021 or accessory papilla), which is not \nusually visualized by imaging, and the major papilla (ampulla of Vater\n\u00a7), which can be visualized on upper gastrointestinal (UGI) \nseries (particularly hypotonic duodenography) as a small, rounded filling defect in the midmedial wall of the second part of the duo-denum (Fig. 3-1).\nIMAGING EVALUATION OF THE DUODENUM\nHistorically visualization of the duodenum involved UGI contrast studies, but this has now been largely replaced by esophagogas-troduodenoscopy (EGD). UGI contrast studies are now usually reserved to evaluate postoperative situations rather than disease de novo. The CT evaluation of the duodenum, though, has become more important. At fluoroscopy and UGI, the duodenal bulb had typically been the area of greatest interest, mainly because of the propensity of duodenal ulcers in the past. These ulcers are now far less common because of effective medications targeting gastric acid production and antibiotic treatment for Helicobacter pylori bac -\nteria (see later in chapter). Good single-contrast or double-contrast technique is required to fully evaluate the duodenal bulb. The double-contrast technique, like optimized evaluation of the stom -\nach, is somewhat of an art, and considerable expertise is required to assess patients with the variable anatomy, disease, or both.\nThe duodenal bulb is typically situated in a posterolateral axis \n(this can readily be appreciated through observation of its posi -\ntion at axial computed tomography [CT]), knowledge of which is required to fully evaluate bulb disease. The bulb will likely fill adequately with contrast once the patient is positioned in the right side down partial decubitus position. Once filled with bar -\nium, the bulb should be brought en face (perpendicular) to the x-ray beam, which usually requires positioning the patient right side up (right anterior oblique). At this point, the bulb should be adequately coated and distended with gas as a double-contrast view. Sometimes the bulb projects directly posteriorly and can be hard to view en face, but rotation of the patient into various positions (e.g., lateral) should bring the bulb en face, sometimes with the patient in a semiprone rather than semisupine position. Other times, the bulb can only be best viewed with the patient standing, which permits the weight of the gastric antrum to \u201cfall away,\u201d exposing the relatively fixed duodenal bulb.\n*V\u00e1clav T reitz (1819-1872), Czech pathologist.\n\u2020Johann Conrad Brunner (1653-1727), Swiss anatomist.\n\u2021Giovanni Domenico Santorini (1681-1737), Italian anatomist.\n\u00a7Abraham Vater (1684-1751), German anatomist.Duodenal folds are usually best evaluated in the semisu -\npine (right side up) position, and compression paddles may be required to move the gastric antrum away. In this semisupine position, ulcers may be seen as the pooling of barium on the posterior wall or radiolucent areas on the anterior wall (because the denser barium is now dependent on the posterior wall). Con -\nversely, with the patient in a semiprone position (left side up or left anterior oblique), the barium will pool into ulcers on the anterior wall and not the posterior wall.", "6c37aee9-c4d1-436a-bbb8-a0f3c21323e1": "Spleen 313\nB\n AAA\nFigure 7-63. Plain upper abdominal radiograph ( A) and axial noncontrast CT ( B) in a 64-year-old man with a calcified splenic mass ( arrows) resulting \nfrom prior treated splenic echinococcal infection.\n Box 7-4. Splenic Calcification\nVascular calcification\nT uberculosisHistoplasmosisHydatid diseaseSickle cell diseaseVasculitis (SLE)Prior hemorrhage\nFigure 7-64. Axial noncontrast CT in a 38-year-old woman with irregu -\nlar splenic calcification caused by sickle cell disease.\nFigure 7-65. Axial contrast-enhanced CT in a 56-year-old woman with \nsystemic lupus erythematosus and multiple splenic calcifications.", "db7e55d7-f153-4aa0-9ec0-0767272e37dc": "88 Gastrointestinal Imaging: The Requisites\nLymphoid Hyperplasia\nLymphoid hyperplasia is recognized as multiple tiny filling \ndefects within the duodenum and can be a normal variant in chil -\ndren. When seen in adults, though, it is usually associated with giardiasis and hypogammaglobulinemia.\nDuodenal Papillitis\nWhen inflamed, the duodenal papilla can protrude into the duodenal lumen with the appearance of a smooth-walled mass. It is usually a result of an impacted gallstone or pancreatic stone.\nDuodenal Hemorrhage\nHemorrhage into the duodenal wall can result spontaneously from trauma, in patients with bleeding diatheses or those taking anticoagulants, and from Henoch-Sch\u00f6nlein purpura (see  \nChapter 4). The findings can present as either an intramural mass or thickened mucosal folds (Fig. 3-41). T raumatic duo-denal injury can result in marked hemorrhage, particularly as the duodenum is relatively fixed in the retroperitoneum and susceptible to acceleration/deceleration forces (Fig. 3-42). At imaging there are thickened and crowded mucosal folds due to the intramural hemorrhage, which at UGI series are thought to resemble a picket fence (see Chapter 4). CT features may even demonstrate a hyperdense duodenal wall, particularly if the patient has been imaged without oral and intravenous contrast material.\nDuodenal Masses\nMost benign and malignant duodenal masses are common to other lesions elsewhere in the GI tract, although there are some that are unique to the duodenum (T able 3-1).\nA B\nB\nFigure 3-41.  Axial ( A) and coronal (B ) contrast-enhanced CT in a 43-year-old woman with duodenal hemorrhage and diffuse duodenal thickening ( arrows).\nB\n A\nFigure 3-42. Axial ( A) and coronal (B) contrast-enhanced CT in a 22-year-old woman after a motor vehicle accident, demonstrating duodenal widening \nwith luminal hemorrhage (arrows), mucosal thickening, and ascites.", "b1329c3a-2668-4ba1-8c6d-ee47d0721a3a": "Stomach  43\nA\n B\nFigure 2-10. UGI series ( A) and coronal CT (B) in a 59-year-old woman with an organoaxial volvulus. The greater curvature (large arrow) is superior \n(cephalad) and the lesser curvature inferior (small arrow). The GE junction is indicated by the arrowhead.\nFigure 2-11. UGI swallow in a 68-year-old woman with mesenteroaxial \nvolvulus. The GE junction is inferior (large arrow) and the pylorus, superior \n(small arrow).\ntable 2-1 Diffuse Gastric Mucosal Thickening\nBenign Malignant\nGastritis (see T able 2-2)PseudolymphomaVaricesCarcinomaLymphomaMetastases\n table 2-2 Causes of Gastritis\nType Features Location\nH. pylori/peptic Thick lobulated folds, \nincreased areae gastricaeAntrum and \nbody\nDrugs Often causes erosions when \nacuteAntrum, body, \nfundus\nCaustic Thickened folds, ulcers with \nnarrowing when healedAntrum and \nbody\nRadiation Thickened folds and ulcers and \nantral narrowing when healedAntrum, body, \nfundus\nEosinophilic Thickened and nodular folds \nand antral narrowingBody and \nantrum\nInflammatory Aphthous ulcers, thickened \nfolds with larger ulcers in Crohn disease, sarcoid, Beh\u00e7et syndrome, amyloidAntrum and \nbody\nInfectious T uberculosis; syphilis can cause \nlinitis plasticaAntrum and \nbody\nEmphysematous Thickened folds and gas in wall Antrum and \nbody\nPancreatitis Thickened folds along greater \ncurvature; gastric narrowing from fluid collectionsBody and \nantrum\nHypertrophic Large lobulated folds Body and \nfundus\nAtrophic Featureless mucosa with \ndecreased folds and narrowed stomachAntrum, body, \nfundus", "33a97753-544a-4a1d-82d6-c5eb62ff5769": "42 Gastrointestinal Imaging: The Requisites\nline across the stomach from the lesser to the greater curvature) \nso that fundus comes to lie caudal to the antrum and pylorus (see Fig. 2-9). It is more common in patients with previous dia -\nphragmatic rupture when large portions of the stomach come to lie in the chest. On plain radiograph of the abdomen, there can be a distended viscus in the left upper quadrant with an air-fluid level and collapsed small bowel if the volvulus has caused obstruction. The diagnosis, however, is readily made with UGI examination, which demonstrates the volvulus ( Fig. 2-11). On \nCT, the precise diagnosis can be more difficult, unless multipla -\nnar reformations are made, which should correspond to the UGI coronal series.\nDiffuse Gastric Mucosal Thickening\nThere are many causes of gastric mucosal abnormalities, both benign and malignant ( T able 2-1). The most common cause \nof benign mucosal disease is gastritis, which remains prevalent throughout the world, primarily because of peptic ulcer disease (T able 2-1).Gastritis\nGastritis is a generic term that refers to gastric mucosa that has become inflamed and edematous; several causes have been isolated (T able 2-2). Many cases (e.g., erosive, antral, Helicobacter pylori) completely heal once the offending agent is removed, but oth-ers (e.g., granulomatous, caustic, radiation) heal with scarring and luminal narrowing. Imaging with a barium UGI series used to be the investigation of choice for the evaluation of gastritis but has now largely been replaced by direct optical endoscopy and because peptic ulcer disease is now readily treated and cured with antibiotics. However, many of the imaging features of gastri -\ntis are characteristic, and contrast evaluation of the gastric mucosa remains a valuable diagnostic tool. In general, however, it is not possible to differentiate the specific cause of gastritis by imag -\ning. Most causes will produce either focal or diffuse gastric wall thickening, which should be readily identified with good single- or double-contrast UGI series ( Fig. 2-12). However, because a \nUGI series is performed less frequently, the imaging findings of gastritis are now usually observed on CT as diffusely thickened folds (Fig. 2-13). Similarly, this is a nonspecific finding, which can sometimes be overdiagnosed in the collapsed stomach. Gastritis, which is mainly an inflammatory condition, may also demonstrate increased FDG uptake, whatever the cause (Figure 2-13). Gastritis commonly may be confined to the antrum, with relative sparing of the body and fundus (Fig. 2-14).\nFigure 2-7. UGI series in a 72-year-old man with a paraesophageal her -\nnia (arrow). The GE junction lies below the diaphragm.\nB\n A\n C\nFigure 2-8. UGI series and axial contrast-enhanced CT in a 44-year-old woman with both a paraesophageal ( large arrows) and sliding hiatal hernia ( small \narrows). The GE junction lies below the diaphragm.Mesenteroaxial\nOrganoaxial\nFigure 2-9. Schematic representation of organoaxial and mesenteroaxial \nvolvulus.", "f14930b4-14e3-470d-a86f-cd5051ad9463": "252 Gastrointestinal Imaging: The Requisites\nmetastases, which tend to have intermediate T2 signal. After \nadministration of extracellular contrast agents, the lesion, in simi-larity to contrast-enhanced CT, briefly enhances intensely in the arterial phase but rapidly becomes isointense in the PVP . The scar usually enhances in later phases (Fig. 6-88).\nHepatobiliary imaging can be helpful and diagnostic and is the \ncontrast agent of choice when attempting to characterize suspected FNH because most FNH lesions retain hepatocyte function. These are similarly hypervascular at hepatobiliary imaging and enhance intensely on dynamic arterial-phase imaging, which may partially wash out in the PVP and be relatively isointense to the liver. At delayed imaging, however, the lesion is again hyperin -\ntense because its hepatocytic function leads to marked retention of contrast agent (Fig. 6-89). The central scar may enhance on \nAB\nDEC\nFigure 6-82. T2, in-phase ( A), out-of-phase (B), T2-weighted (C), PVP (D), and delayed-phase ( E) contrast-enhanced MRI (same patient as in Fig. \n6-81) with a steatotic liver and hemangioma. The lesion ( arrows) is better seen on in-phase MRI because of the T1 bright steatotic liver that loses signal \non out-of-phase images, reducing the contrast differences between liver parenchyma and the hemangioma. The lesion is T2 bright, characteristic of \nhemangioma, and demonstrates peripheral nodular enhancement at PVP and almost complete contrast \u201cfill-in\u201d at delayed imaging.\nB\n A\nFigure 6-83. Axial contrast-enhanced CT ( A) and T2-weighted fat-saturated MRI ( B) in an 81-year-old woman with a sharply marginated, nonenhanc -\ning, mass at CT, which is mildly hyperintense on T2-weighted imaging, (arrows) caused by a sclerosed hemangioma.", "d0a526ac-5be4-4092-845d-d530ba4af9e3": "364 Gastrointestinal Imaging: The Requisites\nfor the detection of small lesions ( Fig. 9-54). Because lesions \nhave high levels of somatostatin receptors, the somatostatin ana -\nlogue indium-111 pentetreotide (octreotide) can help locate and \ncharacterize these pancreatic lesions ( Fig. 9-55) as neuroendo -\ncrine in origin (insulinoma or otherwise). Ultimately, an explor -\natory laparotomy with intraoperative US may be required if the index of suspicion remains very high and noninvasive imaging tests fail to identify the mass (Fig. 9-56).\nNot all islet cell tumors are hypervascular. Some are isodense \nor hypodense on CT imaging (even in the arterial phase) and may therefore occasionally be confused with adenocarcinoma. However, they tend to be more well circumscribed ( Fig. 9-57) \nwithout peripancreatic extension unless very large with a late presentation. Others are heterogeneous and either partially cystic  \n(Fig. 9-58) or almost completely cystic (Fig. 9-59).\nNonfunctioning insulinomas can be more sinister and indolent \nbecause they often present late owing to the lack of hormone pro -\nduction and early clinical signs. They are therefore usually larger at presentation with mass-like symptoms (pain, obstruction, and invasion of other organs) (Fig. 9-60). Because they are large, insu -\nlinomas are often necrotic, but the active periphery of the tumor can enhance avidly like other islet cell tumors. They can also be cystic in appearance, like functioning tumors, and calcification is present in 20% ( Fig. 9-61). They are often metastatic (80% to \n90%), either locally or distantly (hypervascular liver metastases), and consequently patients have a relatively poor 5-year survival rate (45%).Gastrinoma\nGastrinomas are the second most common pancreatic neuroen-docrine tumors and are associated with MEN1 in approximately 20% to 40% of patients. They arise from alpha-1 cells and typi -\ncally reside in the pancreas but can be ectopic in the second part of the duodenum or stomach. They are often small, like insuli -\nnomas, but are more likely to be multiple (75%). Investigation \nof the patient is triggered by clinical symptoms (also known as Zollinger-Ellison* syndrome) that result from profuse ulcer -\nation of the gastric, duodenal, and even proximal jejunal mucosa because of gastrin hyperproductivity ( Fig. 9-62). This peptide \nhormone normally stimulates gastric parietal cells to secrete hydrochloric acid, so with excessive hormonal production, pro -\nfuse upper intestinal tract inflammation and ulceration ensue.\nBecause of their sometimes ectopic location outside the pan -\ncreas, gastrinomas are more frequently missed than insulinomas, and careful evaluation along the medial border of the second part of the duodenum is required. With optimal bolus timing and dedicated arterial multidetector CT, most tumors should be detected. Metastases are far more common (approximately 60% of gastrinomas) than with insulinomas (10%) ( Fig. 9-63) and can \nalso secrete gastrin, and palliative treatment involves gastrectomy or H\n2-blocker therapy.\nGlucagonoma\nGlucagonomas are rarer than either insulinomas or gastrinomas and arise from alpha-2 islet cells. Even though they secrete glu -\ncagon, glucagonomas often present late and large, and up to 80% are metastatic to the liver or regional lymph nodes at the time of diagnosis. They are usually located in the body and tail of the pancreas ( Fig. 9-64). Clinical findings are secondary to the \nelevated glucagon levels and include diabetes mellitus, anemia, weight loss, hypoaminoacidemia, and a characteristic necrolytic migratory erythema.\nVIPoma\nVIPomas secrete vasoactive intestinal polypeptide (VIP) from delta-1 islet cells, producing the WDHA (or WDHH) syndrome of watery diarrhea, hypokalemia, and achlorhydria and hypovo -\nlemia. Up to 50% are malignant, and most occur in the body and tail of the pancreas.", "fcf98cb9-73db-471e-a161-4376dd77895a": "348 Gastrointestinal Imaging: The Requisites\nDorsal pancreas\nVentral pancreas\nFigure 9-2. Schematic representation of an annular pancreas. The  \nventral pancreas rotates abnormally to variable degrees and either  \npartially or whole envelops the second part of the duodenum.\nFigure 9-3. Upper GI series in a 44-year-old woman with narrowing of \nthe second part of the duodenum (arrow) caused by an annular pancreas.\nBB\n AA\nFigure 9-4. Axial ( A) and coronal ( B) CT in a 71-year-old man with an annular pancreas. A cuff of pancreatic tissue surrounds the second part of the \nduodenum (arrows).CBDHepatic ducts\nGB\nVentral pancreasDorsal pancreas\nDuodenum\nAB CVentral pancreasDorsal pancreas\nFused dorsal and\nventral pancreas\nFigure 9-1. Schematic representation of embryological development of the pancreas. The ventral and dorsal buds are originally separate ( A). The \nventral pancreas then rotates clockwise to fuse with the dorsal pancreas (B and C).", "ad79f7fd-5417-42b1-9137-08e53a77a072": "Secretin is a power -\nful hormonal stimulant for pancreatic bicarbonate production (required for duodenal neutralization of gastric acid). When injected, it causes a temporary increase in the production and therefore volume of pancreatic fluid, which should pass nor -\nmally into the duodenum. T ypically, in the healthy patient, after 0.4 \u00b5g/kg is injected, the duct dilates slightly (from a normal 1 to 3 mm to between 4 and 6 mm) but returns rapidly to normal. Conversely, the duct remains dilated for up to 30 minutes in the presence of a functional obstruction. Measurements are made using US or, more commonly, coronal MRCP (Fig. 9-11).\nFigure 9-5. Axial contrast-enhanced CT in a 38-year-old woman with a \ncongenitally short pancreas and missing tail (arrow).\nFigure 9-6. Axial contrast-enhanced CT in a 41-year-old woman with a \npancreatic uncinate (arrow) but no body or tail because of partial agenesis.\nFigure 9-7. Axial and coronal contrast-enhanced CT in a 76-year-old \nman with pancreas divisum. The minor pancreatic duct (Santorini; \nlarge arrow) remains anterior to the bile duct and major pancreatic duct (Wirsung; small arrow).", "025792ed-b93e-4630-b3a0-6bc9536991e9": "DuoDenum  81\nSuperior Mesenteric Artery Syndrome\nAlthough SMA syndrome is a congenital abnormality, it usually \npresents in adulthood, often after significant weight loss from severe acute illness. The theory is that as the retroperitoneal fat is metabolized, the angle between the proximal SMA and aorta becomes more acute, thereby compressing the duodenum that passes left to right immediately beneath this angle. Duode -\nnal and gastric distention then occurs near the obstruction. The diagnosis is made in the correct clinical setting with contrast-enhanced CT demonstrating the features of a dilated duodenum, marked narrowing of the duodenum as it passes behind the SMA, and a relative paucity of retroperitoneal fat ( Fig. 3-16). Duodenal \nnarrowing at the level of the SMA, though, can also be a normal finding, and correlation with clinical symptoms is required.\nDUODENAL BULB DISEASE\nThere are a finite number of duodenal bulb diseases, most of which are benign ( Box 3-1). Malignant lesions are rare. Normal anatomical \nstructures can impress upon the duodenum (colon and gallbladder), which creates a smooth effacement of the duodenal bulb ( Fig. 3-17).\nHeterotopic Gastric Mucosa\nHeterotopic gastric mucosa represents ectopic gastric mucosa most often situated in the duodenal bulb, although it can occur in the esophagus, jejunum, and even ileum. It can be recognized usually only at double-contrast UGI (or EGD) as small, plaque-like filling defects in a mosaic-like pattern (Fig. 3-18).\nBrunner Gland Hyperplasia\nBrunner glands secrete alkali, protecting the proximal small intestine from the hyperacidity produced by the gastric mucosa. The cause of their enlargement is uncertain, but multiple Brun -\nner glands can be seen in the duodenal bulb, extending for a short distance into the second part of the duodenum. They are visualized on UGI series, particularly with double-contrast views, \nwhich dem  onstrate multiple small (<5 mm) nodular filling defects \n(straw  berry-like) in the distended duodenal bulb ( Fig. 3-19). \nWhen there is only one, it is known as Brunner gland adenoma or hamartoma. This can have an appearance similar to flexural pseu -\ndotumor if situated at the inferior margin between the duodenal bulb and second part of the duodenum.Duodenal Flexural Pseudotumor  \nor Pseudopolyp\nDuodenal flexural pseudotumor or pseudopolyp is a normal \nvariant in which the angle between the duodenal apex and the descending duodenum is particularly acute, and it is more com -\nmon in thin, asthenic individuals. The duodenal mucosa on the inner (inferior) aspect of this abrupt angle is sometimes heaped up into the duodenal lumen, giving the spurious appearance of a mass (Fig. 3-20). Repositioning the patient on the fluoroscopy \n Box 3-1. Duodenal Bulb Abnormalities\nHeterotopic gastric mucosaBrunner gland hypertrophy and adenomaFlexural pseudotumorPeptic erosions and ulcerNeoplastic (GIST, adenoma, carcinoma, lymphoma)\nGIST, Gastrointestinal stromal tumor.\nB\n A\nFigure 3-16. UGI ( A) and axial ( B) contrast-enhanced CT in a 65-year-old woman demonstrating gastric and duodenum dilatation ( arrow in A) and \nstricture formation (arrow in B) due to superior mesenteric artery syndrome.\nFigure 3-17.  UGI series in a 39-year-old woman with smooth effacement of \nthe duodenal bulb (arrow) caused by duodenal compression by the gallbladder.", "76e5d796-4ff7-49e2-99bb-8d8b4572ee7a": "Small Bowel 121\nSalmonella, of which there are also many species, is another \ndysenteric disease, ranging from a mild diarrheal food \npoisonin  g\u2013type illness to typhoid fever and responsible for \nmillions of deaths through the ages. Most patients with simple \nfood poisoning have few or no imaging findings. Salmonella typhi  \ninfection, on the other hand, is responsible for typhoid fever, which is often a chronic, systemic disease with terminal ileal changes at imaging. Patients have a progressively high fever, cough, headache, bradycardia, and profound malaise. Although there is marked terminal ileal disease, there is little, if any, diar -\nrhea. T erminal ileal hemorrhage may occur and appear with melena and perforation, and septicemia is often fatal. Ulti-mately, patients become severely dehydrated because of their fever and delirium. Most patients survive, though, with ade -\nquate rehydration alone, and antibiotics will expedite recovery. At imaging, there is nonspecific terminal ileal thickening, and splenomegaly is noted in severe cases (Fig. 4-66).Yersinia enterocolitica, also a gram-negative bacillus, can cause \na self-limiting enterocolitis of the terminal ileum and cecum. The disease can be confused with acute appendicitis, given that patients often have right-sided abdominal pain and fever. At imaging there is nonspecific terminal ileal and/or cecal or ascend -\ning colonic thickness, but there may be regional lymphadenopa -\nthy because the disease can also invade Peyer patches and extend beyond to local lymph nodes (Fig. 4-67).\nCampylobacter jejuni is a gram-negative helical organism, com -\nmonly responsible for gastroenteritis, usually by food poisoning. \nAB\nFigure 4-64. Axial ( A) and coronal (B) contrast-enhanced CT in an immunosuppressed 51-year-old man with tuberculous peritonitis. There are termi-\nnal ileal thickening and stricturing (small arrows), ascites, and peritoneal masses caused by tuberculous adenopathy (large arrows).\nFigure 4-65. Axial contrast-enhanced CT in a 39-year-old man with ter -\nminal ileal wall thickening (arrow) caused by shigellosis.\nFigure 4-66. Axial contrast-enhanced CT in a 41-year-old man with ter -\nminal ileal mural thickening (arrow) due to Salmonella typhi infection.", "47a02333-32e3-4da7-adda-cf0d48a12af8": "Peritoneum , retroPeritoneum , and mesentery  383\nA\n C\nD\n E\nB\nFigure 10-2. Posteroanterior ( A) and lateral plain chest radiograph (B) and axial (C), coronal (D), and sagittal (E) contrast-enhanced CT in a 39-year-old \nwoman with a Bochdalek hernia. A posterior soft tissue supradiaphragmatic density ( large arrow) and gas lucency ( small arrow) are identifiable on chest \nradiograph, and represent stomach and pancreas, identified on axial, coronal, and sagittal CT images (arrowheads).\nC\n B\n A\nFigure 10-3. Lateral plain radiograph of the chest ( A) and axial (B) and sagittal (C) contrast-enhanced CT in a 77-year-old man with a Morgagni hernia \nand the hepatic colonic flexure passing into the chest anteriorly (large arrows). There is also a small left subphrenic collection (small arrows).", "ae95951d-ed03-4d13-80c9-ee4563b1b8f7": "Colon and appendix  177\nedematous mucosa. Eventually, ulceration occurs and further \nextension of the disease results in an ameboma, a relatively large mass that develops from a granulomatous reaction to the infes -\ntation. This can cause luminal narrowing, can appear similar to colon carcinoma, and is a recognized cause of colonic obstruction. Amebae can then infest the liver and are a well-recognized cause of hepatic abscess with an \u201canchovy paste\u201d color at percutaneous drainage.\nThe imaging features are not specific to amebiasis and include \nmucosal thickening, sometimes severe with \u201cthumb-printing\u201d (Fig. 5-57). The disease may progress to toxic megacolon. Unless amebiasis is considered, the disease may be mistakenly diag -\nnosed as IBD, which has a very different treatment regimen. The diagnosis is readily made by identifying stool cysts or by antibody detection at serological testing. Amebomas are recognized at CT as heterogeneous masses, either single or multiple, and are one of the recognized causes of a \u201cconed\u201d cecum, in which the cecum takes on the shape of an inverted cone because of circumferential diffuse inflammation. Other causes of a coned cecum are listed in T able 5-4.Colonic Schistosomiasis\nColonic schistosomiasis is usually due to Schistosoma mansoni or \nSchistosoma hematobium (rather than Schistosoma japonicum), which \ncan infect the genitourinary tract and liver, but chronic infec -\ntion can result in granulomatous polyps, particularly in the rec -\ntosigmoid region. Pericolonic abscess may form, resulting in left colonic fibrotic strictures, not dissimilar to UC. Large granuloma -\ntous masses (bilharziomas *) can develop, mimicking adenocarci -\nnoma. The diagnosis should be suspected in patients traveling from endemic regions.\nColonic Gonorrhea\nColonic gonorrhea in women arises either from secondary ure-thral, vaginal, and cervical infection or from direct infection \n*Theodore Maximilian Bilharz (1825-1862), German physician.\nFigure 5-56.  BE in a 39-year-old man with marked distortion of the cecum \n(coned cecum) (small arrow) and terminal ileum (arrow) due to chronic ileo-\ncecal TB.\nTable 5-4 Causes of Coned Cecum\nType Disease\nInfectious AmebiasisT uberculosisActinomycetes\nInflammation Crohn diseaseAdjacent appendiceal disease\nNeoplastic AdenocarcinomaLymphoma\n \nA\nB\nFigure 5-57. Axial ( A) and coronal ( B) contrast-enhanced CT in a \n33-year-old man with cecal mucosal thickening (arrows) due to amebic colitis.", "5b76c0be-3ca5-41df-8923-8d8684f2f361": "334 Gastrointestinal Imaging: The Requisites\nmost common opportunistic organism is Cryptosporidium parvum, \nbut others include cytomegalovirus, microsporidia, and Cyclospora. \nPatients present with a Charcot * triad of fever, pain, and jaundice, \nand most already have a known diagnosis of AIDS. At imaging, both \nintrahepatic and extrahepatic duct dilatation is usually present, interspersed with multiple stricture formation not dissimilar to that in sclerosing cholangitis. The gallbladder is commonly thickened and often demonstrates irregular linear wall lucencies (Fig. 8-40). Evidence of opportunistic infection elsewhere in the abdomen (ret -\nroperitoneal adenopathy) or enteritis is often present.\nParasitic Cholangitis\nAscaris Species Infection\nAscaris lumbricoides is a parasitic nematode worm that typically \ngrows to 20 to 30 inches long. These worms are highly prevalent in most developing countries, and patients are often infested with numerous worms. Given their thin tubular nature, they have a propensity to burrow into the lower CBD through the ampulla of Vater and may cause biliary and pancreatic duct obstruction, the latter leading to pancreatitis. Occasionally a worm manages to \n*Jean-Martin Charcot (1825-1893), French neurologist.navigate up the bile duct and even into the gallbladder, where it can be identified by US or ERCP (Fig. 8-53).\nAsiatic or Oriental Cholangitis\nOriental cholangiohepatitis, caused by Clonorchis sinensis (or Chi-nese liver fluke), is endemic in Southeast Asia and is responsible for Asiatic or oriental cholangitis, also known as recurrent pyogenic cholangitis. The fluke uses the fresh-water snail as an intermedi -\nate host in which cysts mature into cercariae, burrow their way out of the snail, and penetrate fish bodies. Humans who consume the fish become infected. The cercariae resist degradation in the small intestine and migrate to the biliary system, where they sexu-ally reproduce and set up a biliary inflammatory response. The repeated infections lead to intrahepatic and extrahepatic duct inflammation (compounded by fluke volume and eggs), strictures, and stone formation, which are characteristic of this disease. The CT findings are characteristic in the appropriate clinical setting, with irregular and dilated ducts ( Fig. 8-54), many of which are \nfilled with stone material ( Fig. 8-55). As with gallstones, the overall \nstone burden may not be evident on CT . Given that the stones are predominantly intrahepatic and many are in distal locations, they can prove almost impossible to remove and repeated cholangitic attacks occur. Cholangiocarcinoma is a complication of the disease and is common in regions where the disease is endemic ( Fig. 8-54).\nChemotherapy-Induced Cholangitis\nChemotherapy-induced cholangitis is a complication of transar -\nterial chemoembolization (TACE) with toxic chemotherapeutic \nA1\nB\nFigure 8-51. A and B, US in a 70-year-old man with ascending cholangitis caused by obstructive jaundice from pancreatic adenocarcinoma and a \ndilated CBD (16 mm) (long arrow) and intrahepatic ducts (short arrows).\nFigure 8-53. Sagittal US in a 43-year-old man with a tubular gallbladder \nfilling defect (arrows) caused by Ascaris species worm.\nFigure 8-52. T ranshepatic cholangiogram in a 46-year-old man with \nprior choledochojejunostomy that is strictured ( arrow) with dilated intra -\nhepatic ducts and ascending cholangitis.", "aaf8375e-ca3d-4bea-8b7e-1ccd36a75867": "142 Gastrointestinal Imaging: The Requisites\nAB\nFigure 4-112. Axial ( A) and coronal (B) CT in a 76-year-old man with a strangulated inguinal hernia with infarcted small bowel (arrows).\nFigure 4-113. Axial CT in a 66-year-old woman with a ventral hernia that is incarcerated and partial small bowel obstruction ( arrow).\nB\n A\nFigure 4-114. A and B, Axial contrast-enhanced CT in a 49-year-old woman with an incarcerated incisional hernia. There is proximal small bowel \nobstruction (large arrows) and distal small bowel wall thickening (small arrows) due to vascular compromise."}, "relevant_docs": {"437e2817-a8eb-4999-ba2d-bad745c8c41d": ["b4ad2fb2-768a-41c8-aeaa-f72ac14ae318"], "0a354d69-e6b2-4658-be91-252df509e03a": ["b4ad2fb2-768a-41c8-aeaa-f72ac14ae318"], "ee0947a8-082f-4fb2-b4d8-8f77eef7e976": ["ebfd1aee-fb85-4b39-b2ac-0ff424b56af2"], "acee5ca4-ab70-4c54-b0ac-c467d105cbf8": ["ebfd1aee-fb85-4b39-b2ac-0ff424b56af2"], "6d6a3a1b-1fc5-4e24-a904-035336ca8f6d": ["36661fcf-38a9-49dc-acaf-05b98de64243"], "25b5f145-ef43-4dc0-80f5-6a55636b7a4d": ["36661fcf-38a9-49dc-acaf-05b98de64243"], "cf472d58-6854-48b4-86aa-4076cd546259": ["49c5dd72-d2a4-4570-9557-2f06c06f8c5d"], "57d8b6be-6e95-462d-8287-95722fe45694": ["49c5dd72-d2a4-4570-9557-2f06c06f8c5d"], "3761b8b5-e256-49c7-b96b-b1a3e7854a7f": ["79a16327-5f36-4862-8c7b-6837c350070c"], "0263d73a-7368-4785-bc23-26e0ebd087db": ["79a16327-5f36-4862-8c7b-6837c350070c"], "53b1d552-4fe9-4663-86fe-12ebfeb1babd": ["3461c1b3-544d-4012-adf7-f12632c08bbb"], "7ec446ec-3e2e-4fbb-b0a0-2e3a72f36ed8": ["3461c1b3-544d-4012-adf7-f12632c08bbb"], "df9cff71-86e0-4e43-b93b-7cb29ee2f9a3": ["a2026c64-37f5-4217-85d7-4ea7dac7d47d"], "bb5e31b2-287a-4df3-b58e-92ba58275247": ["a2026c64-37f5-4217-85d7-4ea7dac7d47d"], "423c6a2a-287e-4dd9-b390-a1274ff54d2f": ["f788758b-d8f0-4420-98c7-39454235cb1e"], "9b12663a-5202-40e1-aeea-ed9e2df2688d": ["f788758b-d8f0-4420-98c7-39454235cb1e"], "1330230f-09f0-45b7-bf5e-5f51decc12fb": ["8c8ed924-469e-4ad3-be05-79f9eb536bc7"], "f969d48c-c9ea-4475-b441-4ac369e0b101": ["8c8ed924-469e-4ad3-be05-79f9eb536bc7"], "f94747c6-d77c-4970-9d83-af0868810753": ["170d315d-8392-4243-98b0-39e690983815"], "fb02cc36-9158-4fc5-8265-409f1cb382b1": ["170d315d-8392-4243-98b0-39e690983815"], "dc149985-0fa0-4427-9dec-1f0aee0561a5": ["dd6696de-dd14-4bc0-a121-2bfec817e140"], "5bb3fd0c-04e9-4a62-802d-d85ea187f4e1": ["dd6696de-dd14-4bc0-a121-2bfec817e140"], "c4380032-00ef-4a5e-84a2-280b3b724d75": ["6bdc0a8b-efd5-4f11-b1f9-bdbb4b1f9fe3"], "0224721d-814f-4815-957a-4f591edd8139": ["6bdc0a8b-efd5-4f11-b1f9-bdbb4b1f9fe3"], "d3f2f48a-4cb4-47da-956a-4ef42f8ae0ce": ["9ab2c172-d4a3-4c77-9bac-494aa1dc0bb1"], "10721628-a586-4796-8106-b4692b410d59": ["9ab2c172-d4a3-4c77-9bac-494aa1dc0bb1"], "00eac5b1-80f5-4f74-8e6f-b904e504ef6b": ["ee1b5eef-eb9c-4e32-8c82-f65ec75cc9b2"], "226946b5-00e8-4344-a011-2a26637b93a4": ["ee1b5eef-eb9c-4e32-8c82-f65ec75cc9b2"], "d3cb2f5a-14bc-4a25-926b-796c41d3a370": ["9439454a-9603-42d7-898b-eb0545c640a2"], "529ee77a-14e3-480b-a99e-31046371a3d4": ["9439454a-9603-42d7-898b-eb0545c640a2"], "2ee108d4-1a1b-44b9-9b5e-3cdb232082ca": ["34f36acb-ce3e-4c06-b24c-e1ff19cc5c30"], "b58980a4-4b50-45f3-a3e1-60b358d294f5": ["34f36acb-ce3e-4c06-b24c-e1ff19cc5c30"], "308b0039-1fcb-49d9-96e1-d9105fba2b48": ["0df53e12-11ee-4ac9-90f2-5d2b959ccd49"], "32717a0c-7ebf-4b44-9d24-193690d7130e": ["0df53e12-11ee-4ac9-90f2-5d2b959ccd49"], "8d8ddd51-50fb-4dc7-aaa6-118fae891150": ["aa96b412-89d7-42f0-9074-1e018ad0dd2e"], "ca415049-2bfc-46c8-82b0-7a7105db43f7": ["aa96b412-89d7-42f0-9074-1e018ad0dd2e"], "ad083f5e-57e6-4ae8-ac2d-64992243770a": ["604266c1-e8b9-428e-b08c-7277946bb9ff"], "c05f8e5c-8037-4cea-919e-e7a466ca2726": ["604266c1-e8b9-428e-b08c-7277946bb9ff"], "c528b41c-0598-4a63-a20c-f6e6345761c8": ["98c76c4d-76cd-45e7-bef9-046013a8fa3f"], "c779ab41-5f39-48f1-baf0-c802f49ad589": ["98c76c4d-76cd-45e7-bef9-046013a8fa3f"], "ce2e1fbe-7847-4adf-b494-0d49625000eb": ["c4277636-fa10-41b7-a16d-0b6567abc9e6"], "6f65fe24-7c5d-4e79-a122-39703712d7b4": ["c4277636-fa10-41b7-a16d-0b6567abc9e6"], "8f8e21ec-b895-43d1-b854-1e502158d623": ["7232c25d-348e-49ef-b46d-d13afe31be4a"], "641430e1-2d7a-4a83-bdc0-47833b571901": ["7232c25d-348e-49ef-b46d-d13afe31be4a"], "ee265b35-7eea-4c5b-ac35-9699676943bd": ["e72dd72e-daf7-4f91-a7dc-b9135837747f"], "70687531-fd2a-40dd-8bce-9db001599fad": ["e72dd72e-daf7-4f91-a7dc-b9135837747f"], "ec853d42-3642-4da8-950e-66e6dd639522": ["7fc9d652-25a3-409f-aac3-e3becd3f601b"], "97b36390-811e-4771-be66-9b9fe0389adf": ["7fc9d652-25a3-409f-aac3-e3becd3f601b"], "8e5995ce-95b1-44e3-8ecd-51790e7a82a7": ["841440cf-7f07-4d5d-8048-059c8a81249c"], "479c7680-177d-4bec-a015-68244b21d1a5": ["841440cf-7f07-4d5d-8048-059c8a81249c"], "2d790da8-aa84-431f-a5be-00c8aba4328d": ["e831dcd5-8f43-4305-9954-25fd2b3254d9"], "2f14a8fa-a779-443c-af88-cf6edf104ac2": ["e831dcd5-8f43-4305-9954-25fd2b3254d9"], "57523150-3b82-432d-bda1-c8cd615e92fe": ["fcf83005-a1da-4bec-9195-0170a18603d8"], "31b7b901-f926-410a-8dba-ecff7138db39": ["fcf83005-a1da-4bec-9195-0170a18603d8"], "7a0a45bc-1068-4798-bdd5-0ef2e074ea1c": ["5059cfe3-93be-420e-90df-313ad6e4ff54"], "5aa13a81-c60d-4d1e-a220-e475310c94d2": ["5059cfe3-93be-420e-90df-313ad6e4ff54"], "2da5e234-4537-480b-a9ed-2ab1cf4105b6": ["a5a26d4e-bec6-4488-a119-dd5bb4a5e225"], "0589b771-de76-4c52-83f7-0cdf599a63eb": ["a5a26d4e-bec6-4488-a119-dd5bb4a5e225"], "eb2bcfda-9358-41d8-a636-3891aff11341": ["6e46995f-0e73-4fa6-a360-6941cd870e6b"], "01edf6d9-5605-4764-8a90-ee1abc74a42e": ["6e46995f-0e73-4fa6-a360-6941cd870e6b"], "58d54bdb-3c4a-4315-aff7-9c6508100f12": ["fa36e8f7-e0e0-4ac3-b7f3-5a37c9280da8"], "0029cb99-3173-4daa-8d05-f3098e2a3580": ["fa36e8f7-e0e0-4ac3-b7f3-5a37c9280da8"], "a0ffe8d5-10bf-426e-bf53-b0baa21f97db": ["e8250bd3-9383-4ffd-8ffa-10526c6c529d"], "b51f52ea-acf5-445c-ae29-03142e719d37": ["e8250bd3-9383-4ffd-8ffa-10526c6c529d"], "5384ce97-9bd2-483c-9375-ac8cfddeffbb": ["17642ab8-5b28-42ab-9318-1d302904d697"], "e468296d-1884-42ab-9278-6d6c107ce1c3": ["17642ab8-5b28-42ab-9318-1d302904d697"], "c1504d9a-6759-4a4b-8706-d76d73df1b72": ["9dd2a1e4-8bf1-46e0-a491-44335fd510fe"], "cbe12245-19ec-48ae-a920-980249d8e941": ["9dd2a1e4-8bf1-46e0-a491-44335fd510fe"], "0c167741-bacc-4cce-98f8-29460a72d4dd": ["12b69489-798f-41fd-9642-935740af5068"], "af3a5aba-0508-49d7-8076-2c8db5e9cc14": ["12b69489-798f-41fd-9642-935740af5068"], "9d1814fa-dee8-41ef-9dfd-490833a0862a": ["e0f41b93-29f3-4538-840f-1f1d30aca5de"], "782778d0-77cc-444c-b00e-8b2c91842538": ["e0f41b93-29f3-4538-840f-1f1d30aca5de"], "d11eb348-ecb4-4847-8f8d-c85dfdcc5ea1": ["16305e23-132b-4d45-81ed-e9d0b2e9c025"], "79c5c457-bfa2-490a-9e37-14e00ad381dd": ["16305e23-132b-4d45-81ed-e9d0b2e9c025"], "c54b2b1a-fb52-4213-9c5e-224c59c72648": ["d81943cd-eeea-4053-bb49-2a2acec75ac4"], "c6e6f9d0-9f95-4cb8-8568-59d43a3b8a41": ["d81943cd-eeea-4053-bb49-2a2acec75ac4"], "f69ad2c4-7bed-4e84-9f3e-0ddc649e1657": ["0f7ea807-b22b-4c09-a67c-22618cce2ca2"], "8ddcd7af-18d3-4de3-a96c-40ec31391a4f": ["0f7ea807-b22b-4c09-a67c-22618cce2ca2"], "8913ac30-79ad-45a7-894c-66b46c346de1": ["5dbbc44b-7cd7-47cf-9ac9-50fe887538ed"], "3108575e-39ca-49c5-a1a6-2cdd880e8e6a": ["5dbbc44b-7cd7-47cf-9ac9-50fe887538ed"], "a35d7e1b-86ee-44f6-ab92-d7a165f50d08": ["28a0c88b-9fc7-406a-912f-0c87b618a2e0"], "e44a027c-8b22-4b26-bae3-3b4dc90f9ee3": ["28a0c88b-9fc7-406a-912f-0c87b618a2e0"], "440ec75b-1c68-4883-b469-ff2e4c44dfe3": ["45e0f542-6c67-4daa-a8e4-0a9916fa8f88"], "3c778985-d5e0-486d-9157-07dab5a17f11": ["45e0f542-6c67-4daa-a8e4-0a9916fa8f88"], "c1867c38-7097-44f7-ad8b-599335dc64ee": ["2ca3e571-f509-44ce-89d2-6f6695d194d8"], "452c109e-55c3-4a51-ab86-41eaa3107ae1": ["2ca3e571-f509-44ce-89d2-6f6695d194d8"], "30822c89-6591-448e-bbbe-0f5a351a3219": ["276eed7f-eb6c-4eec-8541-423a02c1769d"], "307f7e6b-c32e-4ebc-8ed5-5b3ddac7a07f": ["276eed7f-eb6c-4eec-8541-423a02c1769d"], "43c85611-2175-48cd-801e-3f5404641dd2": ["4485b446-71e5-40c2-8221-65a9b3230bc6"], "6d6e5dd5-4374-4f31-a7f8-5f0754a47bf9": ["4485b446-71e5-40c2-8221-65a9b3230bc6"], "76ccbb28-2a6a-4a25-8da1-96bbb28f2ea1": ["c95ab101-bcd1-4281-b87d-78cee79071c0"], "a12fa070-9f8f-4d8e-98da-4107c1651d9b": ["c95ab101-bcd1-4281-b87d-78cee79071c0"], "4a01716a-b04e-4cb6-8fb8-809ddebb0d85": ["23050ae4-64a6-4020-8fc2-a9d1ac309db2"], "287af466-d68c-48ff-9311-26d5e33a1897": ["23050ae4-64a6-4020-8fc2-a9d1ac309db2"], "9c08c88e-6e20-42e1-a910-9bd91b51e15e": ["b149d37d-e7e1-4a35-8541-3b36c8aed626"], "bcbe033d-b636-4313-8335-49bd52d73418": ["b149d37d-e7e1-4a35-8541-3b36c8aed626"], "ce5804a8-ab46-4bca-a9ef-22eb790fe93f": ["979d7fc4-44de-4a31-bbbc-b57989ec56eb"], "9dc40129-2d89-428d-b016-75c3e6f6c7f2": ["979d7fc4-44de-4a31-bbbc-b57989ec56eb"], "e380ff90-122f-4098-ae4a-761bdafc4088": ["8e4553ae-772c-47af-8ba7-65d25c675085"], "0b768e43-116f-425b-b635-2fb7f7694e9c": ["8e4553ae-772c-47af-8ba7-65d25c675085"], "ca781d30-993b-4e95-b05c-0e12a4ef3922": ["fede83b8-22e3-4976-8001-e9d7013f068e"], "8e10d124-9bde-429a-96f8-21734593a746": ["fede83b8-22e3-4976-8001-e9d7013f068e"], "fc5d1c0e-b489-4f9e-bf9e-384d9d387af4": ["ec18d084-7c7f-40bb-b180-c4e238e62dbc"], "3d4fb961-8edd-40bd-8c54-f8a0887a92b4": ["ec18d084-7c7f-40bb-b180-c4e238e62dbc"], "1871aa63-93b1-4ef9-8c8e-af83a79ba91b": ["0af82963-1963-46e9-8a34-a70b03b91212"], "adb3296b-8773-4cd3-a2b0-2d59fe16f5ea": ["0af82963-1963-46e9-8a34-a70b03b91212"], "ebab8918-bdc6-4ce8-8166-dcb7e0d220da": ["34ac8a24-1549-43f5-9f4a-008db5b958e4"], "3eb72860-04a6-432f-b5f9-692517650d77": ["34ac8a24-1549-43f5-9f4a-008db5b958e4"], "e854b1d1-2e12-46b1-bace-2a629ff65326": ["4c2453d6-1eff-455e-ac95-9a3b01c45d37"], "6f8cae9d-8f22-4524-b867-ee3a48d7b6fd": ["4c2453d6-1eff-455e-ac95-9a3b01c45d37"], "6aae37e3-2f3a-41d5-b319-9d9143a022eb": ["dda92a7e-f3d2-45ff-bad9-f01d087480dc"], "f1a40edb-5c07-48b7-bbfe-d2a5e9d48a27": ["dda92a7e-f3d2-45ff-bad9-f01d087480dc"], "6f00dcd7-b8c5-4d47-84d1-698e554ae792": ["142bd738-0418-4de7-b14b-170c1a59f546"], "653d5c88-ad20-4c56-87df-c63f92014e57": ["142bd738-0418-4de7-b14b-170c1a59f546"], "2bf23d96-48eb-4fe7-80e4-88e8fb2fb281": ["eee4a4e1-e394-469c-9007-a70c5980af0a"], "25d7ad62-9942-4aea-b52f-93aeac0c9441": ["eee4a4e1-e394-469c-9007-a70c5980af0a"], "bde1516f-5b0e-46b8-b06e-de838d039380": ["e39368e7-0863-4c19-98a5-34c4a7fe1357"], "f2191c3f-ec69-426c-b6fb-1d53bd9276d3": ["e39368e7-0863-4c19-98a5-34c4a7fe1357"], "c51e07a4-f571-4f6e-ba57-818d272a1e7c": ["acbf65b2-fd77-43d0-918c-8f4479781bd4"], "515ff027-93bb-4302-9e35-7b4d08efb2f1": ["acbf65b2-fd77-43d0-918c-8f4479781bd4"], "1e9a9184-07f4-4ea1-a3b6-a0b0c929c3d7": ["498443f1-1573-4a40-9c09-4ac9a914bd0e"], "1ad9ffcd-a210-4e7f-9422-b34783e20ed2": ["498443f1-1573-4a40-9c09-4ac9a914bd0e"], "733517a7-61db-42a5-84cc-dffb56946bdf": ["71a16a95-55bb-4929-a605-6f3e57f5be14"], "a5aab921-a30a-40ed-95d8-5a576de359b6": ["71a16a95-55bb-4929-a605-6f3e57f5be14"], "1800ca21-010e-42d0-93f2-cd97e0639260": ["92d2d1f6-4c6f-4075-8715-0c6fd600ef3c"], "0202b2ab-802e-4643-994f-1e93f7859c96": ["92d2d1f6-4c6f-4075-8715-0c6fd600ef3c"], "0f30e311-1f11-45ae-bf0b-59a892964e86": ["17637e23-2026-4a16-ac08-57190f9b31d9"], "e6cc4d0e-d521-4c52-96fd-6969d576a9b7": ["17637e23-2026-4a16-ac08-57190f9b31d9"], "a101e2a6-7ba5-48c0-8c9d-df8cd57a23a8": ["2841d45d-f6c9-4acd-8136-414b5b9801fe"], "594f0802-3a51-43ca-9fbf-a2b1f05460b2": ["2841d45d-f6c9-4acd-8136-414b5b9801fe"], "ad66f3e4-fb42-429d-bf51-88327d069715": ["aa9a1f8b-19fd-4342-af3a-6ca7c6400a81"], "4720383a-5e6d-4bfc-b0fe-e82472fe6f37": ["aa9a1f8b-19fd-4342-af3a-6ca7c6400a81"], "e35df689-5ff5-4b20-8e3c-a0aa269f788d": ["41c2634d-44cb-4945-8d33-056b71bd61e5"], "96a6c5ff-f2de-4115-a280-4c9a514c1471": ["41c2634d-44cb-4945-8d33-056b71bd61e5"], "67359451-6dbf-49d7-ace4-a21193a30ab8": ["cf428388-04da-417d-add6-19f0013be4bc"], "f2799f86-a33a-4949-8cf6-5162a6c91070": ["cf428388-04da-417d-add6-19f0013be4bc"], "8099b542-ad7b-4586-bf59-8ac74c0ca105": ["952fd7d4-649f-4ff6-bb71-7c3ab4f34f13"], "aadeb000-3e30-4a96-b06c-bd1d131b3e61": ["952fd7d4-649f-4ff6-bb71-7c3ab4f34f13"], "75820e94-a8b4-4a59-9bc4-1d26a3a2d73f": ["46e4b3e2-8cfb-4f50-a86e-967fc553129a"], "084adbc9-5a1e-4f44-829a-0ea6104a53be": ["46e4b3e2-8cfb-4f50-a86e-967fc553129a"], "1a71b04c-2853-4e42-ad8c-e91bf2a0a240": ["dff9376c-e8c8-4cc7-a7a7-f3c6efb36097"], "fdb28673-735e-49d7-8391-bb88fecde3f7": ["dff9376c-e8c8-4cc7-a7a7-f3c6efb36097"], "ea7268dd-843d-4131-84b5-2a0d3029d711": ["7a3a28ee-52fb-4426-8d9b-5d7bd210c5ed"], "6ecabd31-7db6-4431-b86b-2c7e5e338aa5": ["7a3a28ee-52fb-4426-8d9b-5d7bd210c5ed"], "9c4f3524-e7bf-44a9-a17d-0be94378021c": ["52cff6ee-ec13-409c-8d03-e8cb3a45b6c3"], "5f51320e-51ec-45d2-9849-5192e41691e4": ["52cff6ee-ec13-409c-8d03-e8cb3a45b6c3"], "1665c9fe-637d-4243-8093-25bfd352e01c": ["03c37dbe-4d69-4e39-98ea-b7e75d232054"], "5258b428-54b7-4dc1-bbe8-a72740d17fe8": ["03c37dbe-4d69-4e39-98ea-b7e75d232054"], "7b2c6812-2331-4784-a4bc-897833b09c1d": ["cb5e1000-2c28-47cb-bbb8-960d21e74aff"], "ede214e5-b2a9-44cb-8228-66af918c8684": ["cb5e1000-2c28-47cb-bbb8-960d21e74aff"], "cd6e5531-09dd-46bf-bf2f-bbffd008c150": ["a2980349-29dd-4ac7-b3be-63d221aa68a7"], "6c540232-3258-452c-ad93-98da5720e50a": ["a2980349-29dd-4ac7-b3be-63d221aa68a7"], "09aaf308-67e9-4c9c-b8c5-479ca5dca30c": ["dc44aa85-e517-4a54-b7da-94663a6eb281"], "d4cae546-3d56-4388-90c0-2157bf398c5e": ["dc44aa85-e517-4a54-b7da-94663a6eb281"], "8be8bbb4-0ea5-4d4a-a290-85ca4b3da3b2": ["9deac49a-7be1-4cd2-b0c6-2a4c0d3e6f4d"], "dd1bb19a-6da5-4aed-b660-74aae5bd2e59": ["9deac49a-7be1-4cd2-b0c6-2a4c0d3e6f4d"], "01552ec6-9229-4b92-a5f7-f293832568a9": ["c0200280-c24c-4f0e-aaea-dea568d37972"], "86919d91-b78c-41fb-a980-d5e6c7794559": ["c0200280-c24c-4f0e-aaea-dea568d37972"], "2b96398b-2033-4602-a133-fdbbb747d951": ["adca4345-26e9-4f0d-83ae-e3783ecaa0c1"], "cf37962d-03e2-4b93-98cc-ca5fd4f1f839": ["adca4345-26e9-4f0d-83ae-e3783ecaa0c1"], "8cbd2180-08e5-4b03-b0fc-6f7b45763cf2": ["46c7118c-dc21-4947-b8a5-a9da206ba927"], "4363d9cb-22cc-42a1-ab08-e714a4d336a9": ["46c7118c-dc21-4947-b8a5-a9da206ba927"], "58ceb508-5f63-4302-b5f3-18160d2c7c73": ["580a95ae-ef54-497f-9617-daef9e35772d"], "90acb76c-67aa-4dab-903e-c026206df110": ["580a95ae-ef54-497f-9617-daef9e35772d"], "97e80391-c578-408c-ac2c-7a141551b12c": ["26921a02-661f-4c38-a077-f4b448a89430"], "c55c7d22-502e-483b-b3b0-e925b2f2d948": ["26921a02-661f-4c38-a077-f4b448a89430"], "6e3ad3bf-0d3d-4654-9335-2e4ac2437dd5": ["d2105014-4b31-477c-84c3-dfd8847ec2b1"], "398a0e89-ade6-4a6e-8f9e-ab6712677558": ["d2105014-4b31-477c-84c3-dfd8847ec2b1"], "cc0022ac-5656-4c66-9b38-86cf4810bb6b": ["61a9e198-77e1-4466-8401-55ab6a5fb8af"], "bb6fc49a-47e6-4537-85ee-4d781d1016c7": ["61a9e198-77e1-4466-8401-55ab6a5fb8af"], "abe646d7-c5bb-42c5-8cc9-b0f06692bf76": ["abc8a04f-de03-4ab9-a95c-8307663d9f92"], "b7c898b5-e309-4035-b55b-de256b101183": ["abc8a04f-de03-4ab9-a95c-8307663d9f92"], "bc4307f9-fa5f-4177-8e9b-17e237b72110": ["58b9dd9a-62e2-40a0-b1d8-fc6e9737ab4f"], "42b2bd9d-eccd-4674-a606-706df9dcace6": ["58b9dd9a-62e2-40a0-b1d8-fc6e9737ab4f"], "8780cca4-857e-4532-b7eb-7b7d901f0cfb": ["30caf8c5-cf29-4a56-a743-fa0487d4ff95"], "4d32952e-a103-44c6-8f8d-b8f694803ee7": ["30caf8c5-cf29-4a56-a743-fa0487d4ff95"], "c131011a-832e-4bc5-a592-fc4659db6199": ["3758729c-bada-480f-a435-1cdb54cfd8c8"], "438c2a8a-df87-4826-8544-410d869ba0b8": ["3758729c-bada-480f-a435-1cdb54cfd8c8"], "363e0705-e23d-4e3a-8310-7fc78593d143": ["e8dbed0b-d3bb-414d-aaf8-35e0973416c2"], "21fbb8f0-5eb0-4410-8e46-b1ca51e24cab": ["e8dbed0b-d3bb-414d-aaf8-35e0973416c2"], "860783b6-dc28-4a99-bbfd-3f587d56ffba": ["825f6b7d-041d-4274-bbec-9f0477bf3bc0"], "3a12864d-831e-4beb-ab89-de6f725763c2": ["825f6b7d-041d-4274-bbec-9f0477bf3bc0"], "78de0b40-0932-42f6-a08a-618a72ce0082": ["3d93f327-8303-465c-aa03-61469f4bbfe4"], "aea639a0-f180-4a35-991f-81dba3d5dd90": ["3d93f327-8303-465c-aa03-61469f4bbfe4"], "f2cad2e0-b847-47f2-9d2a-41b0e8f7a552": ["46a6fb41-bbf8-4a37-871c-0416ba31db28"], "331c02bc-eede-45fb-9b02-5c455094b66f": ["46a6fb41-bbf8-4a37-871c-0416ba31db28"], "2f2f0426-8c7e-4043-9737-b1ebead69fd2": ["82550bb8-fd02-428f-8f7d-b8c8cb5807d7"], "60f32332-50ce-4b82-94e3-edf4c6a50505": ["82550bb8-fd02-428f-8f7d-b8c8cb5807d7"], "33c229e4-a611-4719-8387-2908fb34761f": ["4129f170-b855-4762-9387-d021e1f974a5"], "d0dd2efd-2725-4d8a-b63d-69072fe9af49": ["4129f170-b855-4762-9387-d021e1f974a5"], "118ee611-c005-4ebb-a79d-4837358975a8": ["435d8828-8b37-4e77-8285-e086c9a3ad64"], "afa017ae-8ef4-4ddd-a0df-c6c29af2dd7b": ["435d8828-8b37-4e77-8285-e086c9a3ad64"], "57e1a5c7-15d2-4222-9309-59d38db3ea20": ["d6782977-1d62-4af6-8c12-cef19bae265b"], "a00b423a-6a55-4150-acb8-5edae158e395": ["d6782977-1d62-4af6-8c12-cef19bae265b"], "349fc4b1-dac0-46c6-b7d4-a49a3dd507fa": ["6f67c8df-f53a-43f8-96cf-c0fa25290e3e"], "1c1c645e-904e-43b7-b227-22a114846a32": ["6f67c8df-f53a-43f8-96cf-c0fa25290e3e"], "78d2c6fc-2179-46b7-a739-571698ea3448": ["e2091619-4d41-454a-bd9b-2771d4181c24"], "e3e0544f-5d21-4b9d-9a83-d7ebf19235c6": ["e2091619-4d41-454a-bd9b-2771d4181c24"], "dad11013-8a41-47e1-afde-4a6ad61f0152": ["bf689911-1e7d-4752-8ef4-fccb503f444b"], "1f1c419a-ac65-4d96-86bf-468859ce44a5": ["bf689911-1e7d-4752-8ef4-fccb503f444b"], "4956bd58-a31b-4a47-bcc7-4d21df41741b": ["92f89bd5-4301-4e5b-bbb3-1b4dd5f4e6bc"], "c7a40202-9655-4b28-bb68-55dfa696bdd5": ["92f89bd5-4301-4e5b-bbb3-1b4dd5f4e6bc"], "8f45af82-b272-4faa-ad14-e79b21b50f38": ["beb38a84-3c7d-4d50-85c7-7055f6d3c5fd"], "92515f1b-a7cb-4d1e-9732-75ab2985b10d": ["beb38a84-3c7d-4d50-85c7-7055f6d3c5fd"], "f6ad0aea-4742-451d-be7e-c1f3dd909dc6": ["cac1cba9-09e9-4300-abc9-58ae9254523d"], "e265e08d-aa69-43d1-b3ed-cc8008de13a2": ["cac1cba9-09e9-4300-abc9-58ae9254523d"], "93f096b1-01db-4840-a497-daf1c4a3f356": ["a3eef9ac-3568-45a1-8097-7bd0d1b11b7b"], "47f40dc1-bbec-4010-9627-c00cd82d4d33": ["a3eef9ac-3568-45a1-8097-7bd0d1b11b7b"], "558fec0a-06ed-4be2-9dea-dfc66ce1a7cd": ["ea586baa-a379-4f6a-9860-2163010a16b6"], "6dd5cd6e-6e99-47cb-86c7-f13d08ac4497": ["ea586baa-a379-4f6a-9860-2163010a16b6"], "d65db8ef-66a9-4c9b-8dbc-ab283bbf7733": ["3ca8bb8b-4f86-4c70-8b3a-f7ba0468477e"], "ca3ddf86-29a9-4aa4-834c-ffe84c758b76": ["3ca8bb8b-4f86-4c70-8b3a-f7ba0468477e"], "32ff2772-22d6-4d88-a8df-a87cc86ee28b": ["d608ca87-9f40-48ad-b734-701ed9072260"], "771a4980-de5b-4a22-8667-2dbd96067bdd": ["d608ca87-9f40-48ad-b734-701ed9072260"], "10b1dbf1-57ea-4b7f-af0a-4da13bdbee8d": ["ffe8804b-c4e1-48a1-87e8-2f574d58d10f"], "a6500919-de02-40ab-9375-9ad42e320378": ["ffe8804b-c4e1-48a1-87e8-2f574d58d10f"], "9c144afe-0d6c-4dc4-b807-59f8f26fe6c5": ["e3386c28-df2b-4b45-be3e-f7e413096160"], "571b2eb9-0c41-4e5f-b1a2-7fce5deabff8": ["e3386c28-df2b-4b45-be3e-f7e413096160"], "0e3b4c89-50f4-4bfe-9474-80ee01bd157d": ["58dbb54c-c577-4f7d-99c0-fe6e7b8edde3"], "ec10065d-f376-45f4-a57c-8bad0d2dcbc1": ["58dbb54c-c577-4f7d-99c0-fe6e7b8edde3"], "24fa1ca0-d476-4513-8ded-25dfe9c587fe": ["cb441f88-2576-4b0f-a780-f410d0409823"], "b2aef51f-5f0a-4768-92b3-854e65c64539": ["cb441f88-2576-4b0f-a780-f410d0409823"], "f659d177-26ec-4c48-904d-2b328c244885": ["8c9ca39b-0450-46af-a9e1-2d20c3deb119"], "dd61dfae-cb8b-4938-8def-d448c08128ce": ["8c9ca39b-0450-46af-a9e1-2d20c3deb119"], "cf499f1b-fbba-4711-83f5-60e89d8e5339": ["3edb902f-e335-49e6-ac6d-620eae25a1d9"], "a8ccf678-39f4-451d-aa82-87121638319f": ["3edb902f-e335-49e6-ac6d-620eae25a1d9"], "89f26272-021c-4a48-92b5-5dc9a06b8e23": ["87998a1b-c6ea-4a46-8cc0-710781304b04"], "edfe6b2a-ccd2-4b3d-b404-25730996412c": ["87998a1b-c6ea-4a46-8cc0-710781304b04"], "0418248f-55b2-4279-9553-7bf729d354a1": ["41c5c495-145f-4f5d-8a4b-2d04868c518d"], "92123227-0e71-4a5f-9634-575d3a134fa9": ["41c5c495-145f-4f5d-8a4b-2d04868c518d"], "109cd728-473b-4eb2-970f-74f8d6aa6e62": ["cae5e488-f40c-43bc-8877-faadfe4a32f0"], "955fcbb6-08c2-49c0-bf84-91c1c58ff974": ["cae5e488-f40c-43bc-8877-faadfe4a32f0"], "af1fb6a1-d593-4149-a65a-bd553f8960b7": ["9f795c88-51e7-47b0-9154-afa495edc34b"], "16c60c73-d6b6-4240-ad75-6a2258848a2f": ["9f795c88-51e7-47b0-9154-afa495edc34b"], "1a25d666-cea1-4ed1-a163-1c995e6f4338": ["23530c02-ce49-4ea0-b21e-57d9f9ef38f8"], "59894219-16ee-4978-becd-1066de1791b1": ["23530c02-ce49-4ea0-b21e-57d9f9ef38f8"], "c422b183-f348-4c2a-9fb8-420644438d65": ["1324acb5-ea09-4e09-bbef-636fe2d73acc"], "8154d88f-b4bc-453a-8973-c5887837f187": ["1324acb5-ea09-4e09-bbef-636fe2d73acc"], "4d91f057-5745-4e60-883d-2363b599932e": ["12a00ddf-19b9-4996-a6ad-b33486667323"], "9d707a85-45f1-4820-9670-68b081e33cb2": ["12a00ddf-19b9-4996-a6ad-b33486667323"], "64b77dfb-5ecc-4d16-8738-f79184aed605": ["dd941da8-881d-408b-acc3-8f80e5ec237d"], "c033d013-f8de-464c-9f1a-a11b277c6862": ["dd941da8-881d-408b-acc3-8f80e5ec237d"], "34634598-71ae-4492-aca5-bbb2a50b8729": ["e36a5a6f-8dc7-4d81-8b74-5ff2ab128c22"], "b652295d-c985-485b-b93e-0c16afab7191": ["e36a5a6f-8dc7-4d81-8b74-5ff2ab128c22"], "e7f391b7-fddd-45e7-be7a-19c1116ba271": ["a8b09a88-4bd8-4827-9b6f-e4526f1e1b51"], "aea77ff1-5585-4fbd-a621-4985fcd8c9f9": ["a8b09a88-4bd8-4827-9b6f-e4526f1e1b51"], "6c01f86a-8a38-4194-b618-5fe3c6896dcc": ["e98b211a-c6b5-4e2d-8aac-acb2a2d61db5"], "f93ec21c-7995-4754-9681-5d8e54171e28": ["e98b211a-c6b5-4e2d-8aac-acb2a2d61db5"], "713c6776-5836-4f03-8924-c1c1d2e098ea": ["717b437d-ed8d-471f-a815-473cae45077b"], "5253739e-cdbc-4257-9de9-6df4aa968017": ["717b437d-ed8d-471f-a815-473cae45077b"], "d9324baf-ca2d-4650-b696-b351884e8705": ["ec0347b8-5d69-4d57-a24b-26e763326e1c"], "1a47839d-ad5e-43c3-8320-c72eae93552f": ["ec0347b8-5d69-4d57-a24b-26e763326e1c"], "b88243be-10c8-45fe-ba31-9d55e966d973": ["c6353dc1-d23e-46f9-9e1e-98d759fedca3"], "e81ef20b-e2fc-4b95-8794-7e57d39dcc7d": ["c6353dc1-d23e-46f9-9e1e-98d759fedca3"], "f6ac7f06-e572-4e8d-893d-3f38786a13e7": ["9b00ef78-1c9b-4872-89b8-ac60da769733"], "2a746347-dff4-42c9-9cb2-431490a76b03": ["9b00ef78-1c9b-4872-89b8-ac60da769733"], "94b42c0f-f1ab-4cb8-96fb-092e4373982d": ["cd8f7c68-8aa7-41a0-b873-a5716c42d75c"], "7c9701ae-663f-485b-aa89-3d9bb8346bad": ["cd8f7c68-8aa7-41a0-b873-a5716c42d75c"], "a663e6ba-1cbb-4558-9c51-6b04e5118179": ["705e6fab-a9b2-4660-8bd6-a0e4216aafb1"], "b337f934-da40-4e45-ab3a-cd0f438186de": ["705e6fab-a9b2-4660-8bd6-a0e4216aafb1"], "12db0280-ba7d-41a5-96db-68d30c5b350c": ["8857a022-80a3-4540-857d-65283794e14c"], "e09dadf2-82f1-4068-8eda-26629f6ab177": ["8857a022-80a3-4540-857d-65283794e14c"], "7688fb2f-ec3c-4adb-9661-b9ec33c93fa3": ["7fe01f03-fd4f-44ac-9121-b984f78702de"], "e601ecea-de58-4c0c-b6dc-b214f845900c": ["7fe01f03-fd4f-44ac-9121-b984f78702de"], "6f27e168-e4af-4027-9ece-9305c66d1cc1": ["5cac1334-4448-4e45-b988-7bee745ddeba"], "037e14b0-9f5a-4fa3-92a3-5b9f1a0cde33": ["5cac1334-4448-4e45-b988-7bee745ddeba"], "46cf1b40-79f2-4c6d-acd7-fa2ac1bd2ae9": ["3ac029c7-2fa3-42ca-b0ff-ede386f4808d"], "0e10881d-5980-4cf5-9e06-4b291a40a77b": ["3ac029c7-2fa3-42ca-b0ff-ede386f4808d"], "0febd83d-b30b-439a-bafd-475b7ebc087f": ["9c8e2f83-f701-4d9a-9e69-cb7bad84cb1e"], "26bbea49-627a-4e53-b502-91a18eb35d66": ["9c8e2f83-f701-4d9a-9e69-cb7bad84cb1e"], "ef822bc5-2282-4b47-845d-9e68086819ae": ["b765ef88-8c28-448f-9a2e-d0067862bdb1"], "8a8c6133-457b-4061-b0fc-05978dee3558": ["b765ef88-8c28-448f-9a2e-d0067862bdb1"], "9cd18c11-0b16-472a-bbdb-8277db82dcce": ["c39179bb-cc8f-4bce-938e-daec550731ba"], "896d584f-18dc-4fd8-a436-585b87a15e20": ["c39179bb-cc8f-4bce-938e-daec550731ba"], "fb240a9a-debc-4fff-8c2a-483a35cf3501": ["f839f199-aa88-4b63-a16f-51b46037db57"], "e2fa415c-482d-4252-9c0e-b2286d7684e4": ["f839f199-aa88-4b63-a16f-51b46037db57"], "ce79ec2c-1f0e-4d92-8e96-aa26b3867d11": ["d8f9a218-3bae-4da1-955b-c5dc933f7a95"], "5ef562ff-ee29-43ff-8188-eab56c170faf": ["d8f9a218-3bae-4da1-955b-c5dc933f7a95"], "11f09d4f-c123-4f23-806c-e8972fa7a5ef": ["fc8e01f0-33da-4d4d-8e02-8bdf727f86fc"], "58314adf-eae4-47d3-bb45-cd93bed65e7e": ["fc8e01f0-33da-4d4d-8e02-8bdf727f86fc"], "445802f6-4581-46fe-8278-08c759c30058": ["3e124fa9-74f4-45fa-ae2b-615949b7aefe"], "641ceaf1-2521-4d5c-a532-3624588fba25": ["3e124fa9-74f4-45fa-ae2b-615949b7aefe"], "e28e636e-6b04-400e-8d83-e04d5422dc9c": ["40e4bd53-952e-4562-910d-aced2771882c"], "0c9e62f9-94a6-46bc-8612-b520447ba00b": ["40e4bd53-952e-4562-910d-aced2771882c"], "9866bf7f-6a67-402b-959a-7e6e33826f5b": ["a7a5f197-d3e9-44fd-a873-78e56dd4b2fc"], "e142d164-94f0-4c74-948a-bec7935b4375": ["a7a5f197-d3e9-44fd-a873-78e56dd4b2fc"], "aa8db727-48e4-437c-ab9f-2296b651c9f7": ["dc3b2a92-d977-4b89-aeee-a458a26117e1"], "b333f708-e588-49da-910a-878ce545ac77": ["dc3b2a92-d977-4b89-aeee-a458a26117e1"], "30fd11fd-5e67-450c-a60f-3bdc9e7b39bd": ["32dc4038-bdc3-467b-9e61-05ed44534567"], "fc459f27-4556-4145-8bfc-122ed37d672f": ["32dc4038-bdc3-467b-9e61-05ed44534567"], "6ee0817a-fa96-4e13-bf7a-c78ffcbecb35": ["b1bdc9e2-a9a6-427f-b0b4-7d7d0d96592a"], "b9903a3c-a10a-4666-b43d-b1501e2d3c14": ["b1bdc9e2-a9a6-427f-b0b4-7d7d0d96592a"], "0c862d5e-adf0-45c7-8805-caf23c82f451": ["62ec0620-c7dd-4679-8fc7-1d7945190b3a"], "9802eef3-2ae0-4c19-b16c-d58ea928d1f9": ["62ec0620-c7dd-4679-8fc7-1d7945190b3a"], "85af8edd-bbc7-4f2b-a37b-e612b46f8a57": ["99002e13-e3fb-4a5e-8dba-81a9a52ca882"], "e4003959-7fdd-4519-8d0b-1ab49379f54b": ["99002e13-e3fb-4a5e-8dba-81a9a52ca882"], "75b14f19-dc0a-4222-87aa-926d187b83a9": ["2b9d5653-832d-452b-862c-0c3d00b05c0e"], "9ed7becb-b032-471f-a82c-07ba66775194": ["2b9d5653-832d-452b-862c-0c3d00b05c0e"], "343d96a1-61f2-4dca-9b2a-8c8117d20d65": ["cc2a5088-28cb-4d71-996c-921b80329f23"], "f78c1739-d388-4c38-a907-e9760eacabf1": ["cc2a5088-28cb-4d71-996c-921b80329f23"], "77d1c8c6-e703-42a4-bdbe-f60c14a7141a": ["f7d63980-5762-40d4-979f-6a25ec27b512"], "3d3486a7-17ab-4a8d-95d0-8b091bf49581": ["f7d63980-5762-40d4-979f-6a25ec27b512"], "a17cc497-b15d-4341-8131-4558b555ed51": ["6230ff00-f163-482f-b361-c2934987026f"], "602c57c2-e2db-4a03-ba5a-a431f62fbeda": ["6230ff00-f163-482f-b361-c2934987026f"], "1f94b8c3-8488-4425-b1fa-1003c39ea445": ["10237474-9dfc-46c2-8258-d28508f19a32"], "3a5d39cb-6ec2-49e6-b95e-f080064210c5": ["10237474-9dfc-46c2-8258-d28508f19a32"], "db4a7efc-254c-40ee-93fa-d1a53e18b949": ["5f2de309-bb7f-4563-a819-16aa4636ee09"], "5c8344de-a3e5-4a77-8793-e63838fcd04f": ["5f2de309-bb7f-4563-a819-16aa4636ee09"], "13c0fabd-2df6-426b-8d64-d113a5df17f0": ["cb98692a-3656-483c-b013-293f570a6edf"], "a9374b72-4bb1-41f5-81b5-e076cda217b1": ["cb98692a-3656-483c-b013-293f570a6edf"], "0e8a00bf-fcdd-4c5e-9903-795fa84240a2": ["ac37685a-8292-4cc3-85c1-fb83f0ec4d59"], "f9a6d713-7ff4-4884-9ab1-1da2991e6456": ["ac37685a-8292-4cc3-85c1-fb83f0ec4d59"], "455ce1c0-10c8-448b-a793-1676c861f7d2": ["aea8a6d0-6417-4b88-afce-ddf67a6e3694"], "82148810-3001-42b8-b678-3a273b4a0f2f": ["aea8a6d0-6417-4b88-afce-ddf67a6e3694"], "3b362211-28c2-4018-a870-3c4015777c80": ["0fa7935f-3d23-4bd4-903a-b903bc2290bd"], "5155ca82-e225-47cd-b84e-054b7b38d43e": ["0fa7935f-3d23-4bd4-903a-b903bc2290bd"], "6ec4fae6-63eb-4be1-8269-0603fce238c3": ["13955f7f-aa8b-496a-8695-6f62bb0e1c67"], "6930ae57-e9f7-4f75-b6dc-c88691c71991": ["13955f7f-aa8b-496a-8695-6f62bb0e1c67"], "87238bc8-b433-4620-aad0-4728f52ea792": ["59f636b2-c1ff-43b5-9f83-02545a1ae15a"], "250e3c63-6bd6-4346-aa77-59f44334e8a1": ["59f636b2-c1ff-43b5-9f83-02545a1ae15a"], "c694afe3-b8a3-4ace-b0f7-095c4a2ec5e3": ["7023c830-1409-44d4-8c36-44a7ee7d4be0"], "24945804-119a-42fa-83be-30318ff49a38": ["7023c830-1409-44d4-8c36-44a7ee7d4be0"], "d6ac6aa4-067d-483e-84b2-32c32370d818": ["bbfba4d3-0823-43d8-a6ea-97b52ea60c69"], "9359daf3-b3e3-4c87-90ed-af752801c727": ["bbfba4d3-0823-43d8-a6ea-97b52ea60c69"], "c470020a-5b3c-4a30-ae2e-3aff1af85dcf": ["27eeb38f-edb4-497d-8775-60da727a4628"], "42c752c8-d285-415c-a973-c72be0cd8a16": ["27eeb38f-edb4-497d-8775-60da727a4628"], "39c445a1-4e7d-4dd0-b648-c808cd65352b": ["ffc5b5db-05da-4713-b35e-ee2b763599c9"], "b9b1e5be-6ed0-48be-9ee5-afebf1ae614e": ["ffc5b5db-05da-4713-b35e-ee2b763599c9"], "49a47485-dda3-4c2c-8981-64904fe1c936": ["b893db48-585e-416e-91ba-745140fe3e38"], "2e8aea1b-55dc-4717-95bd-9c1bcb518b76": ["b893db48-585e-416e-91ba-745140fe3e38"], "46d1f0f9-d8b8-4dfb-9f64-5a3b5e5dbbb1": ["9b7f4c93-57bd-4721-b087-77c8ab191016"], "9a398a78-16f4-4ad4-a667-9f5894a7e7e3": ["9b7f4c93-57bd-4721-b087-77c8ab191016"], "9dc8e79b-af19-4631-bc66-e99006d13839": ["8b987f19-c2d2-4b03-951f-1101bba3b50d"], "398d7932-d1a1-47dc-8ff6-e927261815a4": ["8b987f19-c2d2-4b03-951f-1101bba3b50d"], "48be3595-c033-45df-9233-8447e4406353": ["424105a5-b0d8-49e1-a965-ced506318120"], "38ef115e-086f-40f8-ae2d-f87c12df289d": ["424105a5-b0d8-49e1-a965-ced506318120"], "f8ba1d49-f097-449c-bb2b-b5b07ffcd18f": ["d79405c4-6031-4a67-8e3b-e1464fd12f7c"], "9fc8598c-9462-49d0-b103-ec61ce284999": ["d79405c4-6031-4a67-8e3b-e1464fd12f7c"], "52e1b38a-e846-43b7-be2b-aa6c9f81025a": ["c4ea6fad-ef11-4278-8dee-6d0a750c94a5"], "dac82543-6c79-419a-b084-64922bbb761a": ["c4ea6fad-ef11-4278-8dee-6d0a750c94a5"], "514da75c-e728-4795-b60f-0a67796aff52": ["f7e3a7ae-bb8f-4a28-809c-1e4d54bbd16e"], "26c52f1e-f022-467a-be15-932183124f2e": ["f7e3a7ae-bb8f-4a28-809c-1e4d54bbd16e"], "3bbf9a1d-8615-48da-b49d-169d32b2ff20": ["5d730ce7-ef90-40bf-a25d-2648e13eeaa6"], "cc830e1a-7abf-48e9-8250-30b0d9eaf4c2": ["5d730ce7-ef90-40bf-a25d-2648e13eeaa6"], "00adc2ce-1e92-41ff-a3f1-fa520813f681": ["7625fc96-cd8f-4c81-b3e2-6f2fbcf5a574"], "4b9578cf-f9ac-418b-92fc-a550afcd1e32": ["7625fc96-cd8f-4c81-b3e2-6f2fbcf5a574"], "32e20f2e-0fe6-43b9-b13c-d1ff3cda509b": ["d6cac6b3-fed3-43ae-b362-9d211061af63"], "70015740-0f0e-4c6b-b064-116cbafb3566": ["d6cac6b3-fed3-43ae-b362-9d211061af63"], "29464653-9fe1-48ac-ac95-066d562153f2": ["9abba457-bdf5-4ebd-abbb-1052a070c038"], "45e0cd20-7468-4d53-9444-8b2b3abaab30": ["9abba457-bdf5-4ebd-abbb-1052a070c038"], "50cf92f2-2d6b-480d-a2d2-727cf9ea9b6e": ["922ea653-b475-4d82-907d-359f336ef683"], "9d62336b-bbf5-4958-9b08-5b0d6341b555": ["922ea653-b475-4d82-907d-359f336ef683"], "102b5269-6576-450a-b8b4-37a1138479bd": ["20a18302-bea1-4a29-9b01-5169bf5977a7"], "3942a1d0-875d-4ed6-b93b-ae9c0b68ffe7": ["20a18302-bea1-4a29-9b01-5169bf5977a7"], "9c967d38-2818-437b-abbd-061cefaff947": ["edbd1d71-776d-4bc2-9ec1-902629d36c29"], "11e8762e-b7bf-4f0a-9703-2965f4b243cb": ["edbd1d71-776d-4bc2-9ec1-902629d36c29"], "290f8449-622e-4632-ab8c-c6c5c3d54815": ["94369c7b-7bdd-4448-99a8-ca5649bdcdbe"], "c8472a9f-6e1d-4e62-bf24-dccba794b6e9": ["94369c7b-7bdd-4448-99a8-ca5649bdcdbe"], "a45574d6-6543-4449-b30a-c1fafcaa143f": ["dacd62cc-7115-41f3-974a-9ba23b81e496"], "a9aa7383-1e13-4ab0-b2c1-a64b63b2c37c": ["dacd62cc-7115-41f3-974a-9ba23b81e496"], "be678993-b5cc-4e94-8519-653ca302c6e7": ["73004dbd-2cab-4379-a8d8-9b0645815f14"], "c99e0c9a-2f07-42bc-9648-413950618142": ["73004dbd-2cab-4379-a8d8-9b0645815f14"], "ef0c8251-d85d-4bd5-bfe3-d9028529ba16": ["319b074a-1a53-40ee-a4f7-2cb372e4362b"], "c8a6e66e-0f01-4601-b4fb-bdc6f99ac7aa": ["319b074a-1a53-40ee-a4f7-2cb372e4362b"], "26871561-3ad3-4b3e-885c-26b7e8395547": ["725156ff-8aff-48a8-a217-217721297a82"], "bf9d21e1-e036-4ee1-a3ff-fe41f54f045a": ["725156ff-8aff-48a8-a217-217721297a82"], "441d530a-06c7-4ed1-a920-c7696d069d76": ["b104a099-ee99-4b23-b56c-846c17cc290c"], "486c6e59-9d99-4efa-b706-ff3f730ea237": ["b104a099-ee99-4b23-b56c-846c17cc290c"], "0ef52deb-d0a1-4ef9-8674-941e975ac84a": ["1c666047-533b-4a93-ae59-37dfb08c4765"], "b0a30368-019c-46b4-a77d-5889b75bef13": ["1c666047-533b-4a93-ae59-37dfb08c4765"], "a2204903-db2c-4e22-b9a8-5ae979037f48": ["682c984f-de88-4d30-9b08-ee9becd50f17"], "9d4a4e26-6cc2-45bc-83cf-71c20ec5f348": ["682c984f-de88-4d30-9b08-ee9becd50f17"], "c81685fa-eea3-486a-b89a-559f41b6a639": ["6c37aee9-c4d1-436a-bbb8-a0f3c21323e1"], "d587cfa5-5aac-414a-813c-9bd45ce7560e": ["6c37aee9-c4d1-436a-bbb8-a0f3c21323e1"], "ff48e9ae-ae6a-4542-98c5-ab87dbb22db3": ["db7e55d7-f153-4aa0-9ec0-0767272e37dc"], "748d114d-e90f-4c90-999b-8a0c5ed251d7": ["db7e55d7-f153-4aa0-9ec0-0767272e37dc"], "bbaedbe6-f520-4ebc-b3c8-18d4ab7ec50c": ["b1329c3a-2668-4ba1-8c6d-ee47d0721a3a"], "b59a56c8-f5d8-43ee-9657-9f969609c306": ["b1329c3a-2668-4ba1-8c6d-ee47d0721a3a"], "91fac67b-f86e-427b-a119-4bfe6e28eca4": ["33a97753-544a-4a1d-82d6-c5eb62ff5769"], "b33c87a0-9b02-4a52-b091-a66afdc50de0": ["33a97753-544a-4a1d-82d6-c5eb62ff5769"], "03f2e402-2baf-4535-9307-f8ad175e10ca": ["f14930b4-14e3-470d-a86f-cd5051ad9463"], "e2140247-36a9-4e25-8a03-80c6f8cbd3a0": ["f14930b4-14e3-470d-a86f-cd5051ad9463"], "e70e6e90-e20f-4ff4-9b18-65e428dc54de": ["d0a526ac-5be4-4092-845d-d530ba4af9e3"], "110e556c-1359-421a-87ed-c7eb12577621": ["d0a526ac-5be4-4092-845d-d530ba4af9e3"], "0d4b47fe-cf0c-466b-83f1-b4477d3adc71": ["fcf98cb9-73db-471e-a161-4376dd77895a"], "7e662cdc-e100-4d5b-8f20-8aefd7982035": ["fcf98cb9-73db-471e-a161-4376dd77895a"], "9867425e-f4ac-4ccf-9f87-670d8b877c9c": ["ad79f7fd-5417-42b1-9137-08e53a77a072"], "a321203c-3a68-4021-8fd1-d8251785cbc8": ["ad79f7fd-5417-42b1-9137-08e53a77a072"], "f7be74fc-bfd9-4fb5-892e-28be09604717": ["025792ed-b93e-4630-b3a0-6bc9536991e9"], "93eb7e66-39b9-428d-85c5-62f1c8f9185e": ["025792ed-b93e-4630-b3a0-6bc9536991e9"], "2c403bfb-dd4b-4d76-90f4-cdfe6aac9593": ["76e5d796-4ff7-49e2-99bb-8d8b4572ee7a"], "cb35c164-649c-4bd1-8246-a90dac96d002": ["76e5d796-4ff7-49e2-99bb-8d8b4572ee7a"], "d0187b91-2894-4aac-a7d4-40e9fca137f1": ["47a02333-32e3-4da7-adda-cf0d48a12af8"], "835a0a01-fe00-4d46-a24e-96e21b0cec23": ["47a02333-32e3-4da7-adda-cf0d48a12af8"], "af00e010-fa7f-44bf-ad82-15ecac48681f": ["ae95951d-ed03-4d13-80c9-ee4563b1b8f7"], "516ef998-8dd1-4c09-ad71-2e8beab8c931": ["ae95951d-ed03-4d13-80c9-ee4563b1b8f7"], "2c896681-ed21-4a24-9e61-9dd9dcb8a80e": ["5b76c0be-3ca5-41df-8923-8d8684f2f361"], "109a532d-8e85-4179-8362-20bb92b667de": ["5b76c0be-3ca5-41df-8923-8d8684f2f361"], "4889dd76-1bed-4a33-a721-6bfb59679c30": ["aaf8375e-ca3d-4bea-8b7e-1ccd36a75867"], "667ff32e-493d-4a6d-b756-52fcd5f38227": ["aaf8375e-ca3d-4bea-8b7e-1ccd36a75867"]}}